Specific Advice on Fulfilling Information Requirements for Nanomaterials under REACH (RIP-oN 2) – Final Project Report by Hankin, S. M. et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 19, 2017
Specific Advice on Fulfilling Information Requirements for Nanomaterials under
REACH (RIP-oN 2) – Final Project Report
Hankin, S. M.; Peters, S. A. K.; Poland, C. A.; Hansen, Steffen Foss; Holmqvist, J.; Ross, B. L.; Varet, J.;
Aitken, R. J.
Publication date:
2011
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Hankin, S. M., Peters, S. A. K., Poland, C. A., Hansen, S. F., Holmqvist, J., Ross, B. L., ... Aitken, R. J. (2011).
Specific Advice on Fulfilling Information Requirements for Nanomaterials under REACH (RIP-oN 2) – Final
Project Report. European Commission.
RNC/RIP-oN2/FPR/1/FINAL
01 July 2011
 
 
Specific Advice on Fulfilling Information 
Requirements for Nanomaterials under 
REACH (RIP-oN 2) 
Final Project Report 
RNC/RIP-oN2/FPR/1/FINAL 
 
- ii - 
 
 
DISCLAIMER: This document has been developed by the RIP-oN 2 and 3 
contractor on request of the European Commission. The document may not in 
any circumstances be regarded as an official position of the European 
Commission. 
Permission to reproduce extracts from BS ISO 9276-6:2008 is granted by the 
British Standards Institution (BSI). No other use of this material is permitted.  
The complete British Standard can be purchased from the BSI online shop: 
http://shop.bsigroup.com/en/ProductDetail/?pid=000000000030153567 or by 
BSI Customer Services for hard copies only: Tel: +44 (0)20 8996 9001, Email: 
cservices@bsigroup.com. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Document name Specific Advice on Fulfilling Information 
Requirements for Nanomaterials under 
REACH (RIP-oN 2) – Final Project Report 
 
Document reference RNC/RIP-oN2/FPR/1/FINAL 
Author(s) Hankin S.M., Peters S.A.K., Poland C.A., 
Foss Hansen S., Holmqvist J., Ross B.L., 
Varet J. and Aitken R.J. 
 
Date 01 July 2011 
 
RNC/RIP-oN2/FPR/1/FINAL 
 
- iii - 
EXECUTIVE SUMMARY 
The REACH Implementation Projects on Nanomaterials (RIP-oNs) seek to provide 
scientific and technical advice on key aspects of the implementation of REACH with 
regard to nanomaterials.  The objectives of the RIP-oN 2 project, undertaken by a 
consortium led by the Institute of Occupational Medicine, were to develop specific 
advice on i) how REACH information requirements on intrinsic properties of 
nanomaterials can be fulfilled, including the appropriateness of the relevant test 
methods (and dosimetry) for nanomaterials and outline, when relevant, possible 
specific testing strategies and ii) the information that is needed for safety evaluation 
and risk management of nanomaterials and, in particular, if information is needed 
beyond or in addition to the current information requirements listed in REACH 
Annexes VI-X.   
The project was implemented through a series of specified and linked tasks (A, B1-
B5, and C).  The project identified and reviewed relevant information sources (Task 
A) for carrying out: an analysis of the current REACH guidance on information 
requirements and testing and whether these requirements are applicable for 
nanomaterials (Task B1); identification of additional relevant specific intrinsic 
properties for which an adaptation of the information requirements and testing and 
other information generation methods/strategies might be needed for nanomaterials 
(Tasks B2 & B3); identification of needs for further research and development of test 
methods and other information generation methods/strategies in regard to 
nanomaterials (Tasks B4 & B5); an analysis of the needs and options for 
metrics/parameters in the hazard assessment compatible with the exposure 
assessment parameters/metrics in order to prepare a meaningful risk 
characterisation (Task C).  Where relevant, additional information requirements 
beyond current REACH requirements have been identified when it is considered that 
they are needed to adequately address the properties of nanomaterials. 
Comprehensive discussions of the findings from each stage of the project are 
provided in the individual Task Reports.  This Final Project Report summarises the 
key specific issues related to nanomaterials in a REACH context and recommends 
updates to the Guidance in a form compatible with the possible future integration into 
the existing REACH Guidance on Information Requirements and Chemical Safety 
Assessment.  Clear reference to the existing REACH Guidance Part and Chapter 
and sub-chapter is provided.  For issues which are not currently 
technically/scientifically mature for developing detailed guidance, the need for further 
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research and development is indicated.  All Task Reports were subject to review by 
the project’s European Commission Steering Group (constituting representatives of 
JRC, DG Environment, DG Enterprise and ECHA) and by a Stakeholder Consultation 
Group (SCG) consisting of the members of the REACH Competent Authorities Sub-
Group on Nanomaterials (CASG-Nano) and other relevant experts from Member 
States, industry and NGOs nominated by the REACH and CLP Competent 
Authorities (CARACAL)s.  The draft Task Reports were opened for consultation with 
the above mentioned groups, discussed at meetings of the SCG, revised by the 
Project Consortium and re-opened for comment before being finalised.   
Summary of Findings 
Of the existing Information Requirements reviewed in Task B1, in general the 
guidance on physico-chemical properties is considered to be applicable to 
nanomaterials, with the exceptions of the limited relevance and applicability of the 
property and methods for surface tension, flash point and viscosity. Further 
evaluation of the suitability of existing methods for water solubility, partition 
coefficient, adsorption/desorption has also been recommended.   
The existing guidance on toxicological data Information Requirements is considered 
applicable for the assessment of nanomaterials, although it has been highlighted that 
attention needs to be given to measuring, dosing, delivery and tracking of 
nanomaterials in the test system.  In general, the basic ecotoxicological properties 
and endpoints described in OECD Test Guidelines for the determination of potential 
effects of test substances in relevant environmental compartments (aquatic, 
terrestrial, sediment) after acute or chronic exposure are considered adequate and 
relevant for nanomaterials.  However, OECD acknowledge that the Test Guidelines 
were not specifically designed for the testing of nanomaterials, and the guidance 
provided on the preparation, delivery of test substances to test system, exposure 
quantifications, dose metrics, measurement, and metrology in all of these test 
guidelines is considered to be insufficient for testing of nanomaterials.   
The potential additional relevant specific intrinsic properties, which have been 
identified in Task B2 from an objective review of published scientific sources of 
information, include: 
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Physico-chemical properties 
Particle shape 
Surface area 
Surface energy 
Surface chemistry 
Surface charge 
Redox potential 
Cell-free ROS/RNS 
production capacity 
State of dispersion 
State of agglomeration 
Toxicological endpoints 
Cell uptake 
Cell viability 
Oxidative stress 
Inflammation 
Fibrosis 
Immunotoxicity 
(sensitisation) 
Cardiovascular toxicity 
 
Ecotoxicological endpoints 
Ventilation rate 
Gill pathologies 
Mucus secretion 
Brain pathology 
Animal behaviour 
Oxidative stress biomarkers 
(CAT, SOD, GPX, GST) 
 
 
Consideration of the value and feasibility of incorporating the identified potential 
additional relevant specific intrinsic properties into the REACH Guidance, has been 
undertaken by considering the scientific evidence in Tasks B3 and the gap analysis 
of Task B4.   
Notably, the published scientific evidence reviewed and summarised in Task B3 
demonstrates a consensus that representative sample preparation and thorough and 
accurate physico-chemical characterisation using multiple techniques is an essential 
component of assessing the potential (eco)toxicity of nanomaterials.  With regard to 
toxicity, a range of endpoints have been examined relating to some of the existing 
Information Requirements under REACH, including: acute toxicity, repeated dose 
toxicity, toxicokinetics, mutagenicity, carcinogenicity & reproductive toxicity.  
However, no information regarding other REACH Information Requirements (such as 
dermal and respiratory sensitisation and irritation) was identified.  Frequently, studies 
considered endpoints of cell viability, oxidative stress, and pro-inflammatory effects in 
vitro.  Studies undertaken and reported to date have highlighted a number of key 
issues or gaps in existing testing strategies which may influence the outcome of 
studies, and thus should be observed closely in the assessment of nanomaterials 
within the context of REACH.  Factors such as the exposure method, dose selection, 
species used, cell type under investigation, all have the potential to impact on the 
assessed toxicity of nanoparticles, indicating the importance of how experimental 
design can influence the resulting toxicological profile.  A limited body of scientific 
evidence is available to inform the provision of specific practical advice with regard to 
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the ecotoxicological Information Requirements in REACH, but a number of issues 
have been found to influence the ecotoxicologic responses observed in the study of 
nanomaterials.  These include: 1) coating/functionalisation of the surface and particle 
impurities, 2) suspension preparation methods, 3) release of free metal ions, 4) 
particle aggregation and 5) relevance of dose [concentration] - response for 
ecotoxicological studies of nanomaterials.  The extent of influence of these factors on 
the ecotoxicological impact of nanomaterials is still emerging.  Although at the time of 
writing this report, results from the OECD-WPMN Sponsorship Programme had not 
emerged, the limited information currently available from OECD-WPMN has been 
considered.  ISO/CEN documents published or classified as being at Final Draft 
International Standard (FDIS), Draft International Standard (DIS) stage were 
reviewed and commented upon.  Those at an earlier stage of development (i.e. 
Committee Draft stage or lower) were reviewed and commented upon, to the extent 
possible.   
The gap analysis undertaken in Task B4 of relevant intrinsic properties for 
nanomaterials assembled and further developed the findings from the examination of 
existing REACH Guidance (Task B1), the identification of additional relevant specific 
intrinsic properties for nanomaterials (Task B2), and the assessment of relevance 
and applicability of testing, endpoints and methods described in the scientific 
literature and on-going international work relevant to the fulfilment of the data 
requirements under REACH (Task B3).  The framework used for the gap analysis 
considered physico-chemical properties, toxicological and ecotoxicological endpoints, 
and integrated the existing and identified additional properties/endpoints to identify 
those which may and may not be addressed by standard test guideline methods and 
where further development of in vitro, in vivo or other methodologies is required.  The 
gap analysis was structured by property/endpoint and systematically assessed 
whether a property/endpoint is relevant and methods applicable to nanomaterials.  
Commentary is provided on aspects including whether the property/endpoint is 
applicable to substances, particles, or nanomaterials only; the method type 
(standard, non-standard method or widely-accepted in R&D); the applicability and 
limitations of the method; information on the type of data provided by the method; 
and identification of research and development needs.  The outcomes of the gap 
analysis have informed the development of specific guidance updates and 
recommendations for research and development.   
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In Task B5, the relevance and applicability of the current Integrated Testing 
Strategies (ITS) to nanomaterials for properties and endpoints in the existing 
Guidance have been reviewed and any limitations identified.  For each ITS, the 
relevance and applicability to nanomaterials has been indicated along with the need 
for any update to the existing Guidance text, where this is considered feasible given 
the current state of knowledge.  In general, only minor updates are necessary to 
some of the existing ITS for the properties/endpoints considered, including the 
general testing strategy for physico-chemical properties, water solubility (reflecting a 
need to distinguish between solubilisation and dispersion), and the need to justify 
scientifically the use of QSAR and/or read-across in the toxicological endpoints.  A 
substantive update to the ITS for granulometry is recommended, reflecting the 
recommended substantive update to the guidance for this property.  Advice is 
provided on the scientific basis for the categorisation of nanomaterials and 
application of in silico methods, read-across and category approaches for deriving 
hazard information for nanomaterials from the information on bulk substances or from 
comparison between nanomaterials.  Whilst the lack of data across a wide range of 
structural and compositionally different nanomaterials precludes a fully prescribed 
category-based approach being developed, the suggested approaches for possible 
development indicate where such groupings may be applied.   
Task C identified the critical items on exposure/dose descriptors and outlined needs 
for adequate metrics/parameters as appropriate for exposure assessment compatible 
with those used for hazard assessment.  The metrics currently used in risk 
assessment (both regulatory and otherwise) across the three elements of exposure, 
(eco)toxicology and risk are based on mass or particle number.  The most prominent 
emerging alternative or additional metric identified for use in relation to the risk 
assessment of nanomaterials is surface area.  This is based primarily on toxicological 
evidence relating particle surface area to inflammation, an indicator of toxicity.  There 
are currently no definitive conclusions on the best metric.  However, there is 
consensus that there should be sufficient characterisation of the forms of a 
substance to allow the dose-response to be expressed in the different metrics 
discussed - number, surface area and mass.  It is important to note that there are 
other parameters which can act as modifiers of the (eco)toxicity, including particle 
size, size distribution, density, aggregation and shape, but these parameters would 
not generally be considered as scalable quantities and do not appear to conform to 
the current use of the term “metric” under REACH, and were therefore not 
considered further.   
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On the basis of the activities undertaken in each of the aforementioned Tasks, 
recommendations have been proposed for guidance updates in the following 
documents/chapters:  
Physico-chemical Properties 
Additional relevant specific intrinsic properties of Shape and Surface Area 
are recommended as physico-chemical Information Requirements and 
consequently new guidance chapters are recommended.  Text has been 
developed in accordance with the structure and nature of current guidance and 
compatible with incorporating the properties either as new Information 
Requirements or subordinate to the existing Granulometry Information 
Requirement. 
Updates to guidance have been recommended for: 
 Guidance on Information Requirements and Chemical Safety 
Assessment Part B: Hazard Assessment, B.6.1.4 Other physico-
chemical properties 
 Guidance on Information Requirements and Chemical Safety 
Assessment Part B: Hazard Assessment, Appendix to Part F – CSR 
Template with explanation 
A new section, in the introduction of “Guidance on Information Requirements and 
Chemical Safety Assessment Chapter R7a: Endpoint Specific Guidance” is 
recommended to address sample preparation issues applicable to the 
determination of all properties and endpoints. 
Updates to specific chapters in R7 have been recommended for: 
 R.7.1.1 Introduction 
 R.7.1.7 Water solubility 
 R.7.1.8 Partition coefficient 
 R.7.1.14 Granulometry 
 R.7.1.15 Adsorption/desorption 
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Toxicological Endpoints 
No new additional relevant specific intrinsic properties are recommended for 
toxicological Information Requirements, however, Advisory Notes on the following 
aspects have been recommended and developed: 
 Prior to R.7.2 
o Rat lung overload within inhalation toxicity assessment 
o Assay inhibition/enhancement (interference) 
 R7.7: Mutagenicity & carcinogenicity (in vitro data section) 
o Bacteria assay interference 
Updates to guidance have been recommended for: 
 R7.2 Skin & eye irritation/corrosion 
 R.7.3 Skin & respiratory sensitisation 
 R.7.4 Acute toxicity 
 R.7.5 Repeated dose toxicity 
 R7.6 Reproductive & developmental toxicity 
 R.7.7 Mutagenicity & carcinogenicity  
 
Ecotoxicological Endpoints 
No new additional relevant specific intrinsic properties are recommended for 
ecotoxicological Information Requirements, however, updates to guidance have 
been recommended for: 
 R7.8.4 Evaluation of available data on aquatic pelagic toxicity 
 R.7.9.3 Information on degradation/biodegradation and its sources 
 R.7.10.3.2 Non-testing data on bioaccumulation 
 R.7.11.3.1 Laboratory data for effects on terrestrial organisms 
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On the basis of the activities undertaken in each of the Tasks, recommendations for 
research & development have been indicated for the following aspects, properties or 
endpoints: 
Physico-chemical properties 
• General aspects (e.g. characterisation, standards, protocols etc) 
• Existing Information Requirements 
Relative density 
Surface tension 
Water solubility 
Partition coefficient 
Flammability 
Explosive properties 
Granulometry 
Adsorption/desorption 
Dissociation constant 
 
• Additional specific intrinsic properties 
Shape 
Surface area 
Porosity 
Surface energy 
Surface chemistry 
Surface acidity 
Surface charge 
 
Redox potential 
Cell-free ROS/RNS 
production capacity
Toxicological endpoints 
• Non-testing in silico approaches 
• Study design 
Dispersion 
Selection of dose 
Selection of exposure 
route & duration 
Interactions 
Using physico-
chemical data to 
inform experimental 
design 
Target-organ toxicity 
considerations 
Adopting standardised 
controls 
Interferences 
 
 
 
• Endpoint-specific or ‘mechanism’-associated R&D  
• Study design 
Utilising Bronchio 
Alveolar Lavage (BAL) 
Acute toxicity 
Repeated dose 
toxicity 
Reproductive toxicity 
Inflammation & 
cytotoxicity 
Oxidative stress 
Genotoxicity 
Particle translocation 
Cardiovascular toxicity 
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Ecotoxicological endpoints 
• General considerations 
o Aquatic testing 
o Soil testing 
• Data on aquatic pelagic toxicity (under R.7.8.4.1) 
Growth inhibition in 
aquatic plants 
Short-term toxicity 
testing on 
invertebrates 
Long-term toxicity 
testing on 
invertebrates 
Short-term toxicity 
testing on fish 
Long-term toxicity 
testing on fish 
Fish early-life stage 
test 
 
Short-term testing on 
fish embryo and sac-
fry stages 
Fish, juvenile growth 
test 
 
 
• Data on toxicity to sediment organism (under R.7.8.9.1) 
o Long-term toxicity to sediment organism 
• Information requirements for toxicity to STP microorganisms 
o Activated sludge respiration inhibition testing 
• Ready biodegradability (under R.7.9.2.1) 
• Hydrolysis as a function of pH (under R.7.9.2.2) 
• Data on aquatic bioaccumulation (under R.7.10.3.1) 
o Bioaccumulation in aquatic species 
• Data on avian toxicity (under R.7.11.3.1) 
o Long-term or reproductive toxicity to birds 
• Laboratory data (under R.7.11.3.1) 
Effects on soil micro-
organisms 
Soil short-term toxicity 
to invertebrates 
Long-term toxicity on 
soil invertebrates 
Short-term toxicity to 
plants 
Long-term toxicity on 
plants 
 
• Possible R&D on possible additional specific intrinsic properties (under 
R.7.8.4.1) 
Fish ventilation rate 
Fish gill pathology 
Fish mucous secretion 
Fish brain path 
Animal behaviour 
Oxidative stress 
Daphnia heart rate, 
hoping frequency, 
appendage movement 
Trojan-horse effect of 
nanomaterials 
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The RIP-oN 2 project has been performed as an objective scientific review based on an 
informed, objective and systematic gathering and consideration of evidence by experts who 
have used their knowledge and professional judgement when considering the relevance and 
contribution of the scientific evidence towards delivering the project’s objectives.   
A comprehensive synthesis of findings, implications, issues and advice has been developed 
and integrated through the Task Reports and the Final Project Report.  Where considered 
relevant, feasible and justified, specific advice for updating guidance has been provided.  For 
issues which are not currently technically/scientifically mature for developing detailed 
guidance, the need for further research and development has been indicated.   
The assessment of the scientific evidence and subsequent recommendations are the 
considered opinion of the authors and are submitted for consideration by the European 
Commission.  
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Abbreviation 
 
Definition 
8-OH-dG 8-Oxo-2'-deoxyguanosine 
AAN Average Agglomeration Number  
AFM Atomic Force Microscopy  
AM Alveolar Macrophage 
AP-1 Activator Protein 1 
ApoE Apolipoprotein E 
APS Aerosol Particle Sizer  
ARDS Acute Respiratory Distress Syndrome  
ASTM American Society for Testing and Materials  
ATM Atomic Force Microscopy 
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BAL Bronchoalveolar Lavage  
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CEFIC European Chemicals Industry Council  
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Definition 
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1 INTRODUCTION 
This document constitutes the Final Report provided by the contractor to the JRC on 
the project "Specific Advice on Fulfilling Information Requirements for 
Nanomaterials under REACH" (RIP-oN 2).  
1.1 PREFACE 
1.1.1 The implementation of the European Union's Registration, Evaluation, Authorisation 
and Restriction of Chemicals (REACH) Regulation (EC) No 1907/2006, represents a 
fundamental shift in the regulation of manufactured and imported chemicals in the 
European Union.  Having entered 'into force' on 1 June 2007 and 'into operation' on 
1 June 2008, the new regime's overriding objective, is 'to ensure a high level of 
protection of human health and the environment while including the promotion of 
alternative methods for assessment of hazards of substances, as well as the free 
circulation of substances on the internal market while enhancing competitiveness 
and innovation.' and is underpinned by the precautionary principle.  
1.1.2 REACH effectively shifts responsibility from authorities to industry to gather 
information on chemical substances and assess their safety. The provisions of 
REACH refer to substances (in whatever size or forms) and also apply to 
nanomaterials, that are considered either as distinct substances or forms of a 
substance (CA/59/2008rev1).  However, a degree of uncertainty exists concerning 
the adequacy of the regulation and the accompanying guidance for the emerging 
and rapidly developing nanomaterials industry. 
1.1.3 Therefore the Commission launched the REACH Implementation Projects on 
Nanomaterials (RIP-oNs) with the objective to provide scientific and technical advice  
on key aspects of the implementation of REACH with regard to nanomaterials, 
namely:  
i) Substance Identification (SI) (RIP-oN 1) 
ii) Information Requirements (IR) (RIP-oN 2) 
iii) Chemical Safety Assessment (CSA) (RIP-oN 3) 
1.1.4 The Institute for Health and Consumer Protection (IHCP) of the Joint Research 
Centre (JRC) was asked to perform and coordinate the activities aimed at 
developing advice for possible future REACH guidance improvement.  The advice 
should be based on the scientific and technical state of the art information, 
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experience and methodology regarding nanomaterials (NM). It should provide 
concrete proposals that could be implemented directly, and indicate the possible 
way forward for any issues and methods that need further work and could be 
implemented in the short and medium term. The main focus should be on issues 
and methods that could be included in the REACH guidance and possibly 
implemented in the short term, after the pertinent further development and 
consultation process. These recommendations would contain practical proposals for 
how and based on which information this update could take place.   The outputs are 
to be developed in such a way that the advice on specific issues related to 
nanomaterials can be integrated into the existing REACH guidance documents.  The 
actual inclusion of any of the advice into the guidance documents is the 
responsibility of the European Chemicals Agency (ECHA) and is not part of the 
commissioned projects.  The work is performed in close collaboration with DG 
Environment, DG Enterprise and ECHA who constitute the steering group for these 
activities.   
1.1.5 JRC let competitive tenders and commissioned two REACH Implementation 
Projects on Nanomaterials (RIP-oN 2 and RIP-oN3), with the purpose of 
respectively providing "Specific advice on fulfilling information requirements for 
nanomaterials under REACH" (RIP-oN 2) and "Specific advice on exposure 
assessment and Hazard/Risk Characterisation for nanomaterials under REACH" 
(RIP-oN 3). 
1.1.6 In this document, the consortium that was awarded the tender of the project 
"Specific Advice on Fulfilling Information Requirements for Nanomaterials under 
REACH" (RIP-oN 2) provides its final overall report to the JRC. 
1.2 CONSIDERATION OF THE PURPOSE, SCOPE AND FINDINGS OF THE RIP-ON 
2 PROJECT IN THE CONTEXT OF SUBSTANCE IDENTIFICATION AND 
REGISTRATIONS ADDRESSING SEVERAL FORMS, INCLUDING NANOFORMS 
1.2.1 Assisted by the 'Guidance for identification and naming of substances in REACH'1, 
the registrant shall decide whether different forms of a (nano-)material shall be 
registered in their own right or together with other forms, e.g. the micron or bulk 
(non-nanoscale) form.  It should be noted that the ongoing REACH Implementation 
Project on Nanomaterials 1 (RIP-oN 1) is addressing how the guidance on 
                                                
1 http://guidance.echa.europa.eu/docs/guidance_document/substance_id_en.htm?time=1301642719 
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identification and naming could be updated to reflect in more detail how to address 
nanoforms.  The results of RIP-oN 1 will eventually be handed over to ECHA and 
ECHA might in turn decide to update the guidance for identification and naming of 
substances.   
1.2.2 Until a possible update of the identification and naming guidance, the registrant is 
referred to the document 'Nanomaterials in REACH' (CA/59/2008 rev. 1)2, 
specifying, between others:  
"REACH is based on the principle that it is for manufacturers, importers and 
downstream users to ensure that they manufacture, place on the market or 
use such substances that do not adversely affect human health or the 
environment (Article 1(3) of REACH). This principle is applicable to 
substances in whatever size or form and for all their identified uses. Thus, a 
registration of a nanomaterial has to include all relevant information on the 
nanomaterial as manufactured or imported, covering the properties, uses, 
effects and exposure related information as well as the relevant classification 
and labelling, safety assessment and any relevant exposure scenarios " (p. 6), 
and  
"For substances at nanoscale that are phase-in substances, the registration 
can be more complex, especially when the same substance exists in the 
nanoform as well as in the bulk form. In such a case not only the information 
of the substance in the bulk form should be included in the registration 
dossier, but also any information regarding intrinsic properties where the 
properties of a substance in the nanoform differs from the bulk form, any 
different classification and labelling, any different chemicals safety 
assessment as well as all identified uses (see also Annex VI.3 of REACH) and 
relevant exposure scenarios for the nanoform of the substance." (p.8). 
1.2.3 Until more concrete guidance is provided by ECHA, it is suggested that the 
registrant follows this line.  This has a direct influence on the generation of hazard 
data, e.g. any read-across from one form to the other (being from a bulk form to a 
nanoform or between nanoforms) should be scientifically justified.  It also has 
influence on the information in the supply chain, which has to be appropriate to the 
                                                
2 http://ec.europa.eu/environment/chemicals/reach/pdf/nanomaterials.pdf 
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form(s) passing down the supply chain and the Chemical Safety Assessment should 
support this.  The suggested guidance updates from the RIP-oN 2 project need to 
be seen in this light. 
1.3 PROJECT OBJECTIVES 
1.3.1 The objectives of the RIP-oN 2 project were to: 
 Develop specific advice on how REACH information requirements on 
intrinsic properties of nanomaterials can be fulfilled. This should address 
and advise on the appropriateness of the relevant test methods (including 
dosimetry) for nanomaterials and outline, when relevant, possible specific 
testing strategies. 
 Develop advice on the information that is needed for safety evaluation and 
risk management of nanomaterials and in particular if information is 
needed beyond or in addition to the current information requirements listed 
in REACH Annexes VI-X. 
 
1.4 THE PROJECT CONSORTIUM 
1.4.1 The consortium awarded the tender for RIP-oN 2 comprises the Institute of 
Occupational Medicine (IOM) through its SAFENANO unit, the Nanotechnology 
Industries Association (NIA) and the European Chemicals Industry Council (CEFIC). 
1.4.2 IOM/SAFENANO, with an established reputation for independent scientific work, led 
the consortium and carried out majority of the technical activities.  NIA facilitated and 
provided a transparent interface between the project and the stakeholder group, as 
well direct access to industry and industrial knowledge.  CEFIC contributed a 
breadth of experience and expertise on REACH activity as well direct access to 
industry and industrial knowledge.  
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2 DESCRIPTION OF THE PROJECT 
2.1 OVERVIEW 
2.1.1 The project was implemented through a series of specified and linked tasks (A, B1-
B5, and C).  The relationship between each task is illustrated in the scheme below, 
with specific details of the task description provided in the table of Deliverables 
overleaf. 
 
 
 
 
 
 
 
 
2.1.2 The project commenced with the identification and review of all relevant information 
sources (Task A) for carrying out the subsequent tasks (B1-B5 and C), which 
included: an analysis of the current REACH information requirements and testing 
and whether these requirements are appropriate for nanomaterials (Task B1); 
identification of additional relevant specific intrinsic properties for which an 
adaptation of the information requirements and testing and other information 
generation methods/strategies might be needed for nanomaterials (Tasks B2 & B3); 
identifying needs for further research and development of test methods and other 
information generation methods /strategies in regard to nanomaterials (Tasks B4 & 
B5); an outline of the needs and options for metrics/parameters in the hazard 
assessment compatible with the exposure assessment parameters/metrics in order 
to prepare a meaningful risk characterisation (Task C).  Where relevant, additional 
information requirements beyond current REACH requirements have been identified 
when it is considered that they are needed to address adequately the properties of 
nanomaterials.   
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2.1.3 The Final Project Report (Task D) compiles and summarises all the previous 
Deliverables in a single comprehensive document in such a form that advice on 
specific issues related to nanomaterials can be considered for integration into the 
REACH guidance documents and further research and development on relevant 
issues can be initiated. 
2.2 DELIVERABLES 
2.2.1 A series of reports were developed for the specified tasks, as summarised below.   
Task Deliverable 
A A Short Report containing: 
1. A brief description of the approach/methodology used to identify relevant 
information sources; 
2. A list of identified information sources with clear indications of which ones 
are relevant for the subsequent tasks; 
3. For relevant information sources, a brief summary of relevant content and 
timelines for final outputs (in the case of on-going projects). 
B1 An Analysis Report making direct reference to the existing Guidance on 
IR & CSA for REACH (Part and (sub)Chapter) of the general information 
requirements and testing(/information generation) strategies for 
nanomaterials as applied today, based, among others, on the three case 
example materials. 
B2 A Scientific Report and table/grid on "Identification and overview of 
additional relevant specific intrinsic properties for nanomaterials". 
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Task Deliverable 
B3 A Summary Analysis Report containing sections on: 
1. Practical advice on the relevance and applicability of the experience 
reported in finalised and on-going FP6/7 projects on nanomaterials 
characterisation and hazard identification and assessment for workers, 
consumers and environment into the REACH context; 
2. Practical advice on the relevance and applicability of the experience 
reported in the scientific literature on nanomaterials characterisation and 
hazard identification and assessment for workers, consumers and 
environment into the REACH context; 
3. Practical advice on the use of information from e.g. the Organisation for 
Economic Co-operation and Development Working Party on 
Manufactured Nanomaterials (OECD-WPMN) and other sources on the 
appropriateness of existing testing methods and results from the 
sponsorship programme in fulfilling the REACH data requirements; 
4. Practical advice on the basis of on-going work in ISO and CEN (and, as 
identified, other harmonization bodies) in relation to whether relevant 
methods for substance characterisation could be used in fulfilling 
REACH data requirements. 
B4 A Summary Analysis Report on the "Gap analysis of relevant intrinsic 
properties for nanomaterials, which may not be addressed by standard test 
guideline methods and for which further development of in vitro, in vivo or 
other methodologies is required".   
RNC/RIP-oN2/FPR/1/FINAL 
 
- 8 - 
Task Deliverable 
B5 Scientific Report on Test Methods and Strategies for Nanomaterials, 
including chapters on: 
1. Advice on integrated testing strategies relevant to specific nanomaterials 
properties and how the specific intrinsic properties of nanomaterials 
might affect the need for adaptations to the testing regime; 
2. Advice on the scientific basis for the categorisation of nanomaterials and 
application of in silico methods, read-across and category approaches 
for deriving hazard information for nanomaterials from the information on 
bulk substances or from comparison between nanomaterials; 
3. Proposals for further amendment of the REACH guidance documents in 
regard to information requirements, test methods or testing strategies for 
nanomaterials, where appropriate, taking into account the provisions to 
minimise use of animals for testing.  These should also consider whether 
additional information requirements beyond the standard REACH 
requirements would be appropriate for nanomaterials e.g. for addressing 
the gaps identified in B4; 
4. Proposal for further research and development of test methods and 
other data generation methods/strategies in regard to nanomaterials. 
C A working document on identification of critical items on dose descriptors 
and related parameters, outlining needs for adequate metrics/parameters as 
appropriate for hazard assessment compatible with the ones used for 
exposure assessment as well as for the read-across from bulk substances 
and from other nanomaterials.  This document has been developed in close 
collaboration with RIP-oN 3. 
D A Compiled Summary Report on the overall project, describing:  
1. Specific issues related to nanomaterials that can be integrated into the 
existing REACH Guidance on Information Requirements and Chemical 
Safety Assessment with reference to the corresponding Part and 
(sub)Chapter; 
2. Needs for further research and development of test methods and other 
methods of information generation. 
 
2.2.2 The present report, as already indicated in the introduction, constitutes the Final 
Project Report (Task D) and provides advice for updating the guidance and on 
research and development needs.  This takes the form of specific recommendations 
or options for consideration by the Commission.  For issues which are not currently 
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technically/scientifically mature for developing detailed guidance, the need for 
further research and development is indicated.   
2.2.3 The focus of the RIP-oN 2 has been on nanomaterial relevant issues. Nevertheless, 
due to the nature of some nanomaterials, some proposals may have implications for 
other substances that are not nanomaterials. These would have to be considered if 
reshaping of the REACH guidance would take place. 
2.3 REVIEW AND CONSULTATION 
2.3.1 All Task Reports were subject to review by the project’s Steering Group (constituting 
representatives of JRC, DG Environment, DG Enterprise and ECHA) and a 
Stakeholder Consultation Group (SCG) consisting of the members of the REACH 
Competent Authorities Sub-Group on Nanomaterials (CASG-Nano) and other 
relevant experts from Member States, industry and NGOs nominated by the REACH 
and CLP Competent Authorities (CARACAL).  The draft Task Reports were opened 
for consultation with the above mentioned groups, discussed at meetings of the 
SCG, revised by the Project Consortium and re-opened for comment before being 
finalised.   
2.4 TECHNICAL APPROACH 
2.4.1 The project has been performed as an objective review of the existing guidance and 
available scientific evidence pertinent to the specified tasks.  Existing Information 
Requirements across all tonnage levels have been considered and potential 
additional Information Requirements for nanomaterials identified, prior to conducting 
the gap analysis of properties and methods to facilitate the identification of 
recommendations and research & development requirements.   
2.4.2 The conduct of this scientific review is based on an informed, objective and 
systematic gathering and consideration of evidence by experts who have used their 
knowledge and professional judgement when considering the impact and 
contribution of a source document to the task objective.  It is important to note the 
inherent limitations of a review activity.   Reviews are conducted at a fixed point in 
time which precludes the inclusion of information becoming available after a cut-off 
date.  Information sourced may be incomplete or, on closer inspection, the content 
of a source document bears no relevance to the issues being considered.   
Information may also change in revisions of the sources considered.   
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2.4.3 Based on the objective and informed assessment of published reports constituting 
the evidence-base available, a synthesis of findings, implications and/or issues 
distilled from the sources has been developed and integrated into the task reports.  
The review of source reports has identified the key findings and gaps to establish a 
technical basis facilitating the development of advice pertinent to the project.   
2.4.4 Identification and review of information sources (Task A) 
2.4.5 Relevant information was collected, assessed, categorised and made available to 
the project team.  There is a range of relevant information and information types.  
The information included background information from organisations such as CASG 
Nano, OECD WPMN, SCENIHR, Standards organisation such as ISO and CEN, 
FP6/7 projects, other ongoing national projects, other international regulatory 
organisations such as NIOSH and EPA and from the peer reviewed literature.  
Reports and papers were assessed for specific relevance to the project.   
2.4.6 The report from Task A comprises a brief description of the approach/methodology 
used to identify relevant information sources, the list of identified information 
sources with clear indications of their relevance to the respective tasks and 
comment of the relevant content.   
2.4.7 REACH Information requirements for nanomaterials (Task B) 
2.4.8 Task B comprised five sub-tasks (B1-B5).  Each sub-task was conducted using data 
available from the public domain, in the broadest context of nanomaterials, and used 
case-example materials (MWCNT, Ag, TiO2 and ZnO for ecotoxicology) as 
appropriate, to exemplify specific aspects necessary for these types of 
nanomaterials.  Each of the five sub-task reports built on the previous task(s) and its 
associated report, and comprise multiple components addressing physico-chemical 
properties, toxicology, and eco-toxicology aspects, as well as cross-cutting issues.   
2.4.9 For Task B1, a thorough analysis was carried out of the endpoint specific guidance, 
R7a-c.  Chapter-by-chapter, the current guidance text has been analysed to 
establish if there are any differences in application between what could be called 
conventional substances and those at nanoscale.  The report is organised by 
REACH Guidance headings or groups of headings (in bold and labelled with their 
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corresponding section number from the current REACH Guidance document) and 
comments provided in the context of the task objective.   
2.4.10 The approach undertaken to identify candidate additional relevant specific intrinsic 
properties for nanomaterials in Task B2 utilised key reports from different 
organisations, scientific opinions and working documents of OECD and ISO/CEN.  
Previously suggested properties and endpoints from these reports for use in 
nanomaterials risk assessment are highlighted.  The task report (RNC/RIP-
oN2/B2/2/FINAL) identifies candidate additional relevant specific intrinsic properties 
and provides a contextual or principle-based overview of their relevance to 
nanomaterials and REACH.   
2.4.11 In Task B3, a comprehensive review of information sources identified in Task A was 
carried out.  Detailed consideration of supporting information pertaining to intrinsic 
properties was undertaken in Task B3 in the context of i) the relevance and 
applicability of the experience reported in the scientific literature and gained in 
several finalised and on-going FP6/7 projects; ii) the use of information from OECD-
WPMN; and iii) the basis of on-going work in ISO and CEN.  The review of 
information sources provides a basis for the gap analysis in Task B4 of relevant 
intrinsic properties which may not be addressed by standard test guideline methods 
and for which further development of in vitro, in vivo or other methodologies is 
required.  The associated Task report (RNC/RIP-oN2/B3/2/FINAL) is organised first 
into Sections in accordance with the sequence of objectives (the peer-reviewed 
literature is however reported separately from FP6/7 projects), and then by 
relevance to physico-chemical information, toxicological information and 
ecotoxicological information.  Where possible, it has been identified where OECD 
test guidelines and ISO/CEN (or equivalent) standards have been utilised on the 
basis of the information provided in the publications reviewed.  Thus, in the absence 
of any statement to the contrary, the protocols utilised in the FP7/FP6 projects and 
scientific literature are either non-standardised or there is insufficient information 
provided by the publication’s authors to determine whether a standardised test 
method has been used.  Insufficient information was often stated to describe the 
detail of the non-standardised methods and protocols used.   
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2.4.12 Gap analysis of relevant intrinsic properties for nanomaterials possibly not 
addressed by standard test guideline methods and requiring further 
development of in vitro, in vivo or other methodologies (Task B4) 
2.4.13 The gap analysis table provided in the task report (RNC/RIP-oN2/B4/2/FINAL) is the 
outcome of an informed, objective and systematic consideration of the evidence by 
the Project Consortium, who have used their knowledge and professional judgement 
when considering the relevance of the existing and additional intrinsic properties and 
the applicability of methods for nanomaterials.   
2.4.14 The gap analysis has assembled and further developed the findings from the 
examination of existing REACH Guidance related to information requirements and 
testing (information generation) strategies (Task B1), the identification of additional 
relevant specific intrinsic properties for nanomaterials (Task B2), the assessment of 
relevance and applicability of testing, endpoints and methods described in the 
scientific literature and on-going international work relevant to the fulfilment of the 
data requirements under REACH (Task B3).   
2.4.15 The structural framework used for the gap analysis considers physico-chemical 
properties and toxicological and ecotoxicological endpoints, and integrates the 
existing and additional properties/endpoints to identify those which may and may not 
be addressed by standard test guideline methods and where further development of 
in vitro, in vivo or other methodologies is required.   
2.4.16 The gap analysis tables are structured by property / endpoint, with tables presenting 
systematically an assessment of methods using the following format: 
 Method name; 
 Supporting information from conclusions of the preceding B1, B2, and B3 
reports;  
 A judgement on whether the property / endpoint is applicable to 
nanomaterials and the need for guidance amendment, according to the 
following categories outlined in the table below: 
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Category Judgement Outcome 
1 Property / endpoint not 
applicable to nanomaterials. 
No change to guidance. 
2 Property / endpoint applicable 
to nanomaterials, but no 
difference between nano and 
non-nano in terms of the 
applicability of methods. 
No change to guidance. 
3 Property / endpoint applicable 
to nanomaterials, with 
differences between nano and 
non-nano in terms of the 
applicability of methods 
Change(s) to guidance to 
be suggested. 
4 Property / endpoint applicable 
to nanomaterials, with 
suspected important 
differences between nano and 
non-nano in terms of the 
applicability of methods, but an 
insufficient basis for guidance 
to be provided. 
No change to guidance 
proposed at this time, but 
R&D requirements to be 
stated as needed. 
5 Property / endpoint applicable 
to nanomaterials, with no 
suspected important 
differences between nano and 
non-nano, but an insufficient 
evidence basis to warrant 
acknowledgement in guidance.
No change to guidance at 
this point in time. 
 
 Where specific methods for a relevant property are considered, a 
prioritisation based on whether the method is applicable to nanomaterials 
and the need for guidance amendment was assessed according to the 
following categories outlined in the table below: 
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Category Judgement Outcome 
1 Method not applicable to 
nanomaterials. 
No change to guidance. 
2a Existing method will work with 
nanomaterials, with evidence 
of no difference of applicability 
between nano and non-nano. 
No change to guidance. 
2b New method will work with 
nanomaterials, with evidence 
of no difference of applicability 
between nano and non-nano. 
Change(s) to guidance to 
be suggested. 
3a Existing method will work with 
nanomaterials, but with 
evidence of differences in 
applicability between nano and 
non-nano. 
Change(s) to guidance to 
be suggested. 
3b New method will work with 
nanomaterials, but with 
evidence of differences in 
applicability between nano and 
non-nano. 
Change(s) to guidance to 
be suggested. 
4a Existing method will work with 
nanomaterials, but with 
suspected important 
differences in applicability 
between nano and non-nano, 
but an insufficient evidence 
basis for guidance to be 
provided. 
No change to guidance, but 
R&D requirements to be 
stated as needed. 
4b New method will work with 
nanomaterials, but with 
suspected important 
differences in applicability 
between nano and non-nano, 
but an insufficient evidence 
basis for guidance to be 
provided. 
No change to guidance, but 
R&D requirements to be 
stated as needed. 
5b New method will work with 
nanomaterials, but with no 
suspected important 
differences in applicability 
between nano and non-nano 
but an insufficient evidence 
basis to warrant 
acknowledgement in guidance. 
No change to guidance, but 
R&D requirements to be 
stated as needed. 
 
 (For applicable methods (i.e. categories 2-5), a differentiation is made 
between existing methods (category suffixed with ‘a’) and new methods 
(category suffixed with ‘b’).  The absence of a category 5a is self-evident, 
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as an ‘existing method that will work with nanomaterials, with no 
suspected serious differences in effectiveness between nano and non-
nano’ is equivalent to category 2a and does not have an insufficient 
evidence basis to warrant acknowledgement in guidance.) 
 A comment on the method type, according to the following categories: 
• Standard (e.g. ISO, OECD TG method); 
• Non-standard method; 
• Widely-accepted R&D method. 
 A commentary, providing further detail on the applicability, limitations, and 
R&D needs, where considered necessary; 
 A comment on whether the property / endpoint is applicable to 
substances, particles, or nanomaterials only; 
 Information on the type of data (kind of information) provided by the 
method; 
 Suggested Guidance amendments, where appropriate, identifying the 
relevant Guidance documents, sections, and figures and the basis of the 
change to be suggested.    
2.4.17 Where a consensus opinion could not be reached within the Project Consortium on 
any aspect of the data considered, the different positions are stated.   
2.4.18 On the basis of the gap analysis, the relevant intrinsic properties for nanomaterials 
which may not be addressed by standard test guideline methods (and others) and 
for which further development of in vitro, in vivo or other methodologies is required 
have been identified.  
2.4.19 Scientific Report on Test Methods and Strategies for Nanomaterials (Task B5) 
2.4.20 The Scientific Report on Test Methods and Strategies for Nanomaterials (RNC/RIP-
oN2/B5/2/FINAL) comprises four aspects: i) integrated testing strategies relevant to 
specific nanomaterials properties; ii) categorisation of nanomaterials for deriving 
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hazard information for nanomaterials; iii) proposals for further amendment of the 
REACH guidance documents for nanomaterials; and iv) proposal for further 
research and development of test methods and other data generation 
methods/strategies in regard to nanomaterials.   
2.4.21 The assessment of the integrated testing strategies relevant to specific 
nanomaterials properties, reported in full in RNC/RIP-oN2/B5/2/FINAL, presents the 
current ITS for each of the existing properties and endpoints in the REACH 
guidance, its relevance and applicability for nanomaterials, and any indicated 
recommendations for alteration.   
2.4.22 The latter two objectives (amendment of the REACH guidance documents for 
nanomaterials, and proposal for further research and development) have been 
developed from the comprehensive series of tables that constitute the gap analysis 
undertaken in Task B4, in which the available evidence from Tasks B1, B2 and B3 
has been gathered together and analysed.  Where consensus has not been reached 
on any aspect, this is indicated in the report and requires further consideration by 
the European Commission.   
2.4.23 The philosophy adopted for the development of specific recommendations for 
guidance updates and for research & development related to nanomaterials is 
based on the following aspects:  
 The content of a recommendation for a specific update to guidance is 
consistent with the focus of current REACH Guidance document, its level, and 
language, such that: 
 where the need is for ‘strategic-level’ guidance applicable to 
nanomaterials (i.e. high-level or overarching principles), succinct 
contextual information and reference(s) to primary sources of 
information are provided; 
 where the need is for updated detailed pragmatic information on, for 
example methods, a synopsis of specific guidance with appropriate 
reference(s) are provided; 
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 where there is simply a need identified to acknowledge an important 
relevance or limitation in existing guidance to nanomaterials, a simple 
wording clarification may be proposed.   
 Recommendations for updates to Guidance are made on the basis of the 
findings of the RIP-oN 2 tasks, and where there is a recognised case for doing 
so.  Wide-scale acknowledgement confirming the general applicability of 
Guidance to nanomaterials has not been made.   
2.4.24 Metric(s) to compare in the risk characterisation (Task C) 
2.4.25 Critical aspects concerning descriptors and related parameters, outlining available 
and adequate metrics and needs have been identified based on consideration of the 
published positions of the OECD-WPMN, SCENIHR, and peer-reviewed scientific 
literature.  A key issue considered is the possibility of using metrics which link 
toxicological effects and exposure assessment, based on a relationship between 
measured parameters (e.g. number of particles, alone or in combination) and 
existing metrics used for dosages (mass of substance per kg bodyweight).   
2.4.26 A perspective of metrics used historically and currently in risk assessment and the 
positions of OECD-WPMN and SCENIHR are presented, followed by discussion of 
toxicological (in the context of inhalation, dermal and ingestion exposure routes) and 
ecotoxicological aspects.  The report discusses metrics, measurement methods and 
epidemiological aspects in occupational and environmental settings, and the 
conversion between metrics.   
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3 SUMMARY OF FINDINGS 
3.1 PREAMBLE 
3.1.1 A comprehensive discussion of the findings is provided in the individual Task 
Reports, which were refined using input from consultation with the project’s Steering 
Group and the Stakeholder Consultation Group, and from knowledge gained from 
preceding tasks.   
3.1.2 This Final Project Report compiles findings from the previous deliverables into a 
single document, summarising the key specific issues related to nanomaterials in a 
REACH context and a form compatible with the possible future integration into the 
existing REACH Guidance on Information Requirements and Chemical Safety 
Assessment, with clear reference to the existing REACH Guidance Part and 
Chapter and subchapter.   
3.1.3 The Summary of Findings is presented, with cross-referencing, according to the key 
outcomes from each task undertaken.   
3.1.4 List of Task Reports: 
 Final Report on Task A: Identification and Review of Information Sources 
(RNC/RIP-oN2/A/1/FINAL) 
 Final Report on Task B1: Evaluation of the applicability of existing information 
requirements under REACH for Nanomaterials (RNC/RIP-oN2/B1/2/FINAL) 
 Final Report on Task B2: Identification and Overview of Additional Relevant 
Specific Intrinsic Properties for Nanomaterials (RNC/RIP-oN2/B2/2/FINAL) 
 Final Report on Task B3: Practical advice on relevance and applicability of 
existing information in fulfilling REACH information requirements (RNC/RIP-
oN2/B3/2/FINAL) 
 Final Report on Task B4: Gap analysis of relevant intrinsic properties for 
nanomaterials possibly not addressed by standard test guideline methods and 
requiring further development of in vitro, in vivo or other methodologies 
((RNC/RIP-oN2/B4/2/FINAL) 
 Final Report on Task B5: Scientific report on test methods and strategies for 
nanomaterials (RNC/RIP-oN2/B5/2/FINAL) 
 Joint Final Report on RIP-oN2 Task C & RIP-oN3 Task D: Metric(s) to compare 
in the risk characterisation (RNC/RIP-oN2/C/2/FINAL) 
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3.2 IDENTIFICATION & REVIEW OF INFORMATION SOURCES (TASK A) 
3.2.1 The identification and review of information sources (Task A) in RIP-oN 2 have 
identified screened (for relevance) and then categorised the sources of information 
to compile a resource for use in the subsequent tasks of the project.   
3.2.2 Key organisations, FP6/7 projects and other national projects of relevance to the 
scope of the project were identified by the project team and through consultation 
with the European Commission, via JRC.  Publically-available reports and outputs of 
relevance for the project from these sources were then identified and obtained 
directly from their associated websites and/or through web-based searching.  
3.2.3 In relation to the OECD WPMN, it is recognised that there are three levels of 
accessible documents which can be used and referenced: 
 Published documents available on the public OECD WPMN website; 
 Documents approved for declassification but not yet published; 
 OECD documents developed by the Steering Groups and presented at 
meetings of the WPMN. 
3.2.4 With regard to ISO and CEN publications, only published documents and those 
classified as being at Final Draft International Standard (FDIS) or Draft International 
Standard (DIS) stage were assessed and utilised where appropriate.  Documents in 
development but not possible to be cited at the time of carrying out the RIP-oN 2 
project have been identified; recommendations for them to be considered as soon 
as they become available have been made.   
3.2.5 A substantial resource of peer-reviewed literature references was constructed.  
Literature from the recently completed FP7 Coordination & Support Action entitled 
Engineered Nanoparticles – Review of Health & Environmental Safety (ENRHES) 
(Stone et al., 2009), provided an initial comprehensive listing of literature published 
up to 31st December 2008.  The ENRHES literature search was updated for the 
period 1st January 2009- 3rd March 2010 and supplemented with additional 
literature of specific relevance to the RIP-oN 2 project through a non-date-limited 
Boolean search strategy similar to that of ENRHES using PubMed and Web of 
Knowledge.  In cases where excessively large numbers of references were 
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obtained, the searches were refined by incorporating material-specific terms (e.g. 
silver, titanium dioxide, zinc oxide).   
3.2.6 This search strategy provided a comprehensive bibliography of references across 
the topic areas of physico-chemical characterisation, production, use and exposure, 
toxicology, epidemiology, ecotoxicology, and environmental fate and behaviour.   
3.2.7 The criteria upon which judgements were made for tagging a reference as relevant 
for a task are outlined in the table below: 
Task Task Name Criterion for Inclusion 
B1 Analysis of current REACH 
information requirements and 
testing and information-
generation strategies for 
nanomaterials. 
Reports and publications highlighting or 
commenting generally or specifically on the 
existing information requirements and 
testing approaches for nanomaterials or 
other relevant substances.   
B2  Identification and scientific 
overview of additional relevant 
specific intrinsic properties of 
nanomaterials. 
Reports and publications which discuss 
physico-chemical, toxicological and 
ecotoxicological information concerning 
nanomaterials or other relevant substances, 
which may propose or highlight or identify 
potential additional relevant specific 
intrinsic properties.   
B3 Advice on relevance and 
applicability of existing 
information in fulfilling REACH 
information requirements. 
Reports and publications which discuss 
physico-chemical, toxicological and 
ecotoxicological properties of nanomaterials 
or other relevant substances. 
B4 Gap analysis of relevant 
intrinsic properties for 
nanomaterials, which may not 
be addressed by standard test 
guidelines methods and for 
which further development of 
in vitro, in vivo or other 
methodologies is required. 
Reports and publications which themselves 
provide a property-test gap analysis for 
nanomaterials or extensive discussion of 
knowledge gaps. 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 21 - 
Task Task Name Criterion for Inclusion 
B5 Scientific advice and proposals 
for incorporation of 
(categorised) nanomaterial-
specific requirements into 
REACH: (research on) 
integrated testing/(information 
generation) strategies. 
Reports and publications which themselves 
make specific recommendations for dealing 
with nanomaterials under REACH. 
C Metric(s) to compare in the risk 
characterisation. 
Reports and publications dealing 
specifically with metrics relevant to risk 
characterisation. 
 
3.2.8 The number of information sources identified and categorised for RIP-oN 2 are as 
follows: 
 89 published reports and standards from key organisations; 
 54 reports and standards under development from key organisations; 
 161 reports and publications from EU FP6/7 and other relevant international 
projects; 
 557 reports and publications reviewed in the ENRHES report; 
 931 additional publications from the peer-reviewed literature.  
3.2.9 An appendix in the corresponding task report provides the complete listing of the 
sources of information.   
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3.3 APPLICABILITY OF EXISTING INFORMATION REQUIREMENTS (TASK B1) 
3.3.1 The applicability of the existing Information Requirements to nanomaterials under 
REACH has been considered and summarised for physico-chemical properties, 
toxicological endpoints and ecotoxicological endpoints below.  Tabular summaries of 
the assessment are also provided.   
3.3.2 Conclusions Concerning Physico-chemical Properties 
3.3.3 Of the physico-chemical properties, the guidance to assess melting/freezing point 
(R.7.1.2), boiling point (R.7.1.3), relative density (R.7.1.4) and vapour pressure 
(R.7.1.5), flammability (R.7.1.10), explosive properties (R.7.1.11), self-ignition 
temperature (R.7.1.12) and oxidising properties (R.7.1.13) are all considered to be 
applicable to nanomaterials.  Stability in organic solvent and degradation products 
(R.7.1.16) and dissociation constant (R.7.1.17) are also applicable to nanomaterials.  
Dissociation constant is indicated to be likely applicable to nanomaterials in 
OECD_15 Preliminary Review of OECD Test Guidelines for their Applicability to 
Manufactured Nanomaterials, ENV/JM/MONO(2009)21).  Stability in organic solvent 
is not covered by the OECD review. 
3.3.4 Surface tension (R.7.1.6) is not in general relevant for nanomaterials, except for the 
special sub-classes of Janus particles which may exhibit domains of differing 
hydrophilicity.  Flash point (R.7.1.9) is not considered relevant for nanomaterials; the 
current Guidance states appropriately that “Flash Point is only a relevant property 
for liquids, thus it does not need to be done for substances that are solids or gases 
at room temperature.”  Viscosity (R.7.1.18) is also not considered relevant for 
nanomaterials; the current Guidance states appropriately that “Viscosity is relevant 
only to liquids, therefore for many substances this determination is not required.”   
3.3.5 Water solubility (R.7.1.7) is a significant relevant property for nanomaterials, and in 
many cases its determination is compatible with the determination of the state of 
agglomeration, ideally by the method of simple sedimentation. At strong 
agglomeration, the material would be considered 'not dispersible', which is the 
nanomaterial analogue of 'not soluble'. The state of agglomeration is determined by 
the surface modification / functionalisation shell, not necessarily by the particulate 
core of the nanomaterial. The same applies to the water solubility in the sense of 
dispersability.  Water Solubility may change between as-produced and as-tested 
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materials (which could incorporate an as dosed / as exposed stage, and at the 
point(s) of interaction with the organism), so in situ characterisation is required. 
REACH guidance takes that into account already.  We noted that SCENIHR (Risk 
Assessment of Products of Nanotechnologies; 28th plenary on 19 January 2009) 
devotes a major part of the 2009 report to the spontaneous changes of properties 
and strongly supports the need for in-situ characterisation, in the sense of 
characterisation in the biological test environment and indicated that currently 
available standard methods for measuring dissolution may not be applicable.  
However, OECD concluded that the test guideline relevant to characterising the 
water solubility (OECD TG 105) might be applicable under some circumstance or to 
some classes of manufactured nanomaterials.  It stated that this TG is applicable to 
solutions but it is not known how the results might be impacted by the presence of a 
colloidal suspension, which might be present if the sample manufactured 
nanomaterial does not completely dissolve. Hence, further work is required to 
determine this and to modify the TGs, if necessary (ENV/JM/MONO(2009)21).   
3.3.6 For the methods to determine the partition coefficient n-octanol/water (R.7.1.8) to be 
applicable to nanomaterials, the OECD methods acknowledged in the Guidance 
would need to be revised.  SCENIHR (Risk Assessment of Products of 
Nanotechnologies; 28th plenary on 19 January 2009) finds that the octanol-water 
partition coefficient Kow is likely to have a limited role in predicting water-solids 
partitioning.  All OECD guidelines on this property are marked as applicable under 
some circumstances or to some classes of manufactured nanomaterials in 
OECD_15 Preliminary Review of OECD Test Guidelines for their Applicability to 
Manufactured Nanomaterials, ENV/JM/MONO(2009)21).  The property is 
determined by the presence of the substance in an oil-water interface.  The 
possibility of a particle’s surface changing with age and exhibiting different 
partitioning behaviour may result in the measurement being somewhat artificial with 
limited predictive value for environmental fate. 
3.3.7 Granulometry (R.7.1.14) is, without doubt, the central issue for any nanomaterial.  
This property may change from as-produced, hence as-tested (or in situ) 
characterisation is required.  Consideration of the adequacy of the definition of 
granulometry used in the Guidance and the appropriateness of incorporating 
properties distinct from purely size distribution characterisation, has been 
undertaken as part of Task B2.  Methods specifically mentioned (Cascade impaction 
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"A well established techniques to measure the distribution of particles of respirable 
or inhalable size particles of all kind, size range: 0.1-20 and 0.5-80 microns", Laser 
scattering/diffraction "The method is suitable to determine the distribution of 
particles of respirable and inhalable size. Particles of all kind Size range: 0.1-100 
microns"; Rotating drum method (BS EN 15051) do not cover the range below 
100nm.  Hence they are not adequate to generate data on nanomaterials.  The 
important properties of surface area, state of agglomeration, shape, size & length 
(particle / platelet / fibre etc) are already acknowledged in the REACH Guidance 
under granulometry (Table R.7.1-30 Methods to determine particle size distribution 
of the material as it is), but there is a need of explicit guidance for granulometry of 
nanomaterials.  
3.3.8 For adsorption/desorption (R.7.1.15), the definitions used can be applied with 
minimal changes also to a dispersed (not dissolved) substance such as a non-
soluble nanomaterial.  However, the guidance document states that the methods 
may not be suitable for: i) substances that react with the column, ii) solvent or other 
test system components, iii) surface active substances; iv) substances that interact 
in a specific way with inorganic soil components such as clay minerals; v) inorganic 
compounds; and vi) moderate to strong acids and bases.  Nanomaterials may be 
close in their properties to clay minerals, surface active substances and inorganic 
compounds.  All methods require a quantitative analytical method for the substance, 
reliable over the range of test concentrations.  This presents an issue for many 
nanomaterials, if identification both by chemical nature and physical structure is to 
be performed. A practical solution for most cases is the elemental analysis, e.g. by 
ICP-MS of fractions, since most nanomaterials contain inorganic elements. Similar 
techniques (FFF-ICP-MS) have been developed for ecotoxicology sample 
characterisation, but are far from ISO or OECD standardisation (compare Hasselöv 
et al, Ecotoxicology (2008) 17:344–361). 
3.3.9 Conclusions Concerning Toxicological Information 
3.3.10 The toxicological data requirements under REACH that are further described in the 
corresponding guidance documents R.7a and R.7c are also relevant for the 
assessment of nanomaterials (summarised in Annex 2 of RNC/RIP-
oN2/B1/2/FINAL). According to OECD WPMN and SCENIHR, the described and 
preferred OECD test guidelines to fulfil these data requirements are basically also 
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applicable for the assessment of nanomaterials (SCENIHR, 2007 and 2009; OECD 
WPMN, ENV/JM/MONO(2009)21). 
3.3.11 Concerning toxicological tests, special attention needs to be given to measuring, 
dosing, delivery and tracking of nanomaterials in the test system. Furthermore, 
concerning toxicological endpoints it is also important to consider the 
physicochemical characteristics of the nanomaterial, including in the dosing vehicle. 
Therefore, there is a need for guidance on sample preparation and in situ 
characterisation for the toxicological assessment of nanomaterials. 
3.3.12 For all toxicological tests, an adequate characterisation of the tested nanomaterial 
should be carried out and appropriate consideration of the actual exposure of the 
test system (e.g. allowing for possible agglomeration/disagglomeration) and the 
appropriate dose metric should be given. 
3.3.13 With regard to non-testing data, it should be noted that non-testing approaches such 
as (Q)SAR, read-across etc are currently not applicable to nanomaterials, because 
available models and understanding of issues such as similarity are not 
trained/developed to properly address nanomaterials. As such their use will require 
scientific justification. However, the possibility to extrapolate certain information from 
studies conducted with bulk forms of the substance or modifications of the 
respective nanoforms which could influence the decision on testing or the testing 
strategy of the nanomaterial should be addressed. Guidance on such a grouping 
approach for nanomaterials based on toxicological test results is currently not 
available and therefore needed. Research is needed on these issues so that 
appropriate guidance can be developed. 
3.3.14 According to OECD WPMN, studies on toxicokinetics of nanomaterials are important 
for the assessment of their potential health effects (OECD WPMN, 
ENV/JM/MONO(2009)21). Due to the current lack of knowledge concerning 
toxicokinetic behaviour of nanomaterials, especially concerning absorption, 
distribution and excretion, we propose to include newly developed methods in the 
guidance on toxicokinetics, e.g. barrier transfer methods  (ENRHES review, Stone et 
al., 2009), to assess, if appropriate, the toxicokinetic behaviour of certain 
nanomaterials. 
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3.3.15 Conclusions Concerning Ecotoxicological Information 
3.3.16 The current ECHA guidance document on Chemical Safety Assessment ECHA 
(2008) refers specifically to a number of OECD Test guidelines.  The 
appropriateness of these OECD Test guidelines as well as other guidelines have 
been reviewed by the OECD project ‘Safety Testing of a Representative Set of 
Manufactured Nanomaterials’ (ENV/JM/MONO(2009)21). OECD stated that: “For 24 
OECD ecotoxicity test guidelines, the subgroup for biotic effects section concluded 
that the guidance on preparation, delivery, measurement, and metrology is currently 
insufficient for testing of manufactured nanomaterials” (ENV/JM/MONO(2009)21, p. 
13). 
3.3.17 Currently 31 OECD guidelines exist for the determination of potential 
ecotoxicological effects of test substances in relevant environmental compartments 
(aquatic, terrestrial, sediment) after acute or chronic exposure. Endpoints 
determined in these studies, with a diverse set of species representing different taxa 
and environmental compartments, are mortality and non-lethal endpoints like 
growth, respiration, reproduction and development. The parameters determined in 
these studies generally reflect responses of complete organisms covering several 
modes of toxicity and often also several routes of exposure. Thus, the basic 
toxicological properties as well the endpoints described and determined in these 
guidelines are adequate and relevant also for nanomaterials. 
3.3.18 At the moment, 18 OECD test guidelines exist to determine environmental fate 
covering methods evaluating e.g. ready biodegradability (OECD 301 A-F) to further 
guidelines on physico-chemical properties which will influence substance behaviour 
in the environment (e.g. OECD 105 Water Solubility, OECD 107/117/123 Octanol-
water Partition Coefficient; OECD 111 Hydrolysis; OECD 106/121 Adsorption to soil 
or sediment). OECD test guidelines also exist for bioconcentration (OECD 305) and 
bioaccumulation methods (OECD 315, 317). For the environmental fate 
assessment, a pre-requisite for biodegradation is that the test material is based on 
organic carbon chemistry (for bulk chemicals as well as for nanomaterials). 
Furthermore, the test strategy and studies used in this assessment may need to be 
adapted to the particulate nature of nanomaterials dispersed in water or the test-
specific test media. 
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3.3.19 Within the RNC/RIP-oN2/B1/2/FINAL report, and in the conclusions of the OECD 
WPMN document ENV/JM/MONO(2009)21, it was noted that many of the majority 
of the OECD test guidelines are applicable (in some cases with conditions). 
However, the guidance given on preparation, delivery of test substances to test 
system, exposure quantifications, dose metrics, measurement, and metrology in all 
of these test guidelines is currently insufficient for testing of nanomaterials. 
Therefore preliminary guidance notes have been developed in the OECD-WPMN for 
practical testing (ENV/JM/MONO/201025 Preliminary Guidance Notes on Sample 
Preparation and Dosimetry for the Safety Testing of Manufactured Nanomaterials). 
3.3.20 Currently, research also suggests that particle number, size distribution, surface 
area, charge and other surface characteristics might be better predictors of toxicity, 
and more accurate metrics to be used in statistical determinations of dose-response 
relationships than (mass) concentration. Given the historical and established use of 
(mass) concentration as a dose metric, it continues to be important in assessing 
dose-response relationships and modelling toxic effects, however, its usefulness in 
particle toxicology depends not least on knowledge of the nature of the substance 
under test.  Sample preparation and delivery issues are complicated by the stability 
and consistency of the properties of nanomaterials in the various exposure media 
used.  Due to the current uncertain situation, a combination of dose metrics is 
recommended for nanomaterial testing. In general, the current test guidelines do not 
provide adequate direction for monitoring the characteristics of nanomaterials over 
the duration of tests. (ENV/JM/MONO(2009)21 Preliminary Review of OECD Test 
Guidelines for their Applicability to Manufactured Nanomaterials). 
3.3.21 (Q)SAR analyses are mentioned in the guidance documents R.7b and R.7c as 
another way to fulfil the information requirements, but models currently used are not 
applicable because they were not designed for specific nanomaterial characteristics.  
3.3.22 Field studies in ecotoxicity and environmental fate can contribute significantly to the 
environmental hazard and risk assessment of nanomaterials and are therefore also 
listed as a possible source of information.  Due to the present uncertainties 
regarding analytical characterisation (e.g. distinction between background 
concentration and nanomaterial), exposure quantifications, dose metrics and a 
generally low environmental concentration, field studies are not recommended. 
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3.3.23 The solubility of a test substance is a key parameter in defining the test strategy for 
determining ecotoxicity and environmental fate for bulk material; for nanomaterials 
the stability of a dispersion is the equivalent key parameter.  A soluble nanomaterial 
would loose its particle characteristics when dissolved and exposure conditions 
would not be discernible from dissolved bulk material.   
3.3.24 Conclusions Concerning Classification, Labelling & Packaging (CLP) 
3.3.25 The Regulation on Classification, Labelling and Packaging of substances and 
mixtures (CLP Regulation) (EC) No 1272/2008 does not contain specific provisions 
for nanomaterials nor for particulate materials but some guidance on classification of 
metal powders can be found in its Annex IV.  However, nanomaterials are covered, 
as in REACH, by the definition of substance and therefore the provisions of CLP 
apply to nanomaterials as well. Moreover, the CLP recognises the potential impact a 
change in physicochemical properties might have on the intrinsic properties of a 
substance, see Articles 5 and 9.5.  In doing so the CLP requires the manufacturer or 
importer to first ensure that the information used to classify relates to the forms or 
physical states in which the substance is placed on the market and in which it can 
reasonable be expected to be used.  Secondly, CLP requires additional testing 
relating to physical hazards (explosivity, flammability, etc) to be performed if such 
information is missing or not adequate to conclude on a classification.  
3.3.26 With regard to nanomaterials, if information only exists for coarser materials it 
should be assessed whether this information is also applicable to nanomaterials, 
due to the impact of the increased surface area on physicochemical properties.  
Information derived by registrants to fulfil the registration requirements in REACH, 
according to Annexes VII-IX and following the methods in the Test Methods 
Regulation (EC/440/2008), may not be sufficient to determine all physical hazards in 
accordance with CLP.  Any evaluation of particulate (nano)materials in the context 
of CLP regulation should be conducted in accordance with the principle of using the 
worst case scenario where the finest relevant fraction of the form and physical 
states as placed on the market, should be used when testing for physicochemical 
hazards, Article 33.4.1.4.3.5 in the Manual of Test and Criteria (the Orange Book) 
(United Nations New York and Geneva, 2009).  
3.3.27 Based on the opinions expressed by OECD (ENV/JM/MONO(2009)20, 
ENV/JM/MONO(2009)21, ENV/JM/MONO(2010)25) and the SCENIHR (2007), it is 
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considered that in general there are no significant differences in the applicability of 
the standard test methods themselves between nanomaterials and conventional 
substances.  However, this report has highlighted a number of considerations in 
relation to sample preparation, dosing vehicle and the actual exposure of the test 
system and these consideration remains the same also for any test method 
preformed under CLP.  Nevertheless, the impact of an increased surface area on 
physicochemical properties should be given thorough consideration when 
determining the physical hazards.   
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3.3.28 Summary table of physico-chemical data requirements in REACH and guidance documents 
Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested 
OECD methods REACH 
Guidance 
reference number 
 
Annex VII (required for substances manufactured or imported above 1 t/y): 
Flash point -  - R.7.1.9 
Flammability  O  Apply methods stated R.7.1.10 
Explosive properties  O  Apply methods stated R.7.1.11 
Self-ignition temperature  O  Apply methods stated R.7.1.12 
Oxidising properties O  Apply methods stated R.7.1.13 
Boiling point  O  Apply methods stated R.7.1.3 
Melting/freezing point O  Apply methods stated R.7.1.2 
Vapour pressure  O  Apply methods stated R.7.1.5 
Relative density  O  Apply methods stated R.7.1.4 
Surface tension  -  - R.7.1.6 
Partition coefficient n-octanol/water O  Modify TG107, TG117, TG123 R.7.1.8 
Water solubility  + + Modify TG105  R.7.1.7 
Granulometry  + +  R.7.1.14 
Annex VIII (required for substances manufactured or imported above 10 t/y): 
Adsorption/desorption screening +  Modify TG106, TG108, TG121 R.7.1.15 
Annex IX (required for substances manufactured or imported above 100 t/y): 
Stability in organic solvents O   R.7.1.16 
Dissociation constant O  Modify TG112 R.7.1.17 
Viscosity -  - R.7.1.18 
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3.3.29 Summary table of toxicological data requirements in REACH and guidance documents 
Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
Test methods / 
OECD test guidelines 
REACH Guidance 
reference number 
 
 
 
 
 
Annex VII (required for substances manufactured or imported above 1 t/y): 
Toxicokinetics + 1) OECD TG 427/ EU B.44: (Skin 
Absorption: In Vivo Method)  
OECD TG 428/EU B.45: (Skin 
Absorption: In Vitro Method) 
OECD TG 417/EU B.36: 
(Toxicokinetics) 
R.7.12 
 
Acute toxicity o 
(increased solubility?) 
1) Oral:
OECD TG 420 (EU B.1 bis) (Acute 
oral toxicity – Fixed dose procedure) 
OECD TG 423 (EU B.1 tris) (Acute 
oral toxicity – Acute toxic class 
method) 
OECD TG 425 (Acute oral toxicity – 
Up-and-down procedure) 
R.7.4 
 
Skin Irritation  O 1) In vitro:
OECD TG 430/EU B.40 
(Transcutaneous Electrical 
Resistance (TER using rat skin) test)  
OECD TG 431/EU B.40 bis (Human 
Skin Model tests (EPISKIN™, 
EpiDerm™)) 
OECD TG 435 (In vitro Membrane 
Barrier test method, Corrositex®) 
OECD TG 439 (Human Skin Model 
tests (EPISKIN™, EpiDerm™)) 
R.7.2 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
Test methods / 
OECD test guidelines 
REACH Guidance 
reference number 
 
 
 
 
 
Annex VII (required for substances manufactured or imported above 1 t/y): 
Eye irritation  O 1) In vitro:
Isolated rabbit eye (IRE) test 
OECD TG 438: Isolated chicken eye 
(ICE) test 
OECD TG 437: Bovine corneal 
opacity & permeability (BCOP) test 
Hen’s egg test – chorio-allantoic 
membrane (HET-CAM) test 
R.7.2 
 
Skin Sensitisation O 1) OECD TG 429/EU B.42: Murine 
Local Lymph Node Assay (endorsed 
method) 
OECD TG 406/EU B.6: Guinea pig 
maximisation test (GPMT) and 
Buehler test 
OECD TG 442A: Local Lymph Node 
Assay: DA 
OECD TG 442B: Local Lymph Node 
Assay: BrdU-ELISA 
R.7.3 
Genetic Toxicity 
 
In vitro gene 
mutation in 
bacteria 
O 1) OECD TG 471/EU B.13/14: Bacterial 
reverse mutation test 
R.7.7 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
Test methods / 
OECD test guidelines 
REACH Guidance 
reference number 
 
 
 
 
 
Annex VIII (required for substances manufactured or imported above 10 t/y, in addition to requirements according to Annex VII): 
Acute toxicity 
 
(either dermal or inhalation depending 
on what is most appropriate based on 
exposure) 
+ 
 
 
 
 
 
 
 
 
 
 
 
O 
1) Inhalation:
OECD TG 403 (EU B.2) (Acute 
inhalation toxicity) 
Draft OECD TG 433 (“Acute 
Inhalation Toxicity, Fixed Dose 
Procedure”) 
Draft OECD TG 436 (“Acute 
Inhalation Toxicity, Acute Toxic 
Class Method”) 
ICH compliant studies; mechanistic 
and toxicokinetic studies; studies in 
non-rodent species 
Dermal: 
OECD TG 402 (EU B.3) (Acute 
dermal toxicity) 
Draft OECD TG 434 (“Acute Dermal 
Toxicity, Fixed Dose Procedure”) 
ICH compliant studies; mechanistic 
and toxicokinetic studies; studies in 
non-rodent species 
R.7.4 
Skin Irritation  O 1) In vivo:
OECD TG 404, Acute Dermal 
Irritation/Corrosion 
Commission Directive 2004/73/EC, 
Method B4, Acute Toxicity: Dermal 
Irritation/Corrosion 
R.7.2 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 34 - 
Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
Test methods / 
OECD test guidelines 
REACH Guidance 
reference number 
 
 
 
 
 
Annex VIII (required for substances manufactured or imported above 10 t/y, in addition to requirements according to Annex VII):
Eye irritation  O 1) In vivo:
OECD TG 405, Acute Eye 
Irritation/Corrosion 
Commission Directive 2004/73/EC, 
EU B.5, Acute Toxicity: Eye 
Irritation/Corrosion 
R.7.2 
Repeated dose toxicity, short-term (28 
days) 
 
(either oral, dermal or inhalation 
depending on what is most appropriate 
based on exposure) 
o 
 
 
o 
 
 
+ 
1) Oral: 
OECD TG 407 / EU B.7 
 
Dermal:  
OECD TG 410 / EU B.9 
 
Inhalation:  
OECD TG 412 / EU B.8 
Short-term inhalation test (5 days; 
Ma-Hock L et al., 2008; certified by 
OECD WPMN SG7) 
R.7.5 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
Test methods / 
OECD test guidelines 
REACH Guidance 
reference number 
 
 
 
 
 
Annex VIII (required for substances manufactured or imported above 10 t/y, in addition to requirements according to Annex VII):
Genetic Toxicity 
 
chromosomal 
aberration 
 
 
 
 
 
mammalian cell 
gene mutation 
 
 
 
 
 
 
chromosomal 
aberration 
 
 
 
 
DNA damage 
and/or repair 
o 
 
 
 
 
 
 
 
 
 
 
 
 
 
O 
1) In vitro: 
OECD TG 473/EU B.10: In vitro 
mammalian chromosome aberration 
test. 
OECD TG 487: In vitro mammalian 
cell micronucleus test. 
 
OECD TG 476/EU B.17: In vitro 
mammalian cell gene mutation test 
– HPRT test 
OECD TG 476/ EU B.17: In vitro 
mammalian cell gene mutation test 
– Mouse lymphoma assay 
 
In vivo: 
Somatic cells: 
OECD TG 475/EU B.11: In vivo 
mammalian bone marrow 
chromosome aberration test 
OECD TG 474/EU B.12: In vivo 
mammalian erythrocyte 
micronucleus test 
 
OECD TG 486/EU B.39: 
Unscheduled DNA synthesis (UDS) 
test with mammalian liver cells in 
vivo 
Germ cells (only on very rare 
occasions) 
R.7.7 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
Test methods / 
OECD test guidelines 
REACH Guidance 
reference number 
 
 
 
 
 
Annex VIII (required for substances manufactured or imported above 10 t/y, in addition to requirements according to Annex VII):
Toxicity to reproduction O 1) OECD TG 421: Reproductive 
screening study 
OECD TG 422: Combined repeated 
dose toxicity / reproductive 
screening study
R.7.6 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
OECD methods REACH Guidance 
reference number 
 
 
 
 
 
Annex IX (required for substances manufactured or imported above 100 t/y, in addition to requirements according to Annexes VII and 
VIII):
Repeated dose toxicity, sub-chronic 
(90 days)  
 
(either oral, dermal or inhalation 
depending on what is most appropriate 
based on exposure) 
o 
 
 
 
 
 
 
o 
 
 
 
 
+ 
1) Oral: 
OECD TG 408/409 / EU B.26/B.27 in 
rodent/non-rodent species, 
respectively 
OECD TG 422: 
Combined repeated dose toxicity / 
reproductive screening study 
Dermal:  
OECD TG 411/EU B.28 
OECD TG 422: 
Combined repeated dose toxicity / 
reproductive screening study 
Inhalation:  
OECD TG 413/EU B.29 
OECD TG 422: 
Combined repeated dose toxicity / 
reproductive screening study 
R.7.5 
Toxicity to reproduction O 1) One- or two- (or multi-) generation 
studies (such as B.35, OECD TGs 
415 or 416, or EU B.34 or a ‘F1-
extended one-generation study’) 
R.7.6 
Developmental Toxicity / teratogenicity O 1) OECD TG 414/EU B.31: Prenatal 
developmental toxicity test 
R.7.6 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
OECD methods REACH Guidance 
reference number 
 
 
 
 
 
Annex X (required for substances manufactured or imported above 1000 t/y, in addition to requirements according to Annexes VII, VIII, 
and IX): 
Repeated dose toxicity, long-term 
 
(either oral, dermal or inhalation 
depending on what is most appropriate 
based on exposure) 
o 
(only if indicated) 
1) OECD TG 452/EU B.30: Chronic toxicity 
study 
OECD TG 453/EU B.33: Combined 
chronic toxicity / carcinogenicity study 
 
R.7.5 
Carcinogenicity o 
(only if indicated) 
1) OECD TG 451: Carcinogenicity studies 
OECD TG 453/EU B.33: Combined 
chronic toxicity / carcinogenicity study 
US-EPA 870.4200: Carcinogenicity 
studies 
R.7.7 
 
1) Concerning toxicological endpoints important considerations need to be taken into account which particularly relate to the physicochemical 
characteristics of the nanomaterial, including in the dosing vehicle. For all toxicological tests, an adequate characterisation of the tested 
nanomaterial, appropriate consideration to the actual exposure of the test system, (e.g. allowing for possible agglomeration/disagglomeration) 
and consideration to the appropriate dose metric (if known) should be given. 
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3.3.30 Summary table of ecotoxicological data requirements in REACH and guidance documents 
Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
OECD methods 
REACH Guidance 
reference number 
 
 
 
Annex VII (required for substances manufactured or imported above 1 t/y): 
Aquatic toxicity O + OECD TG 202 Short-term toxicity  
testing on invertebrates (preferred 
species Daphnia) 
OECD TG 201 Growth inhibition study 
aquatic plants (algae preferred) 
R.7.8 
Degradation  O + OECD TG 301 Biotic  
 A-F 310 Ready biodegradability   
R7.9 
Annex VIII (required for substances manufactured or imported above 10 t/y, in addition to requirements according to Annex VII): 
Aquatic toxicity  O 1) OECD TG 203 Short-term toxicity 
testing on fish 
OECD 209 Activated sludge respiration 
inhibition testing 
R.7.8 
 
Degradation o 
 
1) OECD TG 302/303/305/306 Biotic 
OECD TG 111 Abiotic. Hydrolysis as a 
function of pH 
 
R.7.9 
 
Fate and behaviour in the environment  + 1) OECD TG 121 Absorption/ desorption 
screening 
R.7.1.15 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
OECD methods 
REACH Guidance 
reference number 
 
 
 
Annex IX (required for substances manufactured or imported above 100 t/y, in addition to requirements according to Annexes VII and VIII): 
Aquatic toxicity + 
 
 
 
 
 
 
 
 
 
 
1) OECD TG 211 Long-term toxicity 
testing on invertebrates (preferred 
species Dahpnia) unless already 
provided as apart of Annex VII 
requirements 
OECD TG 210 Fish early-life stage 
(FELS) toxicity test 
OECD TG 212 Fish short-term toxicity 
test on embryo and sac-fry stages 
OECD TG 215 Fish juvenile growth test 
R.7.8 
Degradation  O 1) OECD TG 309 Simulation testing on 
ultimate degradation in surface water 
OECD TG 307 Soil simulation testing 
(for substances with a high potential for 
adsorption to soil) 
OECD TG 308 Sediment simulation 
testing (for substances with a high 
potential for adsorption to sediment) 
 
[No test method specified] Identification 
of degradation products 
R.7.9 
Fate and behaviour in the environment  O 1) OECD TG 305 Bioaccumulation in 
aquatic species, preferably fish 
OECD TG 106 Further information on 
adsorption/desorption depending on the 
results of the study required in Annex 
VII 
R.7.10 
R.7.1.15 
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Properties with REACH data 
requirements 
Property relevant for 
nanomaterials? 
 
-   redundant or not 
relevant 
o   as for any substance 
+   specifically relevant 
Property may 
change from as-
produced to as-
tested1) 
OECD methods 
REACH Guidance 
reference number 
 
 
 
Annex IX (required for substances manufactured or imported above 100 t/y, in addition to requirements according to Annexes VII and VIII): 
Effect on terrestrial organisms o 
 
 
 
1) OECD TG 207 Short term toxicity to 
vertebrates  
OECD TG 216/217 Effects on soil 
micro-organisms 
OECD TG 208 Short-term toxicity to 
plants 
R.7.11 
 
Annex X (required for substances manufactured or imported above 1000 t/y, in addition to requirements according to Annexes VII, VIII, and 
IX): 
Degradation  o 
 
1) OECD TG 302/303/304/306 Biotic e.g, 
further simulation testing 
R.7.9 
Fate and behaviour in the environment o 
 
1) [No test method specified] Further 
information on the environmental fate 
and behaviour of the substance and/or 
degradation products 
 
R.7.10 
R.7.1.15 
Effect on terrestrial organisms O 1) OECD TG 220/222 Long-term toxicity 
testing on invertebrates unless already 
provided as part of Annex IX 
requirements 
R.7.11 
 
1) Concerning toxicological endpoints important considerations need to be taken into account which particularly relate to the physicochemical 
characteristics of the nanomaterial, including in the dosing vehicle. For all toxicological tests, an adequate characterisation of the tested 
nanomaterial, appropriate consideration to the actual exposure of the test system, (e.g. allowing for possible agglormeration/disagglomeration) and 
consideration to the appropriate dose metric (if known) should be given. 
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3.4 ADDITIONAL RELEVANT SPECIFIC INTRINSIC PROPERTIES FOR 
NANOMATERIALS (TASK B2) 
3.4.1 It is important to acknowledge that in identifying additional relevant specific intrinsic 
properties for nanomaterials, consideration has been given to how the existing 
Information Requirements included in REACH (considered in Task B1) could reflect 
any new or refined (i.e. improved or clarified description in the guidance) intrinsic 
properties specific for nanomaterials, without unnecessarily duplicating the effort 
and repeating content developed for Task B1.  This has involved acknowledgement 
of the definitions provided in the legal text and guidance (and in nomenclature 
standards as necessary) and current regulatory status of some intrinsic properties, 
so that acceptable and pragmatic recommendations can be made regarding whether 
additional relevant specific intrinsic properties of nanomaterials could and should be 
addressed under the existing Information Requirements or as new ones.   
3.4.2 It is arguable, from a technical/scientific definitions perspective, whether some of the 
candidate additional relevant specific intrinsic properties identified may be 
considered logically under the term ‘granulometry’ (used to describe an already 
existing Information Requirement (IR)).  The only ISO definition of granulometry 
(sourced from the ISO Concept Database; http://cdb.iso.org) is a “measure of the 
particle (grain) content of irrigation water, as characterized by size dispersion and 
total amount of solids”.  No definition of the term ‘granulometry’, including the one 
purported (but not explicitly stated) to be a definition in the current REACH 
Guidance (section R.7.1.14), extends beyond the consideration of a size distribution 
of grain sizes.  Hence, the logic of including intrinsic properties technically unrelated 
to characterising particle size distribution under the existing Information 
Requirement ‘granulometry’ (even in the context of them being particle-associated 
properties), may be questionable and has led the Consortium to suggest the option 
of a limited amendment of the title of an existing Information Requirement.  With a 
more appropriate choice of term (in a similar vein to those adopted for the toxicology 
and ecotoxicity Information Requirements), this could facilitate the inclusion of a 
range of particle-associated properties as subordinate IRs, with provisions in 
Column 2 for the introduction of specific rules for adaptation from Column 1 in 
Annexes VI to X, as appropriate.  Alternatively, a robust definition of the term 
‘granulometry’ is required to be developed and adopted to facilitate the inclusion of 
additional particle-associated subordinates to the existing Information Requirement 
for Granulometry.   
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3.4.3 However, it is noted that Annex II to Regulation (EC) No 1907/2006 has been 
amended and now explicitly states in Section 9.1 that “The physical state (solid 
(including appropriate and available safety information on granulometry and specific 
surface area if not already specified elsewhere in this safety data sheet), liquid, gas) 
and the colour of the substance or mixture as supplied shall be indicated.”  The 
inclusion of specific surface area as a separate term distinct from granulometry in 
the amendment of Annex II is observed.  For specific surface area at least, 
confusion (or even a suggestion of heightened importance) may arise, albeit minor, 
when the property is seen to be stated separately from granulometry in Annex II but 
as subordinate in the guidance, if this were to be the case.  This ambiguity is simply 
highlighted, for resolution by regulators in their future considerations. 
3.4.4 Identifying Potential Additional Relevant Specific Intrinsic Properties for 
Nanomaterials 
3.4.5 The debate over which parameters to use to characterise nanomaterials has been 
ongoing for some years.  The task report’s discussion highlights that in many 
instances the suggestions are generic (e.g. surface chemistry). Furthermore, they 
are made in the absence of a) any detailed understanding of the characteristic, b) 
the relevance and applicability of any interpretable data on the characteristic (should 
it be available), and c) the availability of a technique to gather such data.   
3.4.6 Of the numerous sources considered and commented on in RNC/RIP-
oN2/B2/2/FINAL (including reports from ILSI, ECETOC, SCENIHR, VCI, OECD, and 
RIVM amongst others and more generally in the literature), the ‘pathfinding’ body 
identifying, developing and establishing properties and endpoints for nanomaterials 
hazard assessment is the OECD WPMN and its Sponsorship Programme on the 
Testing of Manufactured Nanomaterials.  In 2008, a list of endpoints was 
recommended by the OECD-WPMN (ENV/JM/MONO(2010)46) for the first phase of 
testing that is intended to take into account ‘human health and environmental safety’ 
and ‘ensure consistency between the various tests to be carried out on specific 
nanomaterials’.  OECD stated that it should also lead to the development of dossiers 
for each selected nanomaterial describing basic characterization, fate, ecotoxicity 
and mammalian toxicity information.  It was acknowledged that the list of endpoints 
should be refined based on the practical results obtained through the testing 
programme and as such, phase one testing was expected to be of an exploratory 
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nature, science-based and without any consequences for existing regulatory 
datasets.  (It is anticipated that incorporation of such refined recommendations and 
methods into appropriate OECD Guidance Documents will be forthcoming.) 
3.4.7 A particular complex issue identified, including by the OECD-WPMN, concerns the 
stability of nanomaterials in the context of i) sample preparation for the 
determination of properties and ii) the behaviour of nanomaterials in the 
environment.  Information on these two aspects is absent from REACH Guidance, 
and has been determined to be of crucial importance in the context of gathering 
characterisation data for Information Requirement purposes.   
3.4.8 A number of suggested physico-chemical ‘properties’ have been identified as having 
a greater bearing on the quality of determining a characteristic or (eco)toxicological 
test outcome, due to its influence on sample preparation considerations.  These 
include dispersion stability and state of agglomeration, which may also be important 
phenomena, in a physico-chemical sense, which influence the behaviour of 
nanomaterials in environmental media.  These have been highlighted before being 
subsequently addressed in recommendations for Guidance amendment as part of 
Task B5.  We suggest that their importance as supplementary information to the 
data gathered for the Information Requirement is acknowledged in the Guidance, 
but not necessarily as additional Information Requirements in their own right, due to 
their supplementary nature (i.e. non-intrinsic), their dependence upon other primary 
properties, and the need for further research and development of applicable 
methods as well as the interpretation of the primary data for these properties (and 
how it may inform the interpretation of data on existing Information Requirements) in 
the context of risk assessment.  Nevertheless, it is acknowledged that such 
supplementary information may importantly advance and facilitate the use of 
responsible waiving, read-across, and QSARs, and the ability to select appropriate 
metrics that in turn widens the relevance and applicability of test methods to 
nanomaterials.   
3.4.9 Furthermore, many biological effects may be only indirectly or non-causatively 
associated with a property or properties being measured.  The potential for 
confounding in the assessment of a nanomaterial’s hazard and exposure is 
particularly pertinent in the context of sample preparation and the limitations of 
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experimental techniques for characterisation and assessment of hazard and 
exposure.   
3.4.10 Conclusions Concerning Additional Relevant Specific Intrinsic Properties For 
Nanomaterials 
3.4.11 Potential additional relevant specific intrinsic properties have been identified on the 
basis of an objective review of published scientific sources of information, and a 
pragmatic and rationalised approach to their incorporation into REACH has been 
suggested.  By virtue of their inclusion in this final report they are considered to be 
relevant to nanomaterials.  For more in-depth considerations and details of the 
additional relevant specific intrinsic properties and how they have been identified in 
Task B2 and considered further in subsequent Tasks, the reader is referred to the 
relevant reports for Task B2, B3, B4 and B5.   
3.4.12 Moreover, some properties or endpoints recommended in the sources considered in 
Task B2 for nanomaterials testing are not strictly intrinsic properties or the proxy-
effect of a single intrinsic property, but are influenced by the material’s ‘conditions’ or 
‘environment’ in which the characterisation or testing is being done, and as a result 
can significantly impact on the determination, relevance and quality of other intrinsic 
properties or endpoints.  These properties, indicated with an asterisk in the 
summary table below, have not been formally considered in the gap analysis 
conducted in Task B4, but are considered to warrant acknowledgement in updated 
guidance and recommendations have been made.  It is also recognised that other 
aspects, such as assay interferences, also influence the determination, relevance 
and quality of intrinsic properties or endpoints, but as these cannot be defined as 
properties or be justified as a specific Information Requirement.  Recommendations 
on issues related to sample preparation and assay interference were identified in 
Task B2 and subsequently have been further elaborated in the recommendations for 
Guidance update in Chapter 4.   
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Candidate property / endpoint 
Suggested IR ‘incorporation’ status 
Possible 
New IR 
Subordinate 
to an existing 
(E) or 
updated (U) 
IR 
Guidance 
recommendation 
(with or without 
an update to the 
appropriate 
Column 2 rule) 
Particle shape  U/E (7.14)  
Surface area  U/E (7.14)  
Surface energy  U/E (7.14)  
Surface chemistry  U/E (7.14)  
Surface charge  U/E (7.14)  
Redox potential    
Cell-free ROS/RNS production 
capacity    
State of dispersion*    
(7.14 & 9.3) 
State of agglomeration*    
(7.14 & 9.3) 
Cell uptake*    
(8.3, 8.4, 8.8) 
Cell viability    
(8.1, 8.2) 
Oxidative stress    
(8.4, 8.5, 8.6) 
Inflammation    
(8.1, 8.2, 8.5, 8.6) 
Fibrosis    
(8.6) 
Immunotoxicity (sensitisation)    
(8.3) 
Cardiovascular toxicity  E 
(8.6)  
Ventilation rate#    
(9.1) 
Gill pathologies#    
(9.1) 
Mucus secretion#    
(9.1) 
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Candidate property / endpoint 
Suggested IR ‘incorporation’ status 
Possible 
New IR 
Subordinate 
to an existing 
(E) or 
updated (U) 
IR 
Guidance 
recommendation 
(with or without 
an update to the 
appropriate 
Column 2 rule) 
Brain pathology#    
(9.1 & 9.6) 
Animal behaviour#    
(9.1 & 9.6) 
Oxidative stress biomarkers (CAT, 
SOD, GPX, GST)#   
 
(9.1 & 9.6) 
 
 *Properties or endpoints recommended in the sources considered in Task B2 for nanomaterials testing are not 
strictly intrinsic properties or the proxy-effect of a single intrinsic property, but are influenced by the material’s 
‘conditions’ or ‘environment’ in which the characterisation or testing is being done, and as a result can significantly 
impact on the determination, relevance and quality of other intrinsic properties or endpoints.   
#In relation to these endpoints and proposed biological markers it should be noted that consensus has not been 
reached within the project consortium and further discussions can be found in section 4.3.157 onwards.  
3.4.13 For the additional relevant specific intrinsic properties identified, an assignment has 
been made in the summary table above according to: 
 whether a new formal Information Requirement is recommended, or; 
 whether the property can be considered to be subordinate to an existing 
(E) Standard Information Requirement of Annex VI-X or following an 
update (U) to an existing Information Requirement, or; 
 whether, acknowledging that the information should be gathered as part of 
good practice, this may be ensured through an update to existing 
Guidance (with or without a statement in Column 2 of the REACH annexes 
alongside an existing Information Requirement).   
3.4.14 Where an existing Information Requirement has provisionally been considered to be 
appropriate for gathering of additional property/endpoint information, a cross 
reference to the existing IR in Annex VI-X of the legal text has been provided in 
parentheses.   
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3.4.15 In summary, on the basis of the evidence considered and extensively described in 
the Task B2 report, the additional relevant specific intrinsic properties identified to 
offer valuable supplementary information to interpreting and using other 
characterisation or endpoint data, in the REACH context, are highlighted in the table 
above.   
3.4.16 The gap analysis conducted under Task B4 has assessed the identified additional 
relevant specific intrinsic properties regarding whether they can be determined using 
a) standard test guideline methods, b) non-standard test methods already in use, or 
through methods already being developed or that need to be developed through 
further research.   
3.4.17 Proposals for updates to the Guidance on Information Requirements and Chemical 
Safety Assessment have been developed under Task B5 and provided in the 
corresponding report and in this Final Project Report.  Suggestion of specific text to 
update the legal text is out with the remit of the project.   
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3.5 PRACTICAL ADVICE ON THE RELEVANCE AND APPLICABILITY OF EXISTING 
INFORMATION IN FULFILLING REACH INFORMATION REQUIREMENTS (TASK 
B3) 
3.5.1 A comprehensive review of information sources identified in Task A was carried out 
and presented in the task report (RNC/RIP-oN2/B3/2/FINAL), first into four Sections 
in accordance with the sequence of objectives / sub-tasks (the peer-reviewed 
literature is reported separately from FP6/7 projects), and then by relevance to 
physico-chemical information, toxicological information and ecotoxicological 
information.  Concluding summaries of the practical advice, distilled from across 
each of sources and organised by property/endpoint, are reproduced below.   
3.5.2 B3 Sub-Task I: Summary of Practical Advice on the Relevance and 
Applicability of the Experience Reported in FP6/7 Projects in the REACH 
Context 
3.5.3 PHYSICO-CHEMICAL PROPERTIES INFORMATION 
3.5.4 Key characterisation issues and properties 
3.5.5 It is evident from the review of the FP6/7 project outputs that there is now a 
consensus that thorough and accurate particle characterisation is an essential 
component of assessing the potential (eco)toxicity of nanomaterials, and it is 
generally indicated that the characterisation of test materials should be broad in 
scope and as thorough as possible. 
3.5.6 Within the FP6/7 projects undertaken to date, the following properties of 
nanomaterials were deemed necessary for characterisation prior to 
(eco)toxicological and/or exposure investigations: elemental composition, purity, 
primary particle size/particle size distribution, aggregation/agglomeration state, 
surface area, surface charge, crystallinity/crystal phase, surface chemistry (primarily 
in terms of surface functionalisation and coatings), solubility and dustiness.  The 
explosivity and flammability of nanopowders, and methods for its determination, has 
also been investigated in a single FP6 project (NANOSAFE2).  Thus, in terms of the 
existing physico-chemical REACH Information Requirements and guidance, the 
FP6/7 outputs may be of use for informing any necessary changes to the guidance 
on Water Solubility (R.7.1.7), Flammability, Explosive Properties and Self-Ignition 
Temperature (R.7.1.9-R7.1.12) and Granulometry (R.7.1.14).  No information has 
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been identified pertaining to the other existing REACH physico-chemical Information 
Requirements and associated guidance. 
3.5.7 Within the FP6/7 project outputs, several publications have been identified which 
provide useful overviews and comparisons of the most common methods for the 
physico-chemical characterisation of nanomaterials, citations for and details from 
which are of relevance for further consideration into relation to the updated REACH 
Guidance (ECHA, 2008. Chapter R.7a), specifically: 
o Chapter 2 of the ENRHES review (Stone et al., 2009); 
o The NanoCap guide on “Measurement Techniques for Nanoparticles” 
(University of Essex, undated); 
o The NANOSH “NanoAtlas of Selected Engineered Nanoparticles” (Vippola 
et al., 2009); 
o Reviews by Fadeel & Garcia-Bennett (2010) and Gwinn & Tran (2009). 
3.5.8 An important general conclusion with regards nanomaterials characterisation that 
has emerged from the findings of the several of the reviewed FP6/7 project outputs 
(e.g. Stone et al., 2009; Tran et al., 2008; University of Essex, undated) is that no 
individual technique can satisfy a meaningful characterisation of nanomaterials such 
that multiple techniques should be used where possible in order to formulate a 
complete understanding of the nanomaterial properties. It is highlighted that different 
techniques will suit different sample forms (e.g. aerosol, suspension etc.) and the 
optimum set of required techniques should be selected based on the specific 
nanomaterial type and form under investigation.  The need for multi-method 
characterisation and material-specific selection of techniques applies across a range 
of nanomaterial properties will be stressed within the updated REACH Guidance 
documents.   
3.5.9 Zuin et al. (2010) developed an evidence-based approach for undertaking a 
preliminary ranking of nanoparticles in terms of their hazard potential.  This involves 
assigning a hazard rating of high, moderate or low to a specific nanoparticle across 
a range of “indicators” (physico-chemical or toxicological endpoints), according to a 
ranking table. 
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3.5.10 The WoE approach developed in PARTICLE_RISK has the potential to inform the 
choice of “triggers” for hazard testing based on nanomaterial type in the context of 
REACH.  However, the current ranking values were based on measurement data 
which differed in their uncertainty and reliability, and it is unlikely that sufficient data 
will be available for some time to enable a robust system to be developed, and 
further research data is required to enable a robust system to be developed. 
3.5.11 It has also been highlighted that further data is required (regarding the toxicity and 
mode of action of nanomaterials, as well as descriptors for characterising their 
structure) before the traditional (Q)SAR paradigm can be extended to nanomaterials 
(Burello & Worth, 2009), and this is therefore recognised as a further development 
need. 
3.5.12 Sample preparation 
3.5.13 The preparation of stable nanoparticle dispersions has been highlighted within the 
FP6/7 project outputs as an important and cross-cutting issue spanning across 
toxicological and ecotoxicological testing and this issue should be further considered 
in relation to recommended updates to the REACH Guidance (ECHA, 2008. Chapter 
R.7). Of key concern is that ions in the physiological media may influence the zeta 
potential and thus destabilise the nanoparticle dispersion resulting in agglomeration.  
This therefore alters the particle size distribution which may then bias the 
(eco)toxicological test result (NanoCare, 2009). 
3.5.14 In relation to this issue, it has been suggested that it is not sufficient to simply 
characterise the intrinsic properties of the nanomaterial (i.e. chemical composition, 
primary particle size, surface chemistry etc) but that many facets of the preparation 
of nanoparticle dispersions must be taken into account before physiological assays 
with nanoparticles can be correctly interpreted including: a suitable dispersion 
protocol; agglomerate size distribution and agglomeration state; zeta-potential; 
wettability and tendency to agglomerate/deagglomerate due to absorption of solvent 
compounds and; desorption of solvent compounds with possible influence on 
passivation, solubility and molecular recognition (NanoCare, 2009; Schultze et al., 
2008). 
3.5.15 A number of projects have published protocols/SOPs that provide useful guidance 
for the preparation and characterisation of stable nanoparticle dispersions in 
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physiological media, specifically Meiβner et al. (2009a), NanoCare (2007, 2008 and 
2009), Bihari et al. (2008) and Vippola et al. (2009b).  Citations to and information 
from these documents are useful in relation to updating the REACH Guidance.  
However, these procedures cannot be universally applied to all nanomaterials and 
certain modifications to the procedures may be required for different nanomaterials. 
It is therefore important to stress that such procedures should be carefully examined 
to determine if they are adequate for the test material under consideration.  
3.5.16 Particle size/size distribution 
3.5.17 The review of the outputs of FP6/7 projects has allowed identification of several 
commonly applied methods for determining the particle size/size distribution of 
nanomaterials in powder, suspension and aerosol form. 
3.5.18 For powders, the following methods have been identified as common methods for 
determining the particle size of nanoparticles: transmission electron microscopy 
(TEM), scanning electron microscopy (SEM), X-ray diffraction (XRD) and atomic 
force microscopy (AFM).  For determining the particle size distribution of 
nanomaterials in powder form, TEM, SEM, scanning mobility particle sizer (SMPS), 
Field Flow Fractionation (FFF), Laser Diffraction Particle Size Analyser and Photon 
Correlation Spectroscopy (PCS) have been identified as available methods. 
3.5.19 For nanomaterials dispersed in suspension, the particle size has been commonly 
determined using SEM and atomic force microscopy (AFM) in the FP6/7 projects.  
Less commonly applied methods include cryo-TEM, cryo-SEM and Fluorescence 
Correlation Spectroscopy (FCS).  For determining the particle size distribution of 
nanomaterials in suspension, Dynamic Light Scattering (DLS), PCS, and 
nanoparticle tracking analysis (NTA) are commonly applied methods, whilst 
Analytical Ultracentrifuge (AUC), Hydrodynamic Fractionation (HDF) and cryo-TEM 
have also been utilised but to a lesser extent.  However, it is important to note that 
Fadeel & Garcia-Bennett (2010) suggest that SEM/TEM often do not reflect the 
average particle size values that may be measured in solutions or biological media 
containing dispersed particles, with the authors suggesting that DLS offers a more 
routine approach for measuring the average particles sizes in different media.   
3.5.20 In addition to the particle size/size distribution of dispersed nanomaterials, the 
effective hydrodynamic diameter (which takes into account the layer of biological 
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molecules on the surface of the nanoparticle) has also been suggested as an 
important parameter to characterise for biological applications, as bigger particles 
may not be able to enter pores of a certain size (Sperling et al., 2007).  This 
parameter may be important to consider in relation to the update of the REACH 
guidance and requires further investigation.  However Sperling et al. (2007) 
conclude that the more molecules attached to the particle surface and the bigger the 
particles become, the more unreliable the measurements are.  Thus, depending on 
the actual particle nature, the adequate method for measurement has to be chosen 
with great care.  Different measurement methods to measure effective sizes of 
colloidal nanoparticles are based on different physical principles, resulting in 
deviations of the resulting particle diameters between the different methods.  These 
difficulties should be taken into consideration. 
3.5.21 For aerosols of nanomaterials, the particle size may be determined using aerosol 
time of flight microscopy.  Commonly utilised methods for determining the particle 
size distribution of nanoaerosols include the differential mobility analyzer and 
scanning mobility particle sizer (SMPS).  Methods such as the electrical low 
pressure impactor (ELPI), Optical Particle Counter (OPC), Aerosol Particle Sizer 
(APS), Fast Mobility Particle Sizer (FMPS) have also been used, although 
somewhat less frequently.   
3.5.22 The cascade impactor may also be used to determine the mass median 
aerodynamic diameter (MMAD) of aerosols.  Ma-Hock et al. (2007) have highlighted 
that, although this method is well established for fine particles with diameters in the 
micrometer range, it fails to describe the dimension of nanoparticles as they no 
longer follow aerodynamic rules.  However, this method is still valuable for inhalation 
studies with nanomaterials, as the cascade impactor can be used to determine the 
MMAD of agglomerates.  In addition, it is noted that assembling the data of the 
measurements from different methods (e.g. OPC, SMPS) to provide a whole picture 
of the particle size distribution may not be appropriate due to the different principles 
employed by the methods (Ma-Hock et al., 2007).  However, data from both 
methods are still valuable in providing information about particle size distribution 
relative to the amount of aerosol in their respective measurement ranges.   
3.5.23 Also important to take into account is that considerable evolution of nanoaerosols 
has been demonstrated to occur over time, with average particle size increasing (as 
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a result of agglomeration) and concentration decreasing, such that nanoparticles will 
be present in size classes other than those in which they were originally emitted (Wu 
et al., 2008).  Thus, in workplace studies, it is not sufficient to look for nanoparticles 
in the nano size range in which they may have been originally emitted, but that the 
size range the agglomerates formed over time also need to be considered. 
3.5.24 Information regarding a potential link between particle size/size distribution and the 
toxicological effects of nanomaterials has been identified as part of the ENRHES 
review (Stone et al., 2009).  In addition, Zuin et al. (2010) outlined the following 
relationship between primary particle size and deposition potential: 
o Particles with size < 10 nm were considered indicative of high deposition, as 
more than 80% of the particles may be retained in three regions of the 
human respiratory tract (i.e. extrathoracic, tracheobroncal and alveolar) if 
inhaled; 
o Particles with size between 10-30 nm were considered indicative of 
moderate deposition, as between 80% and 60%  of inhaled particles are 
deposited in the human respiratory tract; 
o Particles with size > 30 nm were considered indicative of low deposition, as 
less that 60% of the inhaled nanoparticles may be retained. 
3.5.25 Zuin et al. (2010) have also defined the following relationship between primary 
particle size and translocation potential: 
o Particles with sizes < 2.5 nm were considered indicative of high translocation 
potential; 
o Particles with sizes between 2.5 – 5 nm were considered indicative of 
moderate translocation potential; 
o Particles with sizes > 5 nm were considered indicative of low translocation 
potential. 
3.5.26 Within the toxicokinetic studies undertaken as part of the PARTICLE RISK project, 
translocation to other organs beyond portal of entry following intratracheal instillation 
or intravenous injection in rats was determined to be strongly dependent on both the 
size and surface area of gold nanoparticles (Kreyling, undated). Particle size was 
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also suggested to be a critical factor in the assessment of toxicological and 
biological responses of WC-Co materials (Ding et al., 2009).   
3.5.27 Aggregation/agglomeration state 
3.5.28 The review of the outputs of FP6/7 projects has allowed identification of several 
commonly applied methods for determining the aggregation/agglomeration state of 
nanomaterials in powder and suspension form. 
3.5.29 Commonly applied methods for determining the aggregation degree of nanomaterial 
powders include SEM and TEM.  For determining the agglomeration state and 
dispersion stability of nanoparticles in solution, zeta potential measurements are 
often employed.  However, Meiβner et al. (2009a, 2009b and 2010) conclude that 
zeta potential measurements alone are not sufficient for predicting the stability of 
nanoparticles in physiological suspensions, recommending that measurements of 
the particle size distribution are also undertaken using DLS.  It has been suggested 
that a method for measuring the strength of the agglomerates is needed (Wu et al., 
2008), and this will be considered as a potential development need. 
3.5.30 Several projects have suggested that the behaviour and effects of agglomerated 
nanoparticles are important to assess in relation to their potential toxicity (Ma-Hock 
et al., 2007; Wu et al., 2008; Stone et al., 2009), such that studies focusing on the 
toxicity of agglomerates and their stability should be considered as a potential 
development need.  In addition, in relation to nanoaerosols, agglomeration over time 
has been demonstrated in the NANOTRANSPORT project to be of key importance 
to consider in relation to their particle size distribution and in the exposure 
assessment.   
3.5.31 Surface area 
3.5.32 The review of the outputs of FP6/7 projects has allowed identification of the 
Brunauer, Emmet and Teller (BET) method as the most commonly applied 
technique for determining the specific surface area of nanomaterials in powder form 
(providing also providing additional information on average pore size and pore 
volume) information about which may be of relevance for inclusion into the updated 
REACH Guidance.  The surface area of nanoparticle aerosols has been 
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demonstrated to be determined using the nanoparticle surface area monitor 
(NSAM), which is a similar method to the Electrical Aerosol Detector. 
3.5.33 Surface area has been highlighted as an important property in relation to the toxicity 
of nanoparticles, as increased surface area relates to increased potential for 
biological interaction (Stone et al., 2009).  The potential relationship between 
surface area and (eco)toxicological effects has been discussed further in Section 4 
of RNC/RIP-oN2/B3/2/FINAL, taking into account further information available in the 
peer-reviewed literature. 
3.5.34 Surface charge 
3.5.35 Based on the review of FP6/7 project outputs, it is evident that various instruments 
are available for determining the zeta potential of dispersed nanomaterials, such as 
the Zetasizer 3000 HAS. 
3.5.36 It has been suggested by Zuin et al. (2010) that it is essential to measure zeta 
potential as a function of pH, as this allows the determination of the point of zero 
charge (PZC; the pH value where the zeta potential equals zero) where a dispersion 
of engineered nanomaterials exhibits the highest propensity to aggregate.   
3.5.37 Several FP6/7 projects have suggested that the zeta potential is an important 
parameter to characterise, usually in relation to assessing whether engineered 
nanomaterials in suspension remain stable during exposure in toxicity studies (e.g. 
Zuin et al., 2010; Stone et al., 2009).  Based on evidence available in the peer-
reviewed literature, Zuin et al. (2010) outlined the following relationship between 
zeta potential and stability: 
o Nanoparticles with zeta potential at pH 7 of > +30 mV or < -30 mV were 
considered to have high water stability (i.e. no aggregation over time); 
o Nanoparticles with zeta potential at pH 7 of between -30 mV and + 30 mV 
were considered to have a low water stability (i.e. tendency to aggregate 
over time). 
3.5.38 The surface charge of nanoparticles has also been reported as being an important 
factor influencing particle uptake and interaction with exposed cells (Stone et al., 
2009). The potential relationship between surface charge and (eco)toxicological 
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effects has been discussed further in Section 4 of RNC/RIP-oN2/B3/2/FINAL, taking 
into account further information available in the peer-reviewed literature. 
3.5.39 Shape/aspect ratio 
3.5.40 The shape of nanoparticles has been suggested to be an important property to 
characterise in relation to nanoparticle toxicity and fate within a number of literature 
reviews identified as outputs from FP6/7 projects (Stone et al., 2009; Burello & 
Worth, 2009).  However, no studies investigating the relationship between shape 
and (eco)toxicity have been identified as outputs from the reviewed FP6/7 projects.   
3.5.41 Surface chemistry 
3.5.42 The most commonly characterised property in the FP6/7 project outputs reviewed in 
relation to surface chemistry is determination of the nature of surface 
functionalisation and coatings.  Spectroscopic techniques such as Nuclear Magnetic 
Resonance (NMR), Infrared, UV-Vis and Raman Spectroscopy have been utilised 
for this purpose.  In a single project (PARTICLE RISK), the “surface activity” was 
also characterised using electron spin resonance (ESR) (Marcomini, 2007). 
3.5.43 In addition, three studies have been identified in which the surface reactivity of TiO2, 
gold and ferrihydride nanoparticles has been modelled using discrete Fourier 
transform (DFT) (Burello & Worth, 2009).  However, significant differences between 
the experimental data and the calculated values were seen and thus this method is 
concluded to be of limited value/reliability at present for aiding prediction of the 
surface chemistry of nanomaterials in the context of REACH. 
3.5.44 The influence of coating and surface functionalisation of various nanomaterial types 
on toxicological effects has been highlighted as part of the ENRHES review (Stone 
et al., 2009). In addition, it has been suggested that the presence of hydrophilic 
surface groups on the surface of nanoparticles may be used as an indicator of their 
reactivity (in relation to their potential uptake and bioaccumulation) according to the 
following relationship (Zuin et al., 2010): 
o Particles possessing hydrophilic surface groups were considered to be highly 
reactive, as the reactive groups of the particle surface are likely to modify the 
exposure; 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 58 - 
o Particles without reactive surface groups were considered to be of low 
reactivity. 
3.5.45 Dustiness 
3.5.46 The review of the FP6/7 outputs reveals that the measurement of the dustiness of 
the nanomaterial powders has been carried out using the rotating drum and 
continuous drop methods currently suggested in the REACH Guidance chapter for 
granulometry for the measurement of airborne dispersed or nebulised particles 
(ECHA, 2008. R.7.1.14, Table R 7.1-31) (Vippola et al., 2009; Jensen et al., 2009).  
However, studies undertaken as part of the NanoCare project suggest a need for 
modified versions of these tests to be used for determining the dustiness of 
nanomaterials (NanoCare, 2009; Stahlmeche et al., 2009).   
3.5.47 Results of agglomerate stability studies under various sheer forces has suggested 
that the deagglomeration of nanoparticles depends on a multitude of factors, 
including the nanoparticle material and its modification, such that general 
conclusions regarding the propensity of nanomaterials to release particles smaller 
than 100 nm cannot be made (NanoCare, 2009).  Thus, in assessing the dustiness 
behaviour of nanomaterials, each material must be investigated on a case by case 
basis.  This is important to highlight in the updated REACH Guidance on 
granulometry, and may have negative implications for the use of read across in 
relation to dustiness data for nanomaterials. 
3.5.48 Explosivity/flammability 
3.5.49 Within the FP6/7 projects outputs, two dissemination reports have been identified to 
provide valuable information and guidance for assessing and characterising the 
explosivity and flammability of powder-based nanomaterials, citations for and 
information from which should be used to inform the updated REACH Guidance. 
3.5.50 It is highlighted that most nanopowders display high reactivity characteristics that 
can lead to fire or explosion accidents, providing support to suggest that the 
“Explosive Properties” Information Requirement is as relevant for nanomaterials as 
for bulk materials (Bouillard et al., 2008).  The following properties have been 
defined as important for estimating the explosivity risk of nanomaterials (Bouillard, 
2008): 
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o Particle size, size distribution and shape; 
o Surface area and surface charge; 
o Particle and surface composition. 
3.5.51 Investigations of the oxidation of CNT have been demonstrated using differential 
scanning calorimetry (DSC) and isothermal kinetic studies in order to determine the 
onset combustion temperature. These methods are in accordance with those 
suggested in the guidance (ECHA, 2008. R7.1.11.2) for providing supplementary 
data to support an explosivity assessment for bulk materials.   
3.5.52 However, several commonly applied methods for explosivity studies have been 
highlighted as unsuitable for nanopowders (Bouillard et al., 2008), namely: 
o current modified, open-ended Hartmann tubes (used to visualise ignition of 
powders and measure the minimal ignition energy), due to the potential 
release of nanoparticles during the experiment;  
o current falling hammer equipment used to measure mechanical stability with 
regards to shock/impact. 
3.5.53 The limitations and unsuitability of these methods for nanomaterials will be 
considered further in relation to the updated REACH guidance, and any details of 
potential replacement method(s) that can be obtained from Bouillard et al. (2008).  
3.5.54 According to Bouillard et al. (2008), the explosion sensitivity and severity of carbon 
black powders, aluminium nanoparticles and carbon nanotubes can be assessed 
using a 20 L explosion sphere in accordance with standards including the American 
Society for Testing and Materials Methods E 1226 and the National Fire Protection 
Association Standard 68 or German Society of Engineers (VDI) Method 3673.   
3.5.55 They suggested that the oxide layer on aluminium nanopowders may render them 
less explosive than micropowders, CNT may exhibit similar explosion severities and 
sensitivities as coals, food flours and carbon black, and nanopowders which tend to 
agglomerate exhibit explosion characteristics of the same order of magnitude as 
micropowders of the same substance (Bouillard et al., 2008).  However, there is not 
enough supporting evidence available in the publication to judge whether there may 
be the potential for read-across of explosivity data from bulk equivalents for certain 
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nanomaterials.  In addition, it is suggested by others that read-across of explosivity 
data from bulk materials to nanomaterials is not possible, since nanomaterials may 
have explosive properties which are solely due to the small particle size (RIVM, 
2009). 
3.5.56 Solubility and release of metals ions 
3.5.57 ICP-MS has been demonstrated as a useful method for studying the solubility of 
powdered nanomaterials in various solvents (NanoCare, 2009).   
3.5.58 The use of linear regression and multi-linear regression to predict the solubility of 
carbon nanotubes and fullerene in a range of organic solvents has been described 
(Burello & Worth, 2009).  However, many of the studies showed significant 
differences between the experimental data and the calculated values and these 
methods are therefore of limited value/reliability at present for supporting the 
fulfilment of REACH information requirements. 
3.5.59 The water solubility of the fullerenes has been suggested to be related to anti-
oxidant/cytoprotective or pro-oxidant/cytotoxic properties, such that the greater the 
water solubility of the fullerene sample the lower the toxicity (although this situation 
is complicated by the presence of residual solvents which also appeared to 
contribute towards the observed toxicity) (Stone et al., 2009).  The release of silver 
ions from nanoparticulate silver has also been suggested to be a realistic prospect, 
responsible for their antibacterial properties and potentially linked to the observed 
toxicity (Stone et al., 2009).   
3.5.60 TOXICOLOGICAL INFORMATION 
3.5.61 Within the FP6/7 projects undertaken to date, a range of endpoints have been 
examined relating to standard information requirements for human toxicity within 
REACH. These include: acute toxicity, repeated dose toxicity, toxicokinetics, 
mutagenicity, carcinogenicity & reproductive toxicity. No information regarding other 
REACH Information Requirements (such as dermal and respiratory sensitisation 
and irritation) was identified. Almost all projects also consider the non-standardised 
endpoints of cell viability, oxidative stress, pro-inflammatory effects in vitro.  
3.5.62 Within the FP6/7 project outputs, several publications have been identified which 
provide useful overviews and comparisons of the most common methods for the 
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human health hazard testing of nanomaterials, citations for and details from which 
are of relevance for incorporation into the updated REACH Guidance (ECHA, 2008. 
Chapter R.7a), specifically: 
Chapter 6 of the ENRHES review (Stone et al., 2009); 
 Nanocare review on the in vivo and in vitro assessment of nanotoxicology 
(Kroll, 2009) 
 Nanocare review on the issues related to genotoxicity assessment of NMs 
(Landsiedel et al, 2009).  
 Review by Gwinn & Tran (2009). 
3.5.63 The outputs and recommendations of the FP6/7 projects indicate that both in vitro 
and in vivo findings of projects have identified clear variations in fate and biological 
effect according to nanomaterial type.  
3.5.64 In addition, it is notable that for many NM, any toxicity exhibited may result from 
multiple mechanisms. For example, the ENRHES project notes that metal oxide 
nanoparticle toxicity is thought to be inflammogenic, oxidative, and genotoxic in 
mechanism; with all endpoints considered to be inherently linked. Testing for NM 
toxicity within REACH should therefore consider this complexity of mechanism in 
the experimental approach adopted.  
3.5.65 In addition, there also exists a strong consensus from projects that thorough and 
accurate particle characterisation of nanoparticles prior to commencing toxicological 
testing is an essential component of understanding their potential toxicity. 
3.5.66 R.7.2 Skin- and eye irritation/corrosion and respiratory irritation, & R.7.3 Skin 
and respiratory sensitisation 
3.5.67 To date, no information of specific relevance to this information requirement has 
been identified within the outputs of those FP 6&7 projects reviewed. However, the 
Nanoderm project, which aimed to develop new techniques and methodologies to 
complement high resolution transmission microscopy (HRTEM), undertook a 
number of studies to examine dermal penetration by NMs, and in vitro testing to 
investigate damage at the cellular level. This included monitoring for cell 
proliferation, apoptosis, necrosis, expression of adhesion molecules, and 
differentiation).  
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3.5.68 The project concluded that there was no indication that diffusive transport of 
nanoparticles occurred, thus suggesting that existing techniques such as static 
Franz-diffusion cell (OECD 428) might not be suitable to study nanomaterial 
permeation into the skin. Moreover, the project consortium suggested that 
standardised protocols to study mechanical flexion need to be developed to study 
dermal penetration of nanomaterials. 
3.5.69 Within the NANOSH project, exposure in healthy and immune-compromised mice 
(asthmatic model) using a 28 day repeated-dose testing assay (discussed in detail 
within the repeated-dose IR summary), it was found healthy animals expressed an 
immune and cytokine medicated response to TiO2, whereas compromised 
(asthmatic) animals showed suppression of most mediators of allergic asthma when 
exposed. Its results suggest that TiO2 modulates airway inflammation depending on 
allergic status and coating of the nanoparticles.   
3.5.70 R.7.4 Acute toxicity 
3.5.71 A number of FP6/7 projects undertook short term exposure studies both in vivo and 
in vitro. Although the exposure periods were not within a 24hour period, their results 
are nonetheless which are relevant to the acute toxicity IR. Notable examples are 
detailed below: 
3.5.72 In vivo  
3.5.73 The Nanocare developed a short term inhalation study in the rat (short inhalation 
exposures over 5 days, followed or not by a recovery period of 21 days), in order to 
provide an earlier screening of particle toxicity compared to the typical 90-days 
study. Endpoints of cytotoxicity & inflammation were monitored, via analysis of 
broncho alveolar lavage fluid (BALF). The results of this study indicated that the 
effects observed in the lung with TiO2 were similar in this short term inhalation study 
as in typical sub-chronic inhalation studies (such as that outlined within OECD 
TG412). From this pilot study, the authors recommended that analysis be carried 
out at day 3 of exposure, and at 21 days after the end of exposure. Their proposed 
minimal selection of endpoints for inclusion was BALF differential cell count, total 
protein, LDH, GGT and glucosaminidase activities. The authors also suggested that 
haematology and respiratory tract histopathology, which are required in OECD 
studies, were not very sensitive in this short-term inhalation study. 
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3.5.74 The NANOSH project undertook 5 day inhalation exposure testing in mice using 
TiO2, silica coated TiO2, SWCNT, MWCNT and ZnO NPs in order to investigate 
endpoints of genotoxicity & pulmonary inflammation.  
3.5.75 The PARTICLE_RISK project undertook an acute in vivo assessment of 
inflammation and genotoxicity was via intra-tracheal instillation in compromised 
ApoE-/- mice (Jacobsen et al. 2009). 
3.5.76 The NanoKem project undertook work to develop an in vivo murine model for 
screening lung inflammation following intra-tracheal instillation (Roursgaard et al., 
2010).  Acute inflammation was assessed by BALF analysis. The authors also 
suggested that at 3 months BALF analysis and histopathology were sufficient to 
assess sub chronic lung inflammation.  
3.5.77 It is notable that in vivo acute inhalation exposures are not generally encouraged 
within REACH due to their animal welfare implications, and the general move 
towards weight-of-evidence approaches utilising pre-existing information and 
supported by QSAR and other non-animal data sources.  However, as there is little 
pre-existing information on nanomaterial toxicity any information generated by 
projects to date it is likely that the results of those in vivo investigations outlined 
above are of relevance to their evaluation within the context of REACH. 
3.5.78 In vitro 
3.5.79 Work is underway in a number of projects to develop in vitro assays to study 
relevant endpoints of acute toxicity. For example, the NANOSH project 
demonstrated that TiO2, silica coated TiO2, SWCNT, MWCNT and ZnO NPs were 
dose-dependently cytotoxic in macrophages and dendritic cells, and that the most 
significant induction of inflammatory mediators was in macrophages following 
nanoparticle exposure.  The PARTICLE_RISK project also investigated pulmonary 
inflammation and genotoxicity within pulmonary, endothelial and immune cell lines.   
3.5.80 Although at the current time no validated tests exist for in vitro acute toxicity, it is 
recognised that in vitro approaches would be important for the replacement of in 
vivo acute toxicity testing. Therefore, assays such as those utilised here may be 
both relevant and applicable after they will have gone through the appropriate 
validation and regulatory adoption processes. In addition, such approaches will 
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support the 3Rs principle in relation to the number of animals required for acute 
toxicology testing.  
3.5.81 R.7.5 Repeated dose toxicity 
3.5.82 In relation to repeated dose toxicity, the ENRHES project observed that in many 
published peer-reviewed studies a single dose was administered and toxicity 
assessed at a number of post exposure time points. However, it notes that repeated 
dose studies over a long time period are likely to be of greater relevance in 
consideration of the potential risk of fullerenes within occupational or consumer 
settings. 
3.5.83 Of those projects completed to date, the following outcomes are of particular 
relevance to consideration of repeated dose toxicity testing within REACH.  
3.5.84 In vivo 
3.5.85 The Nanocare project undertook a 28 day inhalation study within rats (followed by a 
90 day recovery period) using a protocol similar to that of OECD TG412 (Pauluhn, 
2009). Endpoints of cytotoxicity & inflammation were monitored. The protocol 
produced findings similar to those produced when carrying out repeated dose 
testing according to OECD TG413. ). The authors stressed the importance of 
having at least 3 months recovery post exposure in the study design, to allow 
assessment of pulmonary toxicity related to biopersistence of nanomaterials. In 
particular, the recovery period is essential in order to avoid misinterpretation of the 
results about retention-specific effect due to lung overloading. 
3.5.86 The NANOSH project also developed a (non-standard) 28 day repeated dose 
protocol.    Following inhalation exposure in healthy and immune-compromised 
mice (asthmatic model), the consortium found that particles accumulate in alveolar 
macrophages, and that of the nanomaterials tested, silica-coated TiO2 nanoparticles 
elicited a clear-cut pulmonary neutrophilia in healthy mice. Healthy animals 
expressed an immune and cytokine medicated response to TiO2, whereas 
compromised (asthmatic) animals showed suppression of most mediators of 
allergic asthma when exposed. Its results suggest that TiO2 modulates airway 
inflammation depending on allergic status and coating of the nanoparticles. The 
project therefore provides a repeated-dose testing protocol which may be of 
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relevance to NM toxicity within the context of REACH, and also information which is 
relevant to considering immune-modulated sensitisation.  
3.5.87 Projects underway with relevance to both acute and repeated toxicity testing 
3.5.88 Several of those FP6/7 project reviewed which are underway but yet to provide 
significant outputs include investigations which, once completed, are likely to be of 
relevance to both acute and repeated dose toxicity testing considerations for 
nanomaterials within REACH.  
3.5.89 Of those FP6/7 projects reviewed, the NANOMMUNE project is the only to focus 
solely on the immune aspects of NM toxicity. The project is undertaking an array of 
in vitro (murine and human cell lines, as well as primary and more complex co-
cultures of cell lines and/or primary cells) and in vivo (following exposure via the 
lung and skin) investigations, as well as transcriptomic and oxidative lipidomic 
profiling strategies to determine specific nanotoxic profiles (signatures) of these 
materials.  
3.5.90 In addition, as part of the NANOTEST project, investigations of immune toxicity are 
also underway. These include monitoring of lymphocyte proliferation, phagocytic 
activity, adhesion molecules and interleukins/cytokines.  
3.5.91 The outcomes of this work, once completed and published, should provide relevant 
information to developing testing strategies for consideration of immune toxicity 
within acute and repeated-dose testing paradigms.  
3.5.92 Also of relevance to both acute and repeated dose toxicity IRs, the NANOTEST 
project is working to develop alternative testing strategies and high-throughput 
toxicity-testing protocols using in vitro and in silico methods. In vitro screening tests 
being undertaken by the consortium are intended to provide alternatives to animal 
testing to a number of major target organs (blood, vascular system, live, lung, 
placenta, digestive system and central nervous system), via three main exposure 
routes (intravenous, respiratory and digestive).  In vivo, validation of in vitro testing 
protocols which investigate toxicity to the heart/aorta, liver, lung, brain, blood, 
spleen, and bone marrow, following a maximum of three doses by either 
intravenous injection, intratracheal instillation or per os administration route will be 
selected according to the medical use of the nanoparticles under consideration.. In 
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addition, in silico, development of quantitative structure-activity relationships 
(QSARs) and physiologically-based pharmacokinetic (PBPK) modelling for 
nanomaterials is underway. The outcomes of this work, once completed and 
published, should provide relevant information to further developing NM testing 
strategies within the context of REACH.  
3.5.93 R.7.6 Reproductive and developmental toxicity 
3.5.94 To date, there exists a limited body of work on the reproductive and developmental 
toxicity of nanomaterials. Of the preliminary work undertaken, the following 
experiments and results may be of use when considering testing of nanomaterials 
within the context of REACH.  
3.5.95 A study undertaken as part of the NanoInteract project (Park et al, 2009), examined 
the in vitro effects of silica nanoparticles on stem cell differentiation, with a focus on 
the uptake of particles by the cells and at their cytotoxic effect, using the WST-1 
assay.  One of the important features of this study is that it tested for potential 
interference of the material tested in the WST-1 assay.  Based on the results, the 
authors suggested that this in vitro embryonic stem cell differentiation test might be 
a valuable tool to test embryotoxicity of nanomaterials. 
3.5.96 In vivo work undertaken within the NanoKem project used a non-standard protocol 
to assess the effect of prenatal exposure to TiO2 nanoparticles in mice via 
inhalation (Hougaard et al. 2010). The study focused both on maternal and 
embryonic effects, and investigated endpoints including lung inflammation, 
quantification of Titanium in tissue and milk, and several behavioural tests. 
3.5.97 One published output of the NANOTEST project considers reproductive toxicity in 
vitro. Bhabra et al (2009), details results of in vitro work on the translocation and 
potential for genotoxic effects to be elicited by nanoparticles across the placental 
barrier. However, whilst the results of this work are interesting to the field from a 
mechanistic perspective, no results are of direct relevance to the consideration of 
NM within the context of REACH. 
3.5.98 R.7.7 Mutagenicity & Carcinogenicity 
3.5.99 The endpoint of mutagenicity/genotoxicity was frequently studied within the FP6 & 7 
projects using a variety of different assays and techniques. Amongst these were:  
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 The Comet assay – NanoInteract, NANOSH, PARTICLE_RISK, NANOTEST 
 micronucleus assay – NanoInteract, NANOSH, NANOTEST 
 lacZ assay – NanoInteract 
 FISH (fluorescence in situ hybridisation) – NANOSH 
3.5.100 Of the in vitro test methods outlined, the micronucleus assay (OECD test guideline 
474), comet assay, and chromosome aberration tests are specifically 
recommended as Information Requirements under REACH guidance. However it is 
recognised within the guidance that many protocols for mutagenicity are modified 
following expert judgement, or alternatives used as appropriate. 
3.5.101 As part of the Nanocare project, Landsiedel et al. (2009) published a review 
focusing on the issues related to genotoxicity assessment of NMs. This 
recommended that as the mechanisms triggering genotoxicity are numerous, the 
use of several assays in order to study the potential genotoxicity of any substance 
should be considered. It also highlighted that the most commonly used assay to test 
genotoxicity of nanomaterial was the comet assay, which at this time is not an 
OECD test guideline, but is undergoing validation by ECVAM. This was followed by 
the micronucleus assay, which was recently included in the OECD test guidelines 
collection.  
3.5.102 R.7.12 Guidance on Toxicokinetics 
3.5.103 With reference to toxicokinetics, the ENRHES project considered the toxicokinetics 
of uptake (ingestion, inhalation, dermal adsorption and injection), distribution, 
metabolism and excretion of for four key types of manufactured unfixed 
nanoparticles and nanotubes in and by the body (CNT, fullerenes, metals and metal 
oxides). Toxicokinetic aspects specifically considered included persistence and 
bioaccumulation potential of nanoparticles and nanotubes in the body; differences 
in toxicokinetics and any subsequent toxicity posed by variations in nanoparticle 
size, physical structure, chemical composition; mechanisms of interaction of 
nanoparticles with cells and their components, and partitioning within and between 
tissues in organisms.  
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3.5.104 Although the project did not itself generate any novel data, the body of evidence 
reviewed in ENRHES summarises a wealth of knowledge relating to the 
toxicokinetics of NM within the body, and draws conclusions on this. In particular, 
the review focussed on in vitro and in vivo studies using the lungs, skin, 
gastrointestinal tract (GIT), or blood as routes of entry, with the inclusion of sub-
sections which examine toxicity at a number of target organs following the 
realisation that nanomaterials can distribute from their exposure site within the 
blood or even nerves. As such, ENRHES represents one of the most 
comprehensive reviews of toxicokinetic data available to date, and is thus valuable 
to the consideration of NM within the context of REACH.  
3.5.105 The Nanocare project developed new in vitro models to assess the translocation of 
particles well as their interactions with the cells, both of which provide relevant input 
to the building of a toxicokinetic profile for nanomaterials.  
3.5.106 Using a range of cell types, the INOS project undertook in vitro studies which 
considered cell-particle interactions and translocation into the cellular 
compartments, outcomes of which may be of relevance to establishing toxicokinetic 
profiles of NM within the context of REACH.  
3.5.107 The NANOTEST project is undertaking in vitro investigations of uptake and 
intracellular distribution of NPs Uptake and intracellular distribution of NPs (using 
labelled NPs and endpoints of Phagocytic activity), and Transport of NPs across 
biological barriers (using TEER and diffusion). This work is underway thus there are 
no significant results to date.  
3.5.108 The PARTICLE_RISK project undertook investigation of translocation and effects of 
nanoparticles in vivo via three different routes of administration: (1) intratracheal 
instillation into the lungs (IT) or (2) intravenous injection into the tail vein or (3) intra-
oesophageal instillation (gavage) into the gastro-intestinal-tract (GI-tract). The 
results indicated that the pattern of nanoparticles biodistribution differed according 
to both administration route and physico-chemical characteristics.  
3.5.109 To investigate the potential neurotoxicity of NPs, the Neuronano project is 
undertaking a series of investigations relating to the physico-chemical properties of 
NM dictating their translocational potential and fate in vivo. To date, in vivo 
dosimetry studies have suggested that route of exposure, size and protein corona 
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around the nanoparticle are all influencing factors. However, to date, no significant 
translocation of nanoparticles into the brain has been shown. In vitro results show 
that transcytosis of nanoparticles is an energy-dependent mechanism which is a 
function of the cell polarisation of the system, and depends on many parameters 
such as the surface, size and protein corona.   
3.5.110 It is worth noting that some of the projects stress that the concept of “protein 
corona” associated with NMs forms one of the major differences between chemical 
and particle toxicity. According to these projects (NanoInteract, PARTICLE_RISK), 
such nanoparticle-protein is likely to be important in determining the “identity” of the 
nanomaterial and therefore its subsequent interaction with the environment, such 
as cellular uptake.   
3.5.111 Additional endpoints of specific relevance to NMs  
3.5.112 The following endpoints, although not specific Information Requirements, are 
considered to be of particular relevance to establishing toxicity of NMs and as a 
result are included in many of the FP6/7 projects reviewed. Relevant testing 
outcomes for each are discussed in detail within the B2 report. However, commonly 
utilised assays for each are highlighted below. 
3.5.113 Cell Viability 
3.5.114 The endpoint of cell viability was frequently studied within the FP6 & 7 projects 
using a variety of different non-standardized assays and techniques, and forms an 
important endpoint which should be further considered in relation to recommended 
updates to the REACH Guidance for toxicity testing (ECHA, 2008. Chapter R.7). 
Amongst those assays most commonly utilised were:  
 Cell Morphology - NANOTEST 
 BALF cell count & protein analysis (in vivo) - Nanocare 
 Cell metabolic activity (MTT) – Nanocare, Nanoderm, PARTICLE_RISK, 
NANOTEST 
 Cellular membrane integrity (LDH release) – Nanocare , PARTICLE_RISK 
 Lung cell damage (gamma glutamyl transferase; GGT) - Nanocare 
 TransEpithelial Electrical Resistance (TEER)  - Nanocare  
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 Apoptosis – NanoCare, Nanoderm 
 Necrosis - NANOTEST 
3.5.115 Oxidative Stress  
3.5.116 The initiation of oxidative stress has been frequently studied within the FP6/7 
project outputs, and forms an important endpoint which should be further 
considered in relation to recommended updates to the REACH Guidance for toxicity 
testing (ECHA, 2008. Chapter R.7). Amongst the non-standardised assays most 
commonly utilised were:  
 ROS Production – Nanocare, NANOTEST 
 Glutathione Status – Nanocare, PARTICLE_RISK, NANOTEST 
 NO Generation – NANOTEST 
3.5.117 Within the ENRHES project, the mechanism of toxicity associated with metal oxides 
was thought to be inflammogenic, oxidative, and genotoxic in nature; with all 
endpoints considered to be inherently linked. In addition, ENRHES highlighted that 
it appears fullerene toxicity also involves an oxidant driven response, thus 
suggesting that toxicity evaluations should evaluate the potential of fullerenes to 
cause oxidative stress and related consequences such as inflammation or 
genotoxicity (Johnson et al. 2010). CNT pathogenicity was noted to be most likely 
linked to their ability to elicit oxidative stress and inflammation.  
3.5.118 The INOS project undertook in vitro assays for oxidative stress, the outputs of 
which may be of relevance to supporting consideration of this outcome in its 
recommendation as a specific endpoint for consideration of nanomaterials within 
the context of REACH (justification is outlined within the B2 report). 
3.5.119 Pro-Inflammatory effects in vitro 
3.5.120 The investigation of inflammation has been commonly studied within the FP6/7 
project outputs, and forms an important endpoint which should be further 
considered in relation to recommended updates to the REACH Guidance (ECHA, 
2008. Chapter R.7). Amongst those assays most commonly utilised were:  
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 TNF-ɑ – Nanocare, PARTICLE_RISK 
 Trypan Blue assay – NANOSH 
 Cytokine production – NANOTEST, Nanocare, PARTICLE_RISK 
 Signalling pathways (NFκB, AP-1 etc) - NANOTEST 
3.5.121 The PARTICLE_RISK project also investigated pulmonary inflammation and 
genotoxicity within pulmonary, endothelial and immune cell lines.   
3.5.122 Within the ENRHES project, the mechanism of toxicity associated with metal oxides 
was thought to be inflammogenic, oxidative, and genotoxic in nature; with all 
endpoints considered to be inherently linked. CNT pathogenicity was also noted to 
be most likely linked to their ability to elicit oxidative stress and inflammation.  
3.5.123 The Nanocare project utilised a co-culture system to study pro-inflammatory 
response in vitro (via monitoring for IL-8 release).  Its results indicate that in vitro 
the use of a co-culture system as well as the use of lipopolysaccharide stimulation 
increases the sensitivity of the assay, in detecting pro-inflammatory potential of a 
nanomaterial.   
3.5.124 Mechanistic Aspects / Experimental Design  
3.5.125 All projects were in consensus that the physico-chemical characterisation of NMs to 
be tested for human health endpoints was imperative to enable a full interpretation 
of test results. This is discussed in detail within the physico-chemical 
characterisation section of RNC/RIP-oN2/B3/2/FINAL.  
3.5.126 In relation to study design, the ENRHES review noted that exposure method, dose 
administered, species used, cell type under investigations and light conditions also 
have the potential to impact on the toxicity of metal oxide particles.  In addition, the 
reviewers highlighted that experimental quality (including the concentrations used & 
model selected), of conducted studies is of vital importance when considering the 
risk associated with metal oxide exposure.  
3.5.127 The INOS project emphasised the importance of preliminary characterisation of the 
materials tested, in the media used, when assessing the hazard in vitro (Meissner 
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et al., 2009b). It also stressed that comparing toxicity test results from the salts of 
nanoparticles that contained metals to the particles themselves to establish whether 
the effect produced was linked to the NP or its salt. 
3.5.128 The Nanocare project developed several standard operating protocols (SOP) for 
bioassays, dispersion of the nanomaterial tested in relevant media and for cell 
exposure. This need to develop SOPs highlights the fact that current standard 
guidelines need to be adjusted for the testing of nanomaterials and/or that 
additional tests have to be carried out to avoid misinterpretation of results.  
3.5.129 In addition, the Nanocare project (Kroll, 2009) published a number of reviews on the 
in vivo and in vitro assessment of nanotoxicology, which highlights specific 
properties of nanomaterials which make them more prone to interfere with assays, 
and suggests that new standardised in vitro methods might need to be developed to 
assess the toxicity of nanomaterials which overcome such drawbacks. 
3.5.130 Finally, the IMPART project highlighted undertook a large review of the literature 
about nanotoxicity and highlighted several key issues related to the assessment of 
nanomaterial hazard.  Specifically in relation to experimental design and 
conduction, the project highlighted the need to consider interference of 
nanomaterials with toxicity assays, the importance of verification of oxidative stress 
as a marker for potential toxicity, modification of dosimetrics by particle 
aggregation, development of new strategies to determine the mechanisms of action 
for toxicity, and formation of models to predict potential impacts over their whole 
life-cycle (McCormack et al., 2008). All of these considerations are particularly 
relevant to hazard identification and characterisation within REACH.   
3.5.131 ECOTOXICOLOGICAL INFORMATION 
3.5.132 The key experience relevant to REACH from the FP6/7 projects is summarised 
below.  The advantages, limitations and applicability of which are being considered 
further within the gap analysis (Task B4) with a view to informing the updated 
REACH guidance.   
3.5.133 Only a few FP6/7 projects i.e. ENRHES, INOS and Nanointeract have reported 
results and/or used methods (i.e. fish cytotoxicity, growth inhibition of algae and 
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acute toxicity of crustaceans and fish embryos) that are relevant in regard to 
providing practical advice in the REACH context. 
3.5.134 As noted previously, it is evident from the FP6/7 projects with relevance for the 
ecotoxicity of NM that a thorough and accurate particle characterisation is an 
essential component of assessing the potential ecotoxicity of nanomaterials. 
3.5.135 Considered specifically, ENRHES, INOS and Nanointeract have underlined the 
importance of considering agglomeration behaviour over time in various form of 
medium and hence underline the importance of measuring the state of 
agglomeration both at the beginning and the end of the experiment (Kuhnel et al. 
2009, van Hoecke et al., 2009, Stone et al. 2009).  
3.5.136 An FP6/7 funded review of the scientific literature (ENRHES) has highlighted that 
changes in the metal speciation (association of a nanomaterial with a molecular or 
ionic dissolved chemical substance) can occur depending on redox conditions, salt 
content, etc. and this need to be determined and reported in order to enable to 
interpretation of the reported studies in a REACH context (Stone et al. 2009).  
3.5.137 It has furthermore been highlighted how the use of any solvents (for instance THF 
which was used in some of the first ecotoxicological studies on C60) should be 
avoided since, as for the mammalian toxicology studies, it has been demonstrated 
that not only nanoparticle/solvent interactions may affect ecotoxicity, but also solvent 
degradation products may be responsible for some of the observed effects. Instead 
of using solvents, extensive stirring and sonication can be used as alternatives to 
bring some nanoparticles in dispersion.  
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3.5.138 B3 Sub-Task II: Practical advice on the Relevance and Applicability of 
Experience Reported in the Scientific Literature on Nanomaterial 
Characterisation, Hazard Identification and Assessment for Workers, 
Consumers and Environment in the REACH Context 
3.5.139 PHYSICO-CHEMICAL PROPERTY INFORMATION 
3.5.140 Key characterisation considerations 
3.5.141 Based on a review of the scientific literature, it is evident that it is now widely 
acknowledged that adequate characterisation of a nanomaterial is necessary to 
accompany any toxicity study, particularly in cases where nanomaterials (e.g. 
carbon nanotubes) can be produced by different processes yielding notionally the 
same material, but which exhibit quite different properties (Zuin et al., 2007; 
Boverhof & David, 2010).   
3.5.142 Within the scientific literature, several publications have been identified which 
provide useful overviews and comparisons of the most common methods for the 
physico-chemical characterisation of nanomaterials, further details from which are of 
relevance for consideration in relation to the updated REACH Guidance (ECHA, 
2008. Chapter R.7a), specifically Nanoforum (2006) and Tiede et al. (2008) 
3.5.143 A number of key general points have been noted from the review of the scientific 
literature for further consideration in the gap analysis and subsequent guidance 
amendments: 
o Whilst characterisation of nanomaterials as-produced or as-supplied is the 
most direct and currently realistic approach to obtaining physico-chemical 
information about the material being studied, this data may not appropriately 
represent the properties of the material when in contact with the environment 
in which it is being observed, for example in air or physiological environments 
of in vivo or in vitro assays;   
o It has been suggested that adequate particle characterisation should be 
performed in three distinct phases, primary, secondary, and tertiary, where: 
primary characterisation is performed on particles as-synthesised or as-
received in its dry native state; secondary characterisation is performed on 
particles in the wet phase as a solution or suspension in aqueous media; 
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tertiary characterisations are performed on particles following interactions with 
cells under in vivo or in vitro conditions (Sayes and Warheit, 2009). 
o Characterisation after administration is particularly advantageous where the 
possibility of physico-chemical changes in the material before and after 
administration exists; 
o It is recognised that in many cases characterisation at the point of 
administration will remain to be essential for the comparison of studies;  
o The limitations of each analytical method for nanoparticle characterisation can 
lead to inconsistent results and, therefore, to inaccurate predictions of material 
properties and structure (Carter et al., 2005); 
o Nanoparticle sizing standards, as well as standardised methods for sampling 
and measurement, are urgently required to overcome the problem of 
inconsistent data (Borm et al., 2006); 
o The lack of consistent reference materials and standards further exacerbates 
this problem (Lead and Wilkinson 2006). Some progress has been made 
recently regarding reference materials for characterisation, but standardised 
nanoparticles are not yet widely available and researchers have to rely on 
commercially available, often not well-characterised, nanoparticles. 
3.5.144 Sample preparation 
3.5.145 Within the review of the scientific literature, sample preparation has been 
highlighted as one of the most critical steps towards successful characterisation of 
nanoparticles, in which there are many variables to consider when designing a 
method for preparation.  This issue is of key importance for further consideration in 
the gap analysis (Task B4) and proposals for amendments to the guidance.  In 
relation to this issue, key points to note are: 
o the need to have “reliable” sampling, such that a test alliquot is collected 
from a defined sample of particulate material that can be considered to be 
representative of the entire sample (NIST 960-1); 
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o Powder sampling is more difficult than sampling from suspension, but some 
general guidelines on powder sampling are available (Allen, 2001a and 
2001b); 
o Steps in the sample preparation will be governed largely by the 
requirements of individual measurement methods; 
o Ideally, samples for analysis should be free from the inherent aggregation 
problems associated with nanoparticles and other contaminants not 
associated with the said nanoparticles. However, to achieve such goals are 
not trivial; 
o The use of sonication to disperse nanoparticles in solution has the potential 
to change the size distribution of the nanotubes and introduce defects (Islam 
et al., 2001); 
o It is important to establish the ‘state’ of the sample required for analysis i.e. 
whether the nanoparticles should be fixed on to a solid substrate, 
suspended in liquid media or aerosolised (solid or liquid aerosols).   
3.5.146 A number sample preparation protocols and guidance for nanomaterials such as 
carbon nanotubes (Decker et al., 2009) have been emerging in the scientific 
literature.  However, these procedures cannot be universally applied to all 
nanomaterials and certain modifications to the procedures may be required for 
different nanomaterials. It is therefore important to stress that such procedures 
should be carefully examined to determine if they are adequate for the test material 
under consideration.  
3.5.147 Particle size/size distribution 
3.5.148 The current REACH guidance on particle size measurement (albeit with a focus on 
micron-sized particles) refers to the TG110 document published in 1981, with limited 
recognition of more modern particle sizing techniques.  The literature review has 
identified that there are many methods available for detecting and accurately 
characterising the size/size distribution of nanomaterials in powder form, suspension 
and aerosols.   
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3.5.149 A number of important points have been noted and will be taken forward for further 
consideration in the gap analysis and used to inform proposed amendments to the 
guidance, specifically: 
o It has been highlighted that different methods, based on different 
measurement principles, may yield different results when measuring the same 
nano-object or structural feature (Lövestam et al., 2010); 
o It has been recommended that measured particle size values should be 
regarded as ‘method-dependent’, and should be reported with sufficient detail 
on the analytical technique used to acquire the data and the applied protocol 
used to deduce the size from the measured raw data (Lövestam et al., 2010).  
This also applies to other physico-chemical properties in addition to particle 
size/size distribution measurement; 
o It is noted that no single technique can be considered to be without artefacts 
or can be employed in all cases when determining nanoparticle sizes, and it is 
thus recommended that the multi-analytical techniques and/or multiple 
preparation techniques should be used when characterising nanoparticles 
(Domingoes et al., 2009); 
o It is noted that Dynamic Light Scattering (DLS) does not provide a full particle 
size distribution. DLS measures fluctuations in the intensity of scattered light 
caused by Brownian motion, from which the hydrodynamic diameter is 
calculated, enabling estimation of the particle size distribution.  Thus, even 
though DLS does not measure particle size distribution directly, this method 
provides a good background for the estimation of the full particle size 
distribution.  The method also provides a number (the ‘polydispersity index’) 
indicating the polydispersity of the particle population. There are software 
routines available that facilitate the calculation of a particle size distribution 
from DLS data, but the adequacy and the comparability of these routines 
needs to be further evaluated (Lövestam et al., 2010).   
o Drying samples under vacuum for analysis using electron microscopy may 
alter the size and shape of the particles being characterised.  Plasma sputter-
coating the surface-adhered particles with a layer of a conducting material 
may modify the sample being characterised; 
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o The analysis of particles in solution has been advanced through the 
development of Environmental Scanning Electron Microscopy; this offers the 
potential for dispersed samples prepared for exposure/toxicological 
experiments to be characterised as well as limiting the need to dry samples 
which may influence the observed size distribution; 
o The quality of the images to be analysed using electron microscopy 
techniques is of critical importance and it should also be noted that electron 
microscopy normally provides only two-dimensional images, so care must be 
taken to avoid bias introduced by orientation effects. High-resolution 
microscopy may be subject to artefacts caused by sample preparation or 
special analysis conditions; 
o In aerosol physics, the most commonly used methods for particle sizing are 
differential electrical mobility (from about 10 – 1000 nm) and light scattering 
aerosol spectrometry (from 60 nm – 45 µm).  These methods allow 
determination of the equivalent aerodynamic diameter which may be different 
from the geometric diameter measured with microscopy techniques 
(Lövestam et al., 2010); 
o Relatively few toxicological studies published in the scientific literature have 
directly compared nanoparticulate and microparticulate forms of metals, which 
may limit establishing, at this time, the validity of read-across in the REACH 
context; 
o Overall, the size at which genuinely nanoscale properties are observed 
depends strongly on the material, and although most of these effects appear 
at sizes of 30 nm and below, no general limit can be given (Lövestam et al., 
2010).  As such, case-by-case studies are necessary for every material, since 
there is no direct, material-independent relationship between size and novel 
effects or functions. 
3.5.150 Aggregation/agglomeration state 
3.5.151 The aggregation/agglomeration state of nanoparticles affects the stability of 
nanoparticle dispersions prepared for (eco)toxicological experiments. The size of 
aggregate particles can be determined using many of the same methods described 
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above for ‘particle size/size distribution’ analysis, an overview of which is provided 
earlier in the “particle size/size distribution” and “aggregation/agglomeration state” 
sub-section of chapter 4.1 of RNC/RIP-oN2/B3/2/FINAL.   
3.5.152 In addition, a number of other important points have been noted and will be taken 
forward for further consideration in the gap analysis and used to inform proposed 
amendments to the guidance, specifically: 
o The state of dispersion (i.e. level of (de)agglomeration) is typically estimated 
using comparative particle size measurements, with shaking, sonication, 
and/or surfactants commonly used to disperse nanoparticles in solution.  
However, these tools may damage cells and interfere with toxicity testing if 
used in living systems (Powers et al., 2006); 
o The combined use of dielectrophoretic assembly and Raman spectroscopy 
has been suggested to be a more sensitive measure of the aggregation state 
of carbon nanotubes than either one of these methods alone (Kumatani and 
Warburton, 2008); 
o Surface energy, charge and solvation have been suggested to be relevant 
parameters to consider in relation to nanoparticle-nanoparticle interactions 
(SCENHIR, 2006). 
o The propensity of particles to aggregate has prompted researchers to prevent 
against its occurrence through the use of sonication, or inclusion of 
dispersants within particle suspensions, particularly in the case of CNTs.  
However, the relevance of considering monodispered CNT also requires 
consideration, since, if this is so difficult to achieve experimentally, the 
relevance to human and environmental exposure may be questionable. It 
might be more useful to achieve a CNT suspension with limited or controlled 
aggregation, promoting uniform, more easily characterisable exposure 
conditions for the model under investigation. In addition, the exposure route is 
likely to impact on the aggregation and agglomeration of CNT. For example, 
limiting the aggregation of CNT when generating aerosols is difficult, whereas 
a number of dispersants can be employed to improve the dispersion of CNT 
suspensions; 
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o The use of grinding to increase dispersion has been demonstrated to impact 
on both length and surface properties, and therefore toxicity of the MWCNT 
(Muller et al., 2005). 
o There is a difficulty in testing CNT toxicity due to their high propensity to 
aggregate and achieving a suspension or aerosol where individual CNT are 
contained is difficult.  It is therefore important to consider how interactions 
between CNT, which promote the formation of larger structures, impact on the 
toxicity of CNT; 
o Preliminary studies on the inclusion of commonly used surfactants (namely 
Pluronic L61, Pluronic L92, Pluronic F127, Tween 20, and Tween 60, at 
concentrations of 0.1-10%) in dispersions of MWCNT has illustrated that all 
surfactants (with the exception of Pluronic F127) reduced cell viability at all 
concentrations, and were therefore deemed inappropriate to use despite their 
ability to reduce CNT aggregation (Monteiro-Riviere et al., 2005); 
o Filtering can be used as a technique to reduce the presence of aggregates 
within the dispersing solution of SWCNT (Raja et al., 2007); 
o It has been suggested that the degree of particle aggregation and 
agglomeration associated with metal oxide administration is also likely 
influencing the resultant toxicity of these particle types, in addition to particle 
size. However the nanoparticles that make up the agglomerates are within the 
nano size range, and this appears to be fundamental to driving their toxicity; 
o Nanoparticle aggregation is also general issue that has been reported in a 
wide range of the published environmental studies. The extent of particle 
aggregation has been reported to be influenced by particle type and 
differences in test media as well as procedures to prepare test suspensions 
as note before;  
o Only a few studies have systematically explored the influence of aggregation 
on the ecotoxicity of various nanomaterials; 
o From the research published to date, it is not yet clear how various levels of 
aggregation of nanoparticles influence their ecotoxicity, and the derivation of 
LC50, EC50 and NOEC also remains uncertain.  Adding to the complexity of 
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this issue, it has recently been found that aggregation behaviour in the media 
might follow a non-linear concentration-aggregation relationship (Baalousha et 
al., 2009; Baun et al., 2009). 
3.5.153 Surface area 
3.5.154 The reduction in size to the nanoscale is accompanied by an inherent increase in 
the surface-to-volume ratio, and therefore a greater proportion of entities at the 
surface compared to the bulk (non-nanoscale) material.  For particle-based 
substances, the surface plays an important role in influencing the physical and 
chemical interactions between the substance and the receptor (i.e. cell, tissue, 
organism, media etc).  The influence of surface area on toxicity is obviously 
intrinsically linked to particle size.  Powers et al. (2006) highlight that it has been 
established in several toxicity studies that effects correlate with surface area 
(Powers et al. reference Brown et al., 2001; Donaldson et al., 1998, 2002; 
Oberdorster et al., 1992; Tran et al., 2000) to a greater extent than mass as a dose 
metric.   
3.5.155 Several methods have been identified for measuring the surface area of 
nanoparticles.  A description of the techniques identified has been provided along 
with their advantages and limitations.  Emerging methods such as diffusion charging 
have begun to provide a more viable approach to measuring aerosol surface area in 
situ.  Implications of a number of issues, however, remain to be considered including 
the effect of initial aerosol charge, the composition of the material, presence of 
aggregates and the effect of particle shape. The advantages and disadvantages of 
measuring deposited particle surface area, rather than aerosol surface area, also 
need to be considered further.   
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3.5.156 Shape/Aspect ratio 
3.5.157 Length has been accepted to influence fibre clearance, because it dictates the ability 
of phagocytic cells to completely internalise CNT.  Longer fibres promote the 
development of frustrated phagocytosis, reduced clearance and hence the potential 
to persist to increase their propensity for damage (Brown et al., 2007; Poland et al., 
2008).  The shape of nanoparticles is also likely to influence their uptake by cells, as 
has been demonstrated for metal nanoparticles (Chithrani et al., 2006; Chithrani and 
Chan, 2007; Pal et al., 2007). Only a few studies have documented links between 
physico-chemical characteristics and ecotoxicity.  In regards to shape, only three 
published studies have been identified. It is evident that much more research is 
needed before specific properties, or combinations of properties, can be linked to 
the effects observed in ecotoxicity tests (Stone et al., 2009). 
3.5.158 A number of methods have been identified for measuring the surface area of 
nanoparticles, primarily microscopy based.  A description and comparison of the 
techniques identified is readily accessible in the “shape/aspect ratio” sub-section of 
Chapter 4.1 of RNC/RIP-oN2/B3/2/FINAL.  
3.5.159 In addition, a number of other important points have been noted and will be taken 
forward for further consideration in the gap analysis and used to inform proposed 
amendments to the guidance, specifically: 
o A method for processing SPM images in order to estimate nano-object 
positions and dimensions, using dictated fits based on the least-squares 
method and the matrix operations has been published (Silly, 2009); 
o UV-visible spectroscopy, commonly used to confirm the presence of 
nanoparticles in a liquid, can be used to indicate the shape of the 
nanoparticles, but confirmation is usually performed using imaging methods 
such as TEM (Weir et al., 2008); 
o An extension of thermogravimetic analysis (TGA), a method principally used 
for determining chemical composition and purity, to analyse the specific 
properties of SWCNT including length and diameter has recently been 
reported.  However additional characterisation methods (such as SEM or 
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Raman Spectroscopy) may be needed to support and fully interpret the TGA 
results (Mansfield et al., 2010). 
3.5.160 Surface Charge 
3.5.161 In relation to toxicity testing, the major influence of surface charge is on the stability 
of the administered dispersion (see, for example, Jiang et al. (2009)).  However, size 
and charge can also influence the adsorption of ions, contaminants, and 
biomolecules, and the way cells react when exposed to them (e.g. Goodman et al., 
2004).   Particle uptake by cells has also been observed to be influenced by the 
particle's charge, particularly for metal oxides (Hankin et al., 2008).  It is evident that 
much more research is needed before specific properties, such as surface charge, 
can be related to the effects observed in ecotoxicity tests (Stone et al., 2009).    
3.5.162 A number of methods have been identified for determining the zeta potential of 
nanoparticles, as described in the “surface charge” sub-section of chapter 4.1 of 
RNC/RIP-oN2/B3/2/FINAL.  
3.5.163 Surface chemistry 
3.5.164 The term surface chemistry is often used in the context of surface chemical 
composition, and is somewhat a broad and non-specific term which does not 
predispose itself to ‘quantitative’ characterisation according to a single comparable 
metric or measurand.  Surface chemistry includes elements of solubility equilibrium, 
catalytic properties, surface charge, and surface adsorption and desorption of 
molecules from solution, amongst others.  Most of these properties are functions of 
the atomic or molecular composition of the surface and the physical surface 
structure. Chemical purity, functionalisation and surface coating are also important 
aspects to take into account. 
3.5.165 Modification of the surface of CNTs has been demonstrated to both enhance and 
reduce toxicity.  It is therefore unreasonable to make definite conclusions about how 
the modification of CNT affects their toxicity, as it driven by the particular 
modification employed, which is generally undertaken for a specific purpose.  The 
modification of the surface of TiO2 particles has also been demonstrated to influence 
its toxicity. However, this is likely to be dependent on the modification, and cell type 
in question. The impact of functionalisation on fullerene toxicity has also been the 
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focus of investigation since functionalisation of the surface of fullerenes is often 
completed for a specific purpose, such as improving water solubility.  Fullerene 
functionalisation has also been observed to promote the appearance beneficial 
properties such as antioxidant, or anti-inflammatory activity.  The influence of 
surface attachments on fullerene toxicity may be dependent upon the target 
cell/organ and/or the fullerene type under investigation. 
3.5.166 Although some evidence is available in the literature to suggest that surface 
functionalisation may influence the ecotoxicity of nanomaterials, the number of 
studies is, at present, too limited to draw general conclusions on the influence of 
functionalisation on ecotoxicity, speciation, and accumulation. 
3.5.167 A number of methods have been identified for analysing the surface properties of 
nanoparticles, as described in the “surface chemistry” sub-section of chapter 4.1 of 
RNC/RIP-oN2/B3/2/FINAL.  
3.5.168 In addition, a number of other important points have been noted and will be taken 
forward for further consideration in the gap analysis and used to inform proposed 
amendments to the guidance, specifically: 
o Atomic Force Microscopy (AFM) can provide 3D imaging/visualisation of 
nanoparticles distributed on a flat surface, allowing access to qualitative 
and/or quantitative information about the physical properties of nanoparticles 
including size, morphology, surface texture, and roughness. However, the 
influence of the AFM tip size and shape on the acquired images must be 
properly accounted and corrected for; 
o Another property related to surface chemistry that may be of relevance to 
characterise is porosity.  It has been suggested that there is no all-
encompassing analytical technique available to study porosity and a 
synergistic approach involving application of a combination of various 
techniques is necessary (Heo et al., 2006); 
o The nano scale chemical and structural environment, including factors such 
as surface roughness, may also be important properties to consider in 
relation to bacterial activity. 
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3.5.169 Redox activity 
3.5.170 Redox potential may be useful in determining how active a given nanomaterial (and 
in principal any chemical substance) would be in human and environmental 
oxidation-reduction processes, potentially also generating reactive oxygen/nitrogen 
species (ROS, RNS).  Redox reactions can occur abiotically or biologically, and may 
alter a nanomaterial’s physico-chemical properties including surface area, surface 
charge, and chemical composition, which in turn can affect the material’s potential to 
aggregate, size, toxicity and mobility.  Redox reactions are the basis of chemical 
transformations of inorganic and organic species and the precipitation and 
dissolution of inorganic substances that influences their sequestration and mobility.  
Hence measurement of the redox potential would be potentially meaningful for 
nanomaterials which can participate in electron transfer or uptake.   
3.5.171 It has been suggested that chemically stable inorganic nanomaterials in 
physiological redox conditions do not appear to exhibit cytotoxicity in vitro, whereas 
nanomaterials with strong oxidative (e.g. CeO2, Mn3O4 and Co3O4) or reductive 
powers (e.g. Fe0, Fe3O4, Ag0 and Cu0) can be cytotoxic and genotoxic towards 
biological targets in vitro (Auffan et al., 2009).  Standard electrochemical methods, 
such as cyclic voltammetry, may be used to study the redox activity of 
nanomaterials.   
3.5.172 ROS generation potential 
3.5.173 The ability to generate ROS and oxidant injury is one paradigm that may be used to 
compare the toxic potential of nanomaterials (Xia et al., 2006; Auffan et al., 2009).  
However, the relationship between ROS generation and ecotoxicity has been 
studied to a lesser extent.   
3.5.174 Whilst it has been demonstrated that ROS generation and oxidative stress can be 
used as a paradigm to assess nanomaterial toxicity, not all nanomaterials exhibit the 
electronic configurations or surface properties that allow spontaneous or acellular 
ROS generation; particle interactions with cellular components could generate ROS 
during these interactions.   
RNC/RIP-oN2/FPR/1/FINAL 
 
- 86 - 
3.5.175 A number of methods have been identified for detecting ROS generation from 
nanomaterials, under both abiotic conditions and in cells, as described in the “ROS 
generation potential” sub-section of chapter 4.1 of RNC/RIP-oN2/B3/2/FINAL.  
3.5.176 Photocatalytic activity 
3.5.177 The ability of UVA or visible light to increase the toxic potency of metal oxide 
particles, through increased ROS production, has been a focus of a number of 
toxicology studies (e.g. Dunford et al., 1997; Zhang and Sun, 2004; Dufour et al., 
2006), but does not always transpire (Linnainmaa et al., 1997; Theogaraj et al., 
2007).  Results of ecotoxicology studies to date also do not allow any firm 
conclusions to be drawn regarding the influence of photocatalytic activity on 
ecotoxicity.   
3.5.178 A number of methods for studying the photocatalytic activity have been described in 
the “Photocatalytic activity” sub-section of Chapter 4.1 (RNC/RIP-oN2/B3/2/FINAL).  
However, it is currently unclear what distinct measurand for photocatalytic activity 
could be standardised to the extent that would be meaningful to risk assessment.  
The lack of clarity in the relationship between photoactivty and (eco)toxicity, 
combined with the lack of a clear measurand, may not provide sufficient justification 
for the inclusion of photocatalytic activity as a new Information Requirement. 
3.5.179 Dustiness 
3.5.180 Measurement of the ‘dustiness’ of a material provides information relating to the 
propensity of that material to produce airborne dust, and is important to consider 
from an exposure perspective.  Dustiness is also a key parameter for assessing the 
risk of dust explosions.  This property is covered to some extent under the current 
REACH guidance chapter on Granulometry.   
3.5.181 Rotating drum and continuous drop methods are currently suggested in the REACH 
Guidance chapter for granulometry for the measurement of airborne dispersed or 
nebulised particles (ECHA, 2008. R.7.1.14, Table R 7.1-31).  However, rotating 
drum dustiness tests are usually performed as three replicate tests and need quite 
large amounts of test material, typically 300–600 g. The EN 15051 continuous 
single-drop method requires a total amount of 500 g for the required five single-test 
runs. It has been highlighted that such large amounts of test material may not be 
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practical if very toxic and/or costly materials are to be tested and there is a need for 
test systems that can be operated under controlled atmospheric environments using 
much smaller amounts of material (Schneider & Jensen, 2008).  Several advances 
towards this have been reported in the scientific literature, specifically: 
o A fluidisation (vortex shaker) method has been developed for testing 
nanosize powders (Maynard, 2002; Baron et al., 2003; Maynard et al., 
2004). This method is included in ISO’s forthcoming technical document 
entitled “Nanomaterials – General framework for determining nano-object 
release from powdered nanomaterials by generation of aerosols”.  However, 
sufficient methodological detail has yet to be incorporated into the document 
being developed; 
o A dustiness test that uses only 6 g of material per test run and that 
characterises the test material by both a single-drop and a rotating drum 
type of challenge. The test apparatus is based on a downscaled version of 
the EN 15051 rotating drum, whilst maintaining important test parameters, 
and was demonstrated to provide very reproducible results both in terms of 
amount and size distribution of the generated particles (Schneider & Jensen, 
2008). 
3.5.182 Explosive properties 
3.5.183 No studies have been identified in the literature relating to the explosive properties 
(an existing REACH Information Requirement) of nanomaterials, over and above the 
outputs from the NANOSAFE2 project discussed in the FP6/7 section of RNC/RIP-
oN2/B3/2/FINAL, therefore the ability to prepare practical advice in the context of 
REACH is limited. 
3.5.184 However, it has been suggested that read-across of explosivity data from bulk 
materials (non-nanoscale) to nanomaterials is not possible, since nanomaterials 
may have explosive properties which are solely due to the small particle size (RIVM, 
2009).  This issue will be considered further in the gap analysis (Task B4) and used 
to inform any subsequent amendments to guidance. 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 88 - 
3.5.185 Boiling/Melting/Freezing Point 
3.5.186 No studies have been identified amongst the extensive literature sourced during 
Task A in which the boiling, melting or freezing point (existing REACH Information 
Requirements) of nanomaterials is specifically addressed, therefore the ability to 
prepare practical advice in the context of REACH is limited. 
3.5.187 However, in undertaking a hypothetical registration of nanosilver under REACH, 
RIVM (2009) concluded that these properties will be similar to those of metallic bulk 
(non-nanoscale) silver.  Data for these parameters was effectively read across from 
the bulk form in their hypothetical registration of nanosilver.  However, they conclude 
that “the ‘sameness’ analysis can, as yet, not be properly tackled under REACH, 
and thus the read-across from data on the bulk form of a substance to its nanoform 
will be very troublesome”.  Furthermore, they concluded that “a nanomaterial cannot 
be properly characterized with the data normally required under REACH, and it is 
unclear how to address different sizes of a nanomaterial in substance identification”.   
3.5.188 Relative Density 
3.5.189 No studies have been identified amongst the extensive literature sourced during 
Task A in which the relative density (an existing REACH Information Requirement) 
of nanomaterials is specifically addressed, therefore the ability to prepare practical 
advice in the context of REACH is limited. 
3.5.190 However, RIVM (2009) concluded that the relative density of nanosilver will be 
similar to that of metallic bulk (non-nanoscale) silver.  Data for this parameter was 
effectively read across from the bulk form in their hypothetical registration of 
nanosilver. However, RIVM (2009) highlight that, for relative density, caution needs 
to be taken when performing read-across of data from the bulk form.  Overall, they 
conclude that “the ‘sameness’ analysis can, as yet, not be properly tackled under 
REACH, and thus the read-across from data on the bulk form of a substance to its 
nanoform will be very troublesome”.  Furthermore, they concluded that “a 
nanomaterial cannot be properly characterized with the data normally required 
under REACH, and it is unclear how to address different sizes of a nanomaterial in 
substance identification”.   
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3.5.191 Solubility & release of metal ions into solution 
3.5.192 As stated in the Task B1 report, the property of water solubility is considered to be 
very relevant and applicable to nanomaterials.  The release of ions into solution 
(including through an active electrochemical ‘corrosion’ process) may confound the 
interpretation of results perceived to be the result of solubilised substances.  It is 
anticipated that the release of silver ions from nanoparticulate silver is a realistic 
prospect, responsible for their antibacterial properties and potentially linked to the 
observed toxicity. It is postulated that Ag+ mediates these effects, although the 
mechanism by which this occurs is unknown at this time but likely to involve particle 
oxidation to enable their release.  Further investigations are necessary to confirm 
the contribution of particles and/or ion release to their toxicity.  In relation to 
ecotoxicity of nanosilver, the issue of dissolution may also be crucial to 
understanding the mechanisms involved.  A number of studies have reported that 
the observed ecotoxicity of these nanomaterials towards various organisms may be 
partly or fully attributed to the release of dissolved metal ions, covering zinc oxide as 
well as nanosilver. However, the influence of dissolved metal ions on ecotoxicity is 
not clear based on current literature and requires further investigation. 
3.5.193 In undertaking a hypothetical registration of metallic silver (in bulk and nanoform) 
under REACH, RIVM (2009) highlighted that there is no information available on the 
kinetics of dissolution in dependence of nanosilver particle properties (such as (time-
dependent shifts in) size distribution, shape) and properties of the medium (like pH, 
dissolved organic carbon, silver-complexing ions and recommended the inclusion of 
‘Dissolution Kinetics’ as a sub-information requirement under the existing REACH 
Information Requirement for ‘Solubility’. 
3.5.194 TOXICOLOGICAL INFORMATION 
3.5.195 Considerations for study design 
3.5.196 Investigations undertaken and reported to date have highlighted a number of key 
issues or gaps in existing testing strategies which may influence the outcome of 
studies, and thus should be observed closely in the consideration of nanomaterials 
within the context of REACH. 
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3.5.197 In relation to the manner in which experiments are set up, factors such as the 
exposure method, dose selected, species used, cell type under investigation and in 
the case of photo-reactive nanomaterials such as some metal oxides, light 
conditions (Warheit et al. 2005) all have the potential to impact on the toxicity of 
nanoparticles, indicating that the experimental set up is very influential. 
3.5.198 A summary and discussion of those issues considered to be of importance in this 
respect is provided below.  
3.5.199 Dispersion 
3.5.200 As discussed at various points within this B3 report, it is clear that dispersion 
impacts upon the potential toxicity of NMs in animals or cells. A multitude of 
dispersing processes have been utilised by investigators to improve the dispersion 
including solvents (such as acetone), surfactants (such as pluronic), proteins 
(albumin and serum) or mechanical processes (such as centrifugation, or 
sonication).  At this time it is not possible to conclude which techniques are most 
appropriate, but in designing experimental protocols for consideration of 
nanomaterials in the context of REACH, it is essential that such techniques should 
try to mimic realistic exposure scenarios, routes and avoid interference by 
dispersants.   
3.5.201 Selection of Dose  
3.5.202 Many investigations reported have used very high doses, raising the question of 
whether the toxic effects observed are likely to derive from dose used or the 
material. In particular, at high doses, the aggregation of CNT is promoted, and so 
the toxicity that transpires in vivo is potentially a result of the blockage of airways 
and blood vessels, rather than to a specific toxic effect.   
3.5.203 In order to inform selection of relevant nanomaterial exposure concentrations to be 
used within in vitro and in vivo experiments, information regarding the human 
exposure levels is required as a reference. However, at the current time this is 
severely lacking and thus exposure assessment is of key importance to developing 
sound dose selection for future studies  
3.5.204 In relation to dosing regime, many investigations of NM toxicity have used a single 
dose administered to animals or cells. Within occupational or consumer settings, it is 
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more likely that normal NM exposures (non-accidental) will occur over a period of 
time, depending on their application. 
 
 
3.5.205 Selection of exposure route and duration 
3.5.206 Testing methods for initial in vivo toxicity assessment normally use the oral route of 
exposure. However for the testing of nanomaterials, this may not be the ideal first 
candidate. As a general observation, repeated dose studies with lower doses over a 
long time period and use of a route of exposure appropriate to the end use of the 
nanomaterial in question, are likely to be of greater relevance in consideration of the 
potential risk of nanomaterials within occupational or consumer settings, than 
extremely short exposures at high doses. In addition, the use of chronic studies will 
also allow for the more relevant identification of the potential carcinogenic 
consequences of NM exposure. 
3.5.207 Interaction of nanoparticles with biological molecules  
3.5.208 Attention should be directed to consideration of the role that interaction of NPs with 
biological molecules plays in altering their behaviour within biological systems. It is 
known that on entering the body, particles immediately become coated in biological 
molecules, including proteins. It is hypothesized that this coating can influence 
particle behaviour and toxicity, with different particles having different capacities to 
bind different molecules. Furthermore, there is a possibility that the particles can 
alter the protein structure and function (and thus behaviour), which again may 
contribute to toxicity.  Further research is required to generate a greater 
understanding of this complex area, and it is advised that consideration should be 
given in future experimentation to the role that such interactions may play in toxicity.  
3.5.209 Use physico-chemical data to inform experimental design 
3.5.210 It has been highlighted within this report, but also more fully within the toxicology 
and physico-chemical sections of RNC/RIP-oN2/B3/2/FINAL that the physico-
chemical characteristics of particles used such as size, crystallinity, 
functionalisation, contamination, solubility etc. can impact on their toxicity.  Thus, as 
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these factors are able to influence the findings obtained, a thorough physico-
chemical characterisation should be undertaken and used as justification of the 
relevancy of the experimental approach used in future toxicological investigations 
undertaken. 
3.5.211 In addition, a specific consideration in relation to metal nanomaterials is 
determination of whether any toxicity observed derives from their small size, is 
mediated through the release of ions from particles, or perhaps a combination of 
both. Elucidation of this is essential for the hazard characterisation of metal NPs 
within the context of REACH 
3.5.212 Target Organ Toxicity considerations  
3.5.213 At the current time, there is a paucity of data relating to the systemic transfer of 
particles following exposure via the lungs, skin and gut, and this should be a focus 
of future experiments.  Studies have focused on dermal and pulmonary toxicity of 
particles, but there is an absence of data on the consequences of exposure to the 
gastrointestinal tract, and within damaged/diseased skin.  Other relevant target 
organs include the liver, kidney, cardiovascular system and brain which are 
necessary due to the fact that nanoparticles are likely to become systemically or 
neuronally available.  The liver could be highlighted as a priority due to the 
propensity of particles to accumulate in this organ. Based on this, it has been 
suggested that toxicokinetics and certain additional target organ specific effects be 
considered as specific information requirements for hazard identification and 
characterisation of nanomaterials within the context of REACH 
3.5.214 Adoption of standardised ‘controls’ to assist assessment of toxicity  
3.5.215 The use of both nanoparticulate and non-particulate controls (such as carbon black 
or asbestos within CNT studies, or zymosan within inflammation studies) has been 
reported on numerous occasions. The choice of controls can, to some extent be 
driven by the hypothesis being tested (and links to determination of the physico-
chemical characteristics responsible for toxicity). The use of such benchmark 
controls (those for which extensive background information is available) provides a 
useful indication of the relative toxicity of the nanomaterial under investigation 
versus other particles or reagents of known toxicity (see for example, Warheit et al. 
2004, Shvedova et al. 2005).  Thus, it should be encouraged as standard practise 
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for the hazard identification and characterisation of nanomaterials within the context 
of REACH.  
 
3.5.216 Interference of nanomaterials with toxicity assays  
3.5.217 Nanomaterials have been on occasion found to interfere with some of the assays 
utilised to determine their cellular or toxic effects.  For example, some nanoparticles 
may contribute to the absorbance or fluorescence of colorimetric or fluorometric 
assays.  In addition, due to their large surface area, nanoparticles may bind to assay 
components including the substrates (such as CNT with the reagent in MTT assays; 
Belyanskaya et al. 2007) or the biomarker being measured, (such as LDH and 
cytokine proteins, see for example Davoren et al. 2007).  Kroll et al. (2009) 
undertook a review of cytotoxicity assays commonly used to investigate nanoparticle 
toxicity, and provided a discussion of interference reported for each.   
3.5.218 All of these factors can contribute to the production of inaccurate, misleading results 
that make nanoparticles appear more or less toxic than they actually are.  In many 
of the studies reported it is not possible to ascertain whether the assays were 
adequately controlled to assess for interference. Thus, as a general precaution, it is 
advisable to use more than one assay to assess the endpoint or effect in question. 
Further investigation of this area is required, as is integration of known interferences 
into any guidance developed for the toxicology testing of nanomaterials under 
REACH.  
3.5.219 ECOTOXICOLOGICAL INFORMATION 
3.5.220 Given the current state of the published science, it has not been possible to provide 
specific practical advice with regard to the ecotoxicological Information 
Requirements in REACH, but a number of factors have been found to influence the 
ecotoxicologic responses observed in the study of nanomaterials.  These include: 1) 
particle impurities, 2) suspension preparation methods, 3) release of free metal ions, 
and 4) particle aggregation and 5) relevance of dose [concentration] - response for 
ecotoxicological studies of nanomaterials.  The extent of influence of these factors 
on the ecotoxicological impact of nanomaterials is unknown and, even, the scientific 
evidence for them have an influence in the first place is contradictory and varies 
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from nanoparticle to nanoparticle (Baun et al., 2009). This impedes the reliability and 
interpretation of the available ecotoxicity data as well as the direct use of the 
reported LC50, EC50 and NOEC for PNEC derivation.  
3.5.221 As noted by Stone et al. (2009) traditional predictions of fate and transport are 
based on inherent properties such as phase transfer properties (e.g. boiling point, 
vapour pressure, partition coefficients), reactivity (e.g. photo-reactivity and 
hydrolysis) and biological degradation behaviour (Mackay and Hendry 2009).  Many 
of these inherent properties are reported on for regular chemicals under REACH.  
However, we know at this point that these properties are not adequate to 
understand and predict the fate and behaviour of nanomaterials.  This is further 
complicated by our current lack of understanding of the novel physico-chemical 
properties exhibited by many nanomaterials and the effect these have on particle 
behaviour.  In addition, it is most likely that those nanomaterials released into the 
environment will also exist as modified forms of their primary counterpart 
(SCENIHR. 2009). 
3.5.222 The fate and behaviour of nanomaterials in the environment is dependent on type, 
form and physico-chemical characteristics of the nanomaterial in question, as well 
as those of the receiving environment (Chen et al., 2008; Chen and Elimelech 2008; 
Saleh et al., 2008).  Nanomaterial transport and distribution are influenced by a 
number of factors, such as Brownian diffusion, inertia effects, gravitational 
influences, thermal influences, pH, ionisation, and presence/absence of Natural 
Organic Matter (NOM).  These interactions ultimately affect the processes the 
nanomaterial consequently undergoes in its transport and subsequent fate.   
3.5.223 Nevertheless, the lack of actual measured data in the available public domain in 
relation to the environmental fate and behaviour of nanomaterials in water 
represents a major gap in developing realistic prediction of fate and transport of 
nanomaterials in the aquatic environment.   
3.5.224 Most of our current knowledge stems from colloid science, which provides 
preliminary information, but there is a need for systematic studies on different types 
of nanomaterials within aquatic bodies using a range of physico-chemical 
parameters (e.g. size, shape, form, surface area) to generate data and to support 
development of reliable models.  Predictive modelling of emission scenarios and 
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subsequent transport pathways will also play an important role in furthering 
understanding in this area (Stone et al., 2009).  
3.5.225 Knowledge to date indicates that in many cases rather than remaining intact, 
nanomaterials will tend to aggregate, agglomerate or become associated with other 
dissolved, colloidal or particulate matter present in the environment (SCHENIR 
2009).  However, the novel physico-chemical characteristics which make 
nanomaterials desirable also present a challenge for determining how they interact 
with the environment, how, when and where they are distributed, and in what form 
they ultimately end (Darlington et al., 2009).  
3.5.226 Appropriate metrics for measuring engineered nanomaterials in the environment are 
still subject to much discussion, and in particular those pertaining to exposure 
concentrations, or dose, are considered to be of high importance.  Differences in 
behaviour across different physical and chemical species of the same 
nanoparticulate material must also be considered.  In addition, their tendency to 
aggregate/agglomerate, adsorb to NOM and, in the case of wastewater treatment, 
potentially associate with the solid phase, must be taken in consideration, as all of 
these processes could lead to environmental ‘hot spots’ where concentrations of 
nano-particulates are particularly high.  
RNC/RIP-oN2/FPR/1/FINAL 
 
- 96 - 
3.5.227 B3 Sub-Task III: Summary of practical advice on the use of information from 
OECD-WPMN in fulfilling REACH data requirements 
3.5.228 PHYSICO-CHEMICAL PROPERTY INFORMATION 
3.5.229 The results from the OECD-WPMN sponsorship programme for exploratory testing 
of nanomaterials are expected to become available in 2012 and will provide further 
information for the further development of OECD test guidelines and ISO standards.  
It is anticipated that this work will contribute to the REACH implementation for 
nanomaterials and to the assessment of the REACH Information Requirements.  
The forthcoming results from OECD-WPMN Sponsorship Programme are expected 
to shed further light on practical testing issues and provide a common knowledge 
basis on key nanomaterials.  However, at the time of writing this report, no testing 
results have yet emerged from the Sponsorship Programme.  It is important to 
acknowledge that this limits the ability to identify and critically assess the 
appropriateness of existing test methods and results from the sponsorship 
programme in fulfilling the REACH data requirements for physico-chemical 
properties at this time.  However, any practical advice that can be extracted from 
the information currently available from OECD-WPMN is summarised below. 
3.5.230 Octanol-water partition coefficient (Kow) 
3.5.231 OECD has concluded that the three TGs relevant to characterising the partition 
coefficient (OECD TG 107, 117, 123) might be applicable under some 
circumstances or to some classes of manufactured nanomaterials, although further 
work is required to determine this and modify the TGs, if necessary 
(ENV/JM/MONO(2009)21).  This issue has been considered further in the Task B1 
report, and will be taken forward into the gap analysis (B4). 
3.5.232 Water solubility 
3.5.233 The important points noted from the OECD publications in relation to water solubility 
which will be taken forward for further consideration in the gap analysis and used to 
inform proposed amendments to the guidance, are: 
o It has been suggested that the measurand of interest (beginning with a 
pre-determined unit of particles in a standardised solution and 
temperature) is to measure the mass proportion of nanomaterials which 
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are held in solution, and whether this mass diminishes after a set period of 
time, or; determine the amount of time required for mass to diminish by 
X% (ENV/JM/MONO(2009)20/REV); 
o OECD concluded that the test guideline relevant to characterising the 
water solubility (OECD TG 105) might be applicable under some 
circumstance or to some classes of manufactured nanomaterials.  It stated 
that this TG is applicable to solutions but it is not known how the results 
might be impacted by the presence of a colloidal suspension, which might 
be present if the sample manufactured nanomaterial does not completely 
dissolve. Hence, further work is required to determine this and to modify 
the TGs, if necessary (ENV/JM/MONO(2009)21). 
3.5.234 Particle size/size distribution 
3.5.235 The important points noted from the OECD publications in relation to particle 
size/size distribution which will be taken forward for further consideration in the gap 
analysis and used to inform proposed amendments to the REACH guidance, are: 
o It has been suggested that the conditions to which a substance is subjected 
may affect the size of the discrete form of a substance 
(ENV/JM/MONO(2009)20/REV); 
o It has been highlighted that the measured size of a particle is always 
dependent on the particular method that is being used to examine, measure 
or visualize it such that the size of a particle reported by one technique might 
not be the same as the size when measured with another technique 
(ENV/JM/MONO(2009)20/REV); 
o The appropriate measurands have been suggested to be, for a representative 
sample of nanoparticles, both the average size of individual particles and the 
size distribution of the sample of particles (ENV/JM/MONO(2009)20/REV); 
o OECD concluded that method A (designed to provide information on the 
transportation and sedimentation of insoluble particles in water and air) of the 
test guideline for determining particle size distribution/fibre length and 
diameter distributions (OECD TG 110) "is not applicable to nanomaterials" 
whilst method B (used in the special case of materials which can form fibres, 
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involving microscopic examination) "would, with some modification (the 
inclusion of fibres of less than 5 microns in length and less than 100 nm in 
diameter), be applicable to nanoparticles as well as nanotubes and nano 
fibers”. It is suggested that studies should be carried out in order to extend its 
range of applicability to fibres with nano-scale dimensions. It is known that 
alternative methods for (nano)particle size distribution already exist, which 
OECD suggest should be taken into account if such studies are undertaken 
(ENV/JM/MONO(2009)21). 
3.5.236 The alternative methods suggested by OECD to be used in the Sponsorship 
Programme are clearly detailed in the sub-section “Particle size/size distribution” in 
chapter 5.1 of RNC/RIP-oN2/B3/2/FINAL.   
3.5.237 Agglomeration/aggregation 
3.5.238 The important points noted from the OECD publications in relation to agglomeration 
/ aggregation which will be taken forward for further consideration in the gap 
analysis and used to inform proposed amendments to the REACH guidance, are: 
o The measurands of interest, beginning with a pre-determine unit of 
particles, have been suggested to be (ENV/JM/MONO(2009)20/REV):  
a) The effective mean particle size in a given medium and its 
evolvement over time (including the standard deviation); and/or;  
b) Qualitative assessment of state of aggregation and estimation of 
the primary particle size by TEM pictures; and/or  
c) Indirect confirmation of the estimated primary particle size by BET 
measurements, for materials with low/no internal porosity as is 
typical for pyrogenic oxides. 
o Predictions of agglomeration in natural waters will be limited to homo-
aggregation of the particles since the data needed to predict the 
deposition with a heterogeneous set of natural surfaces (e.g. Hamaker 
constants and zeta potentials) is often not available 
(ENV/JM/MONO(2010)25). 
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3.5.239 The methods suggested by OECD to be used in the Sponsorship Programme for the 
determination of aggregation/agglomeration state are clearly detailed in the sub-
section “Agglomeration/aggregation” in chapter 5.1 of RNC/RIP-oN2/B3/2/FINAL.   
3.5.240 Crystallite and grain size 
3.5.241 Crystallite size is included in OECD's list of testing endpoints of importance for 
(eco)toxicological evaluation (ENV/JM/MONO(2010)46), although no specific 
reason/evidence is provided for this. This limits our ability to provide practical advice 
on this property and its test methods in the REACH context. 
3.5.242 Specific surface area 
3.5.243 The important points noted from the OECD publications in relation to specific 
surface area which will be taken forward for further consideration in the gap analysis 
and used to inform proposed amendments to the REACH guidance, are: 
o It has been suggested that the specific surface area will dictate the surface 
charge density in cases where nanomaterials are surface functionalized 
and that this has direct consequences on (ENV/JM/MONO(2009)20/REV): 
(a) nanomaterial interaction (i.e., agglomeration) with other naturally 
occurring particulate matter (i.e., contaminant vectors);  
(b) route of exposure as a function of surface ligand-biological 
interface (i.e., bioaccumulation pathway, bioavailability); and  
(c) mechanisms of toxicity (e.g., dose response curves normalized for 
surface area may indicate different results compared to results 
presented on a per mass basis) 
o It has been highlighted that in many cases specific surface area 
measurements are derived quantities that depend on the nature of the 
probe molecule. Nevertheless, in comparison with some of the other 
characterisation procedures, measurement of the specific surface area of 
a given sample is relatively straightforward" (ENV/JM/MONO(2010)25); 
o It has been suggested that it may be appropriate to evaluate whether the 
particle size distributions (and surface areas) of sparingly soluble 
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manufactured nanomaterials are altered through ripening and/or phase 
alteration phenomena (ENV/JM/MONO(2010)25); 
o It has also been highlighted that the measurement of the specific surface 
area might most efficiently be conducted concurrently with measurements 
of pore size, pore size distribution, porosity and perhaps even particle 
density as these properties will most probably have an important influence 
on the (eco)toxicological properties of the material 
(ENV/JM/MONO(2010)25). 
3.5.244 OECD propose the Brunauer, Emmett, and Teller method as a possible method for 
determining the specific surface area of nanomaterials within the Sponsorship 
Programme (ENV/JM/MONO(2009)20/REV).   
3.5.245 Surface charge 
3.5.246 The important points noted from the OECD publications in relation to surface charge 
which will be taken forward for further consideration in the gap analysis and used to 
inform proposed amendments to the REACH guidance, are: 
o It has been noted that the zeta potential is not measurable directly but can 
be calculated using theoretical models and an experimentally-determined 
electrophoretic mobility or dynamic electrophoretic mobility 
(ENV/JM/MONO(2009)20/REV); 
o OECD highlighted that the significance of zeta potential is that its value can 
be related to the stability of nanoparticle dispersions, in that 
(ENV/JM/MONO(2009)20/REV): 
a) The zeta potential indicates the degree of repulsion between 
adjacent, similarly charged particles in a dispersion; 
b) For molecules and particles that are small enough, a high zeta 
potential will confer stability, i.e. the solution or dispersion will resist 
aggregation; 
c) When the potential is low, attraction exceeds repulsion and the 
dispersion will break and flocculate.  This has serious implications for 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 101 - 
the interpretation of toxicological affects with a particle’s physical or 
chemical characteristics no longer in effect.   
3.5.247 Surface chemistry 
3.5.248 The important points noted from the OECD publications in relation to surface 
chemistry which will be taken forward for further consideration in the gap analysis 
and used to inform proposed amendments to the REACH guidance, are: 
o It has been highlighted that various modifications of the surfaces of 
nanomaterials will lead to numerous potential interactions and will play a key 
role in determining: i) fate in natural aqueous systems; ii) colloidal stability; 
iii) exposure (ENV/JM/MONO(2009)20/REV); 
o It has been suggested that a given modification to surface chemistry can 
affect other physical-chemical properties, such as agglomeration, dustiness, 
zeta potential, surface area, water solubility (ENV/JM/MONO(2009)20/REV). 
3.5.249 Dustiness 
3.5.250 The methods suggested by OECD to be used in the Sponsorship Programme for the 
determination of dustiness of nanomaterials are clearly detailed in the sub-section 
“Dustiness” in chapter 5.1 of RNC/RIP-oN2/B3/2/FINAL.  The advantages and 
limitations of these methods will be further compared and assessed in Task B4 (gap 
analysis), and information on the most appropriate methods will be recommended to 
be added to the REACH Guidance accordingly in Task B5. 
3.5.251 Porosity 
3.5.252 The important points have been noted from the OECD publications in relation to 
porosity which will be taken forward for further consideration in the gap analysis and 
used to inform proposed amendments to the REACH guidance, are: 
o It has been suggested that porosity data should be taken into account as it 
is relevant to the indirect confirmation of the estimated primary particle 
size by BET measurements, for materials with low/no internal porosity 
(ENV/JM/MONO(2009)20/REV); 
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o An additional consideration while exploring this endpoint is that, in addition 
to the basic large surface area provided by nanomaterials, a high porosity 
may permit the nanomaterials to act as vectors for other contaminants, 
such as heavy metals (ENV/JM/MONO(2009)20/REV). 
3.5.253 The methods suggested by OECD to be used in the Sponsorship Programme for the 
determination of porosity of nanomaterials are clearly detailed in the sub-section 
“Porosity” in chapter 5.1 of RNC/RIP-oN2/B3/2/FINAL.   
3.5.254 Pour density 
3.5.255 On the basis of the limited information identified in OECD-WPMN publications 
pertaining to pour density, a conclusion on the relevance of characterising this 
property for nanomaterials and its inclusion under REACH cannot be determined at 
this time. 
3.5.256 Photo-catalytic activity 
3.5.257 The important points noted from the OECD publications in relation to photo-catalytic 
activity, are: 
o It is suggested that photocatalytic activity may also lead to the generation of 
excited state species on a material’s surface, which have the potential to 
directly and indirectly lead to potential toxicity; 
o OECD states that measuring photocatalytic activity will give an indication of 
the potential for transformations in the environment which in turn represents 
an important point of concern when evaluating the full life-cycle of the 
nanomaterial (ENV/JM/MONO(2009)20/REV); 
o It has been highlighted that, due to absorption of UV-B radiation by water, 
impurities and substances in the environment, and the different masses of 
these at different locations, evaluation of UV activation in the environment is 
likely to be very difficult (ENV/JM/MONO(2009)20/REV). 
3.5.258 However, as highlighted in the literature section of RNC/RIP-oN2/B3/2/FINAL, the 
current lack of clarity in the relationship between photoactivty and (eco)toxicity, 
combined with the lack of a clear measurand, may not provide sufficient justification 
for the inclusion of photocatalytic activity as a new Information Requirement.   
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3.5.259 Radical formation potential 
3.5.260 OECD WPMN have highlighted that the potential to induce free radicals in 
organisms has been demonstrated for a number of nanomaterials and may have 
relevance to the toxicity of a manufactured nanomaterial 
(ENV/JM/MONO(2009)20/REV). 
3.5.261 However, whilst it has been demonstrated that ROS generation and oxidative stress 
can be used as a paradigm to assess nanomaterial toxicity, not all nanomaterials 
exhibit the electronic configurations or surface properties that allow spontaneous or 
acellular ROS generation; particle interactions with cellular components could 
generate ROS during these interactions.   
3.5.262 OECD WPMN have not suggested any specific methods for the determination of 
radical potential, noting that it can be measured by various means for different 
biological systems.   
3.5.263 Redox potential 
3.5.264 OECD WPMN have highlighted that redox reactions are the basis of chemical 
transformations of inorganic and organic species and the precipitation and 
dissolution of inorganic substances that influences their sequestration and mobility 
(ENV/JM/MONO(2010)46).  Hence, OECD suggest that measurement of the redox 
potential would be potentially meaningful for nanomaterials which can participate in 
electron transfer or uptake.   
3.5.265 Flash point 
3.5.266 OECD concluded that the test guideline relevant to characterising flashpoint (OECD 
TG 113) is considered applicable to nanomaterials (ENV/JM/MONO(2009)21). This 
TG is not currently referenced in the REACH Guidance (ECHA, 2008. R.7.1.9) and 
its inclusion will be considered as part of the gap analysis (Task B4). 
3.5.267 Boiling Point 
3.5.268 OECD has concluded that the test guideline relevant to characterising boiling point 
(OECD TG 103), though applicable for determining the boiling point of manufactured 
nanomaterials, is probably not relevant to existing solid nanomaterials 
(ENV/JM/MONO(2009)21). This guideline is currently referenced in the REACH 
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Guidance although not explicitly cited in the text and a number of other methods 
have been suggested (ECHA, 2008. R.7.1.3). 
3.5.269 Melting/freezing point 
3.5.270 OECD has concluded that the test guideline relevant to characterising melting 
point/melting range (OECD TG 102) is considered to be applicable to nanomaterials 
(ENV/JM/MONO(2009)21),. 
3.5.271 Relative density 
3.5.272 OECD has concluded that the test guideline relevant to characterising relative 
density is (OECD TG 109) might be applicable under some circumstances or to 
some classes of manufactured nanomaterials, although further work is required to 
determine this and modify the TG, if necessary (ENV/JM/MONO(2009)21). This 
guideline is currently referenced in the REACH Guidance although not explicitly 
cited in the text (ECHA, 2008. R.7.1.4). 
3.5.273 Surface tension 
3.5.274 In its preliminary review of OECD Test Guidelines and their applicability to 
nanomaterials OECD has concluded that the test guideline relevant to 
characterising surface tension (OECD TG 115) might be applicable under some 
circumstance or to some classes of manufactured nanomaterials.  It stated that this 
TG is applicable to solutions but it is not known how the results might be impacted 
by the presence of a colloidal suspension, which might be present if the sample 
manufactured nanomaterial does not completely dissolve. Hence, further work is 
required to determine this and to modify the TGs, if necessary 
(ENV/JM/MONO(2009)21).  However, as stated in the Task B1 report, surface 
tension is not in general a relevant property for nanomaterials. 
3.5.275 Adsorption/desorption screening 
3.5.276 OECD has concluded that the three test guidelines relevant for 
adsorption/desorption screening (OECD TG 106, 108, 121) might be applicable 
under some circumstances or to some classes of manufactured nanomaterials.  It 
stated that this TG is applicable to solutions but it is not known how the results might 
be impacted by the presence of a colloidal suspension, which might be present if the 
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sample manufactured nanomaterial does not completely dissolve. Hence, further 
work is required to determine this and to modify the TGs, if necessary. 
3.5.277 Dissociation constant 
3.5.278 OECD have highlighted that surface acidity (related to dissociation constants of 
surface ionisable sites) is an aspect of surface chemistry that may be particularly 
relevant, noting that:  
o ionisable sites may influence the surface charge which has been 
considered significant in toxicological studies; and 
o surface ionisation may also play a major role in colloidal particle stability 
and may even inhibit migration into hydrophobic phases (e.g., 
octanol/water partition coefficients).   
3.5.279 OECD has concluded that the test guideline relevant to characterising dissociation 
constant (OECD TG 112) might be applicable under some circumstances or to some 
classes of manufactured nanomaterials.  It stated that this TG is applicable to 
solutions but it is not known how the results might be impacted by the presence of a 
colloidal suspension, which might be present if the sample manufactured 
nanomaterial does not completely dissolve. Hence, further work is required to 
determine this and to modify the TGs, if necessary (ENV/JM/MONO(2009)21).  This 
test guideline is currently referenced in the REACH Guidance (ECHA, 2008. 
R.7.1.17), however a number of other methods are also suggested.   
3.5.280 Viscosity 
3.5.281 OECD has concluded that the test guideline relevant to characterising viscosity 
(OECD TG 114) is only applicable to liquids and does not refer to solutions, 
suspensions or emulsions (ENV/JM/MONO(2009)21). Although the viscosity of a 
solution can be measured, standardised preparation procedures would need to be 
included but are not given in TG 114. Additionally, it is not known what impact a 
colloidal suspension would have on the results. It is not clear yet what the 
importance of this property might be for the behaviour of nanomaterials, both in the 
environment and in living organisms. At the same time, there would be the need to 
define the medium. 
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3.5.282 Sample preparation 
3.5.283 OECD has published a report focusing on providing guidance for nanomaterial 
sample preparation and dosimetry, of high value for further consideration in the 
context of the updated REACH Guidance (ENV/JM/MONO(2010)25). It highlighted 
that: 
o Due to the wide variety of nanomaterials, it is difficult to develop specific or 
detailed advice applicable to all nanomaterials; 
o The Guidance Notes should be used with some degree of expert judgement 
on a case-by-case basis; 
o The Guidance Notes refer and apply to the water insoluble manufactured 
nanomaterials as the OECD considered that soluble nanomaterials are 
unlikely to need different sample preparation techniques than other 
chemicals, other than precautions dictated by the specific reactivity of each 
material. However their size will still affect where they are being deposited 
e.g. in the lung; 
o As few, if any, standard testing approaches have been developed for 
nanomaterials, the OECD stress such guidance cannot be considered a 
“cookbook” for preparing samples and administering doses, but rather an 
outline (often in a general or descriptive manner) of considerations based on 
early results with nanomaterials or other experience with chemicals and 
particulates.   
3.5.284 Common issues regarding sample preparation and dosimetry have been outlined in 
the document of key importance for further consideration in Task B4 and B5, 
including:  
o storage and stability of the test material;  
o the chemical composition of the test media, with the following parameters 
recommended to be measured for ecotoxicology studies or salines used in 
mammalian studies:  
a) ionic strength, calcium concentration and hardness, pH, dissolved 
organic matter, alkalinity, dispersing agents;  
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o characterisation of stock dispersions; characterisation of samples 
(prepared from stock dispersions) prior to administration/testing.  
3.5.285 It is also recommended that, when a procedure for generating nanomaterial 
preparations intended for (eco)toxicological studies is employed, attention should be 
paid to minimising any alteration of the physical, chemical or (eco)toxicological 
properties of the substrate. 
3.5.286 OECD has also outlined a number of media considerations for both airborne 
particles and particles in aqueous solutions (ENV/JM/MONO(2009)20/REV).   
3.5.287 TOXICOLOGICAL INFORMATION 
3.5.288 As previously mentioned, the results from the OECD-WPMN sponsorship 
programme for exploratory testing of nanomaterials have yet to be made available, 
which limits the ability to identify and critically assess the appropriateness of 
existing test methods and results from the Sponsorship Programme in fulfilling the 
toxicological data requirements for REACH at this time.   
3.5.289 It is however notable that ‘ENV/JM/MONO(2009)10: EHS Research Strategies on 
Manufactured Nanomaterials: Compilation of Output’ provides a summary of 
research status documents, and includes: i) a list of research themes relevant to 
EHS of nanomaterials; and ii) an overview on completed, current or planned 
research activities as well as urgent and medium/long term research priorities.  As 
with the opening statement to this summary, the document also recognises that 
current available information on existing research projects and research strategies 
is too limited and heterogeneous to adequately address identifying common 
research needs and undertaking to meet those research needs. 
3.5.290 One set of publications from the OECD sponsorship programme which are likely to 
be of particular importance are the Draft Dossier Development Plans. These are the 
output of a sponsorship programme for testing a set of manufactured nanomaterials 
using appropriate test methods (which include OECD Test Guidelines or other 
internationally agreed methods). No testing results have yet emerged from the 
Sponsorship Programme, however a number of draft dossier development plans 
(DDP) have been published, namely for Zinc Oxide, Cerium Oxide, Silicon Dioxide, 
Single Walled Carbon Nanotubes, Multi-Walled Carbon Nanotubes and Fullerenes.  
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This is of particular value, as many of the FP6/7 studies and much of the published 
literature do not (unless specifically stated) utilise OECD or ISO standardised 
methods.  Thus, upon publication, their results are likely to be of particular 
relevance to consideration of nanomaterial human toxicity within the context of 
REACH.  
3.5.291 ECOTOXICOLOGICAL INFORMATION 
3.5.292 The current ECHA guidance document on Chemical Safety Assessment ECHA 
(2008) refers specifically to a number of OECD Test guidelines.  The 
appropriateness of these OECD Test guidelines as well as other guidelines have 
been review by the OECD project Safety Testing of a Representative Set of 
Manufactured Nanomaterials (ENV/JM/MONO(2009)21).  The reviewers stated that: 
“For 24 OECD ecotoxicity test guidelines, the subgroup for biotic effects section 
concluded that the guidance on preparation, delivery, measurement, and metrology 
is currently insufficient for testing of manufactured nanomaterials”. 
(ENV/JM/MONO(2009)21, p. 13). 
3.5.293 As previously mentioned, the results from the OECD-WPMN Sponsorship 
Programme for exploratory testing of nanomaterials have yet to be made available, 
which limits the ability to identify and further critically assess the appropriateness of 
existing test methods and data generated in fulfilling the ecotoxicological data 
requirements under REACH at this time.   
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3.5.294 B3 Sub-Task IV: Summary of practical advice in relation to whether relevant 
ISO/CEN methods for substance characterisation could be used In fulfilling 
REACH data requirements 
3.5.295 PHYSICO-CHEMICAL PROPERTIES INFORMATION 
3.5.296 Water solubility 
3.5.297 Although no published standards of relevance for assessing the water solubility of 
nanomaterials have been identified, ISO/AWI TR 13014 (currently at Committee 
Draft stage), which aims to provide guidance on physico-chemical characterisation 
for manufactured nano-objects for toxicological testing, should be reviewed in further 
detail when the document reaches FDIS stage in order to assess its relevance to 
determining water solubility in the REACH context. 
3.5.298 Particle size/ size distribution 
3.5.299 CEN EN 481:1994, which currently forms the backbone of the existing REACH 
Guidance on Granulometry (ECHA, 2008. R7.1.14), defines sampling conventions 
for particle size fractions which are to be used in assessing the possible health 
effects resulting from inhalation of airborne particles in the workplace.  A number of 
key issues have been highlighted: 
o For particles of aerodynamic diameter less than 0.5 µm (i.e. including 
nanoparticles < 100 nm), CEN EN 481:1994 states that the particle 
diffusion diameter should be used instead of the particle aerodynamic 
diameter, defined as "the diameter of a sphere with the same diffusion 
coefficient as the particle under the prevailing conditions of temperature, 
pressure and relative humidity"; 
o Thus, the common methods used to determine particle size ranges of 
aerosols may not be appropriate for nanoparticles.   
3.5.300 These issues are acknowledged briefly in the current REACH Guidance chapter on 
Granulometry (ECHA, 2008. R7.1.14) but no information on the availability of 
alternative methods for handling these issues is currently provided.  This has been 
addressed through recommendations to update guidance in Task B5.   
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3.5.301 In ISO/TS 27687:2008 several key issues are highlighted in relation to particle size 
measurement, including:  
o the measured size of a particle is always dependent on the particular 
method that is being used to examine, measure or visualise the particle;  
o interaction with the environment will differ between particle types, and thus 
the particle size reported by one technique may not be the same as that 
reported with another technique;  
o even with a single detection method, the results depend upon how the 
information is processed and length parameters used for particle size 
characterisation should always be indicated; 
o when reporting particle size measurement results, the method used to 
determine the particle size should be reported.   
3.5.302 ISO/TR 27628:2007 contains guidelines on characterising occupational nanoaerosol 
exposures against a range of metrics (mass, number, surface area) with a view to 
forming a basis for extending knowledge on how occupational exposure to 
nanoaerosols should be most appropriately measured.  Specific information is 
provided within this technical report on methods for aerosol characterisation and 
single particle analysis, of relevance to consider in relation to the REACH Guidance 
chapter on Granulometry.  ISO/TR 27628:2007 outlines the principles, advantages 
and disadvantages of each of these methods, of relevance for incorporation into the 
amended REACH Guidance chapter on Granulometry.  In addition, valuable 
guidance on aerosol sample collection and preparation for SEM and TEM analysis is 
also provided.  However, this technical report does not provide specific methodology 
or protocols for undertaking nanomaterials characterisation using these methods. 
3.5.303 ISO 10808:2010 highlights that: 
o measurement of number-weighted particle size distribution and 
measurement of total particle mass concentration are essential 
parameters to characterise for inhalation toxicity testing of nanoparticles; 
o conventional methods of fine or coarse particle monitoring (such as weight 
based mass dose monitoring) are considered insufficient for nanoparticles, 
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since nano-specific parameters such as particle surface area, particle 
number etc. might be critical determinants and thus should also be 
monitored.  
3.5.304 The FDIS currently suggests a battery of inhalation toxicity testing chamber 
monitoring to include a Differential Mobility Analyzing System (DMAS) to measure 
particle size, distribution, number, surface area and estimated mass dose, as well as 
morphological examination using Transmission Electron Microscopy (TEM) or 
Scanning Electron Microscopy (SEM) equipped with an Energy Dispersive X-ray 
Analyzer (TEM-EDXA) for chemical composition. This method thus allows 
evaluation of nanoparticle distribution, surface area, mass dose, composition and 
dispersion to support effective analysis of inhalation toxicity testing results.   
3.5.305 For the purposes of inhalation toxicity testing, measurement with DMAS is the only 
currently available method that meets all of the following requirements in the size 
range below 100 nm: 
o measurement of particle size distribution during particle exposures in a 
continuous manner with time resolution appropriate to check stability of 
particle size distribution and concentration;  
o measurement range of particle sizes and concentrations covers those of 
the nanoparticle aerosols exposed to the test system during the toxicity 
test;  
o particle size and concentration measurements are sufficiently accurate for 
nanoparticle toxicity testing and can be validated by ways such as 
calibration against appropriate reference standards;  
o resolution of particle sizing is sufficiently accurate to allow conversion from 
number-weighted distribution to surface area-weighted or volume-
weighted distribution.   
3.5.306 However, it is noted within the FDIS that, for non-spherical particles (e.g. carbon 
nanotubes), estimation of diameter and mass concentration by DMAS can result in 
significant error.  
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3.5.307 In relation to this, published standard ISO/15900:2009 provides guidelines on the 
determination of aerosol particle size distribution using a DMAS.  This standard is 
not currently referenced in the existing REACH Guidance (ECHA, 2008. R.7a).  It is 
highlighted in the standard that it is important to know the stability of the source, 
since rapid changes of the size distribution, particle concentration, or both, can 
affect measurement of the size distribution. This is relevant to consider for 
nanomaterials, which have a high tendency to agglomerate in the atmosphere. 
3.5.308 ISO 28439:2011 provides further supplementary information regarding the use of 
DMAS to determine the particle size distribution on nanomaterial aerosols.  It is 
noted that: 
o the size range 3-1000 nm in electrical mobility diameter can be partly 
covered by other instruments (e.g. nanometer aerosol differential mobility 
analyser).  However, DEMC has the advantage that the electrical mobility 
diameter is approximately equivalent to the project-diameter of the 
particles (defined as the diameter of a sphere with the same projected 
area as the particles being sized) with compact geometries; 
o particle size calibration is possible with the use of polystyrene reference 
particles, available in the size range 20-900 nm.  However, the smallest 
polystyrene particle that can be used for DMAS is approximately 100 nm.  
This means that the performance of a DMAS cannot be easily tested by 
the user in the size range of ultrafine and nanoparticles smaller than 100 
nm. 
3.5.309 Thus the DMAS method and associated standards are of importance for 
consideration in relation to the updated REACH Guidance on Granulometry, and will 
be further assessed in the gap analysis (Task B4). 
3.5.310 ISO/21501-1:2009 specifies characteristics of a light scattering aerosol 
spectrometer (LSAS) which is used for measuring the size, number concentration 
and number/size distribution of particles suspended in a gas.  Due to its coverage of 
the nano-size range, the LSAS method outlined in ISO/21501-1:2009 may be 
relevant to consider in relation to informing the characterisation of particle size 
distribution under the REACH Granulometry Information Requirement.  However, 
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based on the reviewed literature, there is limited evidence of the application of this 
method for characterising nanomaterials at present. 
3.5.311 ISO/13318-1:2001 outlines general methods for determining the particle size 
distribution of particulate materials, typically in the size range 0.1 - 5 µm by 
centrifugal sedimentation in a liquid.  The methods described are applicable to 
slurries, particulate materials that can be dispersed in liquids and some emulsions. It 
is acknowledged in the standard that no single method of size analysis can be 
specified to cover the many different types of materials encountered, but that 
general procedures can be recommended that are applicable to the majority of 
cases.   
3.5.312 ISO/13322-1:2004 provides a standardised description of static image analysis 
methods for particle size analysis.  An exact standard method is not provided by ISO 
due to the wide variety of applications of the technique.  ISO/13322-1:2004 
highlights that this method is essentially limited to narrow size distributions of less 
than an order of magnitude, requiring over 6, 000 particles to be measured in order 
to obtain a repeatable volume-mean diameter heightening to 61, 000 particles for 
the mass median diameter.  The second part of ISO 13322 (ISO/13322-2:2006) 
provides guidance for measuring and describing particle size distribution, using 
image analysis where particles are in motion (dynamic image analysis) i.e. in a gas 
or a liquid. Neither standard comments on its applicability to nanomaterials, however 
ISO has listed these standards as potentially relevant to nanoscale measurement or 
observation (NIST, 2008).  There is also evidence in the peer-reviewed literature 
and FP6/7 outputs of the application of image analysis alongside electron 
microscopy methods (such as TEM and SEM) for determining the particle size 
distribution of nanomaterials.  
3.5.313 These standards are not currently referenced in the existing endpoint specific 
guidance (ECHA, 2008. R.7a). In relation to the counting procedures of static image 
analysis, in ISO 13322-1 it is stated in the standard that "it is a prime requirement of 
the method that measurements shall be made on isolated particles. There should be 
as few particles as possible touching each other".  This may have implications for 
nanomaterials, which have a high tendency to agglomerate. 
3.5.314 ISO/TS 13762:2001 outlines the principles of the small-angle X-ray scattering 
(SAXS) technique, applicable to particle sizes ranging from 1 - 300 nm, and 
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provides guidance for sample preparation (including preparation of dry powder 
samples and colloidal solutions), the experimental procedure and calculation and 
expression of results (pointing to ISO 9276-1 and ISO 9276-2 on the representation 
of the results of particle size analysis). 
3.5.315 Given its coverage of the nano-size range, ISO/TS 13762:2001 and the SAXS 
method are therefore relevant to consider in relation to determination of particle size 
under REACH.  The success of this technique is mainly based on the fact that SAXS 
effect results from the difference in electron density between particles and their 
surroundings such that the measurement always indicates the size of a primary 
particle rather than the internal crystallite or external agglomerate size.  Thus, the 
requirement of particle dispersion of a sample for SAXS analysis is not as strict as 
that for other methods.  However, SAXS does have limitations: 
o The method cannot distinguish pores from particles and the interference 
effect between particles will arise as the sample is available only in 
concentrated form. 
o In the data analysis for this method, it is assumed that particles isotropic 
and spherically shaped and it is stated that this technical specification 
does not apply to powders containing particles whose morphology is far 
from spherical.   
o This method would therefore not be relevant to consider for non-spherical 
nano-objects such as carbon nanotubes.   
o The method cannot be used for powders consisting of porous particles, 
which may also limit its applicability to the measurement of certain 
nanomaterials. 
3.5.316 ISO/13320:2009 and the method of laser diffraction is relevant to consider in relation 
the characterising the particle size distribution, although no specific advice for sub-
100 nm particles is provided.  It is important to highlight that this technique assumes 
a spherical particle shape.  It is stated in the standard that test products should have 
no extreme aspect ratios, with a restriction of 1:3 for non-spherical particles.  This 
method is therefore unlikely to be applicable to the measurement of high-aspect-
ratio nanomaterials such as carbon nanotubes.  Another major source of error arises 
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from incomplete deagglomeration of the particles, due to an improper dispersion 
procedure.  This highlights the importance of establishing suitable dispersion 
protocols for nanomaterials.   
3.5.317 ISO/22412:2008, which specifies a method for the application of Dynamic Light 
Scattering (DLS) to the estimation of an average particle size and the measurement 
of the broadness of the size distribution of mainly sub micrometre-sized (approx 1 - 
1000 nm) particles or droplets dispersed in liquids, is not currently referenced in the 
existing endpoint specific guidance (ECHA, 2008. R.7a).  As outlined in the literature 
section of RNC/RIP-oN2/B3/2/FINAL, the method of DLS does have several 
limitations in relation to the characterisation of nanomaterials (e.g. lack of 
discrimination between agglomerates of nanoparticles and larger particles) which 
would need to be acknowledged in the amended guidance. It is also likely that the 
DLS method would need to be used in combination with other techniques. 
3.5.318 Related to this standard is ISO/13321:1996 which provides more detailed 
information on the procedures to allow the determination of the correct particle size 
using photon correlation spectroscopy (PCS).  It is highlighted that samples should 
consist of well-dispersed particles in a liquid medium, which may have implications 
for nanomaterials with a tendency to agglomerate and further highlights the need for 
reproducible dispersion protocols. Published standard E56 WK8705 from the 
American Society for Testing and Materials (ASTM) also deals with the 
measurement of particle size distribution of suspended particles, which are solely or 
predominantly sub-100 nm, using PCS.  It is highlighted within E56 WK8705 that 
PCS measurement is hydrodynamically based and therefore provides size 
information in the suspending medium (typically water). Thus the hydrodynamic 
diameter will almost certainly differ from other size diameters isolated by other 
techniques and users of the PCS technique need to be aware of the distinction of 
the various descriptors of particle diameter before making comparisons between 
techniques. 
3.5.319 ISO/22412:2008, ASTM E2490-09 and ISO/13321:1996 are thus also relevant to 
consider with regards characterising the particle size distribution of nanoparticles in 
suspensions, potentially in relation to the REACH Granulometry Information 
Requirement as well as investigating the preparation of stable dispersions for 
(eco)toxicological testing.  
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3.5.320 ISO/20998-1:2006, which describes ultrasonic methods for determining the size 
distributions of one or more material phases dispersed in a liquid, is also relevant to 
consider in relation to determining the particle size distribution of nanoparticles in 
suspension, potentially in relation to the REACH Information Requirement on 
Granulometry.  Ultrasonic methods can be used to monitor dynamic changes in the 
size distribution, including agglomeration or flocculation in concentrated systems 
and may therefore be of use in the preparation of stable dispersions of 
nanomaterials for (eco)toxicological testing.  However, there is limited evidence of 
the application of this method in relation to nanomaterials in the scientific literature 
at present, with methods such as DLS preferred.   
3.5.321 ISO/21501-2:2007, describes a calibration and verification method for a light 
scattering liquid-borne particle counter (LSLPC), which is used to measure the size 
and particle number concentration of particles suspended in liquid. The typical size 
range of particles measured by this method is between 0.1 μm and 10 μm in particle 
size. This standard and the method of LSLPC may be relevant to the 
characterisation of the particle size distribution of nanomaterials in suspension, 
potentially in relation to the REACH Granulometry Information Requirement.  
However, as with acoustic methods, there is limited evidence of the application of 
LSLPC in the scientific literature at present. 
3.5.322 BS EN 13925-1:2003 describes the general principles of X-ray diffraction (XRD) for 
polycrystalline and amorphorphous materials, but does not go as far as to define a 
specific or detailed standard for each field or type of analysis.  XRD allows 
estimation of the average particle size by mathematical adaption of a simulated 
diffractogram, with sensitivity down to 1 nm.  BS EN 13925-1:2003 outlines the 
general principles of the method, characteristics of powder diffraction line profiles, 
types of analysis and experimental conditions.  This standard is further supported by 
BS EN 13925-2:2003, which specifies the basic procedures of the XRD method, 
and BS EN 13925-3:2005, which sets of the characteristics of instruments used for 
XRD as a basis for their control and hence quality assurance of the measurements 
made by this technique.  BS EN 13925-1:2003, BS EN 13925-2:2003 and BS EN 
13925-3:2005 and the method of XRD are relevant to consider in the context of the 
REACH Granulometry Information requirement for nanomaterials.   
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3.5.323 ISO/AWI TS 10797 (which describes the characterisation of SWCNT using TEM, 
ISO/AWI TS 10798 (which describes the characterisation of SWCNT using SEM and 
energy dispersive X-ray spectrometry analysis) are currently at Committee Draft 
stage, while work on ISO/NP TS 10812 (which outlines the use of Raman 
Spectroscopy for the characterisation of SWCNT) has just recently commenced.  It 
is recommended that these documents are reviewed in detail when they reach FDIS 
stage in relation to their potential to inform the determination of particle size 
distribution in the REACH context. 
3.5.324 ISO/NP TS 10868 (currently at FDIS stage) provides guidelines for the 
characterisation of compounds containing SWCNTs by using optical absorption 
spectroscopy. Although this standard does not address particle size/size distribution 
per se, the information provided in relation to diameter determination may be 
relevant to consider under the REACH Granulometry Information Requirement, 
depending on the coverage of this term. 
3.5.325 ISO/AWI TR 13014 (which aims to provide guidance on physico-chemical 
characterisation for manufactured nano-objects for toxicological testing) and 
ISO/DTR 10929 (which outlines a collection of measurement methods for the 
characterisation of multi-walled carbon nanotubes (MWCNT)), currently at 
Committee Draft stage, may offer information of relevance to determining the 
particle size/geometrical properties (e.g. length/diameter) of nanomaterials.  It 
therefore recommended that these documents are reviewed for their relevance in 
the REACH context when they reach FDIS stage. 
3.5.326 In addition, ISO/CD 12025 (which aims to provide a general framework for 
determining nano-object release from powdered engineered nanoparticles into the 
gaseous surroundings by means of analysis of the generated aerosols particles) and 
the methods it advocates, is relevant to consider in relation to REACH Granulometry 
Information Requirement, in terms of measurement related to dustiness as well as 
methods for the generation of nanoaerosols for studying parameters such as particle 
size distribution.  The release of nano-objects from nanomaterials into the 
surrounding air is an important consideration in relation to the hazard potential of 
nanomaterials. However, this document is currently at Committee Draft stage with 
the content still under development.  It is recommended that it should be reviewed in 
further detail when the document reaches FDIS stage. 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 118 - 
3.5.327 Agglomeration/ aggregation state 
3.5.328 A number of the methods and standards described above for determining the 
particle size distribution of particles will also apply to determining the level of 
agglomeration/aggregation of particles in powder and suspension form, of relevance 
to consider in the context of REACH.  Of key importance are ISO/20998-1:2006 
(which describes ultrasonic methods for determining the size distributions of one or 
more material phases dispersed in a liquid), ISO/13322-1:2004 (which describes 
static image analysis for determining the size distribution of particles in both powder 
and suspension form) and ISO/TS 13762:2001 (which describes the small angle X-
ray scattering method, also applicable to both powders and suspensions). 
3.5.329 A number of the standards are currently at Committee Draft level may also offer 
information of value to consider in relation to characterising the 
agglomeration/aggregation state of nanomaterials, specifically ISO/AWI TS 10797 
(which describes the characterisation of SWCNT using transmission electron 
microscopy), ISO/AWI TS 10798 (which describes the characterisation of SWCNT 
using scanning electron microscopy (SEM) and energy dispersive X-ray 
spectrometry analysis) and ISO/AWI TR 13014 (which aims to provide guidance on 
physico-chemical characterisation for manufactured nano-objects for toxicological 
testing).  It is recommended that these standards should be reviewed with regards 
their relevance for informing characterisation under REACH they reach FDIS stage. 
3.5.330 Crystallite or grain size 
3.5.331 A number of the methods and standards described above for determining the 
particle size distribution of particles will also apply to determining the crystallite or 
grain size of nanomaterials, of possible relevance to consider in the context of 
REACH. Of particular relevance is BS EN 13925-1:2003 which describes the 
general principles of X-ray diffraction (XRD) for polycrystalline and amorphorphous 
materials.  XRD can be used to study single crystal or polycrystalline materials in 
powder or dispersion form, with sensitivity down to 1 nm, providing a wealth of 
information, including crystallite size, as well as crystalline phase composition, 
lattice strain and defects, crystallographic orientation and charge distribution.  BS 
EN 13925-1:2003 outlines the general principles of the method, characteristics of 
powder diffraction line profiles, types of analysis (including analysis of crystallite 
size) and experimental conditions.  This standard is further supported by BS EN 
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13925-2:2003, which specifies the basic procedures of the XRD method, and BS 
EN 13925-3:2005, which sets of the characteristics of instruments used for XRD as 
a basis for their control and hence quality assurance of the measurements made by 
this technique. 
3.5.332 In addition, ISO/AWI TS 10797 on the use of TEM for charactering SWCNT, 
currently under development, will also be relevant to consider in this context.  It is 
recommended that this document be fully reviewed when it reaches FDIS status.  
3.5.333 Aspect ratio/ shape 
3.5.334 The static image analysis methods described in ISO/13322-1:2004 and the FDIS 
standard ISO/NP TS 10868 which provides guidelines for the characterisation of 
compounds containing SWCNTs by using optical absorption spectroscopy, covering 
determination of the mean diameter may be particularly useful for studying the 
shape of nanomaterials.  
3.5.335 It is recommended that the following draft standards under development should be 
reviewed when they reach FDIS status in regards to their relevance to inform the 
measurement of the aspect ratio/shape of nanoparticles in the context of REACH: 
ISO/AWI TS 10797 (which describes the characterisation of SWCNT using TEM), 
ISO/AWI TS 10798 (which describes the characterisation of SWCNT using SEM 
and energy dispersive X-ray spectrometry analysis), ISO/AWI TR 13014 (which 
aims to provide guidance on physico-chemical characterisation for manufactured 
nano-objects for toxicological testing), ISO/DTR 10929 (which outlines a collection 
of measurement methods for the characterisation of multi-walled carbon nanotubes 
(MWCNT)) and ISO/DTS 11888 (which addresses the determination of mesoscopic 
shape factors of MWCNT). 
3.5.336 Specific surface area 
3.5.337 ISO/9277:2010 (which outlines a method for determination of the total specific 
external and internal surface area of disperse or porous solids by measuring the 
amount of physically absorbed gas according to the BET method) and 
ISO/18757:2005 (which provides guidelines for the determination of the total specific 
external and internal surface area of disperse or porous (pore diameter > 2 nm) fine 
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ceramic materials by the BET method) are relevant to consider in the context of 
characterising the specific surface area of nanomaterials. 
3.5.338 Although the BET method assumes a mono-dispersed spherical system, it is 
commonly applied to determine both the surface area and average particle size (not 
size distribution) of nanomaterials.  ISO/9277:2010 highlights that, in order to ensure 
proper working conditions and correct data evaluation, the apparatus performance 
should be monitored periodically using a surface-area reference material, with 
certified reference materials listed in an annex.  This highlights the importance of 
defining suitable reference nanomaterials. 
3.5.339 ISO/TR 27628:2007 (which contains guidelines on characterising occupational 
nanoaerosol exposures against a range of metrics) provides general information of 
relevance to consider in relation to characterising the surface area of aerosolised 
nanoparticles.  However, no specific methodological guidance or protocols are 
detailed.  It is important to note that within this standard it has highlighted that the 
BET method has been used with some success for measuring aerosol surface area, 
but that it suffers the disadvantages of requiring the collection of relatively large 
amounts of material, and measurements are influenced by particle porosity and 
collection/support substrate.   
3.5.340 ISO/TS 13762:2001 (which specifies a method for determining particle size 
distribution of ultra-fine powders by the small-angle X-ray scattering (SAXS) 
technique, applicable to particle sizes ranging from 1 - 300 nm) can also be used to 
derive the specific surface area of a powder sample from the measured particle size 
distribution and the mass density of the powder particle. 
3.5.341 Similarly, the static image analysis techniques described in ISO/13322-1:2004 
enable determination of the specific surface area of particles from the particle size 
measurements. 
3.5.342 The DMAS system described within ISO 10808:2010 can be used to calculate the 
surface area based on the determined particle diameter.  However, it is noted that 
for non-spherical particles (e.g. carbon nanotubes), estimation of diameter and mass 
concentration by DMAS can result in significant error. 
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3.5.343 Three published ISO standards which address determination of the pore size 
distribution of solid materials by mercury porosimetry and gas adsorption using 
related methods (ISO 15901-1:2005; ISO 15901-2:2006; ISO 15901-3:2007) may 
enable indirect determination of the specific surface area of the characterised 
material.  Indeed, ISO 15901-1:2005 provides an equation to calculate a specific 
surface area of the intruded pores.  However, these methods are quite specific and 
unlikely to obtain widespread use for the determination of specific surface area 
alone. 
3.5.344 It is recommended that ISO/AWI TR 13014 (which aims to provide guidance on 
physico-chemical characterisation for manufactured nano-objects for toxicological 
testing) should be reviewed in further detail when the document reaches FDIS stage 
in the context of identifying methods for the determination of surface area under 
REACH. 
3.5.345 Surface charge/zeta potential 
3.5.346 No published standards of relevance for determining the surface charge of 
nanomaterials have been identified.   
3.5.347 It is recommended that draft standards under development ISO/CD 13099-1 and 
ISO/CD 13099-2 (which both relate to the measurement of zeta potential)  as well as 
ISO/AWI TR 13014 (which aims to provide guidance on physicochemical 
characterisation for manufactured nano-objects for toxicological testing), should be 
reviewed when the reach FDIS stage in relation to their relevance in providing 
methods for the characterisation of surface charge of nanomaterials 
3.5.348 Surface chemistry 
3.5.349 ISO has published a wide-range of standards related to surface chemical analysis 
using three principle techniques: X-ray photoelectron spectroscopy (XPS), Auger 
electron spectroscopy (AES), and secondary-ion mass spectrometry.  However, 
these documents are highly specific and they most relevant to consider in the 
context of determining the surface chemical composition of materials. 
3.5.350 It is highly recommended that ISO/WD TR 14187 (which looks specifically at the 
surface chemical analysis of nanostructured materials), as well as ISO/NP TS 10812 
(which outlines the use of Raman Spectroscopy for the characterisation of SWCNT) 
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and ISO/AWI TR 13014 (which aims to provide guidance on physico-chemical 
characterisation for manufactured nano-objects for toxicological testing), should be 
reviewed when they reach FDIS stage to assess their relevance for informing the 
characterisation of the surface chemistry of nanomaterials in the REACH context. 
3.5.351 Dustiness 
3.5.352 The standard current referenced in the REACH Guidance on Granulometry for 
determining the dustiness of bulk materials is EN 15051:2006.  The current 
limitation of these methods in relation to nanomaterials is that they measure the 
mass, rather than e.g. the particle number, of the resultant dust and provide no size-
based information. In addition, rotating drum dustiness tests are usually performed 
as three replicate tests and need quite large amounts of test material, typically 300–
600 g. The EN 15051 continuous single-drop method requires a total amount of 500 
g for the required five single-test runs. Modified methods for measuring the 
dustiness of nanomaterials have been described in the FP6/7 section and the 
literature section of RNC/RIP-oN2/B3/2/FINAL.   
3.5.353 It is highly recommended that draft standard under development ISO/CD 12025 
(which aims to provide a general framework for determining nano-object release 
from powdered engineered nanoparticles into the gaseous surroundings by means 
of analysis of the generated aerosols particles, using adapted procedures for 
determining dustiness) should be reviewed in further detail when the document 
reaches FDIS stage as it will likely contain information of importance to consider in 
relation to REACH guidance updates relating to dustiness measurements for 
nanomaterials, 
3.5.354 Porosity 
3.5.355 The three published ISO standards which describe methods for determination of the 
pore size distribution of solid materials by mercury porosimetry and gas adsorption 
(ISO 15901-1:2005; ISO 15901-2:2006; ISO 15901-3:2007) may be applicable to 
determining the porosity of nanomaterials. 
3.5.356 Photocatalytic activity 
3.5.357 ISO 22197-1:2007 (which specifies a test method for determination of the a test 
method for the determination of the air-purification performance of materials that 
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contain a photocatalyst or have photocatalytic films on the surface) may be 
applicable for the determination of the photocatalytic activity of nanomaterials, 
However it has not been established whether the interpretation of data gathered by 
this method, and used for hazard assessment purposes, will be meaningful.  Whilst 
it is being investigated under the OECD Sponsorship Programme, it is stated that 
the method does not apply to powder or granular photocatalytic materials, thus 
restricting its use for some forms of nanomaterials. 
3.5.358 Sample preparation 
3.5.359 ISO/14887:2000 (which provides general guidance to assist in the preparation of 
good dispersions from various powder/liquid combinations) covers procedures for 
wetting a powder into a liquid; deagglomerating the wetted clumps; selecting 
dispersing agents to prevent reagglomeration; evaluating the stability of the 
dispersion against reagglomeration.  This standard is applicable to particles ranging 
in size from approximately 0.05 to 100 µm, and is therefore relevant to consider for 
informing the preparation of nanomaterials dispersions in the REACH context.  For 
examining the resultant dispersion, ISO 14887:2000 states that, for particles smaller 
than 1 µm, the standard method of optical microscopy should be replaced with some 
other form of evaluation. 
3.5.360 The characterisation of particle properties like size, form and specific surface area 
requires very careful sampling and sample splitting practices to be followed.  It is 
considered vital that the test aliquot used for measurement is representative of the 
sample of particulate material. While this standard does not specifically address 
procedures for nano-sized materials, ISO 14488:2007 (which specifies methods for 
obtaining a test alliquot from a defined sample of particulate material that can be 
considered to be representative of the entire sample with a defined confidence level) 
offers general information and good practice of relevance to powder sampling of a 
range of materials of value for further consideration in relation to the updated 
REACH Guidance. 
3.5.361 It is highly recommended that ASTM draft standard E56 WK10417 (which outlined 
standard practice for the preparation of nanomaterial samples for characterisation) 
is reviewed when published. 
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3.5.362 Other information of relevance 
3.5.363 Although ISO/DTR 13121 (which describes a process for evaluating, addressing, 
making decisions about, and communicating the potential risks of developing and 
using engineered nanoscale material) does not address specific methods for 
characterising the physico-chemical properties of nanomaterials, it highlights a 
number of key issues of importance to consider further in development of 
recommendations for guidance updates, specifically: 
o The importance of characterising the physico-chemical properties of a 
nanomaterial over its entire life cycle is highlighted; 
o It is recommended that any anticipated changes in relevant physical and 
chemical properties across the lifecycle of the material should be noted. It 
may be necessary to characterize the material at multiple points unless 
there is good reason to expect that the material will remain unchanged; 
o It is recommended that the properties of the nanomaterial should be 
compared to those of the corresponding bulk (non-nanoscale) materials, 
where appropriate, to determine the nature and extent to which the 
properties are different. 
3.5.364 It is highly recommended that the following draft standards ISO/AWI TS 11931-1 
and ISO/AWI TS 11937-1 which describe characteristics and measurement 
methods for nano-calcium carbonate and nano-titanium dioxide, respectively 
currently under development are reviewed when published to assess their relevance 
in the context of the updated REACH guidance. 
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3.5.365 TOXICOLOGICAL INFORMATION 
3.5.366 Those ISO/CEN documents published or classified as being at Final Draft 
International Standard (FDIS), Draft International Standard (DIS) stage or at an 
early stage of development (i.e. Committee Draft stage or lower) were reviewed and 
commented upon. It is clear that whilst there a number of standards at ballot level 
or under development, there is to date only one published document pertaining to 
the toxicity of nanomaterials (ISO 10801:2010). It is expected that this standard will 
provide a useful contribution to supporting good experimental design in the 
mammalian toxicity testing under hazard identification within the context of REACH. 
In summary, at the current time there exists only one fully published method from 
ISO which may be considered directly relevant for fulfilling the REACH Information 
Requirements relating to toxicity.  
3.5.367 ECOTOXICOLOGICAL INFORMATION 
3.5.368 On the basis of the review carried out, it is considered that no work has so far been 
published by ISO and CEN that is considered directly relevant for fulfilling the 
REACH Information Requirements in regard to ecotoxicity.   
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3.6 GAP ANALYSIS OF RELEVANT INTRINSIC PROPERTIES FOR 
NANOMATERIALS POSSIBLY NOT ADDRESSED BY STANDARD TEST 
GUIDELINE METHODS AND REQUIRING FURTHER DEVELOPMENT OF IN 
VITRO, IN VIVO OR OTHER METHODOLOGIES (TASK B4) 
3.6.1 The gap analysis of relevant intrinsic properties for nanomaterials, which may not be 
addressed by standard test guideline methods and for which further development of 
in vitro, in vivo or other methodologies is required, has assembled and further 
developed the findings from the examination of existing REACH Guidance related to 
information requirements and testing (information generation) strategies (Task B1), 
the identification of additional relevant specific intrinsic properties for nanomaterials 
(Task B2), the assessment of relevance and applicability of testing, endpoints and 
methods described in the scientific literature and on-going international work 
relevant to the fulfilment of the data requirements under REACH (Task B3).   
3.6.2 The structural framework used for the gap analysis considers physico-chemical 
properties and toxicological and ecotoxicological endpoints, and integrates the 
existing and additional properties/endpoints to meet the objective of identifying those 
which may and may not be addressed by standard test guideline methods and 
where further development of in vitro, in vivo or other methodologies is required.   
3.6.3 The outcomes of the gap analysis, specifically addressing the aforementioned 
objective, are summarised below.  (The information developed for the gap analysis 
has been used subsequently in the development of specific guidance updates and 
recommendations for research & development (two of the objectives of Task B5)).   
3.6.4 The following intrinsic properties, identified from the gap analysis, are relevant to 
nanomaterials, with suspected important differences between nano and non-
nanomaterials, which may not be addressed by standard test guideline 
methods and require further development of in vitro, in vivo or other methodologies.  
Those considered to be of low priority for further research and development are 
indicated using an asterisk.  Those for which standards, or other important 
documents, are known to be in preparation are indicated with a  . 
3.6.5 Physico-chemical properties 
Existing Information Requirements 
 R.7.1.7 Water Solubility  
 R.7.1.10 Flammability 
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 R.7.1.11 Explosive properties 
Additional Relevant Specific Intrinsic Properties 
 Porosity 
 Surface energy 
 Surface acidity 
 Surface charge (zeta potential)  
 Redox potential 
3.6.6 Toxicological endpoints 
 None identified. 
3.6.1 Ecotoxicological endpoints 
 #R 7.8.15 Activated sludge respiration inhibition testing 
 R. 7.9.1 Hydrolysis as a function of pH 
 #Daphnia heart rate* 
 #Daphnia hopping frequency* 
 #Number of cycles per minute of daphnia in appendage movement* 
 #In relation to these endpoints and proposed biological markers it should be noted that consensus has not been 
reached within the project consortium and further discussions can be found in section 4.3.157 and onwards.  
3.6.2 The following intrinsic properties / endpoints are considered to be relevant to 
nanomaterials, with no suspected important differences between nano and 
non-nanomaterials in terms of the applicability of the standard test guideline 
methods, but an insufficient evidence basis to warrant acknowledgement in 
the guidance, and further research & development is required.  Those considered 
being of lower priority for further research and development are indicated using an 
asterisk.  Those for which standards, or other important documents, are known to be 
in preparation are indicated with a  . 
3.6.3 Physico-chemical properties 
Existing Information Requirements 
 None identified 
3.6.4 Additional Relevant Specific Intrinsic Properties: 
 Surface chemistry 
 Cell-free ROS/RNS production capacity 
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3.6.5 Toxicological endpoints 
 Acute toxicity (oral and inhalation: it is recommended that either the 
method or the guidance includes extended pathology/ histology) 
o OECD TG 420 (EU B.1 bis) (Acute oral toxicity – Fixed dose 
procedure) 
o OECD TG 423 (EU B.1 tris) (Acute oral toxicity – Acute toxic class 
method) 
o OECD TG 425 (Acute oral toxicity – Up-and-down procedure) 
 Acute toxicity (inhalation: it is recommended that either the method or the 
guidance includes the requirement to use BAL as a measurand) 
o OECD TG 403 (EU B.2) (Acute inhalation toxicity) 
o Draft OECD TG 433 (“Acute Inhalation Toxicity, Fixed Dose 
Procedure”) 
o Draft OECD TG 436 (“Acute Inhalation Toxicity, Acute Toxic Class 
Method”) 
 Repeated dose toxicity (it is recommended that either the method or the 
guidance includes the requirement to use BAL as a measurand) 
o OECD TG 412 / EU B.8 (Subacute Inhalation Toxicity: 28-Day 
Study) 
o OECD TG 413/EU B.29 (Subchronic Inhalation Toxicity: 90-day 
Study) 
 Repeated dose toxicity (it is recommended to include inhalation as a route 
of exposure) 
o OECD TG 422: Combined repeated dose toxicity / reproductive 
screening study 
o OECD TG 424 (rodents) 
 Respiratory Sensitisation 
 Cardiovascular toxicity (focus on understanding mechanism and 
developing predictive standardised models) 
 Reproductive Toxicity 
o Reproductive toxicity (nano-focussed, in vitro) – Embryonic stem 
cell test for embryotoxicity; 
o Reproductive toxicity (nano-focussed, in vitro) – Micromass 
embryotoxicity assay; 
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o Reproductive toxicity (nano-focussed, ex vivo) – Whole rat embryo 
embryotoxicity assay. 
 Inflammation (with relevance to acute, repeated dose) 
o Pro-Inflammatory effects in vitro – Cytokine, chemokine and their 
receptor expression and transcription e.g. IL-8, GRO, TNF-α, IL-1β 
o Pro-fibrogenic effects – Histopathological examination e.g. using 
Collagen staining (e.g. Sirius Red, Trichrome) 
o Pro-fibrogenic effects – Pro-fibrotic mediators e.g. TGF-β ,  IL-6, IL-
10, EGF etc  
o Pro-Inflammatory effects in vitro - Cell signalling and 
Transcriptional activation e.g. AP1, NFkB, STAT, NRF2, MAP 
Kinase* 
o Pro-fibrogenic effects – Collagen production, type and biochemical 
modifications e.g. Hydroxyproline, pro-collagen peptides* 
 Cytotoxicty 
o Propidium Iodide 
o LDH release 
o Neutral Red uptake* 
o Trypan Blue* 
o Apoptosis - Annexin V 
 Oxidative stress (with relevance to inflammation and genetic damage) 
o Oxidative Stress: Antioxidant capacity - Glutathione Depletion 
(intra- and extra-cellular)* 
o Oxidative Stress: Antioxidant capacity - vitamin C depletion* 
o Oxidative Stress: Antioxidant capacity - TEAC (trolox equivalent 
anti-oxidant capacity)* 
o Oxidative Stress: Antioxidant capacity - ORAC (oxygen radical anti-
oxidant capacity)* 
o Oxidative Stress: Antioxidant capacity – FRAP (Ferric/Reducing 
Antioxidant Power)* 
o Oxidative Stress: Redox sensitive dyes e.g. DCFH, DHE etc. 
o Oxidative Stress: Antioxidant capacity – Mitochondrial dysfunction* 
o Oxidative Stress: Antioxidant capacity - Antioxidant gene/protein 
expression and transcription factors (HO-1 expression etc.)* 
 Genotoxicity 
o DNA Repair reporter assays: e.g. GreenScreen assay* 
o Mutagenicity: Oxidative adducts of DNA e.g. 8-OH-dG 
o Mutagenicity: Lipid adducts e.g. N-1,N2 malondialdehyde-2'-
deoxyguanosine (M1dG) 
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 Particle translocation 
o Barrier Transfer Models - Transwell - co culture system (using 
relevant cell types for barrier of interest, e.g. epithelial/ endothelial 
= blood-air barrier; endothelial/ astocyte = blood-brain barrier) 
3.6.6 Ecotoxicological endpoints 
3.6.7 None identified.   
3.6.8 The following intrinsic properties / endpoints have been identified to be relevant to 
nanomaterials, but with differences between nano and non-nanomaterials in 
terms of the applicability of standard test guideline methods and for which guidance 
updates have been recommended: 
3.6.9 Physico-chemical properties 
3.6.10 Existing Information Requirements 
 R.7.7.8 Partition coefficient N-octanol/water 
 R.7.1.14 Granulometry   
3.6.11 Additional Relevant Specific Intrinsic Properties 
 Particle shape   
 Surface area 
3.6.12 Toxicological endpoints 
3.6.13 Existing Information Requirements: 
 R.7.3 Skin and eye irritation 
 R.7.3 Skin and respiratory sensitisation 
 R.7.4 Acute Toxicity 
 R.7.5 Repeated dose toxicity 
 R.7.6 Reproductive and developmental toxicity 
 R.7.7 Mutagenicity and carcinogenicity 
3.6.14 Ecotoxicological endpoints 
In relation to the following parameters currently within guidance, it is noted that in relation to 
ecotoxicity testing there are issues surrounding sample preparation and characterisation. 
These include measuring, dosing, delivery and tracking of the substance in the testing 
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system and in particular aquatic effects issues surrounding dispersability vs. solubility which 
may lead to difficulties and inaccuracies in interpreting results. In addition, suitable analytical 
methods may need to be developed which are capable of characterising actual exposure 
concentration in a test system (e.g. in the soil) during the experimental duration. 
 Short-term toxicity testing on invertebrates (preferred species Daphnia) 
 Growth inhibition study aquatic plants (algae preferred) 
 Ready biodegradability 
 Short-term toxicity testing on fish 
 Adsorption/desorption screening 
 Long-term toxicity testing on invertebrates (preferred species 
Daphnia), (unless already provided as part of Annex VII requirements) 
 Long-term toxicity testing on fish, (unless already provided as part of 
Annex VIII requirements) 
 Fish early-life stage (FELS) toxicity test 
 Fish short-term toxicity test on embryo and sac-fry stages 
 Fish, juvenile growth test 
 Bioaccumulation in aquatic species, preferably fish 
 Soil short-term toxicity to invertebrates 
 Effects on soil micro-organisms 
 Short-term toxicity to plants 
 Long-term toxicity testing on soil invertebrates, unless already 
provided as part of Annex IX requirements 
 Long-term toxicity testing on plants, unless already provided as part of 
Annex IX requirements 
 Long-term toxicity to sediment organisms 
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3.7 SCIENTIFIC REPORT ON TEST METHODS AND STRATEGIES FOR 
NANOMATERIALS (TASK B5) 
3.7.1 B5 Sub-Task I: Advice on integrated testing strategies relevant to specific 
nanomaterials properties and how the specific intrinsic properties of 
nanomaterials might affect the need for adaptations to the testing regime 
3.7.2 The relevance and applicability to nanomaterials of the Integrated Testing Strategies 
provided for each property and testing endpoint has been considered and identified 
any limitations and the need for updates to the current Guidance text.  Any 
recommendation for updating the current Guidance considers the feasibility of doing 
so, given the current state of knowledge.   
3.7.3 A summary of the findings from considering the Integrated Testing Strategies for 
Existing Information Requirements in terms of the relevance to nanomaterials is 
presented in the tables below.  For each ITS, relevance and applicability to 
nanomaterials is indicated along with the need for any update to the existing 
Guidance text, where this is consider feasible given the current state of knowledge.   
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Integrated Testing Strategy Applicable to 
nanomaterials 
Update to Guidance proposed
Physico-chemical properties 
General testing strategy for physico-
chemical properties (R.7.1.1.4) 
 Minor - Update depending upon 
agreed definition of granulometry
Melting point / Freezing point 
(R.7.1.2.5) 
 None 
Boiling point (R.7.1.3.5)  None 
Relative density (R.7.1.4.5)  None 
Vapour pressure (R.7.1.5.5)  None 
Surface tension (R.7.1.6.5)  None 
Water solubility (R.7.1.7.5)  Minor - Distinguish between 
solubilisation and dispersion 
Partition coefficient (R.7.1.8.5)  None 
Flash point (R.7.1.9.5)  None 
Flammability (R.7.1.10.5)  (with some 
limitations) 
None 
Explosive properties (R.7.1.11.5)  (with some 
limitations) 
None 
Self-ignition temperature (R.7.1.12.5)  None 
Oxidising properties (R.7.1.13.5)  None 
Granulometry (R.7.1.14.5)  Substantive - scope of update 
depends on the  concept and 
regulatory status of granulometry 
and parameters included in it 
Toxicological Endpoints 
Irritation / corrosion (R.7.2.6)  Minor - Use of QSAR & read-
across data 
Skin & respiratory sensitisation 
(R.7.3.8) 
 Minor - Use of QSAR 
Acute toxicity (R.7.4.6)  Minor -  Use of QSAR, Route of 
Exposure phrasing 
Repeated dose toxicity (R.7.5.6)  (some TG 
limitations) 
Minor - Use of QSAR and lung 
overload 
Reproductive toxicity (R.7.6.6)  (some TG 
limitations) 
Minor - Use of QSAR and read-
across 
Mutagenicity (R.7.7.6)  (some TG 
limitations) 
Minor - Use of QSAR and use of 
multiple methods re: addressing 
interferences 
Carcinogenicity (R.7.7.13)  Minor - Use of QSAR and read-
across 
Ecotoxicological Endpoints 
Adsorption / desorption (R.7.1.15.5)  None 
Aquatic pelagic toxicity (WoE) 
(R.7.8.5) 
 (with some 
limitations) 
None 
Sediment organisms (R.7.8.5)  (with some 
limitations) 
None 
STP micro-organisms (R.7.8.5)  (with some 
limitations) 
None 
Degradation / biodegradation 
(R.7.9.6) 
 (with some 
limitations) 
None 
Aquatic bioaccumulation (R.7.10.6)  (with some 
limitations) 
None 
Terrestrial bioaccumulation 
(R.7.10.6) 
 (with some 
limitations) 
None 
Avian toxicity (R.7.10.19.3)  None 
Terrestrial organisms (R.7.11.6)  (with some 
limitations) 
None 
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3.7.4 Summary of findings on the Integrated Testing Strategies for Additional 
Relevant Specific Intrinsic Properties relevant to nanomaterials 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.7.5 Full details of the considerations and proposed updates to the Guidance text are 
provided in the final report for Task B5 (RNC/RIP-oN2/B5/2/FINAL) and in Chapter 4 
of this report.   
3.7.6 By way of illustration, three examples of the advice provided on the ITS for i) 
oxidising properties (no changes recommended) and ii) granulometry (updates 
recommended), and iii) skin & respiratory sensitisation, extracted from RNC/RIP-
oN2/B5/2/FINAL, are provided below.   
3.7.7 OXIDISING PROPERTIES 
3.7.8 R.7.1.13.5 Integrated testing strategy (ITS) for oxidising properties 
3.7.9 The following ITS for oxidising properties is outlined in the existing REACH 
Guidance (R.7.1.13.5): 
The screening procedures above represent an intelligent testing strategy for 
oxidising properties. If applied correctly, only substances which, it is suspected, 
will give a positive result in one of the oxidising properties tests will need to be 
tested. Together with the choice of an appropriate test method, this constitutes 
the testing strategy. 
ITS (Physico-chemical properties) Issues identified which require 
clarification / consensus 
Particle shape Status as an additional IR or 
subordinate to Granulometry, will 
determine whether a new ITS is 
developed or included in the existing 
one for granulometry. 
Surface area Status as an additional IR or 
subordinate to Granulometry, will 
determine whether a new ITS is 
developed or included in the existing 
one for granulometry. 
(Note that specific surface area is 
mentioned separately from 
granulometry in the revised Annex 
II.)  
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3.7.10 Relevance and applicability of the ITS for nanomaterials 
3.7.11 The testing strategy for oxidising properties is considered to be relevant and 
applicable to nanomaterials.  This conclusion is consistent with the conclusion in the 
gap analysis (Task B4) that no change to Guidance is required for this property. 
3.7.12 Recommendations for alterations 
3.7.13 No change required. 
3.7.14 GRANULOMETRY 
3.7.15 R.7.1.14.5 Integrated testing strategy (ITS) for granulometry 
3.7.16 The following ITS for granulometry is outlined in the existing REACH Guidance 
(R.7.1.14.5): 
An integrated testing strategy (ITS) detailing the appropriate methods for 
determination of particle size distribution of respirable and inhalable particles is 
shown in Figure R.7.1-7.  
Testing for particle size analysis is not required for those substances which are 
marketed or used in a non solid or non granular form. A testing strategy 
detailing which methods to use to determine particle size distribution of 
respirable and inhalable particles is provided. 
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3.7.17 Relevance and applicability of the ITS for nanomaterials 
3.7.18 The testing strategy for granulometry does not adequately represent the issues for 
nanomaterials and requires substantial amendment.  It is recognised that testing for 
particle size analysis (and all other particle related properties) is not required for 
those substances which are marketed or used in a non-solid or non-granular form.  
The nature of the examples and case studies provided in the current ITS for 
granulometry (second paragraph of R.7.1.14.5) is considered irrelevant and 
inconsistent with the nature of examples and case studies provided for other 
properties in the current Guidance in that no detailed example of studying the 
granulometry of a specific substance is provided.  
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3.7.19 With regard to Figure R.7.1-7 the use of light microscopy and sieving, whilst 
applicable to larger particles, are not suitable for nanomaterials.  The ITS suggests 
that if there are virtually no particles < 100 µm (measurement methods unspecified) 
no further testing is required.  This is clearly inappropriate for nanomaterials not 
suitable detection by light microscopy and sieving.  Where particles < 100 µm are 
present, the determination of relative density and water solubility is suggested but 
these are Information Requirements in their own right with their own ITS and 
Tier/group allocations in the general testing strategy for physico-chemical properties.  
The current granulometry ITS then separates water soluble and water insoluble 
granulates/powders and recombines them for the assessment of inhalation risk 
through a demonstration using a limited number of methods mainly suited to micron 
sized particles. Moreover, posing the question of whether an inhalation study is 
required, whilst important, is considered not relevant to include in the granulometry 
ITS. 
3.7.20 Recommendations for alterations 
3.7.21 Firstly, Figure R.7.1-7 entitled “Integrated testing strategy for granulometry” currently 
resides in R.7.1.14.2 (Available information on granulometry; pg. 144, R.7a) and is 
required to be moved to R.7.1.14.5 (Integrated testing strategies for granulometry; 
pg. 152, R.7a).  Secondly, the ITS requires significant updating.  This should at least 
include referencing to revised versions of Tables R.7.1-30 and R.7.1-31 providing 
more information on methods.  Specifically, additional methods other than solely 
light microscopic examination and sieving (as identified in RNC/RIP-
oN2/B4/2/FINAL and RNC/RIP-oN2/B5/2/FINAL) need to be included at the 
screening level of granulates and powders to take into account testing of 
nanomaterials.   
3.7.22 A greater acknowledgement of the sub-ordinate properties (e.g. particle size, size 
distribution; shape and surface area if not considered to be separate Information 
Requirements, and any others) with reference to available measurement methods 
needs to be incorporated into the ITS for granulometry.   
3.7.23 With regard to examples and case studies on granulometry, a more appropriate 
description of the issues and typical data from granulometry is required to be 
developed, which will be dependant upon the accepted composition of the 
granulometry Information Requirement (i.e. whether shape and surface area are 
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sub-ordinate to granulometry or included as additional relevant specific intrinsic 
properties). 
3.7.24 SKIN & RESPIRATORY SENSITISATION 
3.7.25 R.7.3.8 Integrated testing strategy (ITS) for skin and respiratory sensitisation 
3.7.26 An integrated strategy for skin and respiratory sensitisation is presented in Section 
R.7.3.8. of the REACH Guidance.  An overview of the ITS for skin sensitisation is 
given in Figure R.7.3-1, where LLNA stands for murine local lymph node assay 
(LLNA) (OECD TG 429). 
3.7.27 Testing respiratory sensitisation is not required under REACH. An overview of the 
integrated evaluating strategy for respiratory sensitisation is given in Figure R.7.3-2. 
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3.7.28 Relevance and applicability of the integrated testing strategy for 
nanomaterials 
3.7.29 The ITS for sensitisation is considered to be relevant and applicable to 
nanomaterials although a change should be made in relation to the use of in silico 
approaches towards data gathering as outlined below.  
3.7.30 At present, testing for respiratory sensitisation is not required under REACH and 
methods to address respiratory sensitisation are not sufficiently developed to 
include an amendment to Guidance (although we do consider it a priority R&D area 
for both nanomaterials and other substances alike). The ITS referring to respiratory 
sensitisation (figure R.7.3-2) does outline the use of in silico approaches to data 
gathering but also includes a footnote specifying that such approaches are not yet 
available. As such this is accurate for nanomaterials as well as does not require 
alteration.  
3.7.31 Recommendations for alterations 
3.7.32 Page 279 figure R.7.3-1 Integrated testing strategy for skin sensitisation  
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3.7.33 The testing strategy whilst applicable for nanomaterials identifies the gathering of 
(Q)SAR, read across, and chemical category data. As previously mentioned such 
an approach is not yet appropriate for nanomaterials and is an R&D requirement. 
As such, a foot note should be added and linked to the first step of the ITS (box 1) 
so that the step reads: 
3.7.34 “Gather and evaluate existing information (human-, animal-, in vitro-, 
(Q)SARa, read acrossa and categorya data) on skin sensitisation 
according to Annex VI, step 1.”  
3.7.35 And the following footnote inserted: 
3.7.36  “a For nanomaterials the use of in silico models has yet to be established 
or accepted. Therefore the use of non-testing approaches for 
nanomaterials in deriving an assessment of hazard for humans must be 
scientifically justified and applied strictly on a case-by case basis.” 
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3.7.37 B5 Sub-Task II: Advice on the scientific basis for the categorisation of 
nanomaterials and application of in silico methods, read-across and category 
approaches for deriving hazard information for nanomaterials from the 
information on bulk substances or from comparison between nanomaterials 
3.7.38 CATEGORISATION SCHEME FOR HUMAN HAZARD ASSESSMENT 
3.7.39 Inclusion into the categorisation scheme for nanomaterials is based on the premise 
that the particle in question satisfies the criteria of a nanomaterial. By virtue of its 
small size, nanomaterials have a high external surface area/ volume ratio and as 
such a large, biologically available and hence relevant, surface area is taken as a 
basis within this categorisation framework. This concept of biologically relevant 
surface area relates to the actual surface which is accessible to the biological 
environment/ cells and as such is available for interaction. A particle surface which 
is not accessible by the biological environment, e.g. an internal structure or pore 
which via size etc excludes biomolecules, cannot contribute to a biological reaction 
and as such may be considered biologically irrelevant. As such, within the following 
scheme, the term surface area relates only to the biologically relevant surface area 
which may contribute to a biological response. 
3.7.40 Within the following framework there exists the potential for variation in surface area 
based on those particles within the lower reaches of the nanomaterial size range 
(very high surface area) vs. those at the upper limits of the nanomaterial size range 
(moderately high surface area). In establishing a potential hazard, the greater the 
biologically relevant surface area the greater the hazard due to amplification of 
surface properties.  
3.7.41 The approach taken herein could be described more accurately as an analogue 
approach because the groupings shown are based upon hypothesises, or limited 
particle data. Because of a lack of data across a wide range of structural and 
compositional different nanomaterials, a fully prescribed category approach is not 
yet possible. Instead, the approach applied allows a higher-level overview that 
suggests where such groupings may be applied.  Further development, both of the 
approach itself and of testing methods is needed before a true category approach 
can be taken.   
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3.7.42 Mechanistic basis for hazard categories 
3.7.43 A schematic process for the hazard identification and categorisation based upon 
physico-chemical criteria known to be drivers of toxicity within (nano)particle 
toxicology has been developed by the Consortium and is shown below.  The 
process is broken down into a series of questions to be asked of every 
nanomaterial considered, each of them addressing a proposed key 
physicochemical property. A ‘yes’ answer to any of the attributes is associated with 
either a further question or a hazard attribute. As no question is ranked above or 
below the other in importance and all questions must be asked of particle under 
consideration, both ‘yes’ and a ‘no’ response lead to the next physico-chemical 
attribute.  A hazard attribute is further explained with suggested effect(s) given 
within the context of REACH. 
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Hazard categorisation of nanomaterials based upon physico-chemical property, hazard and effect 
NANOMATERIAL
Is the NM highly acidic/ basic?
NO
Does the NM release 
toxic/ reactive ions?
Is the NM composed of/
contaminated with redox active metals
or other biologically active contaminant?
Is the NM photoreactive?
NM potentially reactive Potentially hazardous due to intrinsic reactivity[surface area metric]NO
Is the NM soluble?
NO
Is the bulk material 
classified as a CMR or sensitiser?
Does the NM have a highly 
charged surface?
NO
YES
YES
YES
YES
YES
YES
Morphology
Chemical 
Composition
YES
Potentially hazardous due to Bulk composition
[Mass/ surface area metric]
Potentially hazardous due to pH changes from  
normal range
Potentially hazardous due to charged surface
[surface area metric]
HARN?
NO
(Particle Paradigm)
Does the particle form fibres 
<15µm* in straight length?
Does the particle form fibres 
>15µm* in straight length?
NM is a poor-solubility, low-toxicity dust and read across may be 
appropriate from other PSLT NM based on a metric such as 
surface area, mass or particle/aggregate volume*
YESNO
NM likely to conform to the fibre pathogenicity 
paradigm and potentially form a fibre type hazard
[fibre number metric]
Potentially hazardous due to toxic ion release
Potentially hazardous due to toxic particle 
effects
PROPERTY HAZARD
Further consideration needed - Potential for repeated dose toxicity, 
carcinogenesis, mutagenesis, 
Sensitisation and/ or reproductive toxicity
Further consideration needed - Potential for inflammogenic 
effects and/ or genotoxicity leading to acute toxicity, repeated dose 
toxicity, and/or carcinogenesis
Further consideration needed - Potential for cytotoxicity/ 
inflammation leading to acute toxicity, repeated dose toxicity
Further consideration needed - Potential for cytotoxicity/ 
inflammation leading to acute toxicity, repeated dose toxicity
Further consideration needed - Potential for cytotoxicity/
inflammation/ oxidative stress leading to acute toxicity, 
repeated dose toxicity (e.g. Fibrosis) and/ or carcinogenicity
Further consideration needed - At high surface area doses 
there may the potential for generating inflammation leading 
to acute toxicity, repeated dose toxicity (e.g. Fibrosis)
Further consideration needed - Potential for ion driven cytotoxicity/ 
inflammation/ Oxidative stress/ leading to acute toxicity, repeated 
Dose toxicity (e.g. fibrosis), sensitisation and/or carcinogenicity
EFFECTS
Further consideration needed - Potential for ion driven cytotoxicity/ 
inflammation/ Oxidative stress/ leading to acute toxicity, repeated 
Dose toxicity (e.g. fibrosis), sensitisation and/or carcinogenicity
NO
NO
(Biopersistant)
Particle may be considered non-toxic
NO
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3.7.44 The basis for properties examined are the scientific literature discussed in task 
RNC/RIP-oN2/B3/2/FINAL and the approaches taken to establish qualitative hazard 
characterisation discussed in RNC/RIP-oN3/C2/2/FINAL and a discussion of each 
question follows. 
3.7.45 Is the (nano)material classified as a CMR or sensitizer? 
3.7.46 The first question relates to the hazard characteristics of the bulk or parent version 
of a nanomaterial (if such exists) and if it is already classified as a carcinogen, 
mutagen, or reproductive toxin (CMR) or skin/ respiratory sensitizer. This enables a 
broad identification of potential hazard (and a form of read-across) from a previously 
identified hazard associated with the material. 
3.7.47 For example both hexavalent chromium (VI) and cobalt dusts are known sensitizers. 
Nanomaterial forms of these compounds may also demonstrate this potential for 
sensitisation and as such a preferential starting point would be to consider that the 
nanomaterial is a sensitizer. It would not necessarily be considered to be any less 
active than the bulk compound and based on their high surface area may in fact be 
far more active than the bulk compound and should therefore be considered as 
potentially hazardous. The nature of CMR and sensitisation suggests that effects 
such as cancer; asthma and reproductive toxicity are likely to occur after repeated 
exposure so one would expect such effects to be covered by REACH repeated dose 
IR.  
3.7.48 Is the (nano)material composed of reactive metal(s)? 
3.7.49 The second question is part of a collection of 3 questions that relate to the potential 
reactivity of a nanomaterial. The first asks if the nanomaterial in question is 
composed of a redox active metal which would infer that the nanomaterial itself is 
likely to be redox active. For example a nanomaterial composed of copper oxide (II) 
is likely to be redox active which may pose a hazard, especially considering the 
nanomaterials large surface area (e.g. 23m2/g for a 42nm powder vs. 1.5 m2/g for a 
3µm powder) over which redox reactions can take place potentially meaning the 
nanomaterial is far more reactive than the parent compound (Karlsson et al. 2009). 
This combination of high surface area and high reactivity may lead to the formation 
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of a ‘double hazard’ in inflammatory potential (Karlsson et al. 2009; Duffin et al. 
2007)  
3.7.50 Is the (nano)material photoreactive? 
3.7.51 The fourth questions relates to the photoreactivity of a particle. Photocatalytic 
nanomaterials such as certain forms of titanium dioxide could release oxygen 
radicals during exposure to light (Konaka et al. 1999) and as such could trigger 
various mechanisms of toxicity including inflammation (via activation of oxidant 
sensitive transcription factors), oxidative damage and genetic aberrations (Hirakawa 
et al. 2004; Carlotti et al. 2009). Any nanomaterial that is photoreactive should 
therefore be considered for further toxicological analysis for various endpoints such 
a carcinogenicity, irritation and inflammation during both acute and repeat dose 
exposure.  
3.7.52 Taken together, these three attributes account for the surface activity and potential 
drivers of toxicity for surface active particles which may well be highly appropriate to 
nanomaterials. Again, when considering the extreme surface area of a nano-sized 
particle in relation to its micro-sized counterpart, any hazard depending on a 
biologically accessible surface area would be correspondingly increased whilst other 
associate with other metrics such as mass, may not.    
3.7.53 Is the (nano)material highly acidic/ basic? 
3.7.54 The fifth criteria for consideration are the acidic/ basic nature of the material. A 
substantial pH derivation away from the normal range of the biological environment 
at the site of deposition could cause local effects such as skin irritation/ corrosion, or 
cell death within the lungs leading to inflammation/ oedema/ fibrosis. In the same 
way that other highly acidic/ basic chemicals are assessed, nanomaterials that fit 
these criteria could also be categorised and risk assessed. 
3.7.55 Does the (nano)material have a highly charged surface? 
3.7.56 The surface charge of a material can influence several factors such as its propensity 
to agglomerate/aggregate, interaction with charged molecules such as proteins and 
cellular uptake. However it is hypothesised that particles with a highly charged 
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surface (e.g. aminated polystyrene particles) may also adversely affect cells by 
strongly binding and disrupting membranes.  
3.7.57 Goodman et al. (2004) examined the effects of gold nanoparticle surface charge on 
cytotoxicity by studying cationic (amine) and anionic (carboxyl) gold nanoparticles 
on Cos-1 cells, red blood cells, and E. coli. It was concluded that cationic gold 
particles were moderately toxic and anionic particles were non-toxic, suggesting the 
initial electrostatic binding of the particles to the negatively charged cell membrane 
as a probable mechanism of toxicity and that electrostatic repulsion may limit 
anionic and neutral particle interaction with the cell surface (Goodman et al., 2004).  
As such within this experiment it can be seen that cationic gold nanoparticles can be 
expected to exhibit more toxic effects relative to anionic particles.  
3.7.58 It is unknown to what extent surface charge may play upon the toxicity of 
nanomaterials within a complex environment such as that found in vivo but currently 
it is thought that surface charge can exert effects on various attributes of particle 
behaviour (e.g. agglomeration, uptake) which may affect toxicity.  
3.7.59 Is the (nano)material soluble? 
3.7.60 Particle solubility can have both positive and negative effects pertaining to a 
particles propensity to cause harm. A soluble particle that does not release toxic 
ions or other components could result in the overall progressive reduction/removal 
of dose as the particle dissolves ultimately removing any toxic stimulus (if caused) 
or be intrinsically non-toxic.  
3.7.61 However if during dissolution, the particle releases reactive or cytotoxic components 
such as toxic ions it may cause toxic effects. It has been shown that soluble 
components such as the release of zinc ions from nanoparticulate zinc oxide can 
play a significant role in toxic effect of ZnO particles (Song et al., 2010). 
3.7.62 An attribute of nanoscale materials is the potential for the alterations in physico-
chemical characteristics such as the solubility. For example bulk silver is insoluble, 
but nanosilver releases free silver ions in aqueous solutions by dissolution and 
subsequent oxidation. It has been hypothesised that the toxic effects of silver 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 147 - 
substances are proportional to the rate of release of free silver ions from them (see, 
for example, Wijnhoven et al., 2009). 
3.7.63 As such when considering the hazardous nature of a material, it is pertinent to 
consider both the insoluble (particle) and soluble component in the hazard 
assessment.   
3.7.64 Is the nanomaterial a high aspect ratio nanomaterial (HARN)? 
3.7.65 Within the paper by Zuin et al. (2010), the authors outline that fibres which have an 
aspect ratio of ≥ 3:1 (length-to-diameter ratio) or greater and are 
insoluble/biopersistent should have a rating value of ‘high harmful’. However the 
derivation of an aspect ratio of ≥ 3:1 and its role in classifying a fibre is based upon 
the definition of a fibre by the World Health Organisation which considers a fibre as 
having an aspect ratio of ≥ 3:1 and a length greater than 5µm. This length 
qualification is crucial when establishing nanomaterial as being ‘a fibre’ as a 
nanomaterial may have a length many times that of its diameter but could still be far 
shorter than the definition of a fibre and as such would be considered a particle. A 
nanomaterial by definition, (e.g. a single aspect 100nm or less in size) would require 
an aspect ratio of 50:1 at minimum to be considered a fibre. Within fibre toxicology, 
the length at which a fibre begins to generate difficulties with normal clearance 
mechanisms is that length in which it cannot be fully enclosed by professional 
phagocytes such as alveolar macrophages which is considered to occur at between 
15-20 µm in length (Donaldson et al. 2010). As such, the cut-off within the proposed 
scheme is placed at 15µm although it should be stressed that further work is needed 
to confirm or refute this demarcation or a more conservative length adopted.  
3.7.66 Within the framework shown, a particle that is not considered a HARN, or is a HARN 
but less than 15µm is considered in a similar way as a non-fibrous particle based on 
its biological relevance. A nanomaterial which exceeds this 15µm could be seen to 
be likely to frustrate clearance mechanisms within the lung if deposited past the 
ciliated airways and cause hazardous effects associated with other harmful fibres.   
3.7.67 In RNC/RIP-oN2/B5/2/FINAL, use of the category approach to derive potential 
sources of hazard from a nanomaterial has been applied to two very different forms 
of nanomaterial to demonstrate the utility of the scheme. 
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3.7.68 CATEGORISATION SCHEME FOR ENVIRONMENTAL HAZARD ASSESSMENT 
3.7.69 The basis for the properties examined in this final report is the scientific literature 
discussed in Task B3 RNC/RIP-oN2/B3/2/FINAL as well as the comprehensive 
literature review performed by Stone et al. (2009) and published in the report 
Engineered Nanoparticles: Review of Health and Environmental Safety (ENRHES).  
The approaches taken to establish qualitative hazard characterisation discussed in 
RIP-oN 3 Task C2.  The scheme proposed represents a work in progress and is 
proposed from Hansen, S.F., Baun, A., Jensen, K.A. 2010. NanoRiskCat - draft. 
Copenhagen: Danish Environmental Protection Agency (forthcoming). The need to 
develop such an environmental hazard categorization scheme was only identified 
recently by the Danish EPA and its relevance is highlighted by its utility to RIP-oN2.  
As noted several times in the RNC/RIP-oN2/B5/2/FINAL, the suggested scheme is a 
draft and still subject to revisions in the light of constructive comments and 
suggestions.  The categorisation scheme is one of the very few that exist in regard 
to nanomaterial environmental hazard evaluation and hence we acknowledge the 
Danish EPA for permission to include a substantial amount of early work associated 
with developing the framework and the information needed to make a sound 
judgement about the nature of the scheme as well as its strengths and weaknesses.   
3.7.70 In the proposed scheme termed NanoRiskCat, a number of indicators/qualifiers 
should, as a minimum, be considered when providing an initial evaluation of the 
environmental hazards related to a given nanomaterial, its application and what is 
already known about the bulk form of the material. These include whether:  
 the nanomaterial in question is reported to be hazardous to environmental 
species 
 the nanomaterial in question is persistent 
 the nanomaterial in question is bioaccumulative 
 use of the nanomaterial in question could lead to potentially irreversible 
harm to the environment (e.g. ecosystem effects) 
 the nanomaterial in question is readily dispersed  
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 the nanomaterial in question is novel (i.e. new materials, new form of 
existing material, new applications, new pathways (Royal Commission on 
Environmental Pollution 2008) 
3.7.71 The task report (RNC/RIP-oN2/B5/2/FINAL) provides a more detailed discussion of 
each question. 
3.7.72 For each of these questions, reasoning should be provided with proper referencing 
to the scientific and/or non-scientific literature and an answer of each of the 
questions should be provided in the form of either: yes, maybe, no, and no 
information.  The answer “yes” implies that there is conclusive evidence for 
categorizing that indicates that the nanomaterial in question as having ir-/reversible 
effects (e.g. reproductive damage) or holding a given property (e.g. persistent, 
accumulates).  “Maybe” implies that there is evidence that indicates that no 
categorization of the nanomaterial can be concluded whereas “no” implies that there 
is conclusive evidence that indicates that the nanomaterial can be categorized as 
not causing adverse ir-/reversible effects and/or hold the properties in question 
(Hansen et al., 2010).  
3.7.73 While in principle none of these indicators are more important than others, the 
proposed scheme shown below gives a guidance on the order in which they may be 
evaluated and a short description of the criteria to be used.   
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Bulk hazard  labelling (GHS):
Acute 1 or  Chronic 1 or Chronic 2
Nano-specific 
(LC50 or EC50) < 10 mg/l
Nano-specific 
(LC50 or EC50) < 100 mg/l
T½>40 d
BCF>50
Dispersive or long range transport
Ecosystem effects
Novelty
+: yes
-: no
(+): maybe
?: not enough data
+
+
+
-
-
- ?
?
+  (+)
- ?
-
+ /(+)
Nano-specific 
(LC50 or EC50) < 100 mg/l
T½>40 d
BCF>50
Dispersive or long range transport
Ecosystem effects
Novelty
+ /(+)
- ?
- ?
- ?
+ /(+)
+ /(+)
-
+ /(+)
? ?
T½>40 d
- ?
+/(+)
- ?- ?
BCF>50
- ?
+/(+)
+/(+)
BCF>50
-
+   (+)
+/(+)
?
*
*outcome will be based on a written evaluation
Bulk hazard  labelling (GHS):
Chronic 3 or Chronic 4
or
Documented nano-specific effects
*
 
Road-map for assigning an environmental hazard colour code in NanoRiskCat 
(reproduced with permission from Hansen et al. 2010 – all rights reserved) 
3.7.74 From the outset, consideration is taken of existing criteria for chemicals with due 
consideration to the uncertainty related to ecotoxicological hazard of nanomaterials 
e.g. by changing the cut-off values for LC50 or EC50.  The cut-off values are 
deliberately made stricter in NanoRiskCat than the existing ones in REACH.  Whilst 
this is not based on any scientific review of the literature, justification is made in 
Hansen et al. (2010) on the basis of expert judgment with reference to current 
uncertainty about the appropriateness of using mass as cut-off value for establishing 
nano-specific thresholds (Stone et al. 2009). Evidence is scarce, but from the 
reported EC50- and NOEC values (reviewed in RNC/RIP-oN2/B3/2/FINAL), it 
seems that there might be between a factor of 1-20 difference in the ecotoxicity of 
bulk size particles and nanosized particle (Templeton et al. 2006, Fujiwara et al. 
2008, Arouja et al. 2008). Based on this, Hansen et al (2010) speculate that a 10-
fold stricter cut-off value is adequate to make up for this uncertainty for most 
nanomaterials.  If a nano-specific endpoint is not triggered even when using the 
stricter cut-off value, Hansen et al. (2010) believe that it is justified to categorise the 
nanomaterial as not causing adverse ir-/reversible effects and/or hold the properties 
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in question.  Below follows a more detailed description of each indicator and the cut-
off values chosen. It should be noted that also the classification according to the 
Global Harmonized System (GHS) for the bulk material is used in the environmental 
hazard categorization in NanoRiskCat.   
3.7.75 The red colour code in the pictorial scheme indicates that adverse effects are 
expected in the environment, the yellow indicate that adverse effects are possible, 
and green that there is no environmental hazard documented. Grey should be used 
if there are numerous data gaps and unknowns to warrant any conclusion to be 
made about the environmental hazards of the nanomaterial toward.  Transparency 
in the assigning of a colour code is key and very important.  Therefore, all 
categorisations made must be accompanied by an explanatory text on how the 
conclusion was reached. 
3.7.76 It is important to note that NanoRiskCat is a tiered approach in the sense that once 
a higher-tier colour code has been triggered (e.g. bulk materials GHS classified as 
Chronic 1 which would trigger “red”) the nanomaterial cannot get a lower-tier colour 
code (yellow, green or grey) even though the LC50 or EC50 might be > 100 mg/l 
and the persistency might be < 40 days and the BCF < 50 (Hansen et al. 2010).  
3.7.77 Use of read-across for environmental hazard characterisation of nanomaterials 
3.7.78 The read-across approach is based upon the identification of a source material or 
analogue for which environmental hazard information exists and using that 
information to make predictions about the target material. The sourcing of an 
analogous material is based upon categorisation of existing materials with similar 
physico-chemical and ecotoxicological properties which may follow a similar pattern 
to structural similarity. For nanomaterials this may be done by employing read-
across from the parent or bulk compound to the nano-form. For example, the 
utilisation of the ecotoxicological information pertaining to bulk silver for accessing 
nano-silver ecotoxicity.  As it has been well-established that bulk silver is toxic to the 
aquatic environment, it would be justified to assume that the same is the case for 
nano-silver (Stone et al. 2009).  
3.7.79 It is known that certain factors such as surface area and particle size alter as we 
move into the nano-scale and these are scalable (although may be affected by other 
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parameters such as aggregation). However other properties such as solubility and 
reactivity may change in unpredictable ways as a material becomes nano-sized.  As 
such, it could be regarded that a lack of ecotoxicity in the bulk form, does not 
necessarily mean that a nanoparticle of the same material is inactive. There is 
however validity, with due care, in perhaps extrapolating certain positive data on the 
ecotoxicity from bulk to nano. For example a bulk material classified as Acute 1 and 
Chronic 1-4 according to GHS should inform the hazard assessment of a 
nanomaterial as this one is likely to have a similar activity (although perhaps 
enhanced due to a larger surface area to volume ratio). It is important to underline 
that if the bulk compound is not classified as Acute 1 and Chronic 1-4, it cannot be 
assumed that a nanomaterial is not potentially hazardous for the environment.    
3.7.80 Generating environmental hazard information based upon read-across from 
analogous materials is also not without its problems but may offer greater reliability if 
such linkages are made based on physico-chemical similarities rather than simple 
bulk chemistry.  
3.7.81 Use of in silico methods for environmental hazard characterisation of 
nanomaterials 
3.7.82 With REACH, there exists guidance on the regulatory use of quantitative structure 
activity relationships (QSAR) in hazard assessment of substances. Within section 
R.6.1.5.1, there is a scheme to enable the determination of the suitability of (Q)SAR 
results to replace a test result which is shown below: 
1. An evaluation of the scientific validity (relevance and reliability) of the model 
2. An assessment of the applicability of the model to the chemical of interest 
and the reliability of the individual model prediction 
3. An assessment of the adequacy of the information for making the regulatory 
decisions, including an assessment of completeness, i.e. whether the 
information is sufficient to make regulatory decision, and if not, what 
additional (experimental) information is needed.  
3.7.83 The Guidance on the regulatory use of quantitative structure activity relationships 
(QSAR) in hazard assessment of substances requires that, for a full replacement of 
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experimental tests, all of the conditions outlined above are met. In situations where 
there are elements missing, the (Q)SAR information may still be used within a 
weight of evidence approach.  
3.7.84 Based on these criteria, currently, in silico approaches for environmental hazard 
assessment of nanomaterials are not validated as there is yet to exist solid 
quantitative structure activity relationships for nanomaterials on which to base such 
models. Several studies have highlighted the need for new interpretative descriptors 
for the development of nanomaterial QSARS and predictive in silico modelling but 
none have yet suggested a validated approach (Hansen et al. 2007, RCEP 2008, 
Stone et al. 2009). There are several on-going studies as summarised in RNC/RIP-
oN 2/B3/2/FINAL such as that of Ennsatox. This project intends to develop a 
comprehensive theoretical model describing the environmental system as a series 
of biological compartments and following optimisation of the transfer functions a 
generic predictive model will be derived for the environmental impact of each class 
of nanoparticles in aqueous systems. Biological membrane models will be used to 
increase the understanding the interaction of nanoparticles with cell membranes 
from an organism health point of view but also to develop suitable nanoparticle 
screening procedures, which can substitute for the more lengthy in vivo tests.  
However, this project is at a very early stage and no information has been identified 
as to which kind of nanoparticles will be subject for the modelling as well as it 
remain unclear what the (eco)toxicological endpoints will be and which kind of 
species will be investigated.  It is therefore not possible to comment at this stage 
whether this project will produce outputs of relevance in the context of REACH. 
3.7.85 As in the case of hazard characterization, it should be stressed however that where 
modelling is possible, it should not be performed on simple classes of nanomaterials 
(e.g. TiO2) as within such a class there exists a very high potential for variability 
making conclusion based on a single arbitrary material class virtually meaningless. 
Instead, it has been suggested that, due to high variability in the molecular 
structures and different mechanisms of toxicity, individual nanoparticles should be 
modelled separately (Puzyn et al., 2009). 
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3.7.86 B5 Sub-Task III: Proposals for further amendment of the REACH guidance 
documents in regard to information requirements, test methods or testing 
strategies for nanomaterials 
3.7.87 The following summary of findings identifies the nature of suggested updates to 
Guidance and the location(s) within the suite of Guidance documents constituting the 
Guidance on Chemical Safety Assessment under REACH.  Specific text for 
Guidance update, developed on the basis of this identification, is recommended in 
the Chapter 4 of this report.   
3.7.88 PHYSICO-CHEMICAL PROPERTIES 
3.7.89 The following section outlines proposals for further amendment of the REACH 
Guidance documents in regards to physico-chemical information requirements, test 
methods or testing strategies for nanomaterials, based on the outcomes of the gap 
analysis (Task B4). 
3.7.90 GENERAL CONSIDERATIONS 
3.7.91 Multi-method analysis 
3.7.92 An important general conclusion with regards nanomaterials characterisation that 
has emerged from the findings of the project is that no individual technique can 
satisfy a meaningful characterisation of nanomaterials, such that multiple techniques 
should be used where possible in order to formulate a complete understanding of 
the nanomaterial’s properties. It is highlighted that different techniques will suit 
different sample forms (e.g. aerosol, suspension etc.) and the optimum set of 
required techniques should be selected and justified based on the specific 
nanomaterial type and form under investigation.  The need for multi-method 
characterisation and material-specific selection of techniques applies across a range 
of nanomaterial properties and would facilitate the gathering of data on multiple 
metrics. 
3.7.93 R.7.1.1 (R.7a, pg. 17) – A new fourth paragraph should be added to the introduction 
which stresses the need for multi-method characterisation and material-specific 
selection of techniques as well as some information on the status of the applicability 
and validation of the methods. 
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3.7.94 Sample Preparation 
3.7.95 Information on sample preparation for the determination of properties has been 
determined to be of crucial importance in the context of gathering data to fulfil  
Information Requirement ((RNC/RIP-oN2/B1/2/FINAL), RNC/RIP-oN2/B2/2/FINAL; 
RNC/RIP-oN2/B3/2/FINAL), regarding physico-chemical, toxicological and 
ecotoxicological (including environmental fate and behaviour) properties for 
nanomaterials, and is currently missing from the REACH Guidance (RNC/RIP-
oN2/B1/2/FINAL).  Within this context, dispersion stability and state of 
agglomeration are recognised as important parameters to study and characterise as 
supplementary information to the data gathered for the formal IRs (RNC/RIP-
oN2/B2/2/FINAL).  These properties are not necessarily additional IRs in their own 
right, due to their secondary nature (i.e. non-intrinsic) and dependence upon other 
primary properties.  Techniques available for monitoring the state of agglomeration 
and state of dispersion will be covered in property-related aspects of the updated 
Guidance (i.e. Granulometry).  These include electron microscopies and Dynamic 
Light Scattering techniques. 
3.7.96 R.7 (R.7a) - Additional sub-section entitled “Sample preparation” should be added 
into the Introduction, providing general guidance on Sample Preparation, 
highlighting the importance of characterising dispersion stability and agglomeration 
state and including information on available methods.  This section will not propose 
a sample preparation protocol (as generic procedures cannot be applied universally 
to all nanomaterials) but should provide useful guidance and references to relevant 
resources.  
3.7.97 It is anticipated that this section will be informed by OECD's "Preliminary Guidance 
Notes on Sample Preparation and Dosimetry for the Safety Testing of Manufactured 
Nanomaterials" (ENV/JM/MONO(2010)25) and "Guidance Manual for the Testing of 
Manufactured Nanomaterials: OECD's Sponsorship Programme; First Revision" 
(ENV/JM/MONO(2009)20/REV), ISO/14887:2000 which provides general guidance 
to assist in the preparation of good dispersions from various powder/liquid 
combinations and ISO 14488:2007 which specifies methods for obtaining a 
representative test aliquot from a defined sample of particulate material, as well as 
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further resources identified and discussed in RNC/RIP-oN2/B2/2/FINAL and 
RNC/RIP-oN2/B3/2/FINAL. 
3.7.98 Reference materials 
3.7.99 R.7.1.1.3 - An acknowledgement of the importance of reference materials is 
recommended for inclusion in this section. 
3.7.100 EXISTING INFORMATION REQUIREMENTS 
3.7.101 Water solubility 
3.7.102 R.7.1.7.5 - The difference between solubilisation and dispersion and a 
recommendation to elucidate between the two for nanomaterials is recommended to 
be included in the ITS, including Figure R.7.1-5. However, as highlighted in 
ENV/JM/MONO(2009)20/REV, specific methods to determine dispersion stability 
remain to be determined. 
3.7.103 Partition coefficient N-octanol/water 
3.7.104 R.7.1.8.3 - A caveat that highlights the limitations of OECD TGs 107, 117 and 123 
for nanomaterials should be included at end of paragraph headed "Experimental 
data on partition coefficient n-octanol/water" (R.7a, p. 100) 
3.7.105 Include acknowledgement of general aspects relating to differences between 
dispersion and solubility. 
3.7.106 Granulometry 
3.7.107 In order to finalise amendments to the REACH Guidance on Granulometry, 
agreement regarding the scope and definition of this term in the context of the 
REACH Regulation is required. 
3.7.108 Part B: Hazard Assessment. B.6.1.4 - Paragraph on Granulometry should be added. 
3.7.109 R.7.1.1.1 - The phrase "Granulometry (particle size distribution)" in Table R.7.1-1 
should be updated to remove "(particle size distribution)".  
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3.7.110 R.1.1.4 – Regarding the general testing strategy for physico-chemical properties, 
the label of “particle size distribution” under Tier 3 should be amended to state 
“Granulometry”, consistent with the Regulation and Guidance.  All other sub-
ordinate or recommended additional relevant specific intrinsic properties are 
appropriate to include in Tier 3.  Figure R.7.1-1 should also be amended to 
incorporate sub-ordinate or additional properties in Tier 3. 
3.7.111 R.7.1.1.5 - Depending on the agreed definition and regulatory scope of the term 
"Granulometry", the scope of the information requirement on Granulometry in Table 
R.7.1-5 may need updating.   
3.7.112 R7.1.14 - The existing text on Granulometry requires substantial updating and 
enhancement, to acknowledge standards and informative sources published since 
the last revision of the chapter.  The definition and regulatory scope of the term 
granulometry needs to be clarified.  Further detail and clarity in this section is 
required to include and describe methods for i) powders; ii) suspensions and iii) 
aerosols. 
3.7.113 Additional introductory text is required in R.7.1.14.2 highlighting that measured 
particle size values are method dependent and should be reported with sufficient 
detail on the analytical technique employed to derive data.  A recommendation for 
the use of multi-analytical techniques for the characterisation of nanoparticles 
should also be included. 
3.7.114 A caveat which highlights the limitations of OECD TG 110 for nanomaterials should 
be included. Information on available modern and standardised equipment (i.e. 
centrifugal sedimentation, ultracentrifuge) should be provided, which can be used to 
provide data in accordance with this method. 
3.7.115 The following alterations are recommended to be made in a revised version of Table 
R.7.1-30: 
 More information on Transmission Electron Microscopy (TEM) should be 
incorporated, including reference for further informative information for 
nanoparticles in ISO 27628:2007 and a note indicating importance of image 
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quality. ISO/13322-1:2004 and ISO/13322-2:2006 which provide general 
image analysis guidance could also be referenced; 
 More information on Scanning Electron Microscopy (SEM) should be 
incorporated, including reference for further informative information for 
nanoparticles in ISO 27628:2007 and a note indicating importance of image 
quality. ISO/13322-1:2004 and ISO/13322-2:2006 which provide general 
image analysis guidance could also be referenced; 
 Information on Centrifugal Sedimentation should be incorporated, including 
reference to available standards (ISO/13318-1:2001; ISO/13318-2:2007; 
ISO/13318-3:2004) and an acknowledgement that this is a new method to 
facilitate the measurement of size under TG 110; 
 Information on Ultrasonic spectroscopy should be incorporated, including 
reference to available standard (ISO/20998-1:2006).  
 Information on Small Angle X-ray Scattering (SAXS) should be incorporated, 
including reference to available standard (ISO/TS 13762:2001), as an 
alternative to the preferred methods of TEM and SEM; 
 Information on X-ray Diffraction (XRD) should be incorporated, including 
reference to available standards (BS EN 13925-1, BS EN 13925-2 and BS 
EN 13925-3).  It should be acknowledged that particle size does not equal 
crystallite size, and that other factors can influence the peak width (e.g. 
microstrain, lattice defects, temperature factors). 
 Information on Dynamic Light Scattering (DLS)/ Photon Correlation 
Spectroscopy (PCS) should be incorporated, including reference to available 
standards (ISO/22412:2008; ISO/13321:1996; ASTM E2490-09) and an 
acknowledgement of some of the limitations associated with this method; 
 In addition, Capillary Hydrodynamic Fractionation (CHDF), Field Flow 
Fractionation (FFF), Capillary electrophoresis (CE), Hydrodynamic 
chromatography (HDC) and Ultracentrifuge could be included as alternative 
methods, but no published reference methods are available for these 
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techniques.  In the case of Ultracentrifuge reference to available standards 
for Centrifugal Sedimentation could be used but with a note that higher 
centrifugal forces can be employed specifically to cover smaller sizes.  
Accordingly, this should link to Method A of OECD TG 110. 
3.7.116 The following alterations are recommended to be made in a revised version of Table 
R.7.1-31: 
 Details of Scanning Mobility Particle Sizer (SMPS) should be incorporated, 
including reference to available standards (ISO/15900:2009; plus ISO 
10808:2010, ISO 28439:2011); 
 Details of Fast Mobility Particle Sizer (FMPS) should be incorporated; 
 Limitations of cascade impaction for HARN should be highlighted, including 
reference to informative description in ISO/TR 27628:2007; 
 Electrical Low Pressure Impactor (ELPI) should be included as an example 
of a cascade impactor, including reference to informative description in 
ISO/TR 27628:2007; 
 Information on diffusion batteries as an alternative method should be 
incorporated, including reference to informative description in ISO/TR 
27628:2007; 
 Details of Optical Particle Counter (OPC) should be incorporated, including 
reference to informative description in ISO/TR 27628:2007; 
 Information on Light scattering aerosol spectrometer (LSAS) should be 
incorporated to complement existing information of light scattering methods, 
including reference to available standard (ISO/21501-1:2009).  The current 
stated size range for light scattering should be extended to 0.06 µm as 
allowed by LSAS; 
 A caveat highlighting the limitations of Laser Diffraction for the sub-100nm 
range and high aspect ratio nanoparticles (HARN) should be included, and 
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the size range widened to up to 3 mm.  A reference to the available standard 
(ISO/13320:2009) should be included; 
 A caveat highlighting the limitations of Rotating Drum and Continuous Drop 
methods for nanomaterials should be included.   References to modified 
methods available in the literature could be included at this stage (i.e. 
Maynard et al., 2004; Schneider & Jensen et al., 2008; Boundy et al., 2006), 
but it is considered more appropriate to wait until they are standardised in 
ISO/CD 12025 before including in the Guidance. 
3.7.117 With regards to the ITS for granulometry (R.7.1.14.5), Figure R.7.1-7 entitled 
“Integrated testing strategy for granulometry” currently resides in R.7.1.14.2 
(Available information on granulometry; pg. 144, R.7a) and is required to be moved 
to R.7.1.14.5 (Integrated testing strategies for granulometry; pg. 152, R.7a).  
Secondly, explanatory text is required to accompany the detailed sequence of steps 
in the ITS.  This should at least include referencing to revised versions of Tables 
R.7.1-30 and R.7.1-31 providing more information on methods.  Specifically, 
additional methods other than solely light microscopic examination and sieving need 
to be included at the screening level of granulates and powders to take into account 
testing of nanomaterials.   
3.7.118 A greater acknowledgement of the sub-ordinate properties (particle size, size 
distribution, dustiness; shape and surface area if not considered to be separate 
Information Requirements) with reference to available measurement methods needs 
to be incorporated into the ITS for granulometry.   
3.7.119 With regard to examples and case studies on granulometry, a more appropriate 
description of the issues and typical data from granulometry is required to be 
developed, which will be dependant upon the accepted composition of the 
Information Requirement for granulometry (i.e. whether shape and surface area are 
sub-ordinate to granulometry or included as separate additional specific intrinsic 
properties). 
3.7.120 Appendix to Part F CSR Template with explanation – Granulometry’s sub-ordinate 
properties need to be added to the CSR template (Table 5: Overview of physico-
chemical properties). 
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3.7.121 ADDITIONAL RELEVANT SPECIFIC INTRINSIC PROPERTIES 
3.7.122 Particle Shape 
3.7.123 The specific guidance amendments for shape are subject to the decision of whether 
the property is sub-ordinate to granulometry or included as an additional Information 
Requirement. 
3.7.124 Suggested changes to Guidance if shape is included as an additional IR 
3.7.125 Part B: Hazard Assessment. B.6.1 – Shape and reference to a new chapter in R.7a 
would need to be included in the list of physico-chemical properties. B.6.1.4 – 
Paragraph on Shape would be required to be added. 
3.7.126 R.7a - A new chapter would be required to be added to R7a entitled "SHAPE", on 
the basis of the properties inclusion as an additional IR.  The section's content will 
follow the standard format of the existing Guidance: Definition; Information 
requirements on shape; Available information on shape; Evaluation of available 
information on shape; Conclusions on shape; Integrated testing strategy (ITS) for 
shape; References on shape.  It is anticipated that this section will incorporate text 
from ISO 9276-6 (with a preliminary suggestion for inclusion of Figure 2 from the 
ISO document), as well as further text from resources identified and discussed in 
RNC/RIP-oN2/B2/2/FINAL and RNC/RIP-oN2/B3/2/FINAL and information on the 
selected methods: 
3.7.127 TEM and SEM, including reference to informative description in ISO/TR 
27628:2007.  ISO/13322-1:2004 and ISO/13322-2:2006, which provide general 
image analysis guidance, could also be referenced.  A note highlighting the 
importance of image quality should also be included; 
3.7.128 Scanning Probe Microscopy (SPM), including reference to informative 
description in ISO/TR 27628:2007. 
3.7.129 Should shape be a separate Information Requirement, as a minimum, we would 
suggest that the ITS for shape follows the tiered approach to testing (Section 
R.7.1.1.4) in conjunction with the choice of an appropriate test method.  The 
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property would be included in Tier 3 of the general testing strategy for physico-
chemical properties. 
3.7.130 R.7.1.1.1 - Shape would be required to be included in Table R.7.1-1.   
3.7.131 R7.1.1.6 - Shape, and details of its impact on other physico-chemical test, 
toxicology, ecotoxicology and risk assessment, would be required to be included in 
Table R.7.1-5.  
3.7.132 R.7.1.14. – The limited existing references to requirements for shape information 
made within this chapter on Granulometry (R7.1.14.1, R7.1.14.2) would need to be 
removed and further clarified in a chapter on "Shape".   
3.7.133 Appendix to Part F CSR Template with explanation – Shape would need to be 
added to Table 5: Overview of physico-chemical properties. 
3.7.134 Suggested changes to Guidance if shape is included under an agreed 
definition of the term "Granulometry"  
3.7.135 R.7.1.14 - A sub-section on shape would be included under R7.1.14.  It is proposed 
that, in the aims of clarity, this should be a distinct sub-section (rather than merged 
into the existing text which focuses primarily on particle size distribution) and follow 
the standard format outlined above.  It is anticipated that this section will incorporate 
text from ISO 9276-6 (with a preliminary suggestion for inclusion of Figure 2 from 
the ISO document), as well as further text from resources identified and discussed 
in RNC/RIP-oN2/B2/2/FINAL and RNC/RIP-oN2/B3/2/FINAL and information on the 
selected methods: 
3.7.136 TEM and SEM, including reference to informative description in ISO/TR 
27628:2007.  ISO/13322-1:2004 and ISO/13322-2:2006, which provide general 
image analysis guidance, could also be referenced.  A note highlighting the 
importance of image quality should also be included; 
3.7.137 SPM, including reference to informative description in ISO/TR 27628:2007. 
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3.7.138 It is evident where shape can feature in the ITS for granulometry: image analysis 
(currently for fibres, but requiring extension to granules and powders in a revised 
ITS). 
3.7.139 Surface area 
3.7.140 The specific guidance amendments for surface area are subject to the decision of 
whether the property is sub-ordinate to granulometry or included as an additional 
Information Requirement. 
3.7.141 Suggested changes to Guidance if surface area is included as an additional IR 
3.7.142 Part B: Hazard Assessment. B.6.1 – Surface area and reference to a new chapter in 
R.7a would need to be included in the list of physico-chemical properties. B.6.1.4 – 
Paragraph on surface area may be required to be added. 
3.7.143 R.7a - A new chapter would be required to be added to R7a entitled "SURFACE 
AREA", on the basis of the properties’ inclusion as an additional IR.  The section's 
content will follow the standard format of the existing Guidance: Definition; 
Information requirements on: Available information on surface area; Evaluation of 
available information on surface area; Conclusions on surface area; Integrated 
testing strategy (ITS) for surface area; References on surface area.  It is anticipated 
that this section will incorporate text from ENV/JM/MONO(2009)20/REV, as well as 
further text from resources identified and discussed in RNC/RIP-oN2/B2/2/FINAL 
and RNC/RIP-oN2/B3/2/FINAL and information on the BET method, including 
reference to the available ISO standards (ISO/9277:1995; ISO/18757:2003) and 
details of potential limitations of this technique (e.g. assumes spherical system). 
Limitations of the indirect calculation of surface area of nanoaerosols from particle 
size using approaches such as SMPS/FMPS requires acknowledgement.  Emerging 
techniques for measuring surface area of particles in dispersion (e.g. NMR) should 
also be acknowledged. 
3.7.144 Should surface area be a separate Information Requirement, as a minimum, we 
would suggest that the ITS for surface area follows the tiered approach to testing 
(Section R.7.1.1.4) in conjunction with the choice of an appropriate test method.  
RNC/RIP-oN2/FPR/1/FINAL 
 
- 164 - 
The property would be included in Tier 3 of the general testing strategy for physico-
chemical properties. 
3.7.145 R.7.1.1.1 – Surface area would be required to be included in Table R.7.1-1.   
3.7.146 R.7.1.1.6 – Surface area, and details of its impact on other physico-chemical test, 
toxicology, ecotoxicology and risk assessment, would be required to be included in 
Table R.7.1-5.  
3.7.147 Appendix to Part F CSR Template with explanation – Surface area would need to be 
added to Table 5: Overview of physico-chemical properties. 
3.7.148 Suggested changes to Guidance if surface area is included under an agreed 
definition of the term "Granulometry" 
3.7.149 R.7.1.14 - A sub-section on surface area should be included under R7.1.14.  It is 
proposed that, in the aims of clarity, this should be a distinct sub-section (rather than 
merged into the existing text which focuses primarily on particle size distribution) 
and follow the standard format outlined above.  It is anticipated that this section will 
incorporate text from ENV/JM/MONO(2009)20/REV, as well as further text from 
resources identified and discussed in RNC/RIP-oN2/B2/2/FINAL and RNC/RIP-
oN2/B2/2/FINAL and information on the BET method, including reference to the 
available ISO standards (ISO/9277:1995; ISO/18757:2003) and details of potential 
limitations of this technique (e.g. assumes spherical system). Limitations of the 
indirect calculation of surface area of nanoaerosols from particle size using 
approaches such as SMPS/FMPS requires acknowledgement.  Emerging 
techniques for measuring surface area of particles in dispersion (e.g. NMR) should 
also be acknowledged. 
3.7.150 The ITS for granulometry does not currently acknowledge surface area and the 
present structure does not facilitate its simple inclusion.  Should surface area be 
included under an agreed definition of the term ‘granulometry, an updated ITS 
(including Figure R.7.1.7) would be required to include surface area, with reference 
to available measurement methods.  
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3.7.151 TOXICOLOGICAL ENDPOINTS & TESTING 
3.7.152 The following section outlines proposals for further amendment of the REACH 
Guidance documents in relation to toxicological information requirements, test 
methods or testing strategies for nanomaterials.   
3.7.153 GENERAL CONSIDERATIONS 
3.7.154 Within RNC/RIP-oN2/B1/2/FINAL, RNC/RIP-oN2/B2/2/FINAL and RNC/RIP-
oN2/B3/2/FINAL several aspects of guidance have been identified that, whilst not 
requiring a specific amendment, could benefit from the insertion of an advisory note. 
Specifically this was identified in situations such as the consideration of lung 
overload phenomena, assay interference and the suitability of bacterial mutation 
assays for assessing particles. Due to their applicability to several endpoints, 
advisory notes on lung overload and assay interference should be positioned at the 
beginning of Chapter R.7A or prior to the commencement of section R.7.2., which 
marks the beginning of the toxicology section of Guidance R.7a.  The ‘Advisory note 
on the consideration of bacterial assay interference’ should be considered for 
insertion into Guidance section R.7.7 under the ‘In vitro data’ heading on page 380 
prior to table R.7.7-2. 
3.7.155 These advisory notes will not propose a protocol but aim to provide useful guidance 
and references to relevant resources.  These advisory notes are outlined below. 
3.7.156 EXISTING INFORMATION REQUIREMENTS 
3.7.157 R.7.3 Skin and eye irritation/ corrosion  
3.7.158 Skin and eye irritation: Non-testing Data 
3.7.159 R.7.2.3.1 Non-human data on irritation/ corrosion 
3.7.160 The use of non-testing is an attractive alternative to animal testing in the face of a 
lack of human epidemiological data on NM. However there does not exist sufficient 
robust evidence on the concept of sameness between non-nano and nano materials 
of the same material and nano to nano comparisons of differing materials.  
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3.7.161 Use of non-testing methods such as read-across may only be suitable in certain 
cases of NM and strong justification must be given for its use. In the context of NM, 
care must be taken when applying read-across from bulk to nano material forms 
taking into account particle size and surface area so that potential hazards are not 
underestimated. Thus far it may be possible to conduct read-across (nano-nano) on 
certain forms of NM such as low toxicity, low solubility particles but this still requires 
further study and validation. 
3.7.162 As such we would propose the insertion of a statement to inform users of Guidance 
of the current ambiguity surrounding the use of non-testing data for nanomaterials, 
into the following sections of R.7.2. 
 R.7.2.3.1 Non-human data on irritation/ corrosion - Page 203 appended to 
paragraph 3 
 R.7.2.4.1 Non-human data on irritation/ corrosion - Page 215 appended to 
paragraph 4 
 Also appendix R7.2.2-2 (p241 under the contents of Appendix 7.2-2 list), 
R7.2.2-3 (p245 under the contents of Appendix 7.2-3 list) 
3.7.163 R.7.3 Skin and respiratory sensitisation   
3.7.164 Skin and respiratory sensitisation: Non-testing Data 
3.7.165 As previously mentioned, the use of in silico approaches such as (Q)SAR, 
groupings and read across are not sufficiently developed for nanomaterials and 
statement to this effect should be made in the following sections: 
 R.7.3.3.1 Non-human data for skin sensitisation – Page 259 appended to 
paragraph 7 
 R7.3.4.1 Non-human data on skin sensitisation - Page 267 appended to 
paragraph 1   
 R7.3.5.1 Non-human data on respiratory sensitisation - Page 271 appended 
to paragraph 1  
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3.7.166 R7.4: Acute Toxicity  
3.7.167 Acute Toxicity: Non-testing Data 
3.7.168 As previously mentioned, the use of in silico approaches such as (Q)SAR, 
groupings and read across are not sufficiently developed for nanomaterials and 
statement to this effect should be made in the following sections: 
 R.7.4.3.1 Non-human data on acute toxicity – Page 291 appended to 
paragraph 3   
 R.7.4.4.1 Non-human data on acute toxicity – Page 297 appended to 
paragraph 1 
 R.7.4.5.1 Conclusions on suitability for Classification and Labelling – Page 
301 appended to paragraph 2  
3.7.169 R7.5 - Repeated Dose Toxicity 
3.7.170 As previously mentioned, the use of in silico approaches such as (Q)SAR, 
groupings and read across are not sufficiently developed for nanomaterials and 
statement to this effect should be made in the following sections: 
 R.7.5.3.1 Non-human data on repeated dose toxicity– Page 314 inserted 
between paragraphs 4 and 5    
 R.7.5.4.1 Non-human data on repeated dose toxicity– Page 320 appended 
to paragraph 6    
3.7.171 R.7.6 Reproductive and developmental toxicity  
3.7.172 As previously mentioned, the use of in silico approaches such as (Q)SAR, 
groupings and read across are not sufficiently developed for nanomaterials and 
statement to this effect should be made in the following sections: 
 R.7.6.4.1 Non-human data on reproductive toxicity– Page 355 inserted 
between paragraphs 4 and 5 
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3.7.173 R.7.7 Mutagenicity and Carcinogenicity 
3.7.174 As previously mentioned, the use of in silico approaches such as (Q)SAR, 
groupings and read across are not sufficiently developed for nanomaterials and 
statement to this effect should be made in the following sections: 
 R.7.7.3.1 Non-human data on mutagenicity – Page 379 appended to 
paragraph 2  
 R.7.7.4.1 Non-human data on mutagenicity – Page 383 appended to 
paragraph 6 
 R.7.7.10.1 Non-human data on carcinogenicity – Page 407 appended to 
paragraph 1  
 R.7.7.11.1 Non-human data on carcinogenicity – Page 412 appended to 
paragraph 5 
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3.7.175 ECOTOXICOLOGICAL ENDPOINTS & TESTING 
3.7.176 As for many substances, the importance of material suspension, method of 
nanomaterials introduction, storage and stability of test material, chemical 
composition of the test media, characterisation of stock dispersions, characterization 
of samples (prepared from stock dispersions) has been identified, both prior to 
administration/testing and possibly during and at least at the end of the test. As 
such, and in line with the recommendations set out in the OECD Guidance Manual 
for testing (ENV/JM/MONO(2009)20/REV) and Preliminary Guidance Notes on 
Sample Preparation and Dosimetry for nanomaterials (ENV/JM/MONO(2010)25) it is 
proposed that a reference be made within the following sections referring Guidance 
users to a general section on “Sample Preparation” to be included in the introduction 
of R.7a. 
3.7.177 This reference should be made in the following sections: 
3.7.178 R.7.8 Aquatic toxicity; long-term toxicity to sediment organisms  
3.7.179 R.7.8.4.1 Data on aquatic pelagic toxicity 
 Short-term toxicity testing on invertebrates (preferred species Daphnia)  
 Growth inhibition study aquatic plants (algae preferred)  
 Short-term toxicity testing on fish 
 Long-term toxicity testing on invertebrates (preferred species Daphnia), 
(unless already provided as part of Annex VII requirements)  
 Long-term toxicity testing on fish, (unless already provided as part of 
Annex VIII requirements)  
 Fish early-life stage (FELS) toxicity test 
 Fish short-term toxicity test on embryo and sac-fry stages 
 Fish, juvenile growth test 
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3.7.180 R.7.8.9.1 Laboratory data on toxicity to sediment organisms  
 Long-term toxicity to sediment organisms  
3.7.181 R.7.11 Effects on Terrestrial organisms 
3.7.182 R.7.11.3.1  Laboratory Data 
 Soil short-term toxicity to invertebrates  
 Effects on soil micro-organisms  
 Short-term toxicity to plants  
 Long-term toxicity testing on soil invertebrates, unless already provided as 
part of Annex IX requirements 
 Long-term toxicity testing on plants, unless already provided as part of 
Annex IX requirements  
3.7.183 In addition to the important, but more general issue of sample preparation outlined 
above, more specific amendments are proposed for the following.  
3.7.184 R 7.9.3.1 Ready biodegradability  
3.7.185 It should be noted that the OECD ready biodegradability test guidelines have been 
developed and validated principally for assessment of organic compounds whereas 
many nanomaterials are principally inorganic and even carbon-based nanomaterials 
tend to behave as if they were inorganic in nature.  However, surface coating and 
functionalisations might be organic and consist of biodegradable materials. Methods 
measuring carbon dioxide production or oxygen uptake are applicable, but they 
require large amounts of test material. If several conclusive aerobic degradation 
tests indicate very low or negligible degradation, then other aerobic degradation 
tests will most likely also be negative and it may be useless to proceed with 
additional tests. It may be better to decide to skip the more elaborate test, and 
conclude that the substance is not biodegradable (ENV/JM/MONO(2010)25). 
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3.7.186 R.7.1.1.15 Adsorption/desorption screening  
3.7.187 It should be noted that the distribution coefficient Kd has to be based on actual 
testing using one of the methods for the measurement of adsorption outlined in 
Table 7.1-33 since estimations of Kd derived from the organic carbon-water partition 
coefficient (Koc) and the octanol-water partition coefficient (Kow) have no merit when 
it comes to nanomaterials. 
3.7.188 R.7.10.3.1 Bioaccumulation in aquatic species, preferably fish  
3.7.189 It should be acknowledged that for bioaccumulation it is not possible to make log 
Kow or solubility estimations since nanomaterials are dispersed and not in solution. 
Measured BCF values are required and stability and changes in e.g. aggregation 
and agglomerate size are of vital importance to consider. There is furthermore a 
need to emphasise that for nanomaterials under dissolution like Ag0 obtaining 
information, if possible, on the form of the substance present in the animal tissue 
may provide useful additional information.  
3.7.190 It should be noted that estimates based on “partitioning” are limited to distribution of 
a substance in molecular form. However, substances may also be distributed in the 
environment as particles (caused by abrasion/weathering of anthropogenic 
materials) and extrapolation based on partitioning may not be relevant. In such a 
case the partitioning method may underestimate exposure of soil and sediment 
environments and overestimate the exposure of water. If the particle size is small 
also air distribution may occur. There are no estimation methods available for 
particle distribution so this has to be dealt with on a case-by-case basis. This issue 
is relevant to and could expressed in the following sections: 
3.7.191 R.7.8 Aquatic toxicity; long-term toxicity to sediment organisms  
3.7.192 R.7.8.9.1 Laboratory data on toxicity to sediment organisms  
 Long-term toxicity to sediment organisms  
3.7.193 R.7.11 Effects on Terrestrial organisms 
3.7.194 R.7.11.3.1  Laboratory Data 
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 Soil short-term toxicity to invertebrates  
 Effects on soil micro-organisms  
 Short-term toxicity to plants  
 Long-term toxicity testing on soil invertebrates, unless already provided as 
part of Annex IX requirements 
 Long-term toxicity testing on plants, unless already provided as part of 
Annex IX requirements  
3.7.195 ADDITIONAL RELEVANT SPECIFIC INTRINSIC PROPERTIES 
3.7.196 In conducting the RIP-oN2 B2 and B3 tasks, a number of potential additional 
relevant specific properties have been identified. These include fish ventilation rates, 
fish gill pathologies, fish mucus secretion, fish brain pathology, animal behaviour, 
oxidative stress. Whilst these biological markers have been used within the peer 
reviewed literature, they are not considered suitably advanced for direct 
incorporation into guidance at this time as required endpoints. Indeed the consortium 
has identified that further research is required to assess both the relevance of the 
markers, their suitability for regulatory testing and the development and adoption of 
standardised testing methodologies. These candidate additional relevant specific 
properties have therefore been listed under B5 subtask IV: Proposals for further 
research and development with further detail given in section 4.3.157 of this report 
onwards. 
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3.7.197 B5 Sub-Task IV: Proposals for further research and development of test 
methods and other data generation methods/strategies in regard to 
nanomaterials 
3.7.198 Research and development needs have been identified systematically during Tasks 
B1, B2, B3, B4 for each property, testing endpoints and methods.  A summary listing 
of the aspects considered to warrant further research and development is provided 
below.  Detailed recommendations are provided in Chapter 4 of this report.   
3.7.199 Physico-chemical Properties 
3.7.200 General aspects (characterisation practice, standards, and protocols) 
3.7.201 Existing Information Requirements 
 Relative density 
 Surface tension 
 Water solubility 
 Partition coefficient 
 Flammability 
 Explosive properties 
 Granulometry 
 Dissociation constant 
3.7.202 Additional Relevant Specific Intrinsic Properties 
 Particle shape 
 Surface area 
 Porosity 
 Surface energy 
 Surface chemistry 
 Surface acidity 
 Surface charge 
 Redox potential 
 Cell-free ROS/RNS production capacity 
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3.7.203 (Particle shape and surface area have been recommended for incorporation into 
REACH Guidance at this time on the basis of the justification and practicability 
developed from the assessment of the available evidence.) 
3.7.204 Toxicological Endpoints 
3.7.205 Aspects relating to study design 
 Dispersion 
 Selection of dose 
 Selection of exposure route & duration 
 Interactions 
 Using physico-chemical data to inform experimental design 
 Target-organ toxicity considerations 
 Adopting standardised controls 
 Interferences 
3.7.206 Existing Information Requirements 
 Skin irritation 
 Eye irritation 
3.7.207 Additional Relevant Specific Intrinsic Properties 
 Inflammation 
 Pro-fibrogenic effects 
 Barrier transfer models 
 Cardiovascular toxicity 
3.7.208 Ecotoxicological Endpoints 
3.7.209 Within the following proposed research and development needs for ecotoxicological 
endpoints, test methods or testing strategies for nanomaterials those considered to 
be low priority are indicated with an asterisk. 
 
3.7.210 General considerations 
 Aquatic testing 
 Soil testing 
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3.7.211 Existing IRs# 
 Short- and long-term toxicity on invertebrates, fish and plants 
 Growth inhibition in aquatic plants 
 Ready biodegradability 
 Short- and long-term toxicity on fish 
 Activated sludge respiration inhibition 
 Hydrolysis as a function of pH 
 Adsorption / desorption screening 
 Fish: early life stage, embryo & sac-fry, juvenile growth 
 Bioaccumulation in aquatic species 
 Soil micro-organisms 
 Sediment organisms 
 Long-term or reproductive toxicity to birds 
3.7.212 Additional Relevant Specific Intrinsic Properties# 
 Fish ventilation rate 
 Fish gill path and mucous secretion 
 Fish brain pathology 
 Animal behaviour 
 Oxidative stress 
 Daphnia heart rate*, hopping frequency*, appendage movement* 
 Trojan-horse effect of nanomaterials* 
 
#In relation to these endpoints and proposed biological markers it should be noted that consensus has not been 
reached within the project consortium and further discussions can be found in section 4.3.157 onwards.  
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3.8 METRIC(S) TO COMPARE IN THE RISK CHARACTERISATION (TASK C) 
3.8.1 The objective of Task C was to develop a working document on the identification of 
critical items on exposure/dose descriptors and related parameters, outlining needs 
for adequate metrics/parameters as appropriate for exposure assessment 
compatible with the ones used for hazard assessment. The underlying principal 
metrics is the number of molecules expected to participate in the process in 
question. Most commonly mass, but particle number or surface area are eventually 
chosen as the proxy for this number.  
3.8.2 The question of what is the best metric to measure the risk of nanoparticles is a 
frequently posed question when attempting to assess the risks of nanomaterials.  In 
practice there are many metrics, all of which include mass or number, which are 
currently used in the risk assessment (both regulatory and otherwise) across the 
three elements of exposure, toxicology and risk.  The most commonly used are 
identified below: 
Target Route 
Exposure 
metric 
(example units) 
Toxicology 
/ecotoxicology 
dose metric  
(example units) 
Risk evaluation 
metric 
(example units) 
Human 
inhalation mass conc in air (mg/m3) 
mass per animal 
or per body part 
(m) 
mass conc in air 
(mg/m3) 
inhalation fibre number conc in air (f/ml) 
fibres per animal 
or per body part 
(#f) 
fibre number 
conc in air (f/ml) 
dermal 
mass per 
surface area of 
skin exposed 
(mg/cm2) 
mass per animal 
or surface area 
(m) 
mass per surface 
area of skin 
exposed 
(mg/cm2) 
dermal 
mass per kg 
body wt per day 
(mg/kg/day) 
mass per animal 
or surface area 
(m) 
mass per kg body 
wt per day 
(mg/kg/day) 
ingestion 
mass per kg 
body wt per day 
(mg/kg/day) 
mass per animal 
(m) 
mass per kg body 
wt per day 
(mg/kg/day) 
Environment air/water/ soil 
Environmental 
concentration 
(mg/L or mg/kg) 
 
Predicted no 
effect 
concentration 
(mg/L or mg/kg) 
Ratio between 
environmental 
concentration and 
predicted no 
effect 
concentration  
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3.8.3 The metrics can be units, concentrations, or ratios. They can be measured directly or 
modelled. 
3.8.4 The most prominent alternative or additional metric identified for use in relation to the 
risk assessment of nanomaterials, is surface area.  This is based primarily on 
toxicological evidence relating particle surface area to inflammation, an indicator of 
toxicity.  The evidence for this has been assessed in the Task report.   
3.8.5 Other parameters debated as possible metrics include surface reactivity and charge.  
Surface reactivity is clearly an important parameter although whether this could be 
considered as a potential metric or simply a unit to express the toxicological 
response is a matter for discussion.  Its use as a metric (in toxicology) would be as 
“units of reactivity per body part”.  This same is true of charge in which the metric 
would be coulomb/body part.  It is considered that the basis of these two properties 
becoming “metrics” is not yet sufficiently advanced to a level at which use and 
guidance for REACH can be recommended.  
3.8.6 It is important to note that there are other parameters which can act as modifiers of 
the toxicity.  These include particle size, size distribution, density, aggregation and 
shape.  These parameters would not generally be considered as scalable quantities 
and do not appear to conform to the current use of the term “metric” under REACH.  
Therefore they have not been considered further in this discussion. 
3.8.7 Metrics in risk assessment need to be scalable quantities which may be used to 
express the levels of hazard, exposure or risk.  To date, conversion between mass, 
number and surface area has largely been based on simple assumptions, treating 
particles as spheres and using mean particle diameters.  It is considered 
advantageous to be able to provide for each nanomaterial functional conversions 
between the three metrics based on established and validated relationships.  
Conversion between the metrics of mass, number and surface area remains 
challenging both within and between exposure, hazard and dose.  Measurement of 
surface area in relation to dose is still mostly indirect and is typically based on a 
mass assessment times a measure of specific surface area of the powdered material 
obtained by BET analysis or similar.  Encouragingly, in relation to inhalation 
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exposure, measurement systems are available to measure mass, number and 
surface area concentrations.   
3.8.8 For example, Wake et al. (2001) carried out a laboratory study to compare the 
performance of Matter LQ1-DC active surface area monitor, a TSI Model 3934 
Scanning Mobility Particles Sizer and an R&P Tapered Element Oscillating 
Microbalance.  Using the three instruments described above, experiments were 
carried out in the laboratory with polydisperse aerosols, containing ultrafine particles, 
to establish what relationships exist between the three measurement parameters 
mass, surface area and number as determined by each instrument and how these 
relationships may be influenced by particle composition and morphology.  For each 
of the five aerosol types investigated, consistent relationships were found for mass 
and active surface area with increasing particle number concentrations for all the 
particle sizes investigated.  However, these relationships were not consistent with 
particle size.  Amongst Wake’s conclusions were that no simple relationship was 
found for predicting active surface area and mass from the results of measurements 
made with the benchmark instrument the SMPS.  This instrument, therefore, should 
not be used to calculate surface area and mass unless a detailed knowledge of the 
aerosol is known.  In view of this, the use of all three instruments, measuring in 
parallel, should continue despite the difficulty in arranging this in the workplace.  
Moreover, Wake considered it unwise to make measurements in terms of just one 
parameter, be it mass, active surface area or number/size, when assessing the 
potential for engineered nanoparticles to cause ill health when the causal factor has 
not yet been established.   
3.8.9 An advantage of mass over surface area (and virtually all other alternatives) is that 
the mass in a system is conserved i.e. remains constant (and could be assessed 
through mass balance), whereas surface area is not.  In other words, the actual 
surface area can change due to aggregation/de-aggregation which may occur 
following deposition of the particles and influence the interpretation of data.  The 
same is also true (to an even greater extent) for particle number.  
3.8.10 However, there is nevertheless evidence that surface area is an important metric in 
describing the human health hazard potential of some types of nanoparticles.  For 
low toxicity low solubility materials, surface area of particles administered rather than 
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mass burden of particles may be a more appropriate dose metric for pulmonary 
toxicity studies.  The same type of relationship has also been demonstrated for 
higher toxicity nanoparticles.  For dermal effects, any metric proposed to assess 
dermal exposure to nanoparticles should be biologically relevant and should relate to 
health effects.  It may be that for local effects, inflammation is the key driver in which 
it could be speculated that surface area would be the important metric.  Further work 
including workplace studies and in-vivo/vitro assessment of penetration is required.  
For the environment, it seems too early to tell whether a dose [concentration] - 
response relationship can be established as well as whether, for instance, size or 
surface area can be substituted with dose by mass.  Too few studies have actually 
investigated alternative dose metrics at this point in time and correlated these with 
the observed effects. 
3.8.11 In relation to the guidance which can be given now on hazard assessment, it is 
considered important to continue with mass based measurement.  This is the basis 
of the current risk assessment process and the linkage to past work in both exposure 
and toxicology.  Based on the evidence available, it seems justified to additionally 
express the data in terms of surface area.  In practical terms, this would only require 
knowledge of BET results for the nanomaterial used.  For exposure assessment, 
both surface area and number concentration data are achievable and provide useful 
information and addition to the standard mass data, and should be collected.   
3.8.12 Further consideration of additional issues relating to metrics, as part of an ongoing 
international dialogue and subsequent to the acceptance of the Task C report, 
warrant acknowledgement in this final report: 
 There is no general rule for the choice of metric as the relevance may 
depend on the exposure route and even the material itself (e.g. aspect ratio), 
so it should be decided on a case-by-case basis by the registrant.  The 
mass metric may not always be the most appropriate or relevant metric.  
However, given the historical and established use of the mass metric, which 
is the case in most if not all elements of hazard, exposure and risk 
characterisation in a Chemical Safety Assessment (CSA) under REACH, it 
continues to be considered appropriate that even in cases where another 
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metric is relevant and has been used, the mass metric 
description/data/result should continue to be provided.  
 It is clear that one, two or more metrics may be relevant to undertake the 
best possible CSA for different forms of a materials covered by one 
registration, including all exposure scenarios etc.  This is to be encouraged, 
albeit with a clear justification and transparency to ensure that the CSA can 
be understood. The most relevant for determination of the Risk 
Characterisation Ratio (RCR) should be considered in such cases.   
 At present, evidence of the emergence of new metrics is strong in some 
case (e.g. surface area), but this is acknowledged as an evolving field.  It 
has been made clear in the RIP-oN 2 and 3 projects that there is evidence to 
recommend surface area as a metric appropriate in inhalation exposure but 
there is no conclusive evidence with regard to dermal exposure.  This has 
already been reflected in the guidance recommendations.  The choice of 
metrics is rightly left to the registrant, with the expectation that the choice is 
scientifically justified. As stated above, as exposure scenarios differ, so can 
the choice of metrics for the related form and the individual scenario. 
 It should always be clear how different metrics have been used (in rare 
cases perhaps even from separate studies) or derived through 
transformation of final results of the same test etc. It should be ensured that 
the whole CSA (hazard, exposure, risk characterisation ratio including any 
required risk management measures) is performed consistently. If the 
Derived No Effect Level (DNEL) or Predicted No Effect Concentration 
(PNEC) are determined using one metric, so should the estimation of the 
Predicted Environmental Concentration (PEC) to characterise the risk ratio.  
The basis for selecting and assessing the efficiency of RMM employed 
should be expressed in the same metric. The same applies to the potential 
application of models and to the justification of any read-across.  If there are 
transformations of metrics involved, they need to be transparent so the 
applicability of the data can be justified.   
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 It is clear that a consideration of Assessment Factors needs to be performed 
for different metrics, separately, and including the uncertainty potentially 
arising from the transformation of metrics and from the differences in the 
tests performed.  
 There is more to the conversion between metrics than simply working in one 
metric and then express results in another. Adequate characterisation and 
the scope of applicability of the test is required, along with consideration of 
the design of the test (e.g. selected doses, sample preparation to minimise 
uncertainty/bias) and the selection of the most appropriate 
instrumentation/method.  
 It remains that there are currently no definitive conclusions on the best 
metric. However, there is growing consensus that if new animal tests on 
nanoforms are performed, there should be a sufficient characterisation of 
those forms allowing the dose-response to be expressed in the different 
metrics discussed - number, surface area and mass.   
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4 RECOMMENDATIONS 
4.1 UPDATES TO EXISTING GUIDANCE 
4.1.1 Specific recommendations for updates to guidance, derived from the work 
undertaken in RIP-oN 2 project, are presented in this chapter on a section-by-section 
basis, using the numbering system of the existing guidance document, chapters and 
sections.  Suggested updates to higher-level guidance (e.g. Part B: Hazard 
Assessment) are made at the time of presenting the Endpoint Specific Guidance 
updates for a particular property.   
4.1.2 R.7 ENDPOINT SPECIFIC GUIDANCE 
4.1.3 Introduction 
4.1.4 It is recommended that the following sub-section is included in the overall 
Introduction for the R.7 Guidance after the sub-section entitled “Adequacy of 
methods for generating additional information” (R.7, pg. 15): 
4.1.5 Sample preparation 
4.1.6 Sample preparation is widely recognised as one of the most critical steps 
towards successful characterisation and subsequent (eco)toxicological testing 
of nanomaterials, in which there are many variables to consider when 
designing a method for preparation.  Common issues regarding sample 
preparation include storage and stability of the test material; the chemical 
composition of the test media; characterisation of stock dispersions, and; 
characterisation of samples (prepared from stock dispersions) prior to 
administration/testing (OECD, 2010).  Preliminary guidance on sample 
preparation for the physico-chemical characterisation of nanomaterials, 
covering properties including particle size distribution, shape, specific surface 
area, octanol-water partition coefficients, degree of agglomeration and 
dispersion behaviour, is available (OECD, 2010).  ISO 14887:2000 outlines 
procedures for the preparation of good dispersions from various powder/liquid 
combinations for particle size analysis of substances in general.  Suggested 
dispersion procedures for a range of nanomaterials are also emerging in the 
scientific literature.  However, such procedures should be carefully examined 
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to determine if they are adequate for the test material under consideration and 
modifications may be required for different materials.   With regards inhalation 
toxicity testing, standards are available that outline procedures for the 
generation of metal nanoparticles using the evaporation/condensation method 
(ISO 10801:2010) and support the characterisation of nanoparticles in 
inhalation exposure chambers (ISO 10808:2010). 
4.1.7 An important component of sample preparation is the need to have “reliable” 
sampling, such that the test aliquot used for measurement represents the 
physical and chemical characteristics of the entire sample.  The 
characterisation of particle properties like size, form and specific surface area 
requires very careful sampling and sample splitting practises to be followed.  
ISO 14488:2007 specifies methods for obtaining a test aliquot from a defined 
sample of particulate material (powder, paste, suspension or dust) that can be 
considered to be representative with a defined confidence level and is of 
particular relevance to the measurement of particle size, size distribution and 
surface area.  
4.1.8 Also in relation to sample preparation, it is necessary to be aware that 
aggregates and agglomerates of nanomaterials can form in solution, powder 
and aerosol forms, and their presence is influenced by a number of factors 
including the method of synthesis, storage, handling and environmental 
conditions.  An agglomerate is defined as a collection of weakly bound 
particles or aggregates or mixtures of the two where the resulting external 
surface area is similar to the sum of the surface areas of the individual 
components.  An aggregate is a particle comprising of strongly bonded or 
fused particles where the resulting external surface area may be significantly 
smaller than the sum of calculated surface areas of the individual components 
(ISO 27687:2008).  
4.1.9 In addition, it is known that the observations and interpretation of toxicity, and 
fate and behaviour, as a result of exposure to agglomerates may or may not 
be associated with the primary particle’s characteristics.  The state of 
agglomeration or aggregation is recognised as an important parameter 
influencing the interpretation of characterisation and testing of nanomaterials 
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(“as received”, “as used”, “as dosed / as exposed”) and should therefore be 
considered during sample preparation.  A number of measurands have been 
proposed for assessing agglomeration or aggregation state, including the 
effective cross-section, determined by measuring aerodynamic/light scattering 
properties or by electron microscopy (OECD, 2009).  OECD (2009) suggest for 
nanomaterials with a non-zero width of the distribution of the degree of 
agglomeration should be characterised.  Other measurands include the 
average agglomeration number (AAN), which is derived from the ratio of the 
volume based median particle size to the average equivalent spherical volume 
derived from BET gas adsorption.   
4.1.10 In addition to aggregation and agglomeration, the behaviour of particles in 
solution presents some additional important aspects and challenges to 
recognise. In particular, it can be difficult to distinguish between when a 
nanomaterial is dispersed and when it is dissolved due to its small particle 
size.  It is important to recognise that solubility and dispersibility are two 
distinct phenomena.  Solubility is the degree to which a material (the solute) 
can be dissolved in another material (the solvent) such that a single, 
homogeneous, temporally stable phase (a suspension down to the molecular 
level) results, and is relevant to solids, liquids and gases.  Dispersibility is the 
degree to which a particulate material can be uniformly distributed in another 
material (the dispersing medium or continuous phase).  Historically, the term 
“dissolved” meant the component of a liquid sample that had passed through a 
0.45µm (or similar) filter.  However, as (colloidal) dispersions of nanoparticles 
might also pass through such filters, it is recommended that use of the term 
“dissolved” should be restricted to the formation of true solutions, and where 
both liquid and particulates are present the term “dispersed” should be used 
(OECD, 2010).  
4.1.11 A dispersion is a suspension of discrete insoluble particles in a fluid, which 
may falsely have the visible appearance of a solution (i.e. the product of the 
conversion of a solid substance to liquid form by mixture with a solvent).  A 
dispersion of an insoluble material may elicit a different response from that 
anticipated from the classical molecular or elemental toxicity expected from the 
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chemical composition. Dispersion stability is an important parameter to assess 
in the context of sample preparation.  
4.1.12 The dispersion of particles is determined by intermolecular forces involving 
particle-particle interactions as well as those between the particles and their 
environment.  Due to attractive forces (e.g. Van der Waals interactions) 
particles tend to agglomerate unless stabilised by surface charge or steric 
effects.  As a result, the state of dispersion is dynamic and determined 
primarily by the environment of the nanoparticles.  In solution, slight 
modifications in pH, ionic strength, and concentrations of molecular 
constituents can significantly alter the dispersion of particles.  For aerosolised 
powders, the situation can be even more complex as the concentration and 
diffusion characteristics of the aerosol can cause the state of dispersion to 
change over time.  
4.1.13 The state of dispersion is typically assessed using comparative particle size 
measurements and requires a reliable method of measuring the baseline 
particle size distribution of the material.  By comparing changes in particle size 
distribution, a qualitative assessment or proxy measure of the state of 
dispersion can be made.  Zeta potential measurement, combined with 
Dynamic Light Scattering (DLS) also enables the stability of nanoparticle 
dispersions to be monitored and a qualitative understanding of the 
agglomeration process.  
4.1.14 If a nanomaterial is soluble in biological or environmental media, then it is 
likely to be presented to the test system in its molecular or ionic form and can 
therefore be expected to elicit the same response as bulk (non-nanoscale) 
solubilised substances.  If, however, the nanomaterial under investigation is 
insoluble or sparingly soluble in biological or environmental media, then it will 
likely be presented to the test system in a particle form. 
4.1.15 In addition, nanoparticles may interact with the liquid phase components, 
partially or totally yielding soluble or dispersed transformation products (as well 
as some solubilised nanomaterial itself) that may influence the overall toxicity 
and fate processes.  This possibility needs to be taken into account when 
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selecting the media and procedures as well as in the assessment of the result 
of any experiment (OECD, 2010). 
4.1.16 Other important considerations to take into account during sample preparation 
include the influence of contaminants and impurities on (eco)toxicological test 
results.  Adverse effects on a number of species used in PNEC derivations for 
nanomaterials have been attributed to particle impurities (e.g. Cheng et al., 
2007: Brayner et al., 2006).  
4.1.17 Of particular concern is the influence of endotoxin on certain testing results.  
Endotoxin (lipopolysaccaride) is a constituent of the outer cell wall of Gram-
negative bacteria and as such is found ubiquitously within the environment.  
Endotoxin however can generate a range of toxic effects either at the whole 
organism level causing responses such as fever, ‘endotoxin shock’ and death, 
or at the cellular level via the triggering of inflammatory cascades leading to 
the secretion of pro-inflammatory mediators.  
4.1.18 Due to the potent response endotoxin can generate in biological assays, 
toxicity testing of a contaminated test sample would lead to a confounding of 
results (including a potential false positive).  As such the establishment of the 
presence or level of endotoxin in a test sample is useful as a preliminary 
undertaking during the preparation of a sample for toxicological testing.  
International standards are available for the testing of nanomaterials (ISO 
29701:2010) although issues regarding endotoxin contamination are not 
necessarily nano-specific and are equally relevant other particles or aqueous 
substances undergoing toxicological evaluation.  
4.1.19 In order to eliminate potential confounding of the interpretation of results due 
to particle contaminants/impurities, data from the characterisation of the test 
material including its purity and, if technically feasible, quantities of identified 
contaminants and impurities should be considered prior to the start of a study, 
consistent with the substance identification requirement. 
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4.1.20 R.7.1.1 Introduction 
4.1.21 The following text is recommended to be added as a new fourth paragraph in 
R.7.1.1. (R.7a, pg. 17), following the paragraph ending "…and be operating within its 
validity range": 
4.1.22 With regards nanomaterials characterisation, it is important to note that 
different techniques will suit different sample forms (e.g. aerosol, suspensions 
etc.) and, in many cases, no individual technique can satisfy a meaningful 
characterisation of nanomaterials (Stone et al., 2009; Tran et al., 2008). 
Multiple techniques should therefore be used where possible in order to 
formulate an appropriate understanding of the nanomaterial’s properties, and 
the optimum set of required techniques should be selected and justified based 
on the specific nanomaterial type and form under investigation.  The need 
need for multi-method characterisation and material-specific selection of 
techniques applies across a range of nanomaterial properties and would 
facilitate the gathering of data on multiple metrics. 
4.1.23 R.7.1.1.3 Evaluation of available information on physico-chemical properties 
4.1.24 Experimental data 
4.1.25 The last sentence of the second paragraph of R.7.1.1.3 sub-section on 
"Experimental data" (R.7a, pg. 27) is recommended to be updated with the following 
text to acknowledge the importance of reference materials: 
4.1.26 Comparison of the experimentally determined physico-chemical property with a 
suitable reference material and a scientifically justified QSAR prediction is 
often, if not always, recommended to provide reassurance that the 
experimentally derived value is acceptable and has not been influenced by the 
presence of impurities in the product.  A number of particle based reference 
materials are available from commercial sources and National or Community 
Measurement Standard Bureaus e.g. NPL, IRMM, NIST.   
RNC/RIP-oN2/FPR/1/FINAL 
 
- 188 - 
4.1.27 R.7.1.1.7 References for introduction of Physico-Chemical properties 
4.1.28 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.1.1.7 (R.7a, pg. 45-47): 
4.1.29 Brayner, R., Ferrari-Iliou, R., Brivois, N., Djediat, S., Benedetti, M.F. and 
Fievet, F. 2006, "Toxicological impact studies based on Escherichia coli 
bacteria in ultrafine ZnO nanoparticles colloidal medium", Nano Letters, vol. 6, 
no. 4, pp. 866-870.  
4.1.30 Cheng, J.P., Flahaut, E. and Cheng, S.H. 2007, "Effect of carbon nanotubes 
on developing zebrafish (Danio rerio) embryos", Environmental Toxicology and 
Chemistry, vol. 26, no. 4, pp. 708-716.  
4.1.31 ISO 10808:2010. “Nanotechnologies -- Characterization of nanoparticles in 
inhalation exposure chambers for inhalation toxicity testing”, ISO TC 229. 
4.1.32 ISO 14488:2007. “Particulate materials – Sampling and sample splitting for the 
determination of particulate properties”, ISO TC 24/SC 4. 
4.1.33 ISO 14887:2000. “Sample preparation – Dispersing procedures for powders in 
liquids”, ISO TC 24/SC 4. 
4.1.34 ISO/TS 27687:2009 “Nanotechnologies - Terminology and definitions for nano-
objects - Nanoparticle, nanofibre and nanoplate”, ISO TTC/229. 
4.1.35 ISO 28439:2011. “Workplace atmospheres -- Characterization of ultrafine 
aerosols/nanoaerosols -- Determination of the size distribution and number 
concentration using differential electrical mobility analysing systems”, ISO TC 
146/SC 2. 
4.1.36 ISO 29701:2010. “Nanotechnologies – Endotoxin test on nanomaterial 
samples for in vitro systems – Limulus amebocyte lysate (LAL) test”, ISO 
TC/229. 
4.1.37 OECD. 2009, "Guidance manual for the testing of manufactured 
nanomaterials: OECD's sponsorship programme. First revision", Series on the 
safety of manufactured nanomaterials, ENV/JM/MONO(2009)20/REV, Paris. 
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4.1.38 OECD. 2010, "Preliminary Guidance Notes on Sample Preparation and 
Dosimetry for the Safety Testing of Manufactured Nanomaterials", Series on 
the safety of manufactured nanomaterials, ENV/JM/MONO(2010)25, Paris. 
4.1.39 Stone, V., Hankin, S., Aitken, R., Aschberger, K., Baun, A., Christensen, F., 
Fernandes, T., Hansen, S.F., Hartmann, N.B., Hutchison, G., Johnston, H., 
Micheletti, C., Peters, S., Ross, B., Sokull-Kluettgen, B., Stark, D., Tran, L. 
2009, “ENRHES – Engineered nanoparticles: review of health and 
environmental safety”, EC contract number 218433. 
4.1.40 Tran, C.L., Hankin, S.M., Ross, B., Aitken, R.J., Jones, A.D., Donaldson, K., 
Stone, V., Tantra, R. 2008, "An outline scoping study to determine whether 
high aspect ratio nanoparticles (HARN) should raise the same concerns as do 
asbestos fibres", Defra Research Report CB0406, UK. 
4.1.41 R.7.1.7 WATER SOLUBILITY 
4.1.42 R.7.1.7.3 Evaluation of available information on water solubility 
4.1.43 Remaining uncertainty on water solubility 
4.1.44 It is recommended that the following text is added as a new third paragraph in 
R.7.1.7.3 sub-section “Remaining uncertainty on water solubility” (R.7a, pg 93): 
4.1.45 Water solubility has the potential to increase in the nano-size range.  For 
nanomaterials, it can be difficult to distinguish between when a substance is 
dispersed and when it is dissolved due to its small particle size.  It is important 
to recognise that solubility and dispersibility are different and distinct 
phenomena, with different implications on testing and characterisation, and it is 
important to differentiate between them. Further information on these issues is 
provided in the Sample Preparation sub-section of the R.7a Introduction. It 
should also be ensured that no undissolved material contributes to what is 
being measured.   
4.1.46 R.7.1.7.5 Integrated testing strategy (ITS) for water solubility 
4.1.47 Figure R.7.1-5 
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4.1.48 It is recommended that, in Figure R.7.1-5 (R.7a, pg. 94), the qualifier in the box 
highlighted red below is replaced with the following text: 
4.1.49 Preliminary test involving visual/instrumental assessment of solubilisation or 
dispersion. Is solubility < 10 mg/l? 
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4.1.50 R.7.1.8 PARTITION COEFFICIENT N-OCTANOL/WATER 
4.1.51 R.7.1.8.3 Evaluation of available information on partition coefficient n-
octanol/water 
4.1.52 Experimental data on partition coefficient n-octanol/water 
4.1.53 It is recommended that the following caveat is added to the end of the second 
paragraph of R.7.1.8.3. sub-section “Experimental data on partition coefficient n-
octanol/water” (R.7a, pg. 101), after the sentence ending “…should equally be 
accepted": 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 192 - 
4.1.54 It is important to note that, following a review of the applicability of test 
guidelines to nanomaterials, OECD concluded that test guidelines 107, 117 
and 123 might be applicable under some circumstances or to some classes of 
manufactured nanomaterials, although further work is required to determine 
this and modify the TGs, if it is considered necessary (OECD, 2009).  Results 
might be impacted upon by the presence of a colloidal suspension, which 
could be present if the manufactured nanomaterial does not completely 
dissolve (OECD, 2009). 
4.1.55 Difficult to test substances 
4.1.56 It is recommended that the following paragraph is added to the end of R.7.1.8.3. 
sub-section “Difficult to test substances” (R.7a, pg. 106), after the paragraph ending 
“…hydrolysis, oxidation, or biotic degradation": 
4.1.57 For nanomaterials, it can be difficult to distinguish between when a substance 
is dispersed and when it is dissolved due to its small particle size.  It is 
important to recognise that solubility and dispersibility are two distinct 
phenomena and it is important to differentiate between them.  Further 
information on these issues is provided in the Sample Preparation sub-section 
of the R.7a Introduction.  
4.1.58 R.7.1.8.6 References on n-octanol/water partition coefficient 
4.1.59 Subject to acceptance of the recommended guidance changes above, the following 
additional reference would need to be included into R.7.1.8.6 (R.7a, pg. 114): 
4.1.60 OECD. 2009, "Preliminary Review of OECD Test Guidelines for their 
Applicability to Manufactured Nanomaterials", Series on the safety of 
manufactured nanomaterials, ENV/JM/MONO(2009)21, Paris. 
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4.1.61 NB. The following guidance update for GRANULOMETRY is recommended if 
the scope of the term “Granulometry” and thus the corresponding information 
IS NOT considered to include additional specific intrinsic properties “shape” 
and “surface area”.  It is noted that Annex II to Regulation (EC) No 1907/2006 has 
been amended and now explicitly states in Section 9.1 that “The physical state (solid 
(including appropriate and available safety information on granulometry and specific 
surface area if not already specified elsewhere in this safety data sheet), liquid, gas) 
and the colour of the substance or mixture as supplied shall be indicated.”  The 
inclusion of specific surface area as a separate term distinct from granulometry in 
the amendment of Annex II is observed.  For specific surface area at least, confusion 
(or even a suggestion of heightened importance) may arise, albeit minor, when the 
property is seen to be stated separately from granulometry in Annex II.  This 
ambiguity is simply highlighted, for resolution by regulators in their future 
considerations. In this circumstance, new chapters are recommended and provided 
in Section 4.2 of this report for Shape and Surface Area, which should accompany 
the updates made below for Granulometry.  The alternative circumstance where the 
information requirement on “Granulometry” IS considered to include Shape and 
Surface Area is addressed in paragraphs 4.1.191 to 4.1.222 of this report.   
4.1.62 Part B: Hazard Assessment 
4.1.63 B.6.1.4 Other physico-chemical properties  
4.1.64 It is recommended that the following paragraphs on Granulometry, Shape and 
Surface Area are added to the end of section B.6.1.4. (PART B – HAZARD 
ASSESSMENT, pg. 21), following the paragraph ending “…are preferred over other 
determinations of Kow”: 
4.1.65 Granulometry, which can be defined as the determination of particle size 
distribution, is an important property to consider from a hazard assessment 
perspective.  Determination of the particle size fractions are used to assess the 
possible health effects resulting from inhalation of airborne particles in the 
workplace. The inhalable size range of particles is important in determining not 
only if the situation poses an inhalation problem, but also where in the 
respiratory tract the particles may deposit. Therefore, the particle size 
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distribution can be used as an argument when considering inhalation testing. A 
number of methods covering different ranges of particle sizes are available, 
although none of them is applicable to the entire size range.  The particle size 
distribution is needed in order to decide which route of administration is most 
appropriate for the acute toxicity and 28-day base set animal studies. Particle 
size is also a factor in environmental exposure assessment. 
Shape is an important parameter in the characterisation of some particles, with 
contextual value to the assessment of deposition, adsorption kinetics, and 
hazard assessment in biological media.  Three corresponding levels of shape 
can be distinguished: macroshape, mesoshape and microshape. 
Surface area is an important parameter in the characterisation of 
nanomaterials, with emerging evidence of quantitative value as an additional 
dose metric / descriptor for hazard assessment.  The surface area will dictate 
the surface charge in cases where nanomaterials are surface functionalised, 
with direct consequences on nanomaterial interaction (i.e. agglomeration) with 
other naturally occurring particulate, route of exposure as a function of surface 
ligand-biological interface and mechanisms of toxicity. 
4.1.66 APPENDIX TO PART F – CSR TEMPLATE WITH EXPLANATION  
4.1.67 1.3. Physico-chemical properties 
4.1.68 Table 5: Overview of physico-chemical properties  
4.1.69 It is recommended that the following rows be added to Table 5 (Appendix to Part F, 
pg. 13): 
Property Value Remarks 
Shape Idem Idem 
Surface area Idem Idem 
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4.1.70 R.7.1.1.1 Information requirements on physico-chemical properties 
4.1.71 Table R.7.1-1 
4.1.72 It is recommended that the phrase “Granulometry (particle size distribution)” in Table 
R.7.1-1 (R.7a, pg. 18) is clarified to the word “Granulometry”, consistent with the 
Regulation and Guidance. 
4.1.73 It is recommended that the additional relevant specific intrinsic properties of “Shape” 
and “Surface Area” are included in Table R.7.1-1 (R.7a, pg. 18). 
4.1.74 R.7.1.1.4 General testing strategy for physico-chemical properties 
4.1.75 Tier 3 
4.1.76 It is recommended that the term “Particle Size Distribution” under R.7.1.1.4 “Tier 3” 
(R.7a, pg. 36) be amended to state “Granulometry”, consistent with the Regulation 
and Guidance. 
4.1.77 It is recommended that the additional relevant specific intrinsic properties of “Shape” 
and “Surface Area” are included under R.7.1.1.4 “Tier 3” (R.7a, pg. 36). 
4.1.78 Figure R.7.1-1 Tiered testing scheme on physico-chemical testing 
4.1.79 It is recommended that the “particle size distribution” box in Tier 3 of Figure R.7.1-1 
(R.7a, pg. 37) is updated to state “Granulometry”, consistent with the Regulation and 
Guidance. 
4.1.80 It is recommended that boxes for the additional relevant specific intrinsic properties 
of “Shape” and “Surface Area” are included under Tier 3 of Figure R.7.1-1 (R.7a, pg. 
37). 
4.1.81 R.7.1.1.6 Overall consistency of the physico-chemical profile 
4.1.82 Table R.7.1-5 Summary of use of physico-chemical properties 
4.1.83 It is recommended that the following rows on shape and surface area are inserted at 
the end of Table R.7.1-5 (R.7a, pg. 45): 
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Test Impact on other 
physico-
chemical test 
Impact on toxicology Impact on 
ecotoxicology 
Impact on Risk 
assessment 
Shape   Knowledge of high 
aspect ratio particles 
and surface area may 
inform interpretation of 
some toxicity test 
results. 
 
Shape is an important 
parameter in the 
characterisation of 
nanoparticles, with 
contextual value to the 
assessment of 
deposition, adsorption 
kinetics, and hazard 
assessment in 
biological media.  
  
Surface area  Knowledge of surface 
area may inform 
interpretation of some 
toxicity test results. 
 
  
 
4.1.84 R.7.1.14 GRANULOMETRY 
4.1.85 It is recommended that the addition of the following paragraph as a new first 
paragraph in R.7.1.14 GRANULOMETRY (R.7a, pg. 142) be considered: 
4.1.86 The potential release of particles into the workplace or environment is an 
important consideration in the design and operation of many industrial 
processes and safe handling of substances. Release of particles may present 
a safety hazard and may cause adverse health effects to humans and affect 
the environment. It is therefore important to obtain data about the propensity of 
substances to be released as particles, allowing risks to be evaluated, 
controlled and minimised. Measurement of the release of particles from 
powdered substances has similarities to the conventional measurement of the 
dustiness of a powder, but with significant differences in the methods and 
instrumentations suited to different particle size ranges.  It is worth noting that 
the particle size distribution and the behaviour of the airborne fraction may be 
different to those determined for the powdered substance. 
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4.1.87 In order to bring the current first paragraph of R.7.1.14 GRANULOMETRY (R.7a, pg. 
142) up to date, it is recommended that the substitution of the current text with the 
following updated text: is considered:  
4.1.88 The CEN document, EN 481 “Workplace Atmospheres – size fraction 
definitions for measurement of airborne particles” (CEN 1993) provides 
definitions of the inhalable, thoracic and respirable size fractions, and target 
specifications (conventions) for sampling instruments to measure these 
fractions. This standard defines sampling conventions for particle size fractions 
which are to be used in assessing the possible health effects resulting from 
inhalation of airborne particles in the workplace.  In addition, the following 
recommended documents provide background information and sampling 
guidelines, representing the current state-of-the-art, to effectively characterise 
and monitor exposures in the workplace: 
 Method for Determination of Hazardous Substances MDHS 14/3 
“General methods for sampling and gravimetric analysis of respirable 
and inhalable dust” (HSE, 2000) 
 “Stationary source emissions – Determination of mass concentration of 
particulate matter (dust) at low concentrations – manual gravimetric 
method” (BS ISO 12141:2002) 
 “Stationary source emissions – Manual determination of mass 
concentration of particulate matter” (BS ISO 9096:2003) 
 “Ambient air quality – Standard gravimetric measurement method for the 
determination of the PM2.5 mass fraction of suspended particulate 
matter” (BS ISO 14907:2005) 
 “Workplace atmospheres – Ultrafine, nanoparticle and non-structured 
aerosols – Inhalation exposure characterization and assessment” 
(ISO/TR 27628:2007) 
 “Nanotechnologies – Health and safety practices in occupational 
settings relevant to nanotechnologies” (ISO/TR 12885:2008)  
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4.1.89 The different particle sizes defined in EN 481 are: 
- inhalable fraction (the mass fraction of particles that can be inhaled by 
nose and mouth).  Particles >100 µm are not included in the inhalable 
convention; 
- thoracic fraction (the mass fraction of particles that passes the larynx). It 
has been shown that 50% of the particles in air with an aerodynamic 
diameter of 10 µm belong to the thoracic fraction; 
- respirable fraction (the mass fraction of particles that reaches the 
alveoli).  It has been shown that 50% of particles with an aerodynamic 
diameter of 4 µm belong to the respirable fraction. 
4.1.90 The first sentence of the current third paragraph of R.7.1.14 GRANULOMETRY 
(R.7a, pg. 143) commencing “Methods capable of particle size distribution 
measurement…”  is recommended to be updated with references to the two more 
recent ISO technical reports as follows: 
4.1.91 Methods capable of particle size distribution measurement can determine the 
appropriate fractions as defined in EN481 (CEN 1993), ISO/TR 27628:2007 
and ISO/TR 12885:2008, using the aerodynamic diameter of a particle, which 
is the measure of its behaviour in air, as the basis of the measurement. 
4.1.92 Definition of granulometry 
4.1.93 It is recommended that the current first sentence of R.7.1.14 sub-section “Definition 
of granulometry” (R.7a, pg. 143) - which states “Details of methods for determining 
particle size distribution and for fibre length and diameter distributions are outlined in 
OECD TG 110 and HSE Guidance document on methods for measuring particle size 
distribution (1996)" - is removed from this section and reinserted in R.7.1.14.2 as 
specified below. 
4.1.94 It is recommended that the following definition of Granulometry is included as a new 
first paragraph in R.7.1.14 sub-section “Definition of granulometry” (R.7a, pg. 143): 
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4.1.95 Particle size is a fundamental attribute of disperse materials.  When a group of 
particles are of differing sizes, they may be described by a particle size 
distribution.   Granulometry can be defined as the determination of particle size 
distribution.   
4.1.96 It is recommended that the following sentence is inserted after the last sentence of 
the current second paragraph in R.7.1.14 sub-section “Definition of granulometry” 
(R.7a, pg. 143) ending “…measured in micrometres (=10-6 m)”: 
4.1.97 When a group of particles are of differing sizes, they may then be described by 
a Particle Size Distribution. 
4.1.98 R.7.1.14.1 Information requirements on granulometry 
4.1.99 No change needed. 
4.1.100 R.7.1.14.2 Available information on granulometry 
4.1.101 Testing data on granulometry 
4.1.102 It is recommended that the first paragraph of R.7.1.14.2 sub-section “Testing data on 
granulometry” (R.7a, pg. 144) is amended to the following text: 
4.1.103 The characterisation of particle requires very careful sampling and sample 
fractionation practises to be followed.  ISO 14488:2007 specifies methods for 
obtaining a test aliquot from a defined sample of particulate material (powder, 
paste, suspension or dust) that can be considered to be representative with a 
defined confidence level. Further is available in the Sample Preparation 
section of the Introduction to R.7. 
Many methods are available for particle size measurements, but none of them 
is applicable to the entire size range (see Tables R.7.1-30 to R.7.1-33). 
Multiple techniques should be used where possible in order to formulate a 
complete understanding of the particle properties, and the optimum set of 
required techniques should be selected based on the specific substance and 
form under investigation.  Methods for determining particle size distribution are 
designed to provide information on the transportation and sedimentation of 
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insoluble particles in water and air.  The OECD test guideline applicable to 
measuring the particle size distribution is OECD TG110.  It is important to note 
that Method A of OECD TG 110 (sedimentation, or centrifugation) is not 
considered applicable to nanomaterials (OECD, 2009), as it is useful only in 
the range 2 µm < Rs < 100 µm.  However, alternative standardised equipment 
(e.g. centrifugal sedimentation) can be used in accordance with this method.  
Method B of OECD TG 110 (electron microscopy) requires a necessary but 
minor deviation in the data reporting for nanomaterials (i.e. particles/fibres of 
less than 5 microns in length and less than 100 nm in diameter).  Details of 
methods capable of measuring nanoparticle size distributions are provided in 
ISO/TR 27628:2007 and ISO/TR 12885:2008.   
4.1.104 It is recommended that the last sentence of the current second paragraph of 
R.7.1.14.2 sub-section “Testing data on granulometry” (R.7a, pg. 144) is updated to 
the following: 
4.1.105 They are applicable to water insoluble (i.e. water solubility < 10-6 g/l) 
substances and cover the range ~5nm -100 μm. 
4.1.106 It is recommended that the last sentence of the current third paragraph of R.7.1.14.2 
sub-section “Testing data on granulometry” (R.7a, pg. 144) stating “Fibres of length 
< 5 µm need not be considered.” is removed.  This is on the basis of the 
granulometry guidance being provided to registrants in the context of characterising 
particle/fibre properties as well as informing the likely impact on hazard assessment.  
Disregarding fibres of length < 5 µm is only on the grounds of using data gathered in 
the assessment of a fibre in the context of the WHO (1997) guidelines. 
4.1.107 It is recommended that the first two sentences of the current fourth paragraph of 
R.7.1.14.2 sub-section “Testing data on granulometry” (R.7a, pg. 144) are updated 
to remove reference to shape, as follows: 
4.1.108 Image analysis of particle size can be used to determine the aspect ratios of 
fibrous particles.  Image analysis generates data by capturing direct images of 
each particle. This provides users with the ultimate sensitivity and resolution as 
subtle differences in particle size can be accurately characterised. 
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4.1.109 It is recommended that the last sentence of the current fourth paragraph of 
R.7.1.14.2 sub-section “Testing data on granulometry” (R.7a, pg. 144) and its bullet 
points, are removed as it is duplication of text in the preceding sentences. 
4.1.110 It is recommended that Figure R.7.1-7 Integrated testing strategy for 
granulometry is removed from R.7.1.14.2 and replaced with a new ITS in 
R.7.1.14.5, as specified later. 
4.1.111 It is recommended that the third column of Table R.7.1-30 (R.7a, pg. 146) entitled 
“MMAD” is removed and replaced with a column on “Data type”. 
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4.1.112 It is recommended that the first row of Table R.7.1-30 (R.7a, pg. 146) is amended to the following: 
 
4.1.113 It is therefore recommended that the last row of the current Table R.7.1-30 (R.7a, pg. 146) on “determination of fibre length 
and diameter distributions” by light microscopy is removed. 
Method and details Material and size range Data type 
Optical microscopic examination 
 
It is preferable to prepare samples directly in order not to influence shape and size of the particles. 
 
This method determines distribution of particles of respirable and inhalable size and does not refer to 
airborne dust or dispersed or nebulised particles. 
 
Optical microscopy can be used to examine likelihood of fibres present by comparing similarities to 
known fibrous or fibre releasing substances or other data.  Extreme care required during sample 
preparation to avoid fibre breaking and clumping. Care should also be taken to avoid contamination by 
airborne fibres.  Samples might be prepared by (a) producing suspensions in water by gentle hand 
agitation or vortex mixing or (b) transfer of dry material onto copper tape either directly or by spraying 
of the dry fibres by use of atomiser or pipette. Length and diameter distributions should be measured 
independently at least twice and at least 70 fibres counted. No two values in a given histogram 
interval should differ by > 50% or 3 fibres, whichever is larger. The presence of long thin fibres would 
indicate a need for further, more precise measurements.  This method might be suitable to determine 
the distribution of fibres of respirable and inhalable size. 
 
Particles of all kinds, 
including fibres 
 
Size range: 0.2–5000 µm. 
 
 
 
Fibre diameters as 
small as 0.2 µm and as 
large as 100 µm and 
lengths as small as 5 µm 
and as large as 300 µm 
 
Particle 
size/size 
distribution, 
from which 
mass median 
aerodynamic 
diameter 
(MMAD) can be 
calculated with 
knowledge of 
the particle 
density. 
 
Fibre number 
as defined by 
WHO (1997): 
Aspect ratio > 
3:1, fibre length 
> 5 microns  
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4.1.114 It is recommended that the following additional rows of methods are added to Table R.7.1-30 (R.7a, pg. 146): 
Method and details Material and size range Data type 
 
Transmission Electron Microscopy (TEM)
 
TEM can be used for samples collected from the air or prepared in suspension on a TEM grid, 
including those from separation and sampling instruments. Powder preparation is very easy 
and fast for this method.  TEM enables qualitative assessment of size and form of particles, 
and differentiation between agglomerates and primary particles.  Quantitative determination of 
size distribution of primary particles is achievable in cases where agglomeration is not 
significant. TEM has a very high local resolution (nm) and is capable of imaging lattice planes 
and individual rows of atoms with resolution better than 0.2 nm.  Additions to TEM can provide 
further information e.g. Scanning Transmission Electron Microscopy (STEM), High-Resolution 
TEM (HRTEM) or in-situ measurements using Environmental TEM, which offers the potential 
for dispersed samples to be characterised. 
 
However, TEM is a highly work-intensive method and requires manual preparation of samples.  
Dispersions need to be diluted (to ca. 1%) or prepared into work-intensive cryo-sections.  
Drying samples under vacuum for analysis may alter the size and shape of the particles being 
characterised.  An extremely small area of the sample is analysed, which might not be 
representative enough. The comparatively small share of evaluated particles (ca. 1,000) 
results in limited statistical precision.  Only a two-dimensional projection of particles is visible 
and can be evaluated; and the interpretation of pictures is difficult.  Picture analysis is 
impossible if agglomeration is significant.  Contours of particles may not be clearly resolved in 
some samples.  The quality of the images to be analysed is of critical importance, and care 
must be taken to avoid bias introduced by orientation effects. 
 
Further informative information on this method is available in ISO/TR 27628:2007.  
ISO/13322-1:2004 and ISO/13322-2:2006 provide general guidance for measurement 
description and its validation when determining particle size by static and dynamic image 
analysis, respectively. 
 
Particles in solid, powder and 
suspension form.   
 
Size range: < 0.1 – 10 µm.  
Particularly suitable for the 
particle size range of 1 - 500 nm. 
Particle size/size 
distribution, from 
which 
number/mass 
median diameter 
can be calculated 
with knowledge of 
the particle density. 
 
Scanning Electron Microscopy (SEM)
 
SEM can be used for samples collected from the air or prepared in suspension on a SEM grid, 
Particles in solid, powder and 
suspension form. 
 
Particle size/size 
distribution, from 
which 
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including those from separation and sampling instruments.  Sample preparation is easier than 
for TEM, and only a small quantity of sample needed. Testing possible with undiluted 
dispersions and emulsions.  SEM enables non-destructive testing of samples, and provides an 
image of the sample structure with very precise size determination at high local resolution.  
This method can be used in-situ as Environmental SEM. 
 
A representative sample of the material must be used.  Where samples are not electrically 
conducting, plasma sputter-coating the surface-adhered particles with a layer of a conducting 
material is often required.  This process may modify the sample being characterised.  Only a 
small section of the sample is pictured and imaging is limited to surface features.  The quality 
of the images to be analysed is of critical importance, and care must be taken to avoid bias 
introduced by orientation effects. 
 
Further informative information on this method is available in ISO/TR 27628:2007.  
ISO/13322-1:2004 and ISO/13322-2:2006 provide general guidance for measurement 
description and its validation when determining particle size by static and dynamic image 
analysis, respectively. 
 
Size range: < 0.01 – 10 µm.  
Particularly suitable for the 
particle size range of 10 nm – 1 
µm. 
 
 
number/mass 
median diameter 
can be calculated 
with knowledge of 
the particle density. 
 
Centrifugal Sedimentation (ISO 13318-1:2001; ISO 13318-2:2007; ISO 13318-3:2004) 
 
Measures the particle size distribution of particulate materials dispersed in a liquid by 
fractionation. Centrifugal sedimentation methods are based on the rate of settling, under a 
centrifugal field, of particles in a liquid.  The relationship between settling velocity and particle 
size reduces to the Stokes equation at low Reynolds numbers.  Thus, the calculation of 
particle size using this method is dependent on Stokes law.  This technique can be used to 
supply data in accordance with Method A of OECD TG 110. 
 
When using optical turbidity detection, the measuring range depends on the density of the 
material, the viscosity of the medium and the number of revolutions of the centrifuge.  High 
absolute precision of particle size through calibration with a particle standard, and high 
resolution compared with other methods.  A small quantity of sample is sufficient.  This 
method involves fewer artefacts and possible errors than integral methods (e.g. light 
scattering), which measure all fractions together without separation.  However, the measuring 
concentration is very low and therefore significant dilution is necessary.  The potential for 
agglomeration must be considered, and the suspension / emulsion must be stable for 
analysis.  A sedimentation liquid suitable for the sample must be determined, in which a 
density gradient can be established for measuring.  The measuring time for samples with 
Particulate materials dispersed in 
a liquid 
 
Size range: 0.1 to 5 µm 
 
Settling velocity (m 
s-1), from which 
particle size can be 
calculated based 
on Stokes law. 
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small particles is long.  For evaluation, the density and optical constants of particles must be 
known.  Evaluation of a fine fraction in a wide distribution can be critical. 
 
When using x-ray detection, the measuring range depends on the density of material. 
Implementation and evaluation is simple, without the need for calibration, gradients, mie 
correction or optical information.  A high resolution of distribution spectra is possible, and only 
a small quantity of sample is required.  This method provides good statistics, with 1010 
particles assessed in one measuring activity.  However, dilution to ~ 5% necessary and, for 
evaluation, the density of particles must be known.  
 
Ultrasonic spectroscopy (ISO/20998-1:2006)
 
Allows determination of the size distribution of one or more material phases dispersed in a 
liquid. Measurements can be made for concentrations of the dispersed phase ranging from 
0.1-50% by volume.  Enables dynamic changes in the size distribution to be monitored, 
including agglomeration or flocculation in a concentrated system.   
 
However, this method is air- and temperature-sensitive.  Parameter adjustment is complex. 
Measurement results may vary with different vol%. 
 
Particles in colloids, dispersions 
and emulsions 
 
Size range: 10 nm - 3 mm 
 
Attenuation 
spectrum, from 
which the particle 
size distribution 
based on 
mass/number can 
be extracted via a 
model (which may 
be empirical or 
based on first 
principles) 
Small Angle X-ray Scattering (SAXS) (ISO/TS 13762:2001) 
 
Allows determination of the particle size distribution of ultra-fine powders and suspensions.  
The requirement for particle dispersion of the sample is not as strict as for other methods. 
 
SAXS cannot distinguish pores from particles and therefore cannot be used for powders 
consisting of porous particles. This method assumes that particles are isotropic and 
spherically shaped, and thus has limited applicability to powders containing particles whose 
morphology is far from spherical e.g. non-spherical nano-objects such as carbon nanotubes. 
In addition, due to the need for a concentrated sample, an interference effect between 
particles may arise. 
 
Particles in powder and 
suspension form 
 
Size range: 1-300 nm 
Average particle 
size for a sample, 
estimated by 
mathematical 
adaption of a 
diffractogram. 
X-ray diffraction (XRD) (BS EN 13925-1, BS EN 13925-2 and BS EN 13925-3) 
 
XRD estimates the average particle size by mathematical adaptation of a simulated 
diffractogram to real measurement. Enables crystallinity to be quantified with high statistical 
Single crystal or polycrystalline 
materials 
 
Crystallite size range: ~1-100 nm 
Average particle 
size for a sample, 
estimated by 
mathematical 
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relevance, and avoids the need for representative sampling. 
 
Crystal structures of existing phases and equipment- and sample-specific parameters must be 
known.  It is important to note that particle size does not equal crystallite size.  Other factors 
can also influence the peak width, such as microstrain, lattice defects and temperature factors.  
Larger crystalline samples (>1mg) are required for analysis. 
adaption of a 
diffractogram. 
Dynamic Light Scattering (DLS)/Photon Correlation Spectroscopy (PCS) 
(ISO/22412:2008; ISO/13321:1996; ASTM E2490 – 09) 
 
Enables rapid and simple estimation of an average particle size and measurement of the 
broadness of the size distribution of sub micrometre-sized particles or droplets dispersed in 
liquids.  For nanoparticles in suspension, DLS/PCS is one of the most commonly employed 
techniques providing in situ characterisation of size and size distribution and is often applied 
with zeta potential measurements to provide an indication of the particle suspension stability 
with respect to time and medium.  Only a small quantity of sample is needed, and in the 
particle size range < 100 nm, no refractive indices are necessary.  DLS/PCS is of particular 
benefit to toxicity assessment as it measures size in solutions that more accurately resemble 
the exposure conditions. An extension of this technique for high concentration opaque 
suspensions is Photon Cross Correlation Spectroscopy (PCCS), which provides particle size 
and stability of nanoparticle suspensions. 
 
However, extensive sample dilution is necessary.  This method is of limited use when particles 
are difficult to maintain in a dispersed state or when particles of > 2 µm in size are present. 
This method is temperature sensitive and only enables low resolution.  Optical parameters 
must be known for data analysis, and this method is not suitable for particles with different 
optical properties. 
 
It is noted that Dynamic Light Scattering (DLS) does not provide a full particle size distribution. 
DLS measures fluctuations in the intensity of scattered light caused by Brownian motion, from 
which the hydrodynamic diameter is calculated, enabling estimation of the particle size 
distribution.  Thus, even though DLS does not measure particle size distribution directly, this 
method provides a good background for the estimation of the full particle size distribution.  The 
method also provides a number (the ‘polydispersity index’) indicating the polydispersity of the 
particle population. There are several software routines that facilitate the calculation of a 
particle size distribution from DLS data, but the adequacy and the comparability of these 
routines needs to be further evaluated (Lövestam et al., 2010).  
Particles or droplets dispersed in 
liquids 
 
Size range: 1 - 1000 nm 
Size distribution 
based on 
mass/number. 
Average particle 
size and 
polydispersity index 
(dimensionless; 
measure of 
broadness of the 
size distribution). 
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4.1.115 It is recommended that the text under the current Table R.7.1-30 (R.7a, pg. 147) is 
amended to the following: 
4.1.116 Using the methods listed in Tables R.7.1-30 to R.7.1-33, the following 
information should be presented (as appropriate): 
 Sample preparation methods and analysis methods used 
 Lot number, sample number 
 Suspending medium, temperature, pH 
 Concentration (relevant to particles or fibres) 
 Representative image(s) from microscopy 
 Particle size distribution histogram from the applied measurement 
technique 
 Average particle size(s) for resolvable peaks in the distribution, as mass, 
number and surface area per unit volume as appropriate 
 Expected % change of reported values in the future (e.g. variations 
between production batches) 
 Reference all Standards (e.g. ISO) and reference materials used. 
4.1.117 It is recommended that the following paragraph is inserted after the bullet point list in 
the text under the current Table R.7.1-30 (R.7a, pg. 147): 
4.1.118 Rules for the graphical representation of particle size analysis data in 
histograms, density distributions and cumulative distributions are specified in 
ISO 9276-1:1998.  It also establishes a standard nomenclature to be followed 
to obtain the distributions mentioned above from the measured data. In a 
graphical representation of particle size analysis data, the independent 
variable, i.e. the physical property chosen to characterise the size of the 
particles, is plotted on the abscissa (x-axis). The dependent variable, which 
characterises the measure and type of quantity (e.g. number, mass) is plotted 
on the ordinate (y-axis).  ISO 9276-2:2001 provides the relevant equations for 
the calculation of average particle sizes or average particle diameters and 
moments from a given particle size distribution. It is assumed that the size 
distribution is available as a histogram. It is nevertheless also possible to apply 
the same mathematical treatment if the particle size distribution is represented 
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by an analytical function.  It is furthermore assumed in ISO 9276-2:2001 that 
the particle size of a particle of any other shape may also be represented by 
the diameter of an equivalent sphere, e.g. a sphere having the same volume 
as the particle concerned. 
4.1.119 It is recommended that the paragraph starting “It is advantageous to have accurate 
information…” in the text under the current Table R.7.1-30 (R.7a, pg. 147) is updated 
to the following: 
4.1.120 It is advantageous to have accurate information about the propensity of 
materials to produce particulate aerosol (including the dustiness of the 
material).  No single method of dustiness testing is likely to represent and 
reproduce the various types of processing and handling used in industry. The 
measurement of dustiness depends on the test apparatus used, the properties 
of the dust and various environmental variables.  The measurand of dustiness 
is the ratio of the inhalable dust produced by the dustiness test procedure, in 
milligrams, to the test mass of material used for the test, in kilograms. There 
are a number of methods for measuring the dustiness of bulk (non-nanoscale) 
materials, based on the biologically relevant aerosol fractions defined in EN 
481. Two methods (the rotating drum method and the continuous drop method) 
are detailed in EN 15051 “Workplace atmospheres – Measurement of the 
dustiness of bulk materials – Requirements and reference test methods” (CEN, 
2006). 
The two methods in EN 15051, however, provide quite different results. A 
recent comparison of dustiness results for a range of minerals based on the 
two methods revealed a difference in classification for the respirable fraction 
for 50% of the tested materials. Considering the inhalable fraction, 
classification was different for 60% of the tested materials. There was no trend 
in the data. Consequently, a recommendation has been given within CEN to 
revise the standard. It is recommended to take the above information into 
account if results derived from these methods are intended to be used for 
classification and labelling purposes. However, an order of relative dustiness 
could be achieved by applying the same method to a range of materials. 
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The particle size distribution of a dust cloud may be different from the powder 
source. Studies on dust generation by free falling powders have demonstrated 
that the manner in which the powder is handled may be as important as the 
dust generating capacity of the material, in terms of the resulting exposure 
(e.g. Heitbrink et al., 1992). Falling height has an important influence on dust 
generation and release for more than one reason. The higher the impact, the 
more dissemination of dust there is. Moreover, the greater the falling height, 
the greater flow of entrained air, which favours dust dissemination. This shows 
the importance of process design and adequate work practices. 
There have been many interesting studies on material flow which demonstrate 
that the influence of the various factors is not so obvious. For example, it is 
sometimes erroneously assumed that a powdered material with a larger 
proportion of coarse particles offers less dust hazard; however, a higher 
proportion of coarse particles in the material may actually increase dustiness 
due to a decrease in the cohesion of the material as the proportion of coarse 
particles increases (Upton et al., 1990), and also due to the agitation of the fine 
particles as there are more collisions with large particles. The higher the 
impact between particles, the more dissemination of dust there is. 
The aerosolisation/sampling methods in Table R.7.1-31 are used in the 
determination of the distribution of respirable particles and (to a lesser extent) 
the distribution of inhalable particles. These methods generate aerosol test 
atmospheres and require coupled particle detection instrumentation.  
The particle detection methods in Table R.7.1-33 can be used to characterise 
the distribution of aerosolised particles.  These methods are preferred since 
they measure particles in the air and as such the mass median aerodynamic 
diameter (MMAD) and geometric standard deviation (GSD), but are subject to 
limitations.  All particle size instrumentation have ranges of particle size limited 
by the principle of operation. This is almost two decades. Therefore more than 
one type of instrument is often used with overlapping size ranges. Often 
depending on the material, these size distributions may not match exactly, 
because different measuring principles deliver different equivalent diameters. 
Moreover, the lower sizes of 1nm to 3 nm cannot be accurately measured in 
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aerosol measurement instrumentation because of diffusion losses in tubes or 
at the inlet of the instruments. Depending on the number based particle size 
distribution the particle number concentration will be determined too low and 
particle counters with different valid lower size limit will give different particle 
number concentrations.  Aerosolisation of substances for particle size 
distribution characterisation also results in a degree of artificiality if the 
engineering set-up introduces an upper limit on the aerosol size as a result of 
the operational conditions (e.g. flow rate and exit orifice).  The upper size limit 
can be predicted using Stoke’s equation. Other methods that measure 
inhalable fractions only or that give no detailed distributions are detailed in 
Table R.7.1-32. 
4.1.121 It is recommended that the last sentence of the current first paragraph on pg. 148 
(R.7a) stating “These methods are only applied if light microscopic examination 
indicates likelihood that fibres are present.” is removed. 
4.1.122 It is recommended that the title of Table R.7.1-31 (R.7a, pg. 149) is modified to 
“Methods to generate/sample airborne dispersed or nebulised particles”.   
4.1.123 It is recommended that cascade impaction, rotating drum method and continuous 
drop method are retained in Table R.7.1-31 and light scattering/diffraction is moved 
to a new table R.7.1-33 entitled “Methods of measuring airborne dispersed or 
nebulised particles”. 
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4.1.124 It is recommended that Table R.7.1-31 (R.7a, pg. 149) is moved to directly below Table R.7.1-30 and updated as follows: 
Method and details Material and size range Data type 
Cascade impaction 
 
Cascade impactors can be used to obtain the size distribution of an aerosol (or a dust cloud). Air 
samples are drawn through a device which consists of several stages on which particles are 
deposited on glass or glass fibre. Particles will impact on a certain stage depending on their 
size. The cut off size can be calculated from the jet velocities at each stage by weighing each 
stage before and after sampling and the MMAD derived from these calculations. 
 
A well established technique to measure the distribution of particles of respirable or inhalable 
size. However, cascade impaction may fail to describe the dimension of high aspect ratio 
nanoparticles when they no longer follow aerodynamic rules (Ma-Hock et al., 2007).  
Conventional cascade impactors will have size selective stages limited to the capture of 
particles greater than ~250 nm.  This is a sampling method and also requires aerosolisation. 
 
ISO/TR 27628:2007 provides an informative description. 
 
Particles in an aerosol 
 
Size range: 0.1-20 µm and 
0.5-80 µm 
 
MMAD can be 
determined via an 
appropriate 
coupled analytical 
technique. 
 
Electrical Low Pressure Impactor (ELPI) 
 
ELPI is a type of cascade impactor that combines inertial collection with electrical particle 
detection to provide near-real-time aerosol size distributions for particles larger than 7 nm in 
diameter.  Aerosol particles are charged in a unipolar ion charger before being sampled by a 
cascade impactor.  The upper size limit of the instrument is 10 µm, but in practice reliable data 
can be obtained only up to about 2.5 µm due to significant losses at larger particle sizes.  
Collected aerosol particles are available for offline analysis, but this is also a limitation as it does 
not provide a direct measurement. It does however enable a range of off-line analytical methods 
to be used with samples, including electron microscopy and chemical speciation.  ELPI has 
useful application in relation to exposure estimation. 
 
Data from the lowest stage have relatively large uncertainty due to losses and uncertainties of 
the true size channel width. 
 
ISO/TR 27628:2007 provides an informative description. 
 
Particles in an aerosol 
 
Size range: 7 nm – 10 µm 
MMAD can be 
determined via an 
appropriate 
coupled analytical 
technique. 
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Rotating drum method (EN 15051)
 
This method is based on size selective sampling of an airborne dust cloud produced by the 
repeated lifting and dropping of a material in a rotating drum. 
Air drawn through the drum passes through a specially designed outlet and a 3-stage 
fractionating system consisting of two porous polyurethane foams and a membrane filter. The 
mass of dust collected on each collection stage is determined gravimetrically to give a direct 
measure of the biologically relevant size fractions. This method simulates a wide range of 
material handling processes in industry and determines the biologically relevant size functions of 
a material in the airborne state. Full size distributions can be obtained by analysing the contents 
on the dust collection stages. 
 
This method is suitable to determine the distribution of particles of respirable or inhalable size. 
Rotating drum dustiness tests are usually performed as three replicate tests and need quite 
large amounts of test material, typically 300–600 g. It has been highlighted that such large 
amounts of test material may not be practical if very toxic and/or costly materials are to be 
tested and there is a need for test systems that can be operated under controlled atmospheric 
environments using much smaller amounts of material (Schneider & Jensen, 2008). 
 
Dry 
powders/granulates/friable 
products 
 
Size range: 0.5-10,000 µm 
 
MMAD can be 
determined via an 
appropriate 
coupled analytical 
technique. 
 
Continuous drop method (EN 15051) 
 
This method is based on the size selective sampling of an airborne dust cloud produced by the 
continuous single dropping of material in a slow vertical air current. The dust released by 
dropping material is conducted by the airflow to a sampling section where it is separated into the 
inhalable and respirable fractions. 
 
This method is suitable to determine the distribution of particles of respirable or inhalable size.  
The continuous single-drop method requires a total amount of 500 g for the required five single-
test runs. It has been highlighted that such large amounts of test material may not be practical if 
very toxic and/or costly materials are to be tested and there is a need for test systems that can 
be operated under controlled atmospheric environments using much smaller amounts of 
material (Schneider & Jensen, 2008). 
Dry 
powders/granulates/friable 
products 
 
Size range: 0.5-10,000 µm 
 
MMAD can be 
determined via an 
appropriate 
coupled analytical 
technique. 
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4.1.125 It is recommended that a new Table R.7.1-33 entitled “Methods of measuring airborne dispersed or nebulised particles” is 
inserted directly after Table R.7.1-32 (R.7a, pg.150), with content as follows (N.B. This has implications for the numbering of 
Tables in the rest of R.7.1.) 
Method and details Material and size range Data type 
Scanning Mobility Particle Sizer (SMPS) (ISO 15900:2009; ISO 10808:2010; ISO 28439:2011) 
 
SMPS operates by charging particles and fractionating them based on their mobility when passing 
between electrodes. This method combines a Differential Mobility Analyser (DMA) and an Optical 
Particle Counter (OPC).  SMPS detects and counts nanoparticles, and enables measurement of 
the particle size distribution and count median diameter of nano aerosols, up to 108 particles /cm³.  
This method also allows evaluation of nanoparticle surface area, mass dose, composition and 
dispersion to support effective analysis of inhalation toxicity testing results.  SMPS also has useful 
application in relation to exposure estimation. 
 
Measurement with SMPS is the only currently available method that meets all of the following 
requirements in the size range below 100 nm: i) measurement of particle size distribution during 
particle exposures in a continuous manner with time resolution appropriate to check stability of 
particle size distribution and concentration; ii) measurement range of particle sizes and 
concentrations covers those of the nanoparticle aerosols exposed to the test system during the 
toxicity test; iii) particle size and concentration measurements are sufficiently accurate for 
nanoparticle toxicity testing and can be validated by ways such as calibration against appropriate 
reference standards; iv) resolution of particle sizing is sufficiently accurate to allow conversion 
from number-weighted distribution to surface area-weighted or volume-weighted distribution.  
 
However, SMPS is relatively slow and requires a scanning approach to measure different size 
intervals in series.  This method is restricted to ambient temperatures below 35 °C (due to 
evaporation of butanol in the CPC) and requires aerosolisation of the sample. SMPS cannot 
distinguish between agglomerates and primary particles.  For non-spherical particles (e.g. HARN), 
estimation of diameter and mass concentration by SMPS can result in significant error.  
Assembling data of measurements from SPMS and OPC to provide a whole picture of particle size 
distribution is not appropriate, due to the different principles employed by the two methods (Ma-
Hock et al., 2007).  It is important to know the stability of the source, since rapid changes of the 
size distribution, particle concentration, or both, can affect measurement of the size distribution. 
This is relevant to consider for nanomaterials, which have a high tendency to agglomerate in the 
Particles in an aerosol 
 
Size range: ~3 – 800 nm 
Size distribution 
based on number 
counted (number 
count per size 
interval).  From the 
distribution, MMAD 
can be calculated, 
with knowledge of 
the density of the 
particles. 
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atmosphere. 
Fast Mobility Particle Sizer (FMPS) 
 
FMPS enables determination of the size distribution of sub-micrometer aerosol particles, up to 107 
particles / cm³ (depending on particle size).  Measurements can be made with a time resolution of 
one second or less, enabling visualisation of particle size distributions in real time.  However, 
FMPS is typically less sensitive than the SMPS at low particle concentrations.  
 
Particles in an aerosol 
 
Size range: ~5 - 560 nm 
Size distribution 
based on number 
counted (number 
count per size 
interval).  From the 
distribution, MMAD 
can be calculated, 
with knowledge of 
the density of the 
particles. 
Diffusion batteries 
 
The operation of diffusion batteries is based on the Brownian motion of the aerosol particles. 
Depositional losses through diffusion are a function of particle diameter.  By measuring diffusion-
based deposition rates through systems with varying geometries, it is possible to determine 
particle size distribution. The deposition systems are usually placed together in series to form a 
diffusion battery.  The diffusion battery can be designed for determination of particle sizes as low 
as 2 nm depending upon instrument setup.  This method has useful application in relation to 
exposure estimation. 
 
The primary property measured is the diffusion coefficient of the particles and this has to be 
converted to particle diameter.  The instrument needs to be operated with a particle counter 
(typically a continuous flow Condensation Particle Counter) in order to determine the number 
concentration before and after each diffusion stage.  Inversion of the raw data to real size 
distribution is complex and the solutions of the equations do not give unambiguous results in the 
case of polydisperse aerosol size distributions. 
 
ISO/TR 27628:2007 provides an informative description of this method. 
 
Particles in an aerosol 
 
Size range: 0.005 – 0.1 µm 
Particle number in 
intervals according 
to diffusion 
diameter, from 
which the median 
diffusion diameter 
can be determined 
with knowledge of 
the density of the 
particles. 
Optical Particle Counter (OPC) 
 
OPC is a widely used method for detecting and counting aerosolised particles, and operates 
across a wide temperature range (0 – 120 °C).  Enables agglomerates/aggregates of primary 
particles to be measured and counted. OPC has useful application in relation to exposure 
estimation. 
 
Particles in an aerosol 
 
Size range: 0.3 – 17 µm 
Particle number 
concentration 
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However, OPC is insensitive to particles smaller than approximately 100-300 nm in diameter and 
provides insufficient coverage of potential primary particle.  Assembling data of measurements 
from SPMS and OPC to provide a whole picture of particle size distribution is not appropriate, due 
to the different principles employed by the two methods (Ma-Hock et al., 2007). 
 
ISO/TR 27628:2007 provides an informative description of this method. 
 
Laser scattering/diffraction 
 
In general, the scattering of the incident light gives distinct pattern which are measured by a 
detector. This technique is particle property dependent – i.e. material has unique scattering and 
diffraction properties which are also particle size dependent. It is important to calibrate the 
instrument with similar material (of the same size range as the material to be measured). Laser 
scattering techniques are suitable for geometric particles, viz spheres, cubes and monocrystals. 
Particle size will be established optically. The MMAD can be calculated by means of a calculation 
correction. 
 
The method is suitable to determine the distribution of particles of respirable and inhalable size. 
Laser diffraction assumes a spherical particle shape.  Test products should therefore have no 
extreme aspect ratios, with a restriction of 1:3 for non-spherical particles.  This method has limited 
applicability really suitable in the sub-100 nm range.   In the range below several microns, results 
strongly depend on optical constants of particles. 
 
Particles of all kind 
 
Size range: 0.06-100 µm 
 
Particle size/size 
distribution*, from 
which mass median 
diameter can be 
calculated, with 
knowledge of the 
density of the 
particles.  
Light scattering aerosol spectrometer (LSAS) 
 
LSAS is a type of light scattering instrument, applicable for measuring the size, number 
concentration and number/size distribution of particles suspended in a gas.  LSAS can be used for 
the determination of the particle size distribution and particle number concentration at relatively 
high concentrations of up to 1011 particles/m3. 
 
The large measurement range of LSAS may result in high uncertainty in nanoscale 
measurements.  Measurements may be dependent on the reflectivity of particles. Laser diffraction 
assumes a spherical particle shape.  Test products should therefore have no extreme aspect 
ratios, with a restriction of 1:3 for non-spherical particles.  This method has limited applicability 
really suitable in the sub-100 nm range.  In the range below several microns, results strongly 
depend on optical constants of particles. 
 
Particles in an aerosol 
 
Size range: 0.06 - 45 µm 
Particle size/size 
distribution*, from 
which mass median 
diameter can be 
calculated, with 
knowledge of the 
density of the 
particles. 
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4.1.126 It is recommended that the bullet point list in the text under the current Table R.7.1-
31 (R.7a, pg. 150) is removed, as this has been combined with the updates 
suggested earlier which is relevant to all tables of methods. 
4.1.127 It is recommended that Table R.7.1-32 “Methods that measure inhalable fractions 
only or that give no detailed distributions” (R.7a, pg. 151) is moved to directly below 
Table R.7.1-31.   
4.1.128 It is recommended that the sub-section on “Reference substances” directly after the 
current Table R.7.1-32 (R.7a, pg. 151) is removed, as this is now sufficiently 
covered in R7.1.1.3 sub-section on "Experimental data" (R.7a, pg. 27) following 
earlier proposed updates. 
4.1.129 R.7.1.14.2 Available information on granulometry 
4.1.130 Published data on granulometry 
4.1.131 It is recommended that current text in R.7.1.14.2 sub-section “Published data on 
granulometry” (R.7a, pg. 152) is updated to the following: 
4.1.132 Particle size measurements have been published in the peer-reviewed 
literature.  No electronic databases that are specific to particle size data could 
be found at the time of publication. 
4.1.133 R.7.1.14.3 Evaluation of available information on granulometry 
4.1.134 It is recommended that the first sentence of the first paragraph of R.7.1.14.3 
Evaluation of available information on granulometry (R.7a, pg. 152) is updated to the 
following: 
4.1.135 The particle size distribution characterisation is carried out on the material 
under investigation and, where appropriate, on the airborne dust. 
4.1.136 It is recommended that the second sentence of the first paragraph of R.7.1.14.3 
Evaluation of available information on granulometry (R.7a, pg. 152) is updated to the 
following: 
4.1.137 It is important to note that the original particle size distribution is highly 
dependent on the industrial processing methods used and care should be 
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taken to ensure that the measurement and assessment activity considers any 
changes to the particle size distribution by subsequent environmental or 
human transformations. 
4.1.138 The asterisk within the fourth sentence starting “Great care should be taken on*…” 
should be removed as it does not link to any information. 
4.1.139 The first sentence of the second paragraph of R.7.1.14.3 Evaluation of available 
information on granulometry (R.7a, pg. 152) is recommended to be updated to:  
4.1.140 Methods which determine the particle size distribution and MMAD need the 
generation of representative test atmospheres using suitable generation 
equipment and correct sampling techniques. 
4.1.141 Experimental data on granulometry 
4.1.142 No change required.  
4.1.143 Non-experimental data on granulometry 
4.1.144 No change required.  
4.1.145 Remaining uncertainty on granulometry 
4.1.146 The last sentence of the first paragraph of R.7.1.14.3 Evaluation of available 
information on granulometry sub-section “Remaining uncertainty on granulometry” 
(R.7a, pg. 152) is recommended to be updated to:  
4.1.147 The effect of impurities should be considered when measuring fibre length and 
particle size distributions. 
4.1.148 It is recommended that the following paragraph is inserted at the end of the current 
R.7.1.14.3 Evaluation of available information on granulometry sub-section 
“Remaining uncertainty on granulometry” (R.7a, pg. 152): 
4.1.149 Aerosolisation of substances for particle size distribution characterisation also 
results in a degree of artificiality if the engineering set-up introduces an upper 
limit on the aerosol size as a result of the operational conditions (e.g. flow rate 
and exit orifice).  The upper size limit can be predicted using Stoke’s equation. 
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4.1.150 R.7.1.14.4 Conclusions on granulometry 
4.1.151 It is recommended that the current text in section R.7.1.14.4 Conclusions on 
granulometry (R.7a, pg. 153) is updated to the following: 
4.1.152 The potential release of particles into the workplace or environment is an 
important consideration in the design and operation of many industrial 
processes and safe handling of substances. Release of particles may present 
a safety hazard and could cause adverse health effects to humans and affect 
the environment. It is therefore important to obtain data about the propensity 
of substances to be released as particles or fibres, allowing risks to be 
evaluated, controlled and minimised. Measurement of the release of particles 
from powdered substances has similarities to the conventional measurement 
of the dustiness of a powder, but with significant differences in the methods 
and instrumentations suited to different particle size ranges.   
In addition, the particle size distribution is needed to inform the decision 
regarding which route of administration is most appropriate for the acute 
toxicity and 28-day base set animal studies. A number of methods are 
provided for determining the particle size fractions which are then used to 
assess the possible health effects resulting from inhalation of airborne 
particles in the workplace. A number of methods covering different ranges of 
particle sizes are available though none of them is applicable to the entire size 
range. Multiple techniques should be used where possible in order to 
formulate a complete understanding of the particle properties, and the 
optimum set of required techniques should be selected based on the specific 
substance and form under investigation. 
4.1.153 R.7.1.14.5 Integrated testing strategy (ITS) for granulometry 
4.1.154 Figure R.7.1-7 Integrated Testing Strategy for Granulometry 
4.1.155 It is recommended that the current Figure R.7.1-7 Integrated testing strategy for 
granulometry (R.7a, pg. 145) is deleted and replaced with the following Figure, 
which has been developed to be consistent with the recommendations for updated 
Guidance text for Granulometry: 
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Representatively sample aliquots of 
material from the substance.
Reproducibly and representatively 
characterise the dustiness and/or 
granulometry of the aerosolised sample.
Reproducibly and representatively 
characterise the granulometry of a surface-
deposited sample.
Select microscopy technique(s) / 
instrument(s), including consideration 
of suitability for the size range of 
particles/fibres under test.  Appropriate 
instruments / techniques are outlined in 
Table R.7.1-30.
Validate technique/instrument 
response using reference 
materials, if required.
Select sampling technique(s),
including consideration of 
suitability for particles/fibres of the 
substance under test.
Select dustiness / dispersion / 
aersolisation method, as required, 
including consideration of the suitability 
of the method for the particles/fibres of 
the substance under test.
Appropriate technique(s) are outlined in 
Table R.7.1-31 and R.7.1-32.  
Data reporting should provide:
- Sample preparation methods and analysis methods used
- Lot number, sample number
- Suspending medium, temperature, pH
- Concentration (relevant to particles or fibres)
- Representative image(s) from microscopy
- Particle size distribution histogram of Stoke’s (effective hydrodynamic) radius Rs
- Average particle size(s) for resolvable peaks in the distribution, as mass, number and surface 
area per unit volume as appropriate
- Expected % change of reported values in the future (e.g. variations between production batches)
- Reference all Standards (e.g. ISO) and reference materials used
Integrate the dustiness and/or granulometry data with the selection of 
appropriate hazard testing and exposure assessment modelling.  
Dustiness testing and/or the 
determination of additional 
granulometry data of an aersolised
form of the substance is required.
Is there a potential for 
particles/fibres of an inhalable size 
(<100 μm) to be released and 
present an inhalation exposure risk?
Select particle size distributuon
measurement techniques(s) / 
instrument(s), including 
consideration of the suitability for 
the particles under test.
Appropriate technique(s) are 
outlined in Table R.7.1-33.
Validate measurement instrument 
response using reference 
materials, if required.
No
Yes
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4.1.156 Examples and case studies on granulometry  
4.1.157 With regard to the examples and case studies on granulometry in the current 
guidance (R.7.1.14.5), a more appropriate description of the issues and typical data 
from granulometry should be developed, which will be dependant upon the accepted 
composition of the granulometry Information Requirement (i.e. whether shape and 
surface area are sub-ordinate to granulometry or included as additional relevant 
specific intrinsic properties).  At this time it is recommended that current text is 
removed. 
4.1.158 Suitable text for inclusion in this section can be developed for nanomaterials from 
the detailed work undertaken in the RIP-oN2 project.  However, this needs to be 
accompanied by other text on non-nano materials before recommending update to 
guidance, which is out with the remit of the RIP-oN2 project. 
4.1.159 R.7.1.14.6 References on granulometry 
4.1.160 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.1.14.6 (R.7a, pg. 154): 
4.1.161 ASTM E2490 – 09. “Standard Guide for Measurement of Particle Size 
Distribution of Nanomaterials in Suspension by Photon Correlation 
Spectroscopy (PCS)”, ASTM. 
4.1.162 BS EN 13925-1:2003. “Non-destructive testing. X-ray diffraction from 
polycrystalline and amorphous materials. General principles”, BSI, WEE/46. 
4.1.163 BS EN 13925-2:2003. “Non-destructive testing. X-ray diffraction from 
polycrystalline and amorphous materials. Procedures”, BSI, WEE/46. 
4.1.164 BS EN 13925-3:2005. “Non-destructive testing. X-ray diffraction from 
polycrystalline and amorphous materials. Instruments”, BSI, WEE/46. 
4.1.165 ISO 9276-1:1998. “Representation of results of particle size analysis -- Part 1: 
Graphical representation”, ISO TC 24/ SC 4. 
4.1.166 ISO 9276-2:2001. “Representation of results of particle size analysis -- Part 2: 
Calculation of average particle sizes/diameters and moments from particle 
size distributions”, ISO TC 24/ SC 4.. 
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4.1.167 ISO 10808:2010. “Nanotechnologies -- Characterization of nanoparticles in 
inhalation exposure chambers for inhalation toxicity testing”, ISO TC 229. 
4.1.168 ISO/TR 12885:2008. “Nanotechnologies – Health and safety practices in 
occupational settings relevant to nanotechnologies” 
4.1.169 ISO 13318-1:2001. “Determination of particle size distribution by centrifugal 
liquid sedimentation methods -- Part 1: General principles and guidelines” ISO 
TC 24/SC 4 
4.1.170 ISO 13318-2:2007. “Determination of particle size distribution by centrifugal 
liquid sedimentation methods -- Part 2: Photocentrifuge method”, ISO TC 
24/SC 4 
4.1.171 ISO 13318-3:2004. “Determination of particle size distribution by centrifugal 
liquid sedimentation methods -- Part 3: Centrifugal X-ray method”, ISO TC 
24/SC 4 
4.1.172 ISO 13321:1996. “Particle size analysis -- Photon correlation spectroscopy”, 
ISO TC 24/ SC 4.  
4.1.173 ISO 13322-1:2004. “Particle size analysis -- Image analysis methods -- Part 1: 
Static image analysis methods”, ISO TC 24/ SC 4.  
4.1.174 ISO 13322-2:2006. “Particle size analysis -- Image analysis methods -- Part 2: 
Dynamic image analysis methods” ISO TC 24/ SC 4. 
4.1.175 ISO TS 13762:2001. “Particle size analysis -- Small angle X-ray scattering 
method”, ISO TC 24/ SC 4. 
4.1.176 ISO 15900:2009. “Determination of particle size distribution -- Differential 
electrical mobility analysis for aerosol particles”, ISO TC 24/SC 4. 
4.1.177 ISO 20998-1:2006. “Measurement and characterization of particles by 
acoustic methods -- Part 1: Concepts and procedures in ultrasonic attenuation 
spectroscopy” ISO TC 24/ SC4.  
4.1.178 ISO 22412:2008. “Particle size analysis -- Dynamic light scattering (DLS)”, 
ISO TC 24/ SC4. 
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4.1.179 ISO/TR 27628:2007 “Workplace atmospheres – Ultrafine, nanoparticle and 
non-structured aerosols – Inhalation exposure characterization and 
assessment”, ISO TD 146/SC 2. 
4.1.180 ISO 28439:2011. “Workplace atmospheres -- Characterization of ultrafine 
aerosols/nanoaerosols -- Determination of the size distribution and number 
concentration using differential electrical mobility analysing systems”, ISO TC 
146/SC 2. 
4.1.181 Lövestam, G., Rauscher, H., Roebben, G., Sokull Kluttgen, B., Gibson, N., 
Putaud, J.-P. & Stamm, H. 2010, "Considerations on a definition of 
nanomaterial for regulatory purposes", JRC Reference Reports, Joint 
Research Centre, European Commission. 
4.1.182 Ma-Hock, L., Gamer, A., Landsiedel, R., Leibold, E., Frechen, T., Sens, B., 
Huber, G., van Ravenzwaay, B. 2007, "Generation and Characterization of 
Test Atmospheres with Nanomaterials," Inhalation Toxicology, 19(10), pp. 
833-848. 
4.1.183 OECD. 2009, "Preliminary Review of OECD Test Guidelines for their 
Applicability to Manufactured Nanomaterials", Series on the safety of 
manufactured nanomaterials, ENV/JM/MONO(2009)21, Paris. 
4.1.184 Schneider, T. & Jensen, K.A. 2008, "Combined single-drop and rotating drum 
dustiness test of fine to nanosize powders using a small drum", Annals of 
Occupational Hygiene, vol. 52, no. 1, pp. 23-34.  
4.1.185 World Health Organization (WHO). (1997). Determination of airborne fibre 
number concentrations. A recommended method, by phase-contrast optical 
microscopy (membrane filter method). Geneva. 
4.1.186 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be removed from R.7.1.14.6 (R.7a, pg. 154): 
4.1.187 Brandrup, J. and Immergut, E.H. (1989) eds “Polymer Handbook”, 3rd edition, 
Wiley. 
4.1.188 Community Bureau of Reference (1979) “Certification Report on Particles of 
Defined Particle Size”, Brussels 
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4.1.189 Hazard Prevention and Control in the Work Environment: Airborne Dust, 
WHO/SDE/OEH/99.14 Chapter 1 – Dust: Definitions and Concepts 
4.1.190 HSE (1996) The Notification of New Substances (NONS): Guidance 
Document on methods for measuring Particle Size Distribution 
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4.1.191 Guidance update for “GRANULOMETRY” recommended if the scope of the 
term “Granulometry” and the corresponding information requirement IS 
considered to include the recommended additional relevant specific intrinsic 
properties “Shape” and “Surface Area” 
4.1.192 Part B: Hazard Assessment 
4.1.193 B.6.1.4 Other physico-chemical properties 
4.1.194 It is recommended that the following paragraph on Granulometry is added to the end 
of section B.6.1.4. (PART B – HAZARD ASSESSMENT, pg. 21), following the 
paragraph ending “…are preferred over other determinations of Kow”: 
4.1.195 Granulometry, the characterisation of particle-related properties which can 
include size distribution, shape and surface area, amongst other properties, is 
an important parameter to consider particularly from a hazard assessment 
perspective.  Determination of the particle size fractions are used to assess 
the possible health effects resulting from inhalation of airborne particles in the 
workplace. The inhalable size range of particles is important in determining not 
only if the situation poses an inhalation problem, but also where in the 
respiratory tract the particles may deposit. Therefore, the particle size 
distribution can be used as an argument when considering inhalation testing. 
A number of methods covering different ranges of particle sizes are available, 
although none of them is applicable to the entire size range.  The particle size 
distribution is needed in order to decide which route of administration is most 
appropriate for the acute toxicity and 28-day base set animal studies. Particle 
size is also a factor in environmental exposure assessment.  Shape is an 
important parameter in the characterisation of particles, with contextual value 
to the assessment of deposition, adsorption kinetics, and hazard assessment 
in biological media.  Three corresponding levels of shape can be 
distinguished: macroshape, mesoshape and microshape.  Specific surface 
area is an important parameter in the characterisation of nanomaterials, with 
emerging evidence of quantitative value as an additional dose metric / 
descriptor for hazard assessment.  The specific surface area will dictate the 
surface charge in cases where nanomaterials are surface functionalised, with 
direct consequences on nanomaterial interaction (i.e., agglomeration) with 
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other naturally occurring particulate, route of exposure as a function of surface 
ligand-biological interface and mechanisms of toxicity. 
4.1.196 R.7.1.1.1 Information requirements on physico-chemical properties 
4.1.197 Table R.7.1-1  
4.1.198 It is recommended that the phrase “Granulometry (particle size distribution)” in Table 
R.7.1-1 (R.7a, pg. 18) is clarified to the word “Granulometry”, consistent with the 
Regulation and Guidance. 
4.1.199 R.7.1.1.4 General testing strategy for physico-chemical properties 
4.1.200 Tier 3 
4.1.201 It is recommended that the term “Particle Size Distribution” under R.7.1.1.4 “Tier 3” 
(R.7a, pg. 36) should be amended to state “Granulometry”, consistent with the 
Regulation and Guidance. 
4.1.202 Figure R.7.1-1 Tiered testing scheme on physico-chemical testing 
4.1.203 It is recommended that the “particle size distribution” box in Tier 3 of Figure R.7.1-1 
(R.7a, pg. 37) is updated to state “Granulometry”, consistent with the Regulation and 
Guidance. 
4.1.204 R.7.1.1.6 Overall consistency of the physico-chemical profile 
4.1.205 Table R.7.1-5 Summary of use of physico-chemical properties 
4.1.206 It is recommended that the Granulometry row in Table R.7.1-5 (R.7a, pg. 44) is 
updated as follows: 
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Test Impact on other 
physico-
chemical test 
Impact on 
toxicology 
Impact on 
ecotoxicology 
Impact on Risk 
assessment 
Granulometry  Computation of 
inhalable, thoracic 
and respirable 
fractions as a 
function of size of 
particles. 
 
Knowledge of high 
aspect ratio particles 
and specific surface 
area may inform 
interpretation of some 
toxicity test results. 
 
Particle shape is an 
important parameter 
in the 
characterisation of 
nanoparticles, with 
contextual value to 
the assessment of 
deposition, 
adsorption kinetics, 
and hazard 
assessment in 
biological media.  
 
  
 
4.1.207 R.7.1.14 GRANULOMETRY 
4.1.208 The suggested new guidance chapters for shape and surface area, provided in 
Section 4.2 of this document, are organised according to the standard chapter 
structure of R.7a.  It is therefore proposed that, if the Information Requirement of 
Granulometry subsumes shape and surface area, the updated R.7.1.14 
Granulometry chapter should become an amalgamation of: i) the proposed updated 
guidance on Granulometry (which would now equate to particle size distribution 
guidance), ii) suggested guidance text for shape iii) suggested guidance text for 
surface area, sub-divided by sub-headings for each property under the standard 
section headings of the chapter.   
4.1.209 An existing example of this approach, for reference, is the current guidance chapter 
R.7.1.10 FLAMMABILITY (R.7a, pg. 121) which incorporates guidance for: i) 
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pyrophoricity, ii) flammability on contact with water, and iii) flammability, structured 
simply by including sub-headings for each property under the standard section 
headings of the chapter. 
4.1.210 In the interests of avoiding the repetition of large amounts of text within this report, a 
merged granulometry chapter of these three sets of proposed text has not been 
produced here.   
4.1.211 Definition of granulometry 
4.1.212 The only additional amended text that would be needed using this approach is an 
updated definition of Granulometry, encompassing all three properties. It is 
recommended that the following definition of Granulometry should be used in this 
case (R.7a, pg. 143): 
4.1.213 Particles exist as populations with a range of sizes, shapes, morphologies and 
compositions, which may be altered by their surrounding environment and the 
action of forces.  Granulometry can be defined as the characterisation of 
particle-related properties which can include size distribution, shape and 
surface area, amongst other properties. 
4.1.214 Definitions of particle size distribution, shape and surface area, as provided earlier in 
this document, should then be included under property-specific sub-headings below 
this. 
4.1.215 R.7.1.14.5 Integrated testing strategy for granulometry 
4.1.216 In the case of R.7.1.14.5 (R.7a, pg. 153), it is proposed that the previously 
recommended updated integrated testing strategies for particle size distribution, 
shape and surface area could be combined as follows to provide an overall ITS for 
Granulometry (if the Information Requirement of Granulometry subsumes shape and 
surface area): 
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Representatively sample aliquots of 
material from the bulk substance.
Reproducibly and representatively 
characterise the dustiness and/or 
granulometry of the aerosolised sample.
Reproducibly and representatively 
characterise the granulometry (particle size 
distribution, shape and specific surface 
area) of a surface-deposited sample.
Select technique(s) / instrument(s), 
for determining particle size 
distribution, shape and specific surface 
area, including consideration of 
suitability for the size range of 
particles/fibres under test.  Appropriate 
instruments / techniques are outlined in 
Tables R.7.1-30, R.7.1-X to R.7.1-Y
Validate technique/instrument 
response using reference 
materials, if required.
Select sampling technique(s),
including consideration of 
suitability for particles/fibres of the 
substance under test.
Select dustiness / dispersion / 
aersolisation method, as required, 
including consideration of the suitability 
of the method for the particles/fibres of 
the substance under test.
Appropriate technique(s) are outlined in 
Table R.7.1-31 and R.7.1-32.  
Data reporting should provide, as appropriate:
- Sample preparation methods and analysis methods used
- Lot number, sample number
-Suspending medium, temperature, pH (where relevant)
For Shape:
- Representative image(s) from microscopy
- Particle shape descriptor(s)
For Specific Surface Area:
- Pre-treatment and degassing conditions (with BET)
- Mass of degassed sample (with BET)
- Adsorptive (chemical nature, purity; with BET)
- Adsorption isotherm (with BET)
- BET evaluation parameters
- Specific surface area
For Particle Size Distribution:
- Concentration (relevant to particles or fibres)
- Particle size distribution histogram of Stoke’s (effective hydrodynamic) radius Rs
- Average particle size(s) for resolvable peaks in the distribution
- Expected % change of reported values in the future (e.g. variations between production batches)
- Reference all Standards (e.g. ISO) and reference materials used
Integrate the dustiness and/or granulometry data with the selection of 
appropriate hazard testing and exposure assessment modelling.  
Dustiness testing and/or the 
determination of additional 
granulometry data of an aersolised
form of the substance is required.
Is there a potential for 
particles/fibres of an inhalable size 
(<100 μm) to be released and 
present an inhalation exposure risk?
Select particle size distributuon
measurement techniques(s) / 
instrument(s), including 
consideration of the suitability for 
the particles under test.
Appropriate technique(s) are 
outlined in Table R.7.1-33.
Validate measurement instrument 
response using reference 
materials, if required.
No
Yes
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4.1.217 OTHER ISSUES 
4.1.218 Integrated testing strategies 
4.1.219 It is recommended that, during their overall review of the guidance, ECHA 
harmonises what is stated in Annex VII-X with what is stated in the general and 
specific ITS sections of Guidance R.7a. 
4.1.220 R.7.1.15.1 Information requirements on adsorption/desorption  
4.1.221 The following text is recommended to be added as a sixth paragraph in R.7.1.15.1 
(R.7a, pg. 157), following the paragraph ending "…higher tiered testing data 
accordingly":  
4.1.222 With regard to nanomaterials the distribution coefficient Kd has to be based on 
actual testing using one of the methods for the measurement of adsorption 
outlined in Table 7.1-33 since estimations of Kd derived from the organic 
carbon-water partition coefficient (Koc) and the octanol-water partition 
coefficient (Kow) have no or questionable merit when it comes to 
nanomaterials. 
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4.1.223 TOXICOLOGICAL INFORMATION REQUIREMENTS 
4.1.224 The current R.7A guidance document does not provide for a general introduction to 
the endpoints or issues, as it does for physico-chemical properties in Section R.7.1.  
It is proposed that development of a new introductory section is considered, 
facilitating the inclusion of the cross-cutting toxicological aspects, such as those 
proposed below from the considerations for nanomaterials.  This should also 
acknowledge the importance of characterisation and sample preparation, which 
have been recommended for inclusion in the introduction of R.7a. 
4.1.225 Within RNC/RIP-oN2/B1/2/FINAL, RNC/RIP-oN2/B2/2/FINAL and RNC/RIP-
oN2/B3/2/FINAL several aspects of guidance have been identified that, whilst not 
requiring a specific amendment, could benefit from the insertion of an advisory 
note.  Specifically this was identified in situations such as the consideration of lung 
overload phenomena, assay interference and the suitability of bacterial mutation 
assays for assessing particles.  Due to their applicability to several endpoints, 
advisory notes on lung overload and assay interference should be included in the 
Introduction to R.7 or in a new toxicological specific introduction prior to the 
commencement of Section R.7.2. which marks the beginning of the toxicology 
section of Guidance R.7a with Skin and Eye Irritation/Corrosion and Respiratory 
Irritation.   
4.1.226 These advisory notes do not propose a protocol but aim to provide useful advice 
and references to relevant resources.  These advisory notes are outlined below with 
a special emphasis on nanomaterial examples and could need to be complemented 
with notes related to other materials. 
4.1.227 Advisory note on the consideration of rat lung overload within inhalation 
toxicity assessment 
4.1.228 The term ‘lung overload’ or ‘particle overload’ as it is also known, is a 
phenomenon associated with exposure to poorly soluble, low toxicity (PSLT) 
particles and occurs when a threshold dose of particles is achieved within the 
lung. During chronic exposure to PSLT particles, the lung burden of particles 
increases until a steady state or equilibrium is achieved between deposition 
and clearance of particles (Miller 2000) as shown by the A, B and C traces in 
Figure R.7-Z. Below the lung overload threshold, particles are cleared via 
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normal mechanisms at a normal clearance rate, generating little or no 
appreciable response.  
 
 
4.1.229 Figure R.7-Z: Schematic representation of the relationship between retained 
lung burden and length of exposure leading to the phenomenon of lung 
overload. Curves A, B, and C are associated with progressively increasing 
exposure concentrations. If the exposure level is sufficiently high and the 
length of exposure sufficiently long, alveolar macrophage-mediated clearance 
of particle can be overwhelmed. When this occurs, retained lung burden 
increases linearly with further exposure (curve C*). Reproduced from Miller 
(2000).  
4.1.230 However, once threshold has been reached, the clearance mechanisms of the 
lung become overloaded which is typified by a progressive reduction of 
particle clearance from the deep lung, reflecting a breakdown in alveolar 
macrophage (AM)-mediated dust removal due to the loss of AM mobility. This 
is shown in the C* trace of Figure R.7-Z1 whereby at the point of threshold, 
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particle retention occurs exponentially rather than an equilibrium being 
established (as demonstrated by the dashed line).  
4.1.231 The result of this rapid net increase in particle accumulation is lung 
inflammation, cessation of alveolar-mediated clearance and an increase in 
accumulation of particle laden macrophages within the lung alveoli. The 
continued build up of particles leads to a higher rate of transfer to lymph nodes 
and accumulation of particles in the lung interstitia. Persistent inhalatory 
exposure leads to chronic inflammation which in turn is likely to lead to 
fibrosis, alveolar cell proliferation (hyperplasia), the conversion of cells to cell 
types not normal associated with the specific lung location (metaplasia). The 
final result maybe local tumour formation (neoplasia) as shown in Figure R.7-
Z2 (Mauderly 1996; Miller 2000; Oberdorster 1996). This occurs only at high 
particle inhalatory exposure and is known as the overload phenomenon. 
 
4.1.232 Figure R.7-2: Suggested pathogenic sequence of effects of chronically 
inhaled particles in rats. Adapted from Oberdörster (1996). 
4.1.233 The driving force behind this cascade of effects is thought to be the particle 
load rather than an intrinsic property of the particles themselves. The situation 
Particle Exposure 
Alveolar Macrophage  
Activation
Acute Inflammation 
Impaired Clearance 
Particle Accumulation  
(C*) 
Chronic  
Inflammation 
Fibrosis  
Mutations  
Epithelial Cell  
Proliferation  
(Hyperplasia)
Metaplasia  
Tumours  
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of overload is most commonly associated with repeated inhalation exposure to 
particles but it can also occur after single or repeated instillation of particles 
into the lung (due to high deposition fraction as result of direct instillation) or 
possible as a result of a single massive inhalation exposure (Mauderly 1996). 
As such since this phenomenon occurs at high level of inhalatory exposure, it 
is often argued that the observed effects are a product of the experimental 
condition and not necessarily a true reflection on the intrinsic toxic potential of 
the particles to cause inflammation, fibrosis and cancer. Indeed this also 
raises the question of particular sensitivity to lung overload between different 
species (e.g. between different experimental species or between an 
experimental species such as rats and humans). In a comparative study 
assessing the long-term pulmonary response rats mice and hamsters to 
inhalation of pigmentary grade titanium dioxide, the authors found species 
differences. Lung burden was shown to be lower in hamsters at 
concentrations which caused overload in rats and mice. Also the inflammatory 
and pathological responses were less severe in mice than rats and diminished 
with time irrespective of the similar lung burdens (Bermudez et al. 2002).  
4.1.234 It should however be noted that this is only the case for PSLT particles. 
Exposure to highly reactive or toxic particles may cause inflammation, fibrosis 
and cancer at non-overload conditions due to intrinsic properties of the 
particles themselves. Inflammation, fibrosis and cancer in rats arising from 
high exposure to PSLT particles could be a result of the exposure conditions 
(overload) rather than a result of an intrinsic particle property. 
4.1.235 The question of which dose metric best describes the association between 
deposited dose in the lung, overload conditions and subsequent pathogenic 
effects is particularly pertinent. There have been several suggested metrics 
with the first being particle volume as suggested by Morrow et al. (1988). 
Morrow hypothesised that overload begins when 6 percent of the macrophage 
volume is filled with particles and total cessation of AM-mediated clearance 
occurs when 60 percent of the macrophage volume is filled. Such a driver of 
lung overload has also been more recently suggested for carbon nanotubes 
(Pauluhn 2010). However, two further metrics have been discussed as 
important in driving lung overload. The first is surface area and there are 
several studies which suggest that, as metric, particle surface area correlates 
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well with induced pathogenic events (Elder et al 2005; Borm et al. (2004)). In a 
study by Tran et al. (2000), data from a series of chronic inhalation 
experiments on rats with two poorly soluble dusts, titanium dioxide and barium 
sulphate was analysed. The results indicated that when lung burden was 
expressed as particle surface area, there was a clear relationship with the 
level of inflammation and translocation to the lymph nodes. Most usefully, the 
authors suggested that based on the shape of the statistical relationship for 
lung response to particles, indicated the presence of a threshold at 
approximately 200-300 cm2 of lung burden. In relation to surface area as a 
driving metric, due to their known high level of surface area, the potential for 
overload effects may be increased with those nanomaterials which exhibit a 
high biologically accessible surface area.  
4.1.236 The third suggested metric is that of mass. Whilst some studies indicate mass 
as a less sensitive indicator of lung overload (Warheit et al. 1997) there is a 
study showing an improved relationship between the mass of three forms of 
PSLT particles, and the generation of inflammation due to lung overload.  
4.1.237 The generation of overload conditions may be seen as a point of weakness 
within a study design and hinder accurate risk assessment due to the 
suggested differences in species susceptibility introducing further uncertainty. 
Indeed in a retrospective analysis by Valberg et al. (2009) they analysed 
studies considering the lifetime tumour occurrence in rats after repeated dose 
short term intratracheal instillation of 19 different PSLT particles. Including 
other draw backs within the studies (such as the lack of low-dose studies) the 
authors pointed towards significant issues with study design that resulted in 
lung overload in the test subjects. They argued that the response of rats to 
PSLT particle lung overload is stereotyped and unique to that species and 
pointed towards human exposure to demonstrate this. Specifically workers 
historically exposed to potentially lung-overloading burdens of inhaled dust 
(e.g., coal workers, underground miners using diesel equipment) do not exhibit 
an established lung-cancer excess despite the potential for lung overload. As 
such in rats, when the lung-overload threshold is exceeded, rats develop lung 
tumours from ongoing inflammation as opposed to particle-specific toxicity, 
whilst humans do not Valberg et al. (2009).  
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4.1.238 Based on this evidence the authors suggested that the reported results for 
PSLT particles were not a reliable basis for predicting human lung cancer risk. 
Such a criticism could be placed on all studies of PSLT particles to which, due 
to dosing regimes (e.g. intratracheal bolus) or exposure levels may generate 
overload conditions.     
4.1.239 The interpretation of data obtained after high doses of PSLT particles should 
be approached with caution and appropriate discussion should be given to the 
mechanistic driver behind any pathogenic effects detected. The reason for this 
is to establish the relevance to human and if alteration of the default 
assessment factors is warranted or appropriate in the derivation of exposure 
limits.  
4.1.240 For further information, review articles covering this subject include Miller 
(2000) which provides an excellent in depth discussion of particle deposition, 
clearance and lung overload; Borm et al. (2004) which discusses the 
importance of overload in the context of risk assessment.    
4.1.241 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included: 
4.1.242 Bermudez E, Mangnum JB, Asgharian B, Wong BA, Reverdy EE, Hexp PM, 
Warheit DB, Everitt JI. (2002) “Long-term pulmonary response of three 
laboratory rodents to subchronic inhalation of pigmentary titanium dioxide 
particles”. Toxicol Sci; 70:86 –97. 
4.1.243 Borm PJ, Schins RP, Albrecht C. (2004) “inhaled particles and lung cancer, 
part B: Paradigms and risk assessment”. Int J Cancer. May 20;110(1):3-14. 
4.1.244 Donaldson K. “Nonneoplastic lung responses induced in experimental animals 
by exposure to poorly soluble nonfibrous particles.” Inhal Toxicol. 2000 Jan-
Feb;12(1-2):121-39. 
4.1.245 Elder A, Gelein R, Finkelstein JN, Driscoll KE, Harkema J, Oberdörster G 
(2005). “ Effects of subchronically inhalaed carbon black in three species. I. 
Retention kinetics, lung inflammation, and histopathology” Toxicol Sci. 
Dec;88(2):614-29.  
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4.1.246 Mauderly JL. "Usefulness of animal models for predicting human responses to 
long-term inhalation of particles.” Chest. 1996 Mar;109(3 Suppl):65S-68S. 
4.1.247 Miller F. J. (2000) “Dosimetry of particles in laboratory animals and humans in 
relationship to issues surrounding lung overload and human health risk 
assessment: A critical review.” Inhal Tox; 12:19-57 
4.1.248 Morrow PE. “Possible mechanisms to explain dust overloading of the lungs.” 
Fundam Appl Toxicol. 1988 Apr;10(3):369-84. 
4.1.249 Mossman BT. “Mechanisms of action of poorly soluble particulates in 
overload-related lung pathology.” Inhal Toxicol. 2000 Jan-Feb;12(1-2):141-8. 
4.1.250 Oberdorster G., (1996) “ Significance of particle parameters in the evaluation 
of exposure-dose-response relationships of inhaled particles”. Inhal Tox; 
8(suppl):73-89 
4.1.251 Pauluhn J. “Subchronic 13-week inhalation exposure of rats to multiwalled 
carbon nanotubes: toxic effects are determined by density of agglomerate 
structures, not fibrillar structures.” Toxicol Sci. 2010 Jan;113(1):226-42. Epub 
2009 Oct 12. 
4.1.252 Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. 
“Inhalation of poorly soluble particles. II. Influence Of particle surface area on 
inflammation and clearance.” Inhal Toxicol. 2000 Dec;12(12):1113-26. 
4.1.253 Warheit DB, Hansen JF, Yuen IS, Kelly DP, Snajdr SI, Hartsky MA. (1997) 
“Inhalation of high concentrations of low toxicity dusts in rats results in 
impaired pulmonary clearance mechanisms and persistent inflammation.” 
Toxicol Appl Pharmacol;145(1):10-22. 
4.1.254 Valberg PA, Bruch J, McCunney RJ. (2009) “Are rat results from intratracheal 
instillation of 19 granular dusts a reliable basis for predicting cancer risk?” 
Regul Toxicol Pharmacol.;54(1):72-83.  
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4.1.255 Advisory note on the consideration of assay inhibition/ enhancement 
(interference) 
4.1.256 Various nanomaterials have been on occasion found to interfere with several 
commonly used assays utilised to determine their cellular or toxic effects.  For 
example, some nanomaterials may contribute to the absorbance or 
fluorescence of colorimetric or fluorometric assays.  In addition, due to their 
large surface area, nanoparticles may bind to assay components including the 
substrates (such as CNT with the reagent in MTT assays; Belyanskaya et al. 
2007) or the biomarker being measured, (such as LDH and cytokine proteins, 
see for example Davoren et al. 2007).   
4.1.257 A summarised list of potential sources of interferences with commonly used 
assays has been developed by Kroll et al. (2009) and reproduced within Table 
7.2.X.   
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4.1.258 Table 7.2.X: Nanoparticle interference with cytotoxicity assays (reproduced from 
Kroll et al., 2009) 
Cytotoxicity 
assay 
Detection 
principle 
NP interference Altered readout Particle/Reference
Cell viability 
MTT Colorimetric 
detection of 
mitochondrial 
activity 
Adsorption of 
substrate 
Reduced 
indication of cell 
viability 
Carbon 
nanoparticles 
LDH Colorimetric 
detection of LDH 
release 
Inhibition of LDH Reduced 
indication of 
necrosis 
Trace metal-
containing 
nanoparticles 
Annexin V/ 
 
 
 
 
Propidium 
iodide 
Fluorimetric 
detection of 
phosphatidylserin
e exposure 
(apoptosis 
marker) 
 
Propidium iodide-
staining of DNA 
(necrosis marker) 
Ca2+-depletion 
 
 
 
 
Dye adsorption 
Reduced 
indication of 
apoptosis 
 
 
Reduced 
indication of 
necrosis 
 
 
 
 
 
Carbon 
nanoparticles 
Neutral red Colorimetric 
detection of intact 
lysosomes 
Dye adsorption Reduced 
indication of cell 
viability 
Carbon 
nanoparticles 
Caspase Fluorimetric 
detection of 
Caspase-3 
activity 
(apoptosis 
marker) 
Inhibition of 
Caspase-3 
Reduced 
indication of 
apoptosis 
Trace metal-
containing 
nanoparticles 
especially Zn2+ 
Stress response  
DCF Fluorimetric 
detection of ROS 
production 
Fluorescence 
quenching 
Reduced 
indication of 
oxidative stress 
Carbon 
nanoparticles 
Inflammatory response 
 
ELISA 
Colorimetric 
detection of 
cytokine 
secretion 
Cytokine adsorption Reduced 
indication of 
cytokine 
concentration 
Carbon 
nanoparticles 
Metal oxide 
nanoparticles 
4.1.259 It should be noted that this list is not exhaustive and proper testing should be 
performed where possible as a matter of course to check for inhibition or 
enhancement of test results.   
4.1.260 Within certain standard methodologies such as ISO/FDS 29701 
(Nanotechnologies - endotoxin tests on nanomaterial samples for in vitro 
systems), the method requires the use of sample ‘spikes’ (addition of a known 
sample control to the test sample) to test for inhibition or enhancement of the 
spiked control. This is calculated by assessing the returned value against the 
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expected value which should be a cumulative value of the spike and sample. 
Any alteration to this may indicate inhibition (return of a value less than 
expected) or enhancement (return of a value greater than expected) of the 
assay. The use of sample spikes is encouraged as it allows a simple yet 
effective method of investigating potential assay interference and would give 
greater confidence in derived results. This is especially important due to the 
uncertainty that surrounds the effect of nanomaterials on the performance of 
routinely used assays.    
4.1.261 The use of such methods to investigate possible inhibition or enhancement of 
results should be carried out wherever possible irrespective of standard 
method requirement; however this may not always be possible. In many of the 
studies reported it is not possible to ascertain whether the assays were 
adequately controlled to assess for interference. Thus, as a general 
precaution, it is advisable to use more than one assay to assess the endpoint 
or effect in question, as advised by Landsiedel et al. (2009) for establishing 
genotoxicity. The potential for inhibition or enhancement of the test result may 
impact on numerous test methods. In certain cases, the potential for assay 
interference has been identified for some nanomaterials, for example carbon 
nanotubes are suggested to interfere with the MTT assay (Wörle-Knirsch et al. 
2006) and as such may cause issues with tests such as OECD TG 431/EU 
B.40 Human Skin Model tests (EPISKIN™, EpiDerm™) due to their use of the 
MTT assay. However knowledge on nanomaterial assay interference is 
incomplete and so precautions to ensure the validity of an assay, such as the 
mentioned use of control spikes could be used.   
4.1.262 Due to the potential for interference resulting in misleading results in 
numerous assays, utmost care should be taken in testing for such interference 
to validate obtained results.  
4.1.263 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.2: 
4.1.264 Belyanskaya L., Manser P., Spohn P., Bruinink A., Wick P. 2007, “The 
reliability and limits of the MTT reduction assay for carbon nanotubes – cell 
interaction,” Carbon, vol. 45, pp. 2643–2648. 
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4.1.265 Davoren, M., Herzog, E., Casey, A., Cottineau, B., Chambers, G., Byrne, H.J. 
and Lyng, F.M. 2007, "In vitro toxicity evaluation of single-walled carbon 
nanotubes on human A549 lung cells", Toxicol In Vitro, vol. 21, no. 3, pp. 438-
448. 
4.1.266 Kroll, A., Pillukat, M.H., Hahn, D., Schnekenburger, J. 2009, "Current in vitro 
methods in nanoparticle risk assessment: Limitations and challenges," 
European Journal of  Pharmaceutics and Biopharmaceutics, 72(2), 370-377. 
4.1.267 Landsiedel, R., Schulz, M., Kapp, MD., Oesch, F. 2009, "Genotoxicity 
Investigations on Nanomaterials: Methods, Preparation and Characterization 
Test Material, Potential Artifacts and Limitations - Many Questions, Some 
Answers," Mutation Research, 681(2-3), 241-58. 
4.1.268 The following update to Guidance should be considered for insertion into Section 
R.7.7 under the ‘In vitro data’ heading on page 380 prior to table R.7.7-2:  
4.1.269 Advisory note on the consideration of bacterial assay interference 
4.1.270 Assessment of substances with regard to genotoxicity is generally based 
on a combination of tests to assess effects on three major end points of 
genetic damage associated with human disease: gene mutation, 
clastogenicity and aneuploidy. 
4.1.271 One such test, the bacterial reverse mutation (Ames) test (OECD TG 
471/EU B.12/13: Bacterial reverse mutation test (in vitro)), uses amino-
acid requiring strains of Salmonella typhimurium and Escherichia coli to 
detect point mutations, which involve substitution, addition or deletion of 
one or a few DNA base pairs (Ames et al., 1975; Maron et al,. 1983; 
Gatehouse et al., 1994). The principle of this bacterial reverse mutation 
test is that it detects mutations which revert mutations present in the test 
strains and restore the functional capability of the bacteria to synthesize 
an essential amino acid (histidine). The revertant bacteria are detected 
by their ability to grow in the absence of the amino acid required by the 
parent test strain (OECD TG471, 1997).  A positive test indicates that the 
test substance might act as a mutagen, or hold carcinogenic potential 
(as cancer is often linked to DNA damage). 
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4.1.272 Generally, the major drawback of the Ames test is that it is difficult to 
translate prokaryotic data for eukaryotic genotoxicity testing, and the test 
is known to generate false positive results (Khandoudi et al., 2009). 
Indeed, it is now clear from the results of international collaborative 
studies and the large databases that are currently available for the 
assays evaluated, that no single assay can detect all genotoxic 
substances (Eastmond et al., 2009). 
4.1.273 In relation to nanomaterials, a recent review of the applicability of 
genotoxicity tests to NM questioned whether the Ames test was 
accurately representative of NM genotoxicity (Landsiedel et al., 2009). 
The Landsiedel study reported that of those studies reviewed, results 
were predominantly negative (5/6 studies). The group speculated that it 
is likely that some NMs are not able to cross the bacterial wall, whilst 
others kill the test organism as they are bactericidal.  
4.1.274 Based on this evidence, it is advisable that any data harvested from such 
bacterial mutation tests should be followed up with other assays after the 
initial screening, perhaps via implementation of a battery of standardised 
genotoxicity testing methods covering an as wide as possible variety of 
potential genotoxic mechanisms. 
4.1.275 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.7: 
4.1.276 Ames, B.N., McCann, J. and Yamasaki, E. 1975, “Methods for Detecting 
Carcinogens and Mutagens with the Salmonella/Mammalian-Microsome 
Maron, D.M. and Ames, B.N. (1983). Revised Methods for the Salmonella 
Mutagenicity Test. Mutation Res., 113, 173-215. 
4.1.277 Eastmond DA, Hartwig A, Anderson D, Anwar WA, Cimino MC, Dobrev I, 
Douglas GR, Nohmi T, Phillips DH, Vickers C (2009) “Mutagenicity testing for 
chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.” 
Mutagenesis. 2009 Jul;24(4):341-9 
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4.1.278 Gatehouse, D., Haworth, S., Cebula, T., Gocke, E., Kier, L., Matsushima, T., 
Melcion, C., Nohmi, T., Venitt, S. and Zeiger, E. (1994). Recommendations for 
the Performance of Bacterial Mutation Assays. Mutation Res., 312, 217-233. 
4.1.279 Khandoudi, N., Porte, P., Chtourou, S., Nesslany, F., Marzin, D., and Le 
Curieux, F., “The presence of arginine may be a source of false positive 
results in the Ames test,” Mutation Research, vol. 679, no. 1-2, pp. 65–71, 
2009  
4.1.280 Landsiedel, R., Schulz, M., Kapp, MD., Oesch, F. 2009, "Genotoxicity 
Investigations on Nanomaterials: Methods, Preparation and Characterization 
Test Material, Potential Artifacts and Limitations - Many Questions, Some 
Answers," Mutation Research, 681(2-3), 241-58. 
4.1.281 UPDATE TO GUIDANCE ON EXISTING INFORMATION REQUIREMENTS 
4.1.282 R.7.3 Skin and eye irritation/ corrosion  
4.1.283 Skin and eye irritation: Non-testing Data 
4.1.284 R.7.2.3.1 Non-human data on irritation/ corrosion 
4.1.285 We propose the insertion of the following statement to inform users of Guidance of 
the current ambiguity surrounding the use of non-testing data for nanomaterials   
4.1.286 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis only. 
4.1.287 The statement would be applicable for insertion as well into the following sections of 
R.7.2: 
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 R.7.2.3.1 Non-human data on irritation/ corrosion - Page 203 appended to 
paragraph 3 
 R.7.2.4.1 Non-human data on irritation/ corrosion - Page 215 appended to 
paragraph 4 
 Also appendix R7.2.2-2 (p241 under the contents of Appendix 7.2-2 list), 
R7.2.2-3 (p245 under the contents of Appendix 7.2-3 list) 
4.1.288 Within Figure (Table) R.7.2-2 section 5a/b (skin irritation/corrosion) and Figure 
R.7.2-3 section 5, the following amendments to the ITS table’s footnotes should be 
made: 
4.1.289 Page 227 R.7.2-2 section 5a/b footnote ‘f’. 
4.1.290 Conclusion on no classification can be made if the in silico model has 
been shown, in a scientifically justified manner, to predict adequately the 
absence of the classified effect and also fulfils the requirements of Annex 
XI. For nanomaterials the use of in silico models has yet to be 
established or accepted. Therefore the use of non-testing approaches for 
nanomaterials in deriving an assessment of hazard for humans must be 
scientifically justified and applied strictly on a case-by case basis. 
4.1.291 Page 232 R.7.2-3 section 5 footnote ‘e’. 
4.1.292 Conclusion on no classification can be made if the in silico model has 
been shown to predict adequately the absence of the classified effect 
and also fulfils the requirements of Annex XI. For nanomaterials the use 
of in silico models has yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
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4.1.293 R.7.3 Skin and respiratory sensitisation 
4.1.294 Skin and respiratory sensitisation: Non-testing Data 
4.1.295 As previously mentioned, the use of in silico approaches such as (Q)SAR, 
groupings and read across are not yet sufficiently developed for nanomaterials and 
as such the following insertion should be made: 
4.1.296 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.297 This insertion would be made into the following sections: 
 R.7.3.3.1 Non-human data for skin sensitisation – Page 259 appended to 
paragraph 7 
 R7.3.4.1 Non-human data on skin sensitisation - Page 267 appended to 
paragraph 1   
 R7.3.5.1 Non-human data on respiratory sensitisation - Page 271 appended 
to paragraph 1 
4.1.298 A footnote should be added and linked to the first step of the ITS (box 1) so that the 
step reads: 
4.1.299 Gather and evaluate existing information (human-, animal-, in vitro-, 
(Q)SARa, read acrossa and categorya data) on skin sensitisation 
according to Annex VI, step 1. 
4.1.300 And a new footnote read: 
4.1.301 a For nanomaterials the use of in silico models has yet to be established 
or accepted. Therefore the use of non-testing approaches for 
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nanomaterials in deriving an assessment of hazard for humans must be 
scientifically justified and applied strictly on a case-by case basis. 
4.1.302 R7.4: Acute Toxicity  
4.1.303 Acute Toxicity: Non-testing Data 
4.1.304 It is suggested that the following insertion should be made into acute toxicity 
Guidance R.7.4 in the use of non-testing approaches: 
4.1.305 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.306 This insertion would be made into the following sections: 
 R.7.4.3.1 Non-human data on acute toxicity – Page 291 appended to 
paragraph 3   
 R.7.4.4.1 Non-human data on acute toxicity – Page 297 appended to 
paragraph 1 
 R.7.4.5.1 Conclusions on suitability for Classification and Labelling – Page 
301 appended to paragraph 2 
4.1.307 The following change is recommended for stage 4 of the ITS (Generation of new 
data/proposal for testing strategy), 3rd paragraph page 306: 
4.1.308 The route of exposure to be used for acute toxicity evaluation depends 
on the nature of the substance (e.g. gas or not, molecular weight, log 
Kow, solid with inhalable particle size (e.g. nanomaterials)) and should 
reflect the most likely route of human exposure.   
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4.1.309 In addition, Figure R.7.4-1 (ITS for acute toxicity endpoint) should be amended 
such that the question “is the substance gaseous” is substituted with “is the 
substance inhalable”. 
4.1.310 R7.5 - Repeated Dose Toxicity 
4.1.311 Repeat Dose Toxicity: Non-testing Data 
4.1.312 It is also suggested that the following insertion should be made into repeated dose 
toxicity Guidance R.7.5 in the use of non-testing approaches: 
4.1.313 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.314 This insertion would be made into the following sections: 
 R.7.5.3.1 Non-human data on repeated dose toxicity– Page 314 inserted 
between paragraphs 4 and 5    
 R.7.5.4.1 Non-human data on repeated dose toxicity– Page 320 appended 
to paragraph 6 
4.1.315 For the ITS, the following paragraph is suggested for inclusion into R.7.5.6.2 page 
335: 
4.1.316 As mentioned within section R.7.5.3.1a, the use of (Q)SAR approaches 
in addressing data gaps is very limited at this time. In addition to this the 
use of such in silico models for nanomaterials has also yet to be 
established or accepted. Therefore the use of non-testing approaches for 
nanomaterials in deriving an assessment of hazard for humans must be 
scientifically justified and applied strictly on a case-by case basis. In the 
use of inhalation exposure as a route to test for repeated dose toxicity of 
poorly soluble low toxicity (nano)particles, the issues surrounding lung 
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overload should be considered.  (Further discussion of lung overload can 
be found in the Lung Overload Advisory Note).   
4.1.317 The ITS states that at the 10 t/y or more tonnage threshold “the use of a combined 
repeated dose toxicity study with the reproductive/developmental toxicity screening 
test (OECD TG 422) is recommended if an initial assessment of repeated dose 
toxicity and reproductive toxicity is required”. However, according to OECD WPMN 
(reference) modifications to this guideline are needed before it can be used for the 
inhalation route instead of the oral route  Therefore the above sentence in R.7.5.6.3 
should be altered to read: 
4.1.318 The use of a combined repeated dose toxicity study with the 
reproductive/developmental toxicity screening test (OECD TG 422) is 
recommended if an initial assessment of repeated dose toxicity and 
reproductive toxicity is required. However in the case of inhalation as a 
route of exposure, as may be the most likely route for (nano)particle 
exposure, further modification of OECD TG 422 may be required with full 
justification. 
4.1.319 R.7.6 Reproductive and developmental toxicity  
4.1.320 It is suggested that the following insertion should be made into reproductive toxicity 
Guidance R.7.6 in the use of non-testing approaches: 
4.1.321 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.322 This insertion would be made into the following sections: 
 R.7.6.4.1 Non-human data on reproductive toxicity– Page 355 inserted 
between paragraphs 4 and 5 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 248 - 
4.1.323 For the ITS, the following text should be inserted into the Stage 2 paragraph under 
Section R.7.6.6.2: 
4.1.324 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.325 R.7.7 Mutagenicity and Carcinogenicity   
4.1.326 It is suggested that the following insertion should be made into reproductive toxicity 
Guidance R.7.6 in the use of non-testing approaches: 
4.1.327 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.328 This insertion would be made into the following sections: 
 R.7.7.3.1 Non-human data on mutagenicity – Page 379 appended to 
paragraph 2  
 R.7.7.4.1 Non-human data on mutagenicity – Page 383 appended to 
paragraph 6 
 R.7.7.10.1 Non-human data on carcinogenicity – Page 407 appended to 
paragraph 1  
 R.7.7.11.1 Non-human data on carcinogenicity – Page 412 appended to 
paragraph 5 
4.1.329 For the ITS, inclusion of the following paragraph in R.7.7.6.2 as a new second 
paragraph is suggested: 
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4.1.330 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.331 A new first paragraph for Section R.7.7.6.3 standard information requirement at 
annex VII is recommended: 
4.1.332 Solid particles, including some nanomaterials, may not penetrate the cell 
wall of bacteria and as such this assay may not allow a robust evaluation 
of (nano)particle mutagenicity as discussed in the bacterial mutagenicity 
advisory note [TO BE INSERTED IN R.7.7 UNDER THE ‘IN VITRO 
DATA’ HEADING ON PAGE 380]. Therefore, bacterial mutation assay 
should not be used as a single test for (nano)particle mutagenicity, but 
instead used in conjunction with a range of mammalian cell gene 
mutation tests to reduce the potential for confounded results due to 
interference with a test method. 
4.1.333 For carcinogenicity, the inclusion of the following statement is recommended at the 
end of the first paragraph of the section R.7.7.13.2 Preliminary considerations. 
4.1.334 The use of non-testing data such as read-across, grouping or (Q)SAR 
approaches in addressing data gaps for nanomaterials is very limited at 
this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the 
use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for humans must be scientifically justified and 
applied strictly on a case-by case basis. 
4.1.335 Within Figure R.7.7-2 a footnote should be attached to all occurrences of ‘non-
testing data’, specifically section ‘Annex VII-IX’ top left hand box and section ‘Annex 
X’ top box, stating: 
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4.1.336 a For nanomaterials the use of in silico models has yet to be established 
or accepted. Therefore the use of non-testing approaches for 
nanomaterials in deriving an assessment of hazard for humans must be 
scientifically justified and applied strictly on a case-by case basis. 
4.1.337 R.712 Guidance on Toxicokinetics 
4.1.338 Page 149, R.7.12.2.1, First paragraph, 7th line. The sentence currently states that: 
4.1.339 “However, the physico-chemical characteristics of the substance will change if 
the substance undergoes metabolic transformation and the physico-chemical 
characteristics of the parent substance may not provide any clues as to the 
identity, distribution, retention and elimination of its metabolites.” 
4.1.340 Within biological fluids, there is the potential that other processes, as well as 
metabolism may alter the substance and as such the following amendment has 
been suggested:  
4.1.341 “However, the physico-chemical characteristics of the substance will change if 
the substance undergoes metabolic transformation or other physical or 
chemical modification in the test system, and the physico-chemical 
characteristics of the parent substance may not provide any clues as to the 
identity, distribution, retention and elimination of its metabolites.” 
4.1.342 Page 194, Appendix R.7.12-2, Sub heading ‘gastro intestinal absorption models’,  
4.1.343 The first sentence states that:  
4.1.344 “In order to be absorbed from the GI tract, substances have to be present in 
solution in the GI fluids, and from there have to cross the GI wall to reach the 
lymph or the venous portal blood.”  
4.1.345 Transport of nanoparticles across the gastrointestinal mucosa can occur via several 
different pathways (summarised by Powell et al. 2010) and has been demonstrated 
from for some insoluble particles such as latex beads (Hussian and Florence 1998), 
TiO2 (Wang et al. 2007) and gold nanoparticles (Schleh et al. 2011) have been 
shown to be absorbed from the GI tract into the systemic circulation. As such, this 
suggests that particles do not need to be in suspension but instead can translocate 
from a suspension of insoluble particles. As particle may translocate which are is 
RNC/RIP-oN2/FPR/1/FINAL 
 
- 251 - 
suspension as a dispersion and not actually as a solution, an appendment to the 
sentence to the following has been suggested:   
4.1.346 “In order to be absorbed from the GI tract, substances have to be present in 
solution in the GI fluids, and from there have to cross the GI wall to reach the 
lymph or the venous portal blood. In the case of particulates, the possibility for 
small sized particles in the nanometer size range to translocate across the GI 
wall in particulate form should be considered.”   
4.1.347 ECOTOXICOLOGICAL INFORMATION REQUIREMEMENTS 
4.1.348 R.7.8.4.1 Data on aquatic pelagic toxicity  
4.1.349 For nanomaterials, some novel endpoints and observations in fish and invertebrate 
test may provide useful information (e.g. for supporting PNEC-derivation and/or 
understanding the possible mode of action) on the material tested. At the moment, 
corresponding methods are well-established in the scientific literature (see Smith et 
al. 2007, Bouskill et al. 2006) but are not internationally validated for these 
endpoints. For fish tests these additional observations can include fish ventilation 
rate, gill pathologies, mucus secretion and brain pathology, animal behaviour 
(Smith et al. 2007, Federici et al. 2007) and activity levels of relevant antioxidant 
enzymes such as catalase (CAT), superoxide dismutase (SOD), glutathione 
peroxidase (GPX), and glutathione-S-transferase (GST) (Oberdörster 2004, Wang 
et al. 2008, Zhu et al. 2008, Klaper et al. 2009, Kim et al. 2010, Wong et al. 2010). 
For invertebrates like Daphnia these additional observations can include hearth 
rate, hopping frequency and appendage movement cycle frequency (Lovern and 
Klaper,2007). As with existing endpoints, the NOEC, LOEC or EC50-values (e.g. 
concentration that causes e.g. 50% increase in ventilation rate in fish or heart rate 
in daphnia) could be estimated and used in PNEC derivations if these EC50-values 
are the most sensitive endpoints and considered relevant in the regulatory risk 
assessment framework.  
4.1.350 The following additional text for guidance is proposed for R.7.8.4.1:  
4.1.351 “For nanomaterials, the provision of data on the following parameters (as part of an 
ensemble of data on additional relevant endpoints considered by the registrant to be 
of value) is recommended: fish ventilation rate, gill pathologies, mucus secretion and 
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brain pathology, animal behaviour, and activity levels of relevant antioxidant 
enzymes such as catalase (CAT), superoxide dismutase (SOD), glutathione 
peroxidase (GPX), and glutathione-S-transferase (GST). “Nevertheless, as a 
thorough understanding of the relevance and impact on the ecosystem and 
population of such parameters in view of the regulatory risk assessment is missing, 
their relevance for overall ecotoxicity assessment remain supportive until further 
research would indicate otherwise.  
4.1.352 The following text is recommended to be added as a new fifth paragraph in 
R.7.8.4.1 (R.7b, pg. 26), following the paragraph ending "… before reviewing a test 
report.":  
4.1.353 “NANOMATERIALS: With regards nanomaterials and aquatic pelagic toxicity, 
the recommendations set out in the OECD Guidance Manual for testing  
(OECD, 2009) and Preliminary Guidance Notes on Sample Preparation and 
Dosimetry for nanomaterials (OECD, 2010) need to be taken into 
consideration, especially in regard to methods of suspension, method of 
nanomaterials introduction, storage and stability of test material, chemical 
composition of the test media, characterisation of stock dispersions, 
characterization of samples (prepared from stock dispersions) prior to 
administration/testing and possibly during and at least at the end of the test.” 
4.1.354 R.7.8.6 References on aquatic pelagic toxicity 
4.1.355 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.8.6: 
4.1.356 Kim, K.T., Klaine, S.J., Cho, J., Kim, S.H. & Kim, S.D. 2010, "Oxidative stress 
responses of Daphnia magna exposed to TiO(2) nanoparticles according to 
size fraction", The Science of the total environment, . 
4.1.357 Klaper, R., Crago, J., Barr, J., Arndt, D., Setyowati, K. & Chen, J. 2009, 
"Toxicity biomarker expression in daphnids exposed to manufactured 
nanoparticles: Changes in toxicity with functionalization", Environmental 
Pollution, vol. 157, no. 4, pp. 1152-1156.  
4.1.358 Lovern SB, Strickler JR, Klaper R., 2007, "Behavioral and physiological 
changes in Daphnia magna when exposed to nanoparticle suspensions 
(titanium dioxide, nano-C60, and C60HxC70Hx)", Environ Sci Technol., vol. 4, no. 
12, pp. 4465-70. 
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4.1.359 OECD. 2009, "Guidance manual for the testing of manufactured 
nanomaterials: OECD's sponsorship programme. First revision", Series on the 
safety of manufactured nanomaterials, ENV/JM/MONO(2009)20/REV, Paris. 
4.1.360 OECD. 2010, "Preliminary Guidance Notes on Sample Preparation and 
Dosimetry for the Safety Testing of Manufactured Nanomaterials", Series on 
the safety of manufactured nanomaterials, ENV/JM/MONO(2010)25, Paris. 
4.1.361 Oberdorster, E. 2004, "Manufactured nanomaterials (Fullerenes, C-60) induce 
oxidative stress in the brain of juvenile largemouth bass", Environ.Health 
Perspect. vol. 112, no. 10, pp. 1058-1062.  
4.1.362 Smith, C.J., Shaw, B.J. and Handy, R.D. 2007, "Toxicity of single-walled 
carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): Respiratory 
toxicity, organ pathologies, and other physiological effects", Aquatic 
Toxicology, vol. 82, no. 2, pp. 94-109.  
4.1.363 Templeton, R.C., Ferguson, P.L., Washburn, K.M., Scrivens, W.A. and 
Chandler, G.T. 2006, "Life-cycle effects of single-walled carbon nanotubes 
(SWNTs) on an estuarine meiobenthic copepod", Environ.Sci.Technol., vol. 
40, no. 23, pp. 7387-7393.  
4.1.364 Wang, J., Liu, Y., Jiao, F., Lao, F., Li, W., Gu, Y., Li, Y., Ge, C., Zhou, G., Li, 
B., Zhao, Y., Chai, Z. and Chen, C. 2008, "Time-dependent translocation and 
potential impairment on central nervous system by intranasally instilled TiO2 
nanoparticles", Toxicol, vol. 254, no. 1-2, pp. 82-90. 
4.1.365 Wong, S. W. Y. Leung, P.T. Y., Djurišić, A. B. Leung, K.M.Y. 2010. Toxicities 
of nano zinc oxide to five marine organisms: influences of aggregate size and 
ion solubility. Anal Bioanal Chem (2010) 396:609–618 
4.1.366 Zhu, X.S., Zhu, L., Lang, Y.P. and Chen, Y.S. 2008, "Oxidative stress and 
growth inhibition in the freshwater fish Carassius auratus induced by chronic 
exposure to sublethal fullerene aggregates", Environmental Toxicology and 
Chemistry, vol. 27, no. 9, pp. 1979-1985. 
4.1.367 R.7.8.9.1 Laboratory data on toxicity to sediment organisms  
4.1.368 The following text is recommended to be added as a new third paragraph in 
R.7.8.9.1 (R.7b, pg. 124), following the paragraph ending "…categories is given in 
Section R.6.2.":  
4.1.369 “Estimates based on results from “equilibrium partitioning methods” are limited 
to distribution of a substance in molecular form. However, substances may 
also be distributed in the environment as particles (caused by 
abrasion/weathering of anthropogenic materials) and hence extrapolation 
based on partitioning may not be relevant. In such a case the partitioning 
method may underestimate exposure of soil and sediment environments and 
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overestimate the exposure of water. If the particle size is small also air 
distribution may occur. There are no estimation methods available for particle 
distribution so this has to be dealt with on a case-by-case basis. With regard 
to nanomaterials, the recommendations set out in the OECD Guidance 
Manual for testing  (OECD, 2009) and Preliminary Guidance Notes on Sample 
Preparation and Dosimetry for nanomaterials (OECD, 2010) need to be taken 
into consideration, especially in regard to methods of suspension, method of 
nanomaterials introduction, storage and stability of test material, chemical 
composition of the test media, characterisation of stock dispersions, 
characterization of samples (prepared from stock dispersions) prior to 
administration/testing and possibly during and at least at the end of the test. 
4.1.370 R.7.8.10.1 Laboratory data on toxicity to sediment organisms  
4.1.371 The following text is recommended to be added as a new fifth paragraph in 
R.7.8.10.1 (R.7b, pg. 127), following the paragraph ending "…categories is given in 
Section R.6.2.":  
4.1.372 “Estimates based on “partitioning” are limited to distribution of a substance in 
molecular form. However, substances may also be distributed in the 
environment as particles (caused by abrasion/weathering of anthropogenic 
materials) and hence extrapolation based on partitioning may not be relevant. 
In such a case the partitioning method may underestimate exposure of soil 
and sediment environments and overestimate the exposure of water. If the 
particle size is small also air distribution may occur, at least in the local 
perspective. There are no estimation methods available for particle distribution 
so this has to be dealt with on a case-by-case basis. With regard to 
nanomaterials, the recommendations set out in the OECD Guidance Manual 
for testing  (OECD, 2009) and Preliminary Guidance Notes on Sample 
Preparation and Dosimetry for nanomaterials (OECD, 2010) need to be taken 
into consideration, especially in regard to methods of suspension, method of 
nanomaterials introduction, storage and stability of test material, chemical 
composition of the test media, characterisation of stock dispersions, 
characterization of samples (prepared from stock dispersions) prior to 
administration/testing and possibly during and at least at the end of the test.”  
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4.1.373 R.7.8.13 References on toxicity sediment organisms 
4.1.374 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.8.13: 
4.1.375 OECD. 2009, "Guidance manual for the testing of manufactured 
nanomaterials: OECD's sponsorship programme. First revision", Series on the 
safety of manufactured nanomaterials, ENV/JM/MONO(2009)20/REV, Paris. 
4.1.376 OECD. 2010, "Preliminary Guidance Notes on Sample Preparation and 
Dosimetry for the Safety Testing of Manufactured Nanomaterials", Series on 
the safety of manufactured nanomaterials, ENV/JM/MONO(2010)25, Paris. 
4.1.377 R.7.9.3 Information on degradation/biodegradation and its sources  
4.1.378 The following text is recommended to be added as a third paragraph in R.7.9.3 
(R.7b, pg. 163), following the paragraph ending "…higher tiered testing data 
accordingly":  
4.1.379 With regard to nanomaterials it should be noted that the OECD 
biodegradability test methods have been developed and validated principally 
for assessment of organic compounds whereas many nanomaterials are 
principally inorganic and even carbon-based nanomaterials arguably tend to 
be of an inorganic nature. However, surface coating and functionalizations 
might be organic and consist of biodegradable materials.  Methods measuring 
carbon dioxide production or oxygen uptake are applicable, but they require 
large amounts of test material. If several conclusive aerobic degradation tests 
indicate very low or negligible degradation, then other aerobic degradation 
tests will most likely also be negative and it may be useless to proceed with 
additional tests. It may be better to decide to skip the more elaborate test, and 
conclude that the substance is not biodegradable (OECD, 2010).   
4.1.380 R.7.9.7 References on biodegradation 
4.1.381 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.9.7: 
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4.1.382 OECD. 2010, "Preliminary Guidance Notes on Sample Preparation and 
Dosimetry for the Safety Testing of Manufactured Nanomaterials", Series on 
the safety of manufactured nanomaterials, ENV/JM/MONO(2010)25, Paris. 
4.1.383 R. 7.10.3.2 Non-testing data aquatic bioaccumulation 
4.1.384 The following text is recommended to be added as a final paragraph in R.7.10.3.2 
(R.7c, pg. 16), following the paragraph ending "… data on the chemical of 
interest":  
4.1.385 With regard to nanomaterials, it is not possible to make log Kow or solubility 
estimations since nanomaterials are dispersed and not in solution. Measured 
BCF values are required and stability and changes in e.g. aggregation and 
agglomerate size are of vital importance to consider. There is furthermore a 
need to emphasise that for nanomaterials that undergo dissolution like Ag0 it 
is very important to get information, if possible, on the form of the substance 
present in the animal tissue. The use of non-testing data such as read-across, 
grouping or (Q)SAR approaches in addressing data gaps for nanomaterials is 
very limited at this time. In addition to this the use of such in silico models for 
nanomaterials has also yet to be established or accepted. Therefore the use 
of non-testing approaches for nanomaterials in deriving an assessment of 
hazard for the environment must be scientifically justified. 
4.1.386 R.7.11.3.1 – Laboratory data a) Non-testing data 
4.1.387 The following text is recommended to be added as a final paragraph in R.7.11.3.1 a) 
Non-testing data (R.7c, pg. 111), following the paragraph ending "… as in the ITS in 
Section R.7.11.6. ":  
4.1.388 Estimates based on “partitioning” are limited to distribution of a substance in 
molecular form. However, substances may also be distributed in the 
environment as particles (caused by abrasion/weathering of anthropogenic 
materials) and hence extrapolation based on partitioning may not be relevant. 
In such a case the partitioning method may underestimate exposure of soil 
and sediment environments and overestimate the exposure of water. If the 
particle size is small also air distribution may occur. There are no estimation 
methods available for particle distribution so this has to be dealt with on a 
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case-by-case basis. animal tissue. The use of non-testing data such as read-
across, grouping or (Q)SAR approaches in addressing data gaps for 
nanomaterials is very limited at this time. In addition to this the use of such in 
silico models for nanomaterials has also yet to be established or accepted. 
Therefore the use of non-testing approaches for nanomaterials in deriving an 
assessment of hazard for the environment must be scientifically justified.   
4.1.389 R.7.11.3.1 – Laboratory data b) testing data 
4.1.390 The following text is recommended to be added as a final paragraph in R.7.11.3.1 
(R.7c, pg. 111), following the paragraph ending "…reliability, adequacy, relevance 
and completeness":  
4.1.391 With regard to nanomaterials, the recommendations set out in the OECD 
Guidance Manual for testing  (OECD, 2009) and Preliminary Guidance Notes 
on Sample Preparation and Dosimetry for nanomaterials (OECD, 2010) need 
to be taken into consideration, especially in regard to methods of suspension, 
method of nanomaterials introduction, storage and stability of test material, 
chemical composition of the test media, characterisation of stock dispersions, 
characterization of samples (prepared from stock dispersions) prior to 
administration/testing and possibly during and at least at the end of the test. 
4.1.392 R.7.11.7 REFERENCES 
4.1.393 Subject to acceptance of the recommended guidance changes above, the following 
references would need to be included into R.7.11.7 
4.1.394 OECD. 2009, "Guidance manual for the testing of manufactured 
nanomaterials: OECD's sponsorship programme. First revision", Series on the 
safety of manufactured nanomaterials, ENV/JM/MONO(2009)20/REV, Paris. 
4.1.395 OECD. 2010, "Preliminary Guidance Notes on Sample Preparation and 
Dosimetry for the Safety Testing of Manufactured Nanomaterials", Series on 
the safety of manufactured nanomaterials, ENV/JM/MONO(2010)25, Paris. 
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4.2 NEW CHAPTERS FOR ENDPOINT SPECIFIC GUIDANCE 
4.2.1 In the event that the regulatory interpretation of the term Granulometry and 
consequently the associated information requirement does not include “shape” and 
“surface area”, it is recommended that two new chapters (entitled Shape and 
Surface Area) are included into R.7a.  Proposed text has been drafted below.  In this 
draft of the chapter contents, figure and table legends have been given generic 
numbers (R.7.1-X for all proposed figures and tables in the Shape chapter and 
R.7.1-Y for Surface Area).  It is evident from the position in the chapter and 
description in the text which tables/figures are being referred to.  Permission would 
be required from ISO to reproduce the suggested images. 
4.2.2 R.7.1.19 SHAPE 
4.2.3 Solid particulates/granulates with identical composition can have a variety of well- or  
ill-defined shapes, including spheres, rods, tubes, fibres and plates, which may have 
different physical, chemical, and biological properties.  Shapes are determined by 
the way in which the entities are bound together and particles will assume the shape 
that minimises free energy and is kinetically achievable under given environmental 
conditions.  Particle shape is an important parameter in the characterisation of some 
nanoparticles, with contextual value to the assessment of deposition, adsorption 
kinetics, and hazard assessment in biological media. Knowledge of high aspect ratio 
particles may inform interpretation of some toxicity test results. 
4.2.4 Definition of shape 
4.2.5 Shape is a qualitative or, at best, semi-quantitative geometrical description or 
dimension-less term(s) of the extremities of the particle or collections of particles, 
their agglomerates or aggregates, that make up the material under investigation 
(adapted from OECD, 2009). 
4.2.6 Particles may have readily definable shapes such as spheres, rods, or defined 
crystal morphologies.  More often, particle shape is much more variable and ‘shape 
factors’ such as sphericity, circularity, aspect ratio, convexity and fractal dimension 
are needed to characterise shape.   
RNC/RIP-oN2/FPR/1/FINAL 
 
- 259 - 
4.2.7 ISO 9276-6:2008 specifies rules and nomenclature for the description and 
quantitative representation of particle shape and morphology.  Three corresponding 
levels of shape can be distinguished: macroshape, mesoshape and microshape. 
4.2.8 Macrodescription is a description of the overall form of a particle in terms of the 
geometrical proportions of the particle.  In general, simple geometrical descriptors 
calculated from the size measurements made on the particle silhouette are used.  
Low-order Fourier descriptors can also be regarded as macrodescriptors. 
4.2.9 Mesodescription provides information about details of the particle shape and/or 
surface structure that are in a size range not much smaller than the particle 
proportions, like Barrett’s roundness and concavity (Barrett, 1980). 
4.2.10 The following mesodescriptors can be defined: 
a) morphological mathematical descriptors, computing robustness and largest 
concavity index; 
b) a concavity tree, providing general insight into the organisation of concavities 
and their complexity; 
c) angularity descriptors, determining those parts of the boundary that are active 
in the abrasion process: 
i. an angularity factor, selecting the apices on corners which are 
coincident with the convex hull because it is these points that 
will make contact with the surface of another particles, 
ii. a quadratic spike parameter, taking into account those spikes 
that are outside a circle, of area equal to that of the particle, 
centred over the particle centroid, 
iii. slip chording, generating information on the number of cutting 
edges and their sharpness in the facet signature waveform; 
d) fractal dimension, providing data on the overall structural complexity by 
consideration of a larger measurement step; 
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e) Fourier descriptors, of higher order than macrodescriptors, specifying the 
smaller-scale components of morphology; 
f) bending energy, measuring the overall complexity of contour lines. 
4.2.11 Microdescription determines the roughness of shape boundaries using two of the 
descriptors mentioned above: 
- fractal dimension, measured using a measurement step smaller than that 
used for structural description; 
- higher-order Fourier descriptors/coefficients for surface-textural analysis. 
4.2.12 R.7.1.19.1 Information requirements on shape 
4.2.13 The study does not need to be conducted if the substance is marketed or used in a 
non-solid or non-granular form. Shape determination requires information on water 
solubility. Fibre length and diameter distribution require information on the fibrous 
nature of the product and on stability of the fibrous shape under electron microscope 
conditions. 
4.2.14 The summary should include a microscopy image of the particle and a qualitative or 
semi-quantitative geometrical description of the extremities of the particle and/or 
collections of particles, agglomerates or aggregates that make up the material under 
investigation.  Size-independent macro-, micro- and meso-shape descriptors 
(examples are ratios of extensions in different directions; unit [meter/meter] such as 
aspect ratio or fractal dimension are available (ISO 9276-6:2008) and should be 
used wherever possible.  A combination of terms and/or measurands may be 
needed to describe shape; this is essential to circumvent the challenges already 
foreseeable where materials are capable of concurrently exhibiting multiple shapes 
in a sample which may present different hazard potentials.  Information should also 
be included on the temperature at which measurements were made, purity of the 
sample used, physical state, method used and reference substance used (if any). 
4.2.15 The level of inspection used in a method is a very practical criterion for the 
classification of the method, since many methods provide shape information at 
different size levels.  Another convenient way of classifying methods is to 
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differentiate between those which derive shape descriptors from particle images and 
those which derive shape descriptors from physical properties: 
a) Calculation of geometrical descriptor/shape factors: 
Geometrical shape factors are ratios between two different geometrical 
properties, such properties usually being some measure of the proportions of 
the image of the whole particle or some measure of the proportions of an ideal 
geometrical body that envelops, or forms an envelope around, the particle.  
These results are macroshape descriptors similar to an aspect ratio. 
b) Calculation of dynamic shape factors from physical equivalent diameters: 
These shape factors are similar to geometrical shape factors except that at 
least one physical property is considered in the comparison.  Usually, the 
results are expressed as the ratio of equivalent diameters, e.g. Stokes 
sedimentation velocity to volume-equivalent diameter xStokes/xV. 
c) Morphological analysis 
Morphological analysis descriptors give mean values of particle shape that are 
not much smaller than the proportions of the whole particle.  A typical example 
is concavity analysis. 
d) Analysis of the contour line (shape boundary): 
Multiple operations on the grey-level pixel image of a particle can produce a 
set of shape descriptors which can be correlated with the topology or surface 
texture of the particle. 
e) Analysis of the physical spectra: 
Multiple operations on, or the mathematical treatment of, the physical spectra 
of a single particle can extract the shape of information as a set of descriptors.  
Such a procedure has been described for shape analysis by azimuthal light 
scattering and diffraction spectroscopy. 
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4.2.16 Figure R.7.1-X Classification of some methods for shape description (adapted 
from ISO 9276-6:2008) 
 
Shape 
Shape coefficients, 
e.g. size or proportion parameters 
Macro-,meso- and microshape descriptors 
(e.g. geometrical descriptors like Feret 
diameter, aspect ratio)
Dynamic (physical) shape parameters (e.g. 
sedimentation velocity, pressure drop 
Other parameters 
(e.g. electrical resistance) 
Description in 
words 
Standard shapes 
(e.g. rod, disc) 
Mathematical shape 
functions 
Radius-angle function 
(e.g. Fourier analysis) 
Line-angle function 
(e.g. slip chording) 
Tangent-angle function 
(e.g. angularity factors) 
 
4.2.17 In the context of hazard assessment of nanomaterials, there are three forms in 
which properties should be characterised: ‘‘as produced’’, ‘‘as dosed / as exposed”, 
and at the point(s) of interaction within the organism (which are sometimes 
collectively referred to as “as tested”, but this and the equally un-specific term in situ 
require some further description of the context).  “As dosed / as exposed” should 
reflect as much as possible the state of the substance to which humans and /or 
environment are exposed.  The latter (at the point of interaction with the organism) is 
the most challenging measurement, because invasive techniques usually cannot be 
used without compromising the integrity of the organism and possibly invalidating 
the test, but acknowledged to be of more interest to advancing mechanistic 
toxicology rather than to regulatory toxicology.  Although potentially confounded by 
issues of artefacts, insufficient statistical reliability, and difficulties in measurement 
and interpretation, an indirect way of assessing this form is through post-exposure 
evaluation, examining the shape distribution (i.e. a description of the proportion of 
particles with particular shapes in a sample) of particles in cells, tissues, organs or 
the environmental compartment after exposure. 
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4.2.18 R.7.1.19.2  Available information on shape 
4.2.19 Testing data on shape 
4.2.20 The characterisation of particle properties requires very careful sampling and 
sample splitting practices to be followed.  ISO 14488:2007 specifies methods for 
obtaining a test sub-sample from a defined sample of particulate material (powder, 
paste, suspension or dust) that can be considered to be representative of the whole 
sample with a defined confidence level.  Further information is available in the 
Sample Preparation section of the Introduction to R.7. 
4.2.21 A number of different methods for the qualitative or semi-quantitative description of 
particle shape and morphology are available (Table R.7.1-X). The shape of particles 
is usually determined by electron microscopy (e.g. TEM, SEM), which includes 
many qualitative and semi-quantitative techniques to investigate the morphology 
(size and shape) and also the aggregation state. 
4.2.22 The choice of an appropriate shape description method depends on the 
measurement technique available and the particle system under examination (in 
particular its size range).  Methods based on mathematical operations on contour 
lines (e.g. fractal dimension analysis or Fourier analysis) require a relatively high 
resolution of particle images.  This may be obtained by using a scanning electron or 
light microscope.  Apart from such factors, the results of shape analysis may also be 
significantly affected by sample preparation (e.g. by the sample size and its 
representativeness of the whole sample) by particle orientation in 2D-analysis. 
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4.2.23 Table R.7.1-X Methods for the qualitative or semi-quantitative description of 
particle shape and morphology 
Method details Material and size 
range 
Data type 
Transmission Electron Microscopy (TEM) 
 
TEM can be used for samples collected from 
the air or prepared in suspension on a TEM 
grid, including those from separation and 
sampling instruments. Powder preparation is 
very easy and fast for this method.  Enables 
qualitative assessment of size and shape of 
particles, and differentiation between 
agglomerates and primary particles.  TEM 
has a very high local resolution (nm) and is 
capable of imaging lattice planes and 
individual rows of atoms with resolution better 
than 0.2 nm.  Additions to TEM can provide 
further information e.g. Scanning 
Transmission Electron Microscopy (STEM), 
High-Resolution TEM (HRTEM) or in-situ 
measurements using Environmental TEM, 
which offers the potential for dispersed 
samples to be characterised. 
 
However, TEM is a highly work-intensive 
method and requires manual preparation of 
samples.  Dispersions need to be diluted (to 
ca. 1%) or prepared into work-intensive cryo-
sections.  Drying samples under vacuum for 
analysis may alter the size and shape of the 
particles being characterised.  An extremely 
small area of the sample is analysed, which 
might not be representative enough. The 
comparatively small share of evaluated 
particles (ca. 1,000) results in limited 
statistical precision.  Only a two-dimensional 
projection of particles is visible and can be 
evaluated; and the interpretation of pictures is 
difficult.  Picture analysis is impossible if 
agglomeration is significant.  Contours of 
particles may not be clearly resolved in some 
samples.  The quality of the images to be 
analysed is of critical importance, and care 
must be taken to avoid bias introduced by 
orientation effects. 
 
Further informative information on this 
method is available in ISO/TR 27628:2007.  
ISO 13322-1:2004 and ISO 13322-2:2006 
provide general guidance for measurement 
description and its validation when 
determining particle size by static and 
dynamic image analysis, respectively. 
Particles in solid, 
powder and 
suspension form.   
 
Size range: < 0.1 – 
10 µm.  Particularly 
suitable for the 
particle size range 
of 1 - 500 nm. 
Image, providing 
opportunity to 
determine macro-, 
meso- and micro-
descriptors of 
shape 
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Scanning Electron Microscopy (SEM) 
 
SEM can be used for samples collected from 
the air or prepared in suspension on a SEM 
grid, including those from separation and 
sampling instruments.  Sample preparation is 
easier than for TEM, and only a small 
quantity of sample needed. Testing possible 
with undiluted dispersions and emulsions.  
SEM enables non-destructive testing of 
samples, and provides an image of the 
sample structure with very precise 
determination of size and shape at high local 
resolution.  This method can be used in-situ 
as Environmental SEM. 
 
A representative sample of the material must 
be used.  Where samples are not electrically 
conducting, plasma sputter-coating the 
surface-adhered particles with a layer of a 
conducting material is often required.  This 
process may modify the sample being 
characterised.  Only a small section of the 
sample is pictured and imaging is limited to 
surface features.  The quality of the images to 
be analysed is of critical importance, and care 
must be taken to avoid bias introduced by 
orientation effects. 
 
Further informative information on this 
method is available in ISO/TR 27628:2007.  
ISO 13322-1:2004 and ISO 13322-2:2006 
provide general guidance for measurement 
description and its validation when 
determining particle size by static and 
dynamic image analysis, respectively. 
Particles in solid, 
powder and 
suspension form. 
 
Size range: < 0.01 
– 10 µm.  
Particularly suitable 
for the particle size 
range of 10 nm – 
µm  
 
Image, providing 
opportunity to 
determine macro-, 
meso- and micro-
descriptors of 
shape 
Scanning Probe Microscopy (SPM) 
 
SPM includes both atomic force microscopy 
and scanning tunnelling microscopy (STM), 
which are all based, with some minor 
modifications, on a scanning probe (called 
the tip), which is moved across a substrate 
where particles have been deposited.  SPM 
techniques allow individual nanoparticles and 
aggregates to be profiled in three dimensions 
from which shape can be studied.  This is an 
advantage over SEM and TEM, which can 
measure only two dimensions. Air samples or 
liquid dispersions can be assessed, including 
those from separation and sampling 
instruments.   SPM images give directly the 
three-dimensional morphology of complex 
samples such as carbon nanotubes, and can 
resolve simultaneously both their atomic 
structure and the electronic density. SPM 
enables rapid sample analysis under ambient 
conditions, and requires minimal sample 
Particles in air or 
dispersed in a 
liquid 
 
Size range: 1nm – 
8 µm 
Image, providing 
opportunity to 
determine macro-, 
meso- and micro-
descriptors of 
shape 
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preparation. 
 
For analysis, the sample must disperse onto 
and adhere to a substrate. The roughness of 
the substrate must be less than the size of 
the particles being measured to avoid a lack 
of clarity regarding image interpretation.  
Although SPM can resolve horizontal and 
vertical details to fractions of a nanometre, it 
is unable to deal with large changes in 
vertical profile occurring over a few 
nanometres. 
 
ISO TR/27628:2007 provides an informative 
description of this method. 
 
Optical microscopic examination 
 
It is preferable to prepare samples directly in 
order not to influence shape and size of the 
particles. 
 
This method provides images for the 
characterisation of the shape and distribution 
of samples of respirable and inhalable 
particles and does not refer to airborne dust 
or dispersed or nebulised particles. 
 
Optical microscopy can be used to examine 
likelihood of fibres present by comparing 
similarities to known fibrous or fibre releasing 
substances or other data.  Extreme care 
required during sample preparation to avoid 
fibre breaking and clumping. Care should 
also be taken to avoid contamination by 
airborne fibres.  Samples might be prepared 
by (a) producing suspensions in water by 
gentle hand agitation or vortex mixing or (b) 
transfer of dry material onto copper tape 
either directly or by spraying of the dry fibres 
by use of atomiser or pipette. Length and 
diameter distributions should be measured 
independently at least twice and at least 70 
fibres counted. No two values in a given 
histogram interval should differ by > 50% or 3 
fibres, whichever is larger. The presence of 
long thin fibres would indicate a need for 
further, more precise measurements. 
Particles of all 
kinds, including 
fibres. 
 
Size range: 0.2–
5000 
µm. 
 
 
 
Fibre diameters as 
small as 0.2 µm 
and as large as 
100 µm and 
lengths as small as 
5 µm and as large 
as 300 µm. 
 
Image, providing 
opportunity to 
determine macro-, 
meso- and micro-
descriptors of 
shape  
 
4.2.24 Using the methods listed in Table R.7.1-X, the following information should be 
presented: 
 Sample preparation methods and analysis methods used 
 Lot number, sample number 
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 Suspending medium, temperature, pH 
 Representative image(s) from microscopy 
 Shape descriptor(s) 
 Reference all Standards (e.g. ISO) used and reference materials used 
 
4.2.25 Published data on shape 
4.2.26 No electronic databases that are specific to particle shape data could be found at 
the time of publication.  Software used with commercial instruments characterising 
shape by image analysis often contain libraries of reference shapes to categorise 
the particles under test.   
4.2.27 R.7.1.19.3 Evaluation of available information on shape 
4.2.28 Experimental data on shape 
4.2.29 Shape is very often not a specific physico-chemical property of a substance. The 
original shape is highly dependent on the industrial processing methods used and 
can also be affected by subsequent environmental or human transformations. In that 
respect any published data on shape will only be pertinent to that particular sample 
or process. 
4.2.30 Macroshape descriptors represent the geometrical proportions of particles.  Most of 
them are ratios of descriptors of different geometrical properties. Geometrical (Table 
R.7.1-X) and proportion (Table R.7.1-X) descriptors of macroshape, mesoshape 
descriptors (Table R.7.1-X), combination of shape descriptors (Table R.7.1-X) and 
roughness descriptors (which represent microshape properties) (Table R.7.1-X) are 
available (ISO 9276-6:2008).  Fractal dimensions are necessary to distinguish 
between mesoshape (concavity) and microshape (descriptors). 
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4.2.31 Table R.7.1-X Geometric macroshape descriptors (reproduced from ISO 9276-
6:2008) 
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4.2.32 Table R.7.1-X Proportion macroshape descriptors (reproduced from ISO 9276-
6:2008) 
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4.2.33 Table R.7.1-X Mesoshape descriptors (reproduced from ISO 9276-6:2008) 
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4.2.34 Table R.7.1-X Combination of shape descriptors (reproduced from ISO 9276-
6:2008) 
 
4.2.35 Table R.7.1-X Roughness descriptor (reproduced from ISO 9276-6:2008) 
 
4.2.36 Non-Experimental data on shape 
4.2.37 At present, there are no QSPR/QSAR tools available for accurately predicting 
particle shape.  Therefore the property will need to be experimentally determined. 
4.2.38 Remaining uncertainty on shape  
4.2.39 It is useful to distinguish between aggregates and agglomerates. While an 
aggregate may be considered to be permanent in most situations, agglomerates 
may break up under certain circumstances. As small particles often form 
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agglomerates, sample pre-treatment (e.g. the addition of dispersing agents, 
agitation or low-level ultrasonic treatment) may be required before the shape can be 
determined. However, great care must be taken to avoid changing the shape or size 
of the particle during sample preparation and the influence of any dispersant on 
testing results. 
4.2.40 A combination of terms and/or measurands may be needed to describe shape; this 
is essential to circumvent the challenges already foreseeable where materials are 
capable of concurrently exhibiting multiple shapes in a sample which may present 
different hazard potentials. 
4.2.41 Problems associated with image analysis are manifold and errors can be introduced 
in the generation of shape descriptors.  These errors can exist at many levels, but 
most of them are fundamentally different from those observed in the more traditional 
techniques used for the characterisation of dispersed matter.  Such shape descriptor 
errors are usually introduced by the protocols necessary to perform calculations on 
any given image (ISO 13322-1:2004, Annex D).  The common sources of errors 
which occur when performing image analysis and in the comparison of image 
analysis protocols include image resolution, binarization and algorithms for 
calculating shape descriptors (ISO 9276-6:2006). 
4.2.42 R.7.1.19.4 Conclusions on shape 
4.2.43 Shape is an important parameter in the characterisation of particles, with contextual 
value to the assessment of deposition, adsorption kinetics, and hazard assessment 
in biological media.  Three corresponding levels of shape can be distinguished: 
macroshape, mesoshape and microshape.  The shape of particles is usually 
determined by electron microscopy (e.g. TEM, SEM), which includes many 
qualitative and semi-quantitative techniques to investigate the morphology (size and 
shape) and also the aggregation state.   
4.2.44 Concluding on C&L and Chemical Safety Assessment 
4.2.45 Shape is not used as a classification and labelling criterion. However, it can be used 
in the chemical safety assessment in considering risks associated with the 
substance. 
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4.2.46 R7.1.19.5 Integrated testing strategy (ITS) for shape 
4.2.47 The following schematic diagram (Figure R.7.1-X) presents an integrated testing 
strategy for shape. 
Representatively sample aliquots of 
material from the substance.
Reproducibly and representatively 
characterise the shape particles/fibres in a 
surface-deposited sample.
Select microscopy technique(s) / 
instrument(s), including consideration 
of suitability for the size range of 
particles/fibres under test.  Appropriate 
instruments / techniques are outlined in 
Table R.7.1-X.
Validate technique/instrument 
response using reference 
materials, if required.
Select sampling technique(s),
including consideration of 
suitability for particles/fibres of the 
substance under test.
Data reporting should provide:
- Sample preparation methods and analysis methods used
- Lot number, sample number
- Suspending medium, temperature, pH
- Representative image(s) from microscopy
- Particle shape descriptor(s)
- Reference all Standards (e.g. ISO) used and reference materials used
 
4.2.48 R.7.1.19.6 References on shape 
4.2.49 Barrett, P.J. 1980, “The shape of rock particles, a critical review”, Sedimentology, 
27, pp. 291-303 
4.2.50 ISO 9276-6:2008 “Representation of results of particle size analysis. Part 6: 
Descriptive and quantitative representation of particle shape and morphology”.  
ISO/TC 24. 
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4.2.51 ISO 13322-1:2004. “Particle size analysis -- Image analysis methods -- Part 1: Static 
image analysis methods”, ISO TC 24/ SC 4.  
4.2.52 ISO 13322-2:2006. “Particle size analysis -- Image analysis methods -- Part 2: 
Dynamic image analysis methods” ISO TC 24/ SC 4. 
4.2.53 ISO 27628:2007 “Workplace atmospheres – Ultrafine, nanoparticle and non-
structured aerosols – Inhalation exposure characterization and assessment”, ISO 
TC 146/SC 2. 
4.2.54 OECD. 2009, "Guidance manual for the testing of manufactured nanomaterials: 
OECD's sponsorship programme. First revision", Series on the safety of 
manufactured nanomaterials, ENV/JM/MONO(2009)20/REV, Paris. 
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4.2.55 R.7.1.20 SURFACE AREA 
4.2.56 For particle-based substances, the surface plays an important role in influencing the 
physical and chemical interactions.  As chemical reactions take place at surfaces, a 
sample of material with a high specific surface area to volume ratio can be expected 
to have a higher reactivity than a sample of the same material with a low specific 
surface area to volume ratio. 
4.2.57 Surface area is an important parameter in the characterisation of nanoparticles, with 
emerging evidence of quantitative value as a dose metric or descriptor for hazard 
assessment.  The total surface area should not be confused with the specific 
surface area where smaller particles have a larger specific surface area 
independent of whether they are present as primary, agglomerated or aggregated 
particles (SCENIHR, 2009).  For nanoscale materials, the reduction in size is 
accompanied by an inherent increase in the surface-to-volume ratio.   
4.2.58 The specific surface area will dictate the surface charge in cases where 
nanomaterials are surface functionalised. This in turn has direct consequences on 
(a) nanomaterial interaction (i.e., agglomeration) with other naturally occurring 
particulate matter (i.e., contaminant vectors); (b) route of exposure as a function of 
surface ligand-biological interface (i.e., bioaccumulation pathway, bioavailability); 
and (c) mechanisms of toxicity (e.g., dose response curves normalized for surface 
area may indicate different results compared to results presented on a per mass 
basis)" (OECD, 2009).  
4.2.59 The volume specific surface area (VSSA) is determined from the entire particulate 
powder material including the whole size range distribution, with all external and/or 
internal surfaces.  It characterises the entire particulate surface area per volume of a 
solid and/or powder material.  The VSSA can be used to distinguish dry solid 
nanostructured material from non-nanostructured material based on its integral 
material surface area per material volume (SCENIHR, 2010; Kreyling et al., 2010). 
4.2.60 The toxicity of some nanoparticles has been demonstrated in a number of studies to 
be related to their small size and therefore high surface area (e.g. Duffin et al., 2002, 
Duffin et al., 2007, Stoeger et al., 2006; Oberdörster et al., 2005).  In addition, it has 
been observed in several nanotoxicity studies that effects correlate with surface 
area (e.g. Brown et al., 2001; Donaldson et al., 1998; Oberdorster et al., 1992; Tran 
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et al., 2000) to a greater extent than mass as a dose metric. Other studies have 
demonstrated that the mass or volume may be a better descriptor in some cases. 
No scientific consensus has been reached at this stage regarding whether a single 
metric will be appropriate or possible given the complexity of different toxicological 
profiles and physico-chemical characteristics. 
4.2.61 Definitions of surface area 
4.2.62 Surface area is defined as the area of the exposed surface of a single particle, or 
more general, the area of the exposed surface of a certain amount of a material 
(OECD, 2009).  
4.2.63 Surface area as an extensive quantity depends on the amount of the material, and 
therefore a better comparable characteristic is the ratio of the surface area to the 
mass of a certain amount of a material. This is the so called specific surface area 
which is an intensive quantity and thus independent of the amount of the material. 
The volume specific surface area (VSSA) of a material is an ensemble 
measurement, only valid for the entire material as analysed; if a fraction/subset of 
the material (e.g. fractionated by size) is analysed, this subset will have a different 
VSSA which may be above or below the VSSA of the initial entire material.   
4.2.64 Specific surface area = surface area of a material divided by its mass [SI unit: 
m2/kg].  
4.2.65 Volume specific surface area = density multiplied by the mass specific surface area 
[SI unit: m2/cm3].    
4.2.66 R.7.1.20.1 Information requirements on surface area 
4.2.67 The study does not need to be conducted if the substance is marketed or used in a 
non-solid or non-granular form. Specific surface area requires information on water 
insolubility. Fibre length and diameter distributions require information on the fibrous 
nature of the product and on stability of the fibrous shape under electron microscope 
conditions.   
4.2.68 The summary should include a determination of the specific surface area [m2/kg] 
and (where appropriate) the calculated volume specific surface area [m2/cm3] of the 
material under investigation, the temperature and conditions at which 
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measurements were made, purity of the sample used, physical state, method used 
and reference substance used (if any). 
4.2.69 R.7.1.20.2  Available information on surface area 
4.2.70 Testing data on surface area 
4.2.71 The characterisation of particle properties requires very careful sampling and 
sample splitting practices to be followed.  ISO 14488:2007 specifies methods for 
obtaining a test sample from a defined sample of particulate material (powder, 
paste, suspension or dust) that can be considered to be representative of the whole 
sample with a defined confidence level.  Further is available in the Sample 
Preparation section of the Introduction to R.7. 
4.2.72 By far the most common technique for measurement of the surface area of particles 
is by gas absorption measurements using Brunauer, Emmet and Teller (BET) 
adsorption isotherm theory (Table R.7.1-Y) (Brunauer et al., 1938). This is a high 
vacuum method and requires a clean, dry sample of the nanomaterial.  Nitrogen is 
the most common adsorbate, although many other gases such as argon, carbon 
dioxide, or krypton are also used.  The BET technique involves measuring the 
amount of adsorbate released on vaporisation.  The BET surface represents the 
surface area that is freely accessible to gases.  The primary particle diameter 
(assumed as equivalent sphere diameter) is subsequently calculated from already 
available specific surface area and density of particles. Although this method 
provides measurement of two parameters simultaneously, i.e. size as well as 
surface area, the drawback of this procedure is in the assumption of a mono-
dispersed spherical system which reports only an average size and does not provide 
the size distribution or a surface area distribution. 
4.2.73 Emerging techniques for measuring particle surface area of nanoparticles in 
dispersion are being commercialised but are not yet standardised, such as the NMR 
analysis system for specific surface area determination of nano dispersions. This 
technique is based on the fact that liquid in contact with or “bound” to the surface of 
a particle behaves differently from that of the “free” liquid.  Bound liquid molecules 
undergo restricted motion while free liquid can move unrestricted. The NMR 
relaxation time of liquid “bound” to the particle surface is much shorter than that of 
“free” liquid, the difference can be several orders of magnitude. In most situations 
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there is a rapid exchange between liquid molecules on the surface and in the rest of 
the fluid, and an average relaxation time can be measured; this is then a direct 
measure of the amount of available particle surface area.   
4.2.74 Table R.7.1-Y Brunauer, Emmet and Teller (BET) for determination of surface 
area 
Method and details Material Data type 
BET method (ISO 9277:2010; ISO 18757:2005) 
 
Enables determination of the total specific external and 
internal surface area of by measuring the amount of 
physically absorbed gas.  Commonly applied to 
determine the surface area of nanomaterials.  Allows an 
assessment of the agglomeration state of powders. 
 
Method assumes a mono-dispersed spherical system 
and provides a measurement of the surface area of a dry 
particle, which is not necessarily representative of the 
surface area of the particle when dispersed in the 
exposure medium.  In order to ensure proper working 
conditions and correct data evaluation, the apparatus 
performance should be monitored periodically using a 
surface-area reference material.  The BET method 
cannot reliably be applied to solids which absorb the 
measuring gas. 
 
ISO 9277:2010 is applicable to adsorption isotherms of 
type II [disperse, nonporous or macroporous solids] and 
type IV [mesoporous solids, pore diameter between 2-50 
nm].  ISO 18757:2005 is applicable for determination of 
the total specific external and internal surface area of 
disperse or porous [pore diameter > 2 nm] fine ceramic 
materials. 
 
Disperse or porous 
solids (e.g. powders) 
Specific surface 
area (m2/kg) 
 
4.2.75 Using the BET method, the following information should be presented: 
- sample preparation methods and analysis methods used 
- lot number, sample number 
- pre-treatment and degassing conditions, e.g. degassing in a vacuum or in inert 
gas flow, temperature and duration of degassing; 
- mass of degassed sample; 
- adsorptive (chemical nature, purity); 
- adsorption isotherm (na, plotted against relative pressure, p/p0), measurement 
temperature; 
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- evaluation parameters: multipoint or single-point determination, BET plot or range 
of linearity, monolayer amount, BET parameter C, molecular cross-sectional area 
used; 
- specific surface area; 
- references for all Standards (e.g. ISO) and reference materials used. 
4.2.76 Published data on surface area 
4.2.77 No electronic databases that are specific to particle surface area data could be 
found at the time of publication. 
4.2.78 R.7.1.20.3 Evaluation of available information on surface area 
4.2.79 Experimental data on surface area 
4.2.80 Surface area is not a specific physico-chemical property of a substance. Any 
published data on surface will only be pertinent to that particular sample or process. 
4.2.81 Non-Experimental data on surface area 
4.2.82 At present, there are no QSPR/QSAR tools available for accurately predicting the 
surface area of nanomaterials.  Therefore the property will need to be 
experimentally determined. 
4.2.83 Remaining uncertainty on surface area  
4.2.84 In many cases specific surface area measurements are derived quantities that 
depend on the nature of the probe molecule. (OECD, 2010).  In the case of porous 
materials, it is often useful to distinguish between external and internal surface. The 
external surface is usually regarded as the envelope surrounding the discrete 
particles or agglomerates, but is difficult to define precisely because solid surfaces 
are rarely smooth on an atomic scale.  The external surface include all the 
prominences and also the surface of those cracks which are wider than they are 
deep; the internal surface comprises the walls of all cracks, pores and cavities which 
are deeper than they are wide and which are accessible to a test gas (the 
adsorptive). In practice, the demarcation depends on the methods of assessment 
and the nature of the pore size distribution; hence accessibility of pores depends on 
the size and shape of gas molecules, the area of, and the volume enclosed by, the 
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internal surface as determined by gas adsorption will depend on the adsorptive 
molecules (molecular sieve effect).   
4.2.85 Not all particulate materials are amenable to a meaningful VSSA determination, for 
example where the specific surface area of substances with complex structural 
assemblies where the internal components are intrinsically not measurable.   
4.2.86 R.7.1.20.4 Conclusions on surface area 
4.2.87 For particle-based substances, the surface plays an important role in influencing the 
physical and chemical interactions.  Surface area is an important parameter in the 
characterisation of nanoparticles in particular, with emerging evidence of 
quantitative value as a dose metric / descriptor for hazard assessment.  The surface 
area will dictate the surface charge in cases where nanomaterials are surface 
functionalised, with direct consequences on nanomaterial interaction (i.e., 
agglomeration) with other naturally occurring particulate, route of exposure as a 
function of surface ligand-biological interface and mechanisms of toxicity (OECD, 
2009). By far the most common technique for measurement of the surface area of 
particles is by gas absorption measurements using Brunauer, Emmet and Teller 
(BET) adsorption isotherm theory. 
4.2.88 Concluding on C&L and Chemical Safety Assessment 
4.2.89 Surface area is not used as a classification and labelling criterion. However, it can 
be used in the chemical safety assessment in considering risks associated with the 
substance. 
4.2.90 R.7.1.20.5 Integrated testing strategy (ITS) for surface area 
4.2.91 The tiered approach to testing (Section R.7.1.14) combined with the choice of an 
appropriate test method and implemented in conjunction with the ITS for 
granulometry (R.7.1.14.4) represents an integrated testing strategy for specific 
surface area. 
4.2.92 R.7.1.20.6 References on surface area 
4.2.93 Brown, D.M., Wilson, M.R., MacNee, W., Stone, V. and Donaldson, K. 2001, and 
"Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for 
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surface area and oxidative stress in the enhanced activity of ultrafines", Toxicology 
and Applied Pharmacology, vol. 175, no. 3, pp. 191-199. 
4.2.94 Brunauer, S., Emmett, P.H. and Teller, E. 1938, “Adsorption of gases in 
multimolecular layers,” J. Am. Chem. Soc., 60, p. 309. 
4.2.95 BS EN ISO 18757:2005. “Fine ceramics (advanced ceramics, advanced technical 
ceramics). Determination of specific surface area of ceramic powders by gas 
adsorption using the BET method”, BSI. 
4.2.96 Donaldson, K., Li, X.Y., MacNee, W. 1998, “Ultrafine (nanometer) particle mediated 
lung injury”, J. Aersol. Sci., vol. 29, 553-560.   
4.2.97 Duffin, R., Tran, C. L., Clouter, A., Brown, D. M., MacNee, W., Stone, V. and 
Donaldson, K. 2002, "The importance of surface area and specific reactivity in the 
acute pulmonary inflammatory response to particles", Ann Occup Hyg, vol. 46, no. 
1, pp. 242-245. 
4.2.98 Duffin, R., Tran, L., Brown, D., Stone V. and Donaldson, K. 2007, 
"Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: 
highlighting the role of particle surface area and surface reactivity", Inhal Toxicol, 
vol. 19, no.10, pp. 849-856. 
4.2.99 ISO 9277:2010. “Determination of the specific surface area of solids by gas 
adsorption -- BET method”, ISO TC 24/SC 4. 
4.2.100 Kreyling WG, Semmler-Behnke M, Chaudhry Q. 2010. „A complementary definition 
of nanomaterial”. Nano Today, 5:165-8 (Available online 5 May 2010, ISSN 1748-
0132, DOI:10.1016/j.nantod.2010.03.004). 
4.2.101 Oberdorster, G., Ferin, J., Gelein, R., Soderholm, S.C., Finkelstein, J. 1992, “Role of 
the alveolar macrophage in lung injury studies with ultrafine particles“, Env. Health 
Perspect., vol. 97, 193-199.  
4.2.102 Oberdörster G, Oberdörster E, Oberdörster J. 2005b. Nanotoxicology:  an emerging 
discipline evolving from studies of ultrafine particles. Environ Health Perspect 
113:823–839. 
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4.2.103 OECD. 2009, "Guidance manual for the testing of manufactured nanomaterials: 
OECD's sponsorship programme. First revision", Series on the safety of 
manufactured nanomaterials, ENV/JM/MONO(2009)20/REV, Paris. 
4.2.104 OECD. 2010, "Preliminary Guidance Notes on Sample Preparation and Dosimetry 
for the Safety Testing of Manufactured Nanomaterials", Series on the safety of 
manufactured nanomaterials, ENV/JM/MONO(2010)25, Paris. 
4.2.105 SCENIHR. 2010, (Scientific Committee on Emerging and Newly Identified Health 
Risks), "Scientific basis for the definition of the term nanomaterial”, Pre-consultation 
opinion, 6 July 2010.   
4.2.106 Stoeger, T., Reinhard, C., Takenaka, S., Schroeppel, A., Karg, E., Ritter, B., Heyder, 
J. and Schulz, H. 2006, "Instillation of six different ultrafine carbon particles indicates 
a surface area threshold dose for acute lung inflammation in mice", Environ Health 
Perspect. vol. 114, no.3, pp. 328-333. 
4.2.107 Tran, C.L., Buchanan, D., Cullen, R.T., Searl, A., Jones, A.D., Donaldson, K. 2000, 
“Inhalation of poorly soluble particles. II. Influence of particle surface area on 
inflammation and clearance”, Inhalat. Toxicol., vol. 12, 1113-1126. 
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4.3 RESEARCH & DEVELOPMENT REQUIREMENTS 
4.3.1 The following section outlines proposals for further R&D in relation to enhancing the 
evidence base of relevance/applicability of the information requirements, test 
methods or testing strategies for nanomaterials in the context of REACH.  These 
recommendations do not preclude the determination and consideration of data 
where it can be feasibly gathered.  It is not within the remit of the RIP-oN2 project to 
develop a strategy for addressing the research & development needs.  Where it is 
identified that an important R&D need exists by other organisations (e.g. by OECD) 
or on the basis of the evidence and guidance reviewed, by default a high priority is 
assigned to specific properties, endpoints and/or methods.  All others are 
considered to be of lower priority for further research and development and are 
indicated using an asterisk.   
4.3.2 In relation to the recommendations for guidance which introduce additional 
information requirements (i.e. shape, surface area), we recommend that emerging 
standards and guidance documents, and implementations from the OECD 
Sponsorship Programme be considered. 
4.3.3 PHYSICO-CHEMICAL PROPERTIES 
4.3.4 EXISTING INFORMATION REQUIREMENTS 
4.3.5 R.7.1.4 Relative density 
4.3.6 Further research is required to assess the applicability of OECD TG 109 to 
nanomaterials, and modify if necessary (OECD, 2009). 
4.3.7 R.7.1.6 Surface tension 
4.3.8 Further research is required to assess the applicability of OECD TG 115 for 
nanomaterials, and modify if necessary (OECD, 2009). 
4.3.9 R.7.1.7 Water solubility 
4.3.10 On the basis of SCENIHR’s 2009 opinion and OECD’s conclusion in 
ENV/JM/MONO(2009)21, further work is required to determine the applicability of 
TG 105 and whether the results might be impacted by the presence of a colloidal 
suspension, which might be present if the sample manufactured nanomaterial does 
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not completely dissolve.  Further research required to resolve/overcome issues with 
agglomeration of nanomaterials in water solubility tests (RNC/RIP-oN2/B1/2/FINAL, 
4.9-16).   
4.3.11 ISO/AWI TR 13014 may contain information of relevance to consider in relation to 
the solubility and dispersibility of nanomaterials and it is recommended that this 
standard be reviewed when it reaches Final Draft International Standard (FDIS) 
status ((RNC/RIP-oN2/B3/2/FINAL, 6.1.10) for possible future citation in updated 
REACH Guidance. 
4.3.12 R.7.1.8 Partition coefficient N-octanol/water 
4.3.13 Further research is required to assess the applicability of OECD TG 107, 117 and 
123 for nanomaterials, and modify if necessary (OECD, 2009). 
4.3.14 R.7.1.10 Flammability 
4.3.15 Further research required into applicability of current flammability test methods for 
nanopowders (RNC/RIP-oN2/B4/2/FINAL, table 4.9), building on initial work by 
NANOSAFE 2 (RNC/RIP-oN2/B3/2/FINAL, 3.1.75-85).  This should include the 
validation of methods and the development of Standard Operating Procedures 
(SOP).   
4.3.16 R.7.1.11 Explosive properties  
4.3.17 Further research needed into applicability of current explosivity test methods for 
nanopowders (RNC/RIP-oN2/B4/2/FINAL, table 4.10), building on initial work by 
NANOSAFE 2 (RNC/RIP-oN2/B3/2/FINAL, 3.1.75-85).  This should include the 
validation of methods and the development of Standard Operating Procedures 
(SOP).   
4.3.18 R.7.1.14 Granulometry 
4.3.19 The definition and scope of the term “Granulometry” under REACH is required to be 
developed and agreed (RNC/RIP-oN2/B2/2/FINAL, 5.1.4).  This is a priority 
requirement. 
4.3.20 OECD TG 110 is required to be updated and extended to cover nanoparticles, 
including acknowledgement of other standardised equipment (e.g. Centrifugal 
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Sedimentation) (RNC/RIP-oN2/B4/2/FINAL, table 4.13 Method B).  Method A of 
OECD TG 110 (sedimentation, or centrifugation) is not applicable to nanomaterials 
(OECD, 2009), as it is useful only in the range 2 µm < Rs < 100 µm.  However, 
alternative standardised equipment (e.g. centrifugal sedimentation) can be used in 
accordance with this method.  Method B of OECD TG 110 (electron microscopy) 
requires a necessary but minor deviation in the data reporting for nanomaterials 
(i.e. particles/fibres of less than 5 microns in length and less than 100 nm in 
diameter).   
4.3.21 The following draft standards are recommended to be reviewed when they reach 
FDIS status, with a view to assessing their relevance for incorporation into the 
REACH Guidance on Granulometry (RNC/RIP-oN2/B3/2/FINAL, 6.1.46-47): 
 ISO/AWI TS 10797, which describes the characterisation of SWCNT using 
transmission electron microscopy (currently at Committee Draft stage); 
  ISO/AWI TS 10798, which describes the characterisation of SWCNT using 
scanning electron microscopy (SEM) and energy dispersive X-ray 
spectrometry analysis (currently at Committee Draft stage) 
 ISO/CD 12025, which aims to provide a general framework for determining 
nano-object release from powdered engineered nanoparticles into the 
gaseous surroundings by means of analysis of the generated aerosols 
particles (currently at Committee Draft Stage). 
4.3.22 R.7.1.15 Adsorption / Desorption 
4.3.23 Further work may be required to establish the relevance of this property for 
nanomaterials.  A consensus opinion on this matter could not be reached within the 
Project Consortium. 
4.3.24 R.7.1.17 Dissociation constant 
4.3.25 Further work is required to assess the applicability of OECD TG 112 for 
nanomaterials, and modify it, should this be necessary (OECD, 2009). 
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4.3.26 ADDITIONAL RELEVANT SPECIFIC INTRINSIC PROPERTIES 
4.3.27 Shape 
4.3.28 ISO/AWI TS 10797, which describes the characterisation of SWCNT using 
transmission electron microscopy, (currently at Committee Draft stage) is 
recommended to be reviewed when it reaches FDIS status, with a view to 
assessing its relevance for incorporation into REACH Guidance on shape 
(RNC/RIP-oN2/B3/2/FINAL, 6.1.62). 
4.3.29 Specific Surface Area 
4.3.30 Further work required to develop suitable reference materials for nanomaterials, to 
be used in methods such as BET (RNC/RIP-oN2/B4/2/FINAL, table 4.18; RNC/RIP-
oN2/B3/2/FINAL 4.1.233, 6.1.67).  This should include the validation of material and 
method combinations and the development/adoption of a Standard Operating 
Procedures (SOP).  Should the new work item under ISO/TC 229 on "Generic 
requirements for reference materials for development of methods for characteristic 
testing, performance testing and safety testing of nano-particle and nano-fibre 
powders" be accepted, this work may produce important outputs of relevance to the 
characterisation of nanomaterials.    
4.3.31 The validity of calculating surface area based on particle size measurements 
(obtained via methods such as SMPS, SAXS etc.) requires further investigation for 
nanomaterials (RNC/RIP-oN2/B4/2/FINAL, table 4.18 SMPS/FMPS) and the 
development/adoption of a Standard Operating Procedure (SOP).   
4.3.32 Porosity 
4.3.33 Further research into the relevance of the property of porosity is required, in terms of 
both its influence on the (eco)toxicological effects of nanomaterials and the 
applicability of available methods for nanomaterials (RNC/RIP-oN2/B2/2/FINAL, 
5.2.19; RNC/RIP-oN2/B4/2/FINAL table 4.19).  This will likely emerge as part of the 
OECD Sponsorship Programme, as porosity is included on the list of properties to 
be investigated.  The R&D requirement includes basic research to establish the 
relevance of the property and applicability of methods, the validation of methods and 
the development of Standard Operating Procedures (SOP).   
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4.3.34 Surface energy 
4.3.35 Further research is needed in order to investigate the influence of surface energy 
on (eco)toxicological effects and to develop robust methods for the determination of 
the surface energy of nanomaterials. (RNC/RIP-oN2/B4/2/FINAL, table 4.20).  The 
R&D requirement includes basic research to establish the relevance of the property 
and applicability of methods, the validation of methods and the development of 
Standard Operating Procedures (SOP).   
4.3.36 Surface chemistry 
4.3.37 Further research is required into the relationship between surface chemistry and 
(eco)toxicological effects, and the utility of subsequent data for hazard assessment 
in a regulatory context.  This will likely emerge from the OECD Sponsorship 
Programme, as this property is one of those under consideration.  The R&D 
requirement includes basic research to establish the relevance of the property and 
applicability of methods, the validation of methods and the development of 
Standard Operating Procedures (SOP).   
4.3.38 It is recommended that ISO/DTR 14187 (which looks specifically at the surface 
chemical analysis of nanostructured materials), ISO/NP TS 10812 (which outlines 
the use of Raman Spectroscopy for the characterisation of SWCNT) and ISO/AWI 
TR 13014 (which aims to provide guidance on physico-chemical characterisation for 
manufactured nano-objects for toxicological testing), should be reviewed when they 
reach FDIS stage. 
4.3.39 Surface acidity 
4.3.40 Further research is required into surface complexation models and methods to 
study the surface acidity of nanomaterials (OECD, 2010), as well as the relationship 
between surface acidity and (eco)toxicological effects of nanomaterials (RNC/RIP-
oN2/B4/2/FINAL, table 4.21).  The R&D requirement includes basic research to 
establish the relevance of the property and applicability of methods, the validation 
of methods and the development of Standard Operating Procedures (SOP).   
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4.3.41 Surface charge 
4.3.42 Further research into the relationship between surface charge (zeta potential) and 
(eco)toxicological effects of nanomaterials is required (RNC/RIP-oN2/B3/2/FINAL, 
3.1.253-257, 4.1.120-128, 5.1.37-40; RNC/RIP-oN2/B4/2/FINAL, table 4.22).  The 
R&D requirement includes basic research to establish the relevance of the property 
and applicability of methods, the validation of methods and the development of 
Standard Operating Procedures (SOP).   
4.3.43 ISO/TC 24 is currently in the process of developing two standards on zeta potential 
determination, ISO/DIS 13099-1 and ISO/DIS 13099-2.  Although these standards 
are not specifically for the characterisation of nanomaterials, it is recommended 
they be reviewed once published (RNC/RIP-oN2/B3/2/FINAL, 6.1.77) for possible 
future citation in updated REACH Guidance. 
4.3.44 Redox potential 
4.3.45 Research into the applicability of standard electrochemical methods, as well as 
alternative methods, for determining the redox potential of nanomaterials is required 
(RNC/RIP-oN2/B3/2/FINAL, 4.1.176-178; RNC/RIP-oN2/B4/2/FINAL, table 4.23).  
The R&D requirement includes basic research to establish the relevance of the 
property and applicability of methods, the validation of methods and the 
development of Standard Operating Procedures (SOP).   
4.3.46 Cell-free ROS/RNS production capacity 
4.3.47 Further research required into the relationship between ROS/RNS generating 
capacity and (eco)toxicological effects of nanomaterials, as well as the 
development of standard measurement methods for nanomaterials (RNC/RIP-
oN2/B4/2/FINAL, table 4.24).  The R&D requirement includes basic research to 
establish the relevance of the property and applicability of methods, the validation 
of methods and the development of Standard Operating Procedures (SOP).   
4.3.48 GENERAL CONSIDERATIONS 
4.3.49 As part of the PARTICLE_RISK project, Zuin et al. (2010) developed an evidence-
based approach for undertaking a preliminary ranking of nanoparticles in terms of 
their hazard potential.  This involves assigning a hazard rating of high, moderate or 
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low to a specific nanoparticle across a range of “indicators” (physico-chemical or 
toxicological endpoints), according to a ranking table.  The weight-of-evidence 
approach developed in PARTICLE_RISK has the potential to inform the 
development of thresholds for hazard testing based on nanomaterial type in the 
context of REACH.  However, the current ranking values were based on 
measurement data which differed in their uncertainty and reliability, and further 
research data is required to enable a robust set of criteria/thresholds for hazard 
assessment within the physico-chemical property information requirements to be 
developed. 
4.3.50 A number of key general points have been noted from the review of the scientific 
literature (RNC/RIP-oN2/B3/2/FINAL, section 4.1) for further consideration in the 
context of research and development requirements to further establish or validate 
emerging outputs.  These include: 
 It has been suggested that adequate particle characterisation should be 
performed in three distinct phases, primary, secondary, and tertiary, where: 
primary characterisation is performed on particles as-synthesised or as-
received in its dry native state; secondary characterisation is performed on 
particles in the wet phase as a solution or suspension in aqueous media; 
tertiary characterisations are performed on particles following interactions 
with cells under in vivo or in vitro conditions (Sayes and Warheit, 2009).  
Characterisation after administration is particularly advantageous where the 
possibility of physico-chemical changes in the material before and after 
administration exists.  Hence, there is need to establish the limits of when 
characterisation of nanomaterials as-produced or as-supplied (which is the 
most direct and currently realistic approach to obtaining physico-chemical 
information about the material being studied) can represent the properties of 
the material when in contact with the environment in which it is being 
observed, for example in air or physiological environments of in vivo or in 
vitro assays;   
 A wider set of reference materials and procedural standards (including for 
sampling and measurement) are urgently required to overcome the problem 
of inconsistent data (Lead and Wilkinson, 2006; Borm et al., 2006). Some 
progress has been made recently regarding reference materials for 
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characterisation, but standardised nanoparticles are not yet widely available 
and researchers have to rely on commercially available, often not well-
characterised nanoparticles (Linsinger et al., 2011).   
 It is highly recommended that NanoImpactNet (NIN) protocols are reviewed 
when published with a view to assessing their relevance for incorporation 
into the REACH Guidance (RNC/RIP-oN2/B3/2/FINAL, 3.1.192-194). 
Protocols submitted to NIN thus far relate to exposure systems, particle 
preparation, particle characterisation, oxidative stress, cytotoxicity and 
exposure assessment. 
 There is a need to develop (and include in the REACH Guidance, when 
available) standardised and validated methodologies for sampling 
nanomaterials and accompanying SOPs. 
 There is a need to develop clear guidance on in situ characterisation and 
testing.  This requires basic research to establish the applicability of 
methods, the validation of methods and the development of Standard 
Operating Procedures (SOP).   
4.3.51 There are also a number of generic standards under development by ISO which, 
although they may not provide information of relevance to a specific REACH 
Information Requirement or additional relevant specific intrinsic property, are 
important to consider in the future (RNC/RIP-oN3/B3/2/FINAL, 6.1.99-6.1.105). 
4.3.52 ISO/DTR 13121, which describes a process for evaluating, addressing, making 
decisions about, and communicating the potential risks of developing and using 
engineered nanoscale material (currently at FDIS stage). While this technical report 
does not address specific methods for characterising the physico-chemical 
properties of nanomaterials, it does provide guidance for establishing a physico-
chemical profile of the nanomaterial as part of an overall risk evaluation process 
and is recommended to be reviewed once published. 
4.3.53 ISO/DTR 13121 (currently at Committee Draft stage) is recommended to be 
reviewed once published as it highlights the importance of characterising the 
physico-chemical properties of a nanomaterial over its entire life cycle, and 
suggests that any anticipated changes in relevant physical and chemical properties 
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across the lifecycle of the material should be noted.  For these reasons, the 
document suggests that it may be necessary to characterise the material at multiple 
points, unless there is good reason to expect that the material will remain 
unchanged.  It provides the recommendation that the properties of the nanomaterial 
should be compared to those of the corresponding bulk (non-nanoscale) materials, 
where appropriate, to determine the nature and extent to which the properties are 
different.  This information will be useful to further assess the possibility of read-
across of data from the bulk form to the nano-form.  Currently, ISO/DTR 13121 lists 
the following properties as being relevant to characterise in relation to the risk 
assessment of nanomaterials: chemical composition (including surface coating), 
molecular and crystal structure, physical form and shape (at room temperature and 
pressure), particle size, size distribution and surface area, particle density, solubility 
(in water and biologically relevant fluids), dispersibility, bulk density, agglomeration 
state, porosity, surface charge and surface reactivity. 
4.3.54 There are also two further draft standards under development by ISO, which are 
recommended to be reviewed once published, as they are expected to provide 
valuable information in relation to the physico-chemical characterisation of 
nanomaterials, namely ISO/AWI TS 11931-1 and ISO/AWI TS 11937-1 which 
describe characteristics and measurement methods for nano-calcium carbonate 
and nano-titanium dioxide, respectively.  
4.3.55 In addition, ISO/TC 229 has a new work item on "Generic requirements for 
reference materials for development of methods for characteristic testing, 
performance testing and safety testing of nano-particle and nano-fibre powders" 
currently out for ballot.  This work will undoubtedly produce important outputs of 
relevance to the characterisation of nanomaterials, but it is unlikely that this will be 
available for some time.   
4.3.56 TOXICOLOGICAL ENDPOINTS & TESTING 
4.3.57 The following section outlines proposals for further R&D in relation to toxicological 
information requirements, test methods or testing strategies for nanomaterials, 
based on the outcomes of the gap analysis (RNC/RIP-oN2/B4/2/FINAL).   
RNC/RIP-oN2/FPR/1/FINAL 
 
- 292 - 
4.3.58 R.6 QSARS AND GROUPING OF CHEMICALS  
4.3.59 The advice provided on the “scientific basis for the categorisation of nanomaterials 
and application of in silico methods, read-across and category approaches for 
deriving hazard information for nanomaterials from the information on bulk 
substances or from comparison between nanomaterials” concluded that a fully 
prescribed category approach is not yet possible for nanomaterials. As such, the 
approach presented is a higher level overview and suggests where such groupings 
could potentially be applied. However further development and validation of both 
testing methods as well as the category approach itself is required before a true 
category approach can be taken.   
4.3.60 The use of QSAR/read across/grouping is not recommended unless scientifically 
justified and validated by experimental values in the same range that applies to the 
characteristics of the (nano)material.  
4.3.61 It is recommended that the advice provided be considered for further development 
of a possible new sub-section on nanomaterials under R.6.2.5 Guidance on specific 
types of categories.   
4.3.62 NON-TESTING IN SILICO APPROACHES  
4.3.63 The potential value of the development of validated in silico or non-testing 
approaches for nanomaterials, as with all substances under REACH, cannot be 
over stated and as such this could be considered a high, short term to medium term 
priority. However as discussed in sections 4.2 and 4.3 of this document, such 
approaches are not yet sufficiently developed for nanomaterials. The use of non-
testing data, where justified and acceptable is beneficial in several ways not least 
due to the reduction of testing resources required for registration improving the 
speed in which substances can be registered and associated cost. 
4.3.64 Where in silico approaches are based on extensive data sets, especially those 
consisting of human epidemiological data for analogous materials, these may allow 
a clearer insight into the potential long term effects of materials in a ‘real world’ 
situation that may not be as accurately gleaned from standard test methods using 
animal models. This again may be particularly pertinent in the case of complex 
disease state for which extrapolation between animal models and humans maybe 
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difficult such as for carcinogenicity. As such further research development and 
validation of such approaches should be considered one the highest priorities to 
ascertain their applicability to nanomaterials. Such R&D should focus on the 
following areas of  non-testing approaches: 
4.3.65 Basis for grouping or categorisation of nanomaterials based upon physico-
chemical characteristics could allow the broad identification of hazardous 
properties which would inform of the need for furtherer testing and potential 
endpoints to be tested. A preliminary scheme is suggested based upon the 
current scientific evidence behind drivers of (nano)particle toxicology and has 
been discussed. Thorough characterization of NM and efficient sharing of this 
data along hazard information are important conditions for the rapid 
development in this area.  
4.3.66 The development of a greater understanding and implementation of (Q)SAR 
approaches would be enormously beneficial to allow rapid screening of 
materials based upon structural/ chemical attributes with defined toxicological 
importance.   
4.3.67 Further R&D into read-across is also required for validation of non-testing 
approaches. However the nature of the read-across requires consideration. 
By this, we mean read-across between to differing forms of particle, both 
within the nano-dimension (nanoparticle to nanoparticle read-across) or 
between a bulk (non-nano dimension) material and a nanomaterial of the 
same composition (bulk to nano read-across). The benefit of this is that 
testing data that has already been obtained for a bulk compound may be 
usable and applicable for nanomaterials and as such reduce or remove the 
need for further testing (reducing animal testing). 
4.3.68 CONSIDERATIONS FOR STUDY DESIGN 
4.3.69 Investigations undertaken and reported to date have highlighted a number of key 
issues or gaps in existing testing strategies which may influence the outcome of 
studies, and thus should be observed closely in the consideration of nanomaterials 
within the context of REACH. 
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4.3.70 In relation to the manner in which experiments are set up, factors such as the 
exposure method, dose selected, species used, cell type under investigation and in 
the case of photo-reactive nanomaterials such as some metal oxides, light 
conditions (Warheit et al. 2005) all have the potential to impact on the toxicity of 
nanoparticles, indicating that the experimental set up is very influential. 
4.3.71 A summary and discussion of those issues considered to be of importance in this 
respect is provided below.  
4.3.72 Dispersion 
4.3.73 As discussed at various points within the RNC/RIP-oN2/2/B3/FINAL report, it is 
clear that dispersion impacts upon the potential toxicity of nanomaterials in animals 
or cells. A multitude of dispersing processes have been utilised by investigators to 
improve the dispersion including solvents (such as acetone), surfactants (such as 
pluronic), proteins (albumin and serum) or mechanical processes (such as 
centrifugation, or sonication).  At this time it is not possible to conclude which 
techniques are most appropriate, but in designing experimental protocol for 
consideration of nanomaterials in the context of REACH, it is essential that such 
techniques should try to mimic realistic exposure scenarios, routes and avoid 
interference by dispersants.   
4.3.74 Selection of Dose  
4.3.75 Many investigations reported have used very high doses, raising the question of 
whether the toxic effects observed are likely to derive from dose used or the 
material. In particular, at high doses, the aggregation of CNT is promoted, and so 
the toxicity that transpires in vivo is potentially a result of the blockage of airways 
and blood vessels, rather than to a specific toxic effect.   
4.3.76 In order to inform selection of relevant nanomaterial exposure concentrations to be 
used within in vitro and in vivo experiments, information regarding the human 
exposure levels is required as a reference. However, at the current time this is 
severely lacking and thus exposure assessment is of key importance to developing 
sound dose selection for future studies  
4.3.77 In relation to dosing regime, many investigations of nanomaterial toxicity have used 
a single dose administered to animals or cells. Within occupational or consumer 
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settings, it is more likely that normal nanomaterial exposures (non-accidental) will 
occur over a period of time, depending on their application. 
4.3.78 Selection of exposure route and duration 
4.3.79 Testing methods for initial in vivo toxicity assessment normally use the oral route of 
exposure. However for the testing of nanomaterials, this may not be the ideal first 
candidate. As a general observation, repeated dose studies with lower doses over a 
long time period and use of a route of exposure appropriate to the end use of the 
nanomaterial in question, are likely to be of greater relevance in consideration of 
the potential risk of nanomaterials within occupational or consumer settings, than 
extremely short exposures at high doses. In addition, the use of chronic studies will 
also allow for the more relevant identification of the potential carcinogenic 
consequences of nanomaterial exposure. 
4.3.80 Interaction of nanoparticles with biological molecules  
4.3.81 Attention should be directed to consideration of the role that interaction of 
nanoparticles with biological molecules plays in altering their behaviour within 
biological systems. It is known that on entering the body, particles immediately 
become coated in biological molecules, including proteins. It is hypothesized that 
this coating can influence particle behaviour and toxicity, with different particles 
having different capacities to bind different molecules. Furthermore, there is a 
possibility that the particles can alter the protein structure and function (and thus 
behaviour), which again may contribute to toxicity.  Further research is required to 
generate a greater understanding of this complex area, and it is advised that 
consideration should be given in future experimentation to the role that such 
interactions may play in toxicity.  
4.3.82 Use of physico-chemical data to inform experimental design 
4.3.83 It was been highlighted both within the toxicology and physico-chemical sections of 
RNC/RIP-oN2/B3/2/FINAL that the physico-chemical characteristics of particles 
used (size, crystallinity, functionalisation, contamination etc.) can impact on their 
toxicity.  Thus, as these factors are able to influence the findings obtained, a 
thorough physico-chemical characterisation should be undertaken and used as 
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justification of the relevancy of the experimental approach used in future 
toxicological investigations undertaken. 
4.3.84 In addition, a specific consideration in relation to metal nanomaterials is 
determination of whether any toxicity observed derives from their small size, is 
mediated through the release of ions from particles, or perhaps a combination of 
both. Elucidation of this is essential for the hazard characterisation of metal 
nanoparticles within the context of REACH 
4.3.85 Target Organ Toxicity considerations  
4.3.86 At the current time, there is a paucity of data relating to the systemic transfer of 
particles following exposure via the lungs, skin and gut, and this should be a focus 
of future experiments. The benefit of this data is to indentify target organs which 
particles may preferentially transfer to and/or accumulate in. Such organs would 
therefore be identified for specific system/ organ toxicity studies (Appendix R.7.5-1). 
Studies have focused on dermal and pulmonary toxicity of particles and 
demonstrated the transfer of test nanoparticles in small amounts (~1-8%). However 
there is an absence of data on the consequences of exposure to the 
gastrointestinal tract, and within damaged/diseased skin. Once systemically 
available, target organs currently identified include the liver, kidney, cardiovascular 
system and brain. The effect of particle interaction with these organs requires 
further elucidation to establish if the small percentage of transfer is toxicologically 
significant and if repeat exposure leads to retention of particles within such organs/ 
systems resulting in a build up of dose.  
4.3.87 Due to the sensitivity of the system, the transfer of nanoparticles to the reproductive 
system, in particular the foetus should be considered a very high short term priority.  
4.3.88 Another interesting attribute which requires further investigation is which physico-
chemical parameters influence particle transfer rates and retention? In the study by 
Semmler-Behnke et al (2008) they demonstrated the importance of particle surface 
charge in particle transaction by demonstrating an increase in translocation to 8% 
of the instilled dose into the lungs.  
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4.3.89 Adoption of standardised ‘controls’ to assist assessment of toxicity  
4.3.90 The use of both nanoparticulate and non-particulate controls (such as carbon black 
or asbestos within CNT studies, or zymosan within inflammation studies) has been 
reported on numerous occasions. The choice of controls can, to some extent be 
driven by the hypothesis being tested (and links to determination of the physico-
chemical characteristics responsible for toxicity). The use of such benchmark 
controls (those for which extensive background information is available) provides a 
useful indication of the relative toxicity of the nanomaterial under investigation 
versus other particles or reagents of known toxicity (e.g. Warheit et al. 2004, 
Shvedova et al. 2005).  In addition, the use of comparative testing between nano 
and non-nano forms of a substance should be encouraged as this would provide 
high value, within study comparisons of different size forms which would help inform 
the feasibility and process of bulk to nano read-across. Thus, comparative testing 
and use of benchmarking controls could be encouraged for the hazard identification 
and characterisation of nanomaterials within the context of REACH. However this 
needs to be considered in relation to the need for extra control groups, thus 
requiring extra animals within testing regimes which may out weigh the potential 
benefits. As such the most appropriate use of benchmark controls could be within in 
vitro testing, including their use in the development of in vitro methods. This would 
provide a link and point of comparison between previous in vivo results using the 
benchmark material and the in vitro results using the benchmark material and the 
new test substance.  In relation to comparative testing, R&D which specifically 
addresses the issue of bulk and nano-form comparison should be undertaken to 
elucidate grounds for read across. 
4.3.91 Interference of nanomaterials with toxicity assays  
4.3.92 Nanomaterials have been on occasion found to interfere with several commonly 
used assays utilised to determine their cellular or toxic effects.  For example, some 
nanoparticles may contribute to the absorbance or fluorescence of colorimetric or 
fluorometric assays.  In addition, due to their large surface area, nanoparticles may 
bind to assay components including the substrates (such as CNT with the reagent 
in MTT assays; Belyanskaya et al. 2007) or the biomarker being measured, (such 
as LDH and cytokine proteins, see for example Davoren et al. 2007).   
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4.3.93 As the potential for inhibition or enhancement of the test result may impact on 
numerous test methods, some of which are known or suspected as outlined in 
RNC/RIP-oN2/2/B4/FINAL report Section 5 (e.g. OECD TG 431/EU B.40 Human 
Skin Model tests (EPISKIN™, EpiDerm™), and some may not be currently known. 
As such further R&D to ascertain potential grounds of inhibition/enhancement is 
required within this area so that test methods can be amended appropriately or 
recommendations made against their use within guidance in situations of confirmed 
reliability problems with nanomaterials. As a R&D requirement, a greater 
understanding of inhibition/enhancement could be considered a short term goal of 
high priority.  
4.3.94 ENDPOINT SPECIFIC R&D PRIORITIES 
4.3.95 As echoed in RNC/RIP-oN2/B1/2/FINAL paragraph 5.15, in the utilisation of 
inhalation exposure to (nano)particles and other substances it would be prudent to 
consider the utilisation of Bronchoalveolar Lavage (BAL) data as a standard 
practice in inhalation studies and possibly, a requirement. The justification of the 
usefulness of BAL in improving sensitivity of inhalation study results is given in the 
following paragraphs and the guidance alterations are outlined in the relevant 
sections of the following Guidance endpoint sections.  
4.3.96 BAL is a methodology developed to sample the cells of the airspaces of the lungs, 
the airways and alveoli, which allow monitoring of pathological processes that are 
occurring there. The normal population of the BAL are the cells that normally move 
around on the surface of the airspaces ingesting microbes and dust and turning 
over the fluids that line the airspaces.  This normal population is predominantly 
alveolar macrophages with a small population, normally less than 10% of 
lymphocytes and 1% polymorphonuclear leukocytes (PMN) in humans (Balbi et al., 
2007). This pattern of the normal cell population is much the same in rats and 
humans. Any damage or disease process that is ongoing in the lungs is reflected in 
a change in the cell population in the BAL, as immuno-inflammatory cells are 
recruited into the lungs and this cellular exudate appears in the air spaces. In 
general the more severe the damage or injury, the greater the cellular exudate and 
the greater is the change in the inflammatory cell population in the BAL and the 
deviation from normalcy in the BAL cell population. Thus in the most severe lung 
diseases in humans, acute respiratory distress syndrome (ARDS) or pneumonia for 
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example, the BAL is overwhelmed with neutrophils the defining cell of acute 
inflammation. In asthma or other immunopathology of the lung, eosinophils and 
lymphocytes can become prominent revealing the unique underlying role of the 
immune system. Along with cells the BAL fluid also contains a sample of the 
proteins and other biomolecules that are present in the airspaces and lining fluid. 
Thus extra information on the levels of exudated protein, cytokines, products of 
oxidative stress, cytoplasmatic enzymes indicative of membranolysis etc. can also 
be obtained, which illuminate the underlying cellular pathology. 
4.3.97 The use of BAL in particle toxicology (Henderson, 2006) is predicated on the 
understanding that BAL provides a quantitative index of the extent of lung damage 
and subsequent inflammation that arises in response to pulmonary deposition of 
dust. BAL is considered to be much more sensitive to early effects of particle-
induced injury, detecting the injury before an overt pathological change can be seen 
in histological sections of rat lungs or where changes are minimal making them 
impossible to quantify in sections. Practice and a huge number of published studies 
has shown that the lung injury caused by inhalation of a damaging dust follows a 
well defined course of developing inflammation that can be tracked in the BAL as 
increasing numbers of cells, the proportion of PMN and levels of inflammatory 
markers . In general the inflammation evident in the BAL profile undergoes a 
decline when the exposure ceases, although the most toxic dusts cause 
inflammation that persists after exposure ceases. Exposure to low toxicity dusts 
causes only a very slight change in the population in the BAL, typically increased 
numbers of macrophages and the accumulation of particle-laden macrophages in 
the airspaces. This is a normal ’physiological’ response and if the exposure to such 
a low toxicity dust is moderate then even long term exposure shows little other 
change in the BAL and little pathological change. If the exposure is to a more 
intrinsically toxic dust there is a more rapid change in the BAL with accumulation of 
PMN in the BAL even at low lung burdens of such a dust and accompanying 
pathological changes such as fibrosis in the long term.  
4.3.98 R7.3: Skin and Respiratory sensitisation 
4.3.99 There is currently no information requirement for respiratory sensitisation under 
REACH but the issue of respiratory sensitisation and associated health effects such 
as occupational asthma is substantial. Some nanomaterials have been shown to 
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produce allergic type inflammation in the lung (Cho et al. 2010) raising the question 
if certain forms of nanomaterials may be allergenic. The requirement to evaluate 
respiratory sensitisation is hampered by the availability of acceptable and validated 
test methods. Indeed current R.7a Guidance in relation to respiratory sensitisation 
states the “No in vitro tests specific for respiratory sensitisation are available yet, 
owing to the complexity of the mechanisms of the sensitisation process.”. Guidance 
also reports that whilst several in vivo test methods have been published, these are 
not yet validated or internationally accepted. Owing to the importance of potential 
respiratory sensitisation to human health, it would prudent to further develop assays 
for the detection of respiratory sensitisers so that respiratory sensitisation may 
become a future information requirement. This is important not just for 
nanomaterials, but also other substances.    
4.3.100 In addition the cytokine profiling of BAL obtained from exposed animals to detect a 
Th2 (allergic type) cytokine profile may allow the elucidation of respiratory 
sensitisation and shows again the usefulness of BAL. This would however require 
further R&D to ascertain its predictiveness for clinical manifestation of allergic 
disease.    
4.3.101 R7.4: Acute Toxicity  
4.3.102 Acute toxicity as an endpoint is used for both classification and labelling purposes 
as well as for a chemical safety assessment for acute exposure. This is also 
reflected in the recent OECD GD39 document which states that “acute inhalation 
toxicity data are used to satisfy hazard classification and labelling requirements, to 
estimate the toxicity of mixtures and to assess human health and environmental 
risks”.  The use of simple lethality is a blunt measure of negative effects and is 
unsuitable for the derivation of accurate human exposure limits. Indeed, as 
mentioned within the R.8 guidance for the derivation of human derived no effect 
levels (DNEL), where no NOAEL is apparent, e.g. use of LD50 or LC50 data, then a 
much higher assessment factor should be applied. The limitation of acute toxicity 
measurements is to such a blunt endpoint is not necessary and guidance states 
that in relation to CSA, information on acute toxicity is not normally limited to 
availability of LD50 or LC50 value. Specifically it suggests clinical signs of toxicity, 
local irritant effects time of onset and reversibility of the toxic effects. These are 
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attributes that could not be evaluated using lethality and body weight would be of 
only limited use.  
4.3.103 The following include alterations to the current standard test methods to improve 
sensitivity and allow for nano-relevant routes of exposure. As such these would 
require a change to the guidance suggested test method, but not to the Guidance 
document itself.  
4.3.104 The use of gross necropsy is an insensitive method of establishing pathogenic 
effects as it would only reveal effects manifesting in surface changes visible to the 
naked eye. Therefore using only grass pathology would not indentify potentially 
serious pathogenic effects such as large scale cell death, internal organ 
haemorrhaging (not visible that the organ surface) and test substance/ inflammatory 
cells accumulation within an organ. As a result we would propose that the following 
test methods be updated to include a more extensive evaluation of the pathogenic 
effects via the use of extended pathology / histology (ENVJM MONO 2009/21) of 
the internal organs, over and above the currently required gross pathology: 
 Acute toxicity: Oral - OECD TG 420 (EU B.1 bis) (Acute oral toxicity – 
Fixed dose procedure) 
 Acute toxicity: Oral - OECD TG 423 (EU B.1 tris) (Acute oral toxicity – 
Acute toxic class method) 
 Acute toxicity: Oral - OECD TG 425 (Acute oral toxicity – Up-and-down 
procedure) 
4.3.105 As discussed in paragraphs 5.2.18 to 5.2.20, the use of BAL aides in the 
toxicological evaluation of (nano)particles as well as other substances by providing a 
quantitative index of the extent of lung damage and subsequent inflammation that 
arises in response to pulmonary exposure top attest substance or (nano)particle. . 
Such a quantitative index of sub-lethal effects would allow the derivation of no effect 
levels which can be more easily and confidently used within a CSA for hazard 
assessment and the derivation of acute human exposure limits. BAL is considered to 
be much more sensitive to early effects of particle-induced injury, detecting the injury 
before an overt pathological change can be seen in histological sections of rat lungs 
or where changes are minimal making them impossible to quantify in sections. It is 
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not suggested that BAL is performed on live animals as this is associated with welfare 
issues and within the toxicological literature is more commonly performed on 
euthanized animals at the cessation of the experiment/ timepoint to detect pathogenic 
effects (e.g. Pauluhn 2010). The use of BAL is considered an enhancement of current 
test procedures and does not nesecariliy constitute the use of extra groups of 
animals. Indeed rather than the superficial analysis of body weight and/ or gross 
necropsy, the dead animal would also be subject to BAL and analysis of the BAL fluid 
so that more information may be gleaned from the animal thereby maximising its use 
within an experiment. The use of such non-lethal endpoints such as lung 
inflammation detected by BAL is also extolled within the recent OECD GD39 
document concerning acute toxicity which states that “the non-lethal endpoints at the 
lower end of the concentration response curve might be just as useful as lethal 
endpoints”. The benefits of the use of BAL to improve the usefulness of experimental 
data and maximise the use of experimental animals very apparent. BAL is also 
commonly used within those inhalation studies using nanomaterials reported within 
the peer review literature including for acute toxicity (Ellinger-Ziegelbauer, 2009). 
4.3.106 Because of the relative benefits of BAL, and as recommended use within the 
RNC/RIP-oN2/B1/2/FINAL paragraph 5.15. we propose the incorporation of BAL as 
standard into the following acute toxicity test methods: 
 OECD TG 403 (EU B.2) (Acute inhalation toxicity) 
 Draft OECD TG 433 (“Acute Inhalation Toxicity, Fixed Dose 
Procedure”) 
 Draft OECD TG 436 (“Acute Inhalation Toxicity, Acute Toxic Class 
Method”) 
4.3.107 R7.5 - Repeated Dose Toxicity 
4.3.108 We propose the incorporation of BAL as standard into the following acute toxicity 
test methods: 
 Repeated Dose: Inhalation - OECD TG 412 / EU B.8 Subacute 
Inhalation Toxicity: 28-Day Study 
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 Repeated Dose: Inhalation - OECD TG 413/EU B.29 Subchronic 
Inhalation Toxicity: 90-day Study 
 Repeated Dose: Inhalation - OECD TG 422: Combined repeated dose 
toxicity / reproductive screening study 
4.3.109 Inhalation is thought to be the most likely route of nanoparticle exposure, however 
methodology for the use of inhalation exposure for this method appears to be 
lacking. We recommend following the advice of the OECD WPMN as stared in 
RNC/RIP-oN2/B1/2/FINAL that the following methodology should be amended to 
include an appropriate OECD standard inhalation exposure protocol in combination 
with the reproductive & developmental toxicity screening endpoint. 
 Neurotoxicity - OECD TG 424 (rodents) 
4.3.110 Reproductive Toxicity (relevance to R.7.6 reproductive and developmental 
toxicity, and R.7.5 repeated dose toxicity) 
4.3.111 We recommend following the advice of the OECD WPMN as stared in RNC/RIP-
oN2/B1/2/FINAL that the following methodology should be amended to include an 
appropriate OECD standard inhalation exposure protocol in combination with the 
reproductive & developmental toxicity screening endpoint. 
 Reproductive and developmental toxicity - OECD TG 422: Combined 
repeated dose toxicity / reproductive screening study 
4.3.112 In relation to reproductive effects of nanomaterials, there exist three in vitro tests 
which, following further research and development to investigate their suitability for 
use as assays for nanomaterials , might together offer a route by which to reduce 
and refine the use of animals within reproductive toxicity testing. These are:  
 the embryonic stem cell test for embryotoxicity (EST), 
 the micromass embryotoxicity assay, and 
 the whole rat embryo embryotoxicity assay. 
4.3.113 The EST uses two cell lines (mouse embryonic stem cells (ES) and mouse 3T3 
fibroblast cells) and three endpoints (inhibition of differentiation of the ES cells, 
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inhibition of ES and 3T3 cell viability, and inhibition of ES and 3T3 cell proliferation) 
to classify the embryotoxic potential of test chemicals. 
4.3.114 The micromass test evaluates effects of a test substance on the differentiation and 
growth of micromass cultures of rat limb bud. Limb bud cultures provide a model 
which represents various developmental processes in cartilage histogenesis such 
as cell to cell communication, cell proliferation and cell differentiation.  
4.3.115 The whole rat embryo culture uses isolated and cultured early post-implantation rat 
embryos to study embryotoxic effects of chemicals on cultured embryos. 
Comparison of controls and chemical exposed cultures over a 48-hour period 
allows assessment of delays or malformation during the development of certain 
organ systems. 
4.3.116 All three assays have undergone and passed ECVAM validation (ECVAM, 2002). 
For the embryonic stem cell test (EST), the accuracy of correlation between in vitro 
and in vivo data was 78%. For the micromass embryotoxicity assay, in vitro to in 
vivo correlation was 70%; and for the whole rat embryo embryotoxicity assay, 
correlation was 80%. Following conduction of formal validation studies by ECVAM, 
all three were deemed to be “scientifically validated tests which were ready to be 
considered for regulatory purposes” by ECVAM’s Scientific Advisory Committee 
(ECVAM, 2002). 
4.3.117 There exists limited evidence of research into the applicability of these tests to 
nanomaterials to date. However, with relation to the EST, paragraph 3.2.70 of the 
RNC/RIP-oN2/B3/2/FINAL report states that Park et al. (2009) suggested that in 
vitro embryonic stem cell differentiation test may be a valuable tool to test 
embryotoxicity of nanomaterials. 
4.3.118 Thus, it is considered that following further research and development to investigate 
the applicability of the assays to testing for nanotoxicology, the three tests may offer 
a route by which to reduce and refine the use of animals within reproductive toxicity 
testing. 
4.3.119 Inflammation & cytotoxicity (with relevance to R.7.2 Skin and eye irritation/ 
corrosion and respiratory irritation, R.7.3 Skin and respiratory sensitisation, R.7.4 
acute toxicity, and R.7.5 repeated dose toxicity)   
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4.3.120 The use of assays to detect markers of inflammation, fibrosis and cytotoxicity 
provide valuable tools to improve current test methods to detect the effects of 
nanoparticle exposure. This has value in both improving the sensitivity by detecting 
sub-clinical changes and generating mechanistic information which can inform the 
potential for disease outcomes which would further improve risk assessment. 
Current test methods are focused towards clinical pathology with a modest range of 
clinical chemistry markers, few of which inform as the level or type of inflammation 
or sub-clinical fibrosis and as such could be seen as relatively insensitive method of 
establishing pathogenic effects of nanoparticles. The use of markers of cytotoxicity, 
(such as lactate dehydrogenase release (LDH)), inflammation (cytokines and 
chemokines) and fibrosis have been long used in the research community as a 
sensitive way if establishing effects, have also been extensively used 
nanotoxicological research and are frequently discussed throughout the RNC/RIP-
oN2/B3/2/FINAL report and within large scale EU funded studies (e.g. NanoKem, 
paragraph 3.2.133).   
4.3.121 An example is the use of cytokine and chemokine measurements in samples 
obtained from testing subjects either from primary target organs (e.g. the lung via 
BAL fluid) or from the circulation. A cytokine/chemokine profile provides information 
both as to the intensity and type of inflammatory reaction generated by exposure to 
a test substance which is very relevant for nanomaterials (hence inclusion herein) 
and other substances. For example, profiling can indicate the polarisation towards a 
TH1 (cell-mediated) pro-inflammatory response or TH2 (humoral immunity) type 
response which can indicate allergy/ sensitisation. 
4.3.122 Therefore the use of such an array type approach to inform as to what is occurring 
at the cellular level can actually inform of the scale and type of a response. This 
may mean potentially greater information can be obtained from a single experiment 
which could result in the need for fewer test protocols (and hence animals used) 
through the merging of experimental approaches. For example a repeated dose 
inhalation study may also inform as to the generation of respiratory sensitization. 
This is an example of maximising the information gleaned from a single animal 
leading to the reduction and refinement of animal testing.   
4.3.123 The use of such assays as cytokine/ chemokine measurements, cytotoxicity and 
markers of pro-fibrogenic effects can be used both with in vitro and in vivo analysis 
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and provide a useful point of comparison between such systems. The dual use at 
this stage of R&D would go some way to developing a comparative knowledge 
base that may allow a reduction or replacement of animal testing, and is an 
approach taken within the NanoCare project discussed in RNC/RIP-
oN2/B3/2/FINAL report paragraph 3.2.30. As such when considering alterations to 
guidance and identification of areas requiring further development for testing 
nanomaterials, it seems prudent to put in place steps (via further R&D) towards the 
ultimate goal of a reduction in animal testing for both nanomaterials and other 
substances as the range of in vitro alternatives to in vivo testing is current deficient 
in guidance for all substances.  
4.3.124 In addition when conducting testing, including comparative testing between in vitro 
and in vivo as well as between materials (e.g. bulk and nano) there should be a 
consideration of appropriate metric. The consideration of metric should be based on 
the driving effect of toxicity (the biologically effective dose) and may be different 
depending on the chemistry, shape and form of the material in question. Ideally 
several metrics could be considered and measured to allow generated data to be 
expressed in different ways to ascertain which is the most appropriate.      
4.3.125 Those assays which provide useful points of comparison or improve the sensitivity 
of current clinical-chemistry performed during testing are highlighted as priority 
areas for the short/medium term. Those assays which inform more towards the 
mechanistic basis of understanding the pathogenic effects are seen as a lower 
priority (*) and could be considered as long-term research targets. The reasoning 
and approach discussed herein are equally applicable to the subsequent test assay 
sections     
 Pro-Inflammatory effects in vitro/ vivo – Cytokine, chemokine and their 
receptor expression and transcription e.g. IL-8, GRO, TNF-α, IL-1β 
 Pro-fibrogenic effects in vitro/ vivo – Pro-fibrotic mediators e.g. TGF-β ,  IL-6, 
IL-10, EGF etc  
 Pro-fibrogenic effects in vivo – Histopathological examination e.g. using 
Collagen staining (e.g. Sirius Red, Trichrome) 
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 *Pro-Inflammatory effects in vitro - Cell signalling and Transcriptional 
activation e.g. AP1, NFkB, STAT, NRF2, MAP Kinase 
 *Pro-fibrogenic effects – Collagen production, type and biochemical 
modifications e.g. Hydroxyproline, pro-collagen peptides 
4.3.126 Cytotoxicity 
 Cytotoxicity - Propidium Iodide 
 Apoptosis - Annexin V 
 Cytotoxicty – LDH release 
 *Cytotoxicty – Neutral Red uptake 
 *Cytotoxicty - Trypan Blue 
4.3.127 Oxidative stress (of mechanistic value to R.7.2 Skin and eye irritation/ corrosion 
and respiratory irritation, R.7.4 acute toxicity, R.7.5 repeated dose toxicity as well 
as R.7.7 mutagenicity and carcinogenicity) 
4.3.128 The generation of oxidative stress can impact on numerous systems within the 
body and can arise through several mechanisms. These can include direct particle/ 
chemical production of oxidants, an inhibition of normal cellular process leading to 
an increase in intracellular oxidants/ decrease in intracellular antioxidants or 
through the stimulation of oxidant production by inflammatory cells though the 
generation of inflammation leading to a pro-oxidant environment (Schins 2002). The 
result of oxidative stress can be the activation of oxidant sensitive pro-inflammatory 
transcription factors such as nuclear factor kappa B (Rahman and MacNee 2000) 
leading to inflammation and direct genetic damage potentially leading to mutation 
and/or carcinogenesis. The use of assays both in vitro and in vivo can further 
improve the sensitivity of current biomarkers of adverse effects and point further 
inform as to other pathological effects (e.g. high levels of oxidative stress and 
antioxidant depletion could point towards an increased need for evaluation of 
mutagenicity and carcinogenicity). As the use of oxidative stress markers provides 
a more mechanistic understanding of the effects caused by nanoparticle exposure 
and is considered a driver of pathogenic effects, these could be considered as a 
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lower priority of the longer term which may inform hazard evaluation but may not 
currently be of overt use to risk assessment.   
 *Oxidative Stress: Antioxidant capacity - Glutathione Depletion (intra- and 
extra-cellular) 
 *Oxidative Stress: Redox sensitive dyes e.g. DCFH, DHE etc. 
 *Oxidative Stress: Antioxidant capacity - vitamin C depletion 
 *Oxidative Stress: Antioxidant capacity - TEAC (trolox equivalent anti-oxidant 
capacity) 
 *Oxidative Stress: Antioxidant capacity - ORAC (oxygen radical anti-oxidant 
capacity) 
 *Oxidative Stress: Antioxidant capacity – FRAP (Ferric/Reducing Antioxidant 
Power) 
 *Oxidative Stress: Antioxidant capacity – Mitochondrial dysfunction 
 *Oxidative Stress: Antioxidant capacity - Antioxidant gene/protein expression 
and transcription factors (HO-1 expression etc.) 
4.3.129 As expressed before, there should be a consideration of appropriate metric when 
developing and utilising test of oxidative stress. The consideration of metric should 
be based on the driving effect of toxicity (the biologically effective dose) and may be 
different depending on the chemistry, shape and form of the material in question. 
Ideally several metrics could be considered and measured to allow generated data 
to be expressed in different ways to ascertain which is the most appropriate. 
4.3.130 Genotoxicity 
4.3.131 The establishment of the genotoxic effects of particles is critical in understanding 
the long term implication of particle exposure. However, how these assays relate to 
actually presentation of carcinogenic effects (e.g. tumour formation) is still required 
and should be a focus of R&D in the short term. If found to be adequately predictive 
the development of standardised methods would be considered a further priority. 
The result would be an improvement in the current approach to generating 
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mutagenicity/ carcinogenicity data for which robust data is currently difficult and 
costly to obtain. In addition, the consideration of alterative metrics to mass should 
be made and ideally several metrics could be considered and measured to allow 
generated data to be expressed in different ways to ascertain which is the most 
appropriate. 
4.3.132 As such the following assays, commonly used with in the research community are 
suggested for further R&D:    
 Mutagenicity: Oxidative adducts of DNA e.g. 8-OH-dG (Khalil et al. 2011) 
 Mutagenicity: Lipid adducts e.g. N-1,N2 malondialdehyde-2'-
deoxyguanosine (M1dG) (Blair 2008) 
 *DNA Repair reporter assays: e.g. GreenScreen assay (Benton et al. 2008) 
4.3.133 Particle translocation 
4.3.134 At the current time, there is a paucity of data relating to the systemic transfer of 
particles following exposure via the lungs, skin and gut, and this should be a focus 
of future experiments. The benefit of this data is to indentify target organs which 
particles may preferentially transfer to and/or accumulate in. Such organs would 
therefore be identified for specific system/ organ toxicity studies (Appendix R.7.5-1). 
Studies have focused on dermal and pulmonary toxicity of particles and 
demonstrated in some cases the transfer of test nanoparticles in small amounts 
(~1-8%). However there is an absence of data on the consequences of exposure to 
the gastrointestinal tract, and within damaged/diseased skin. Once systemically 
available, target organs currently identified include the liver, kidney, cardiovascular 
system and brain. The effect of particle interaction with these organs requires 
further elucidation to establish if the small percentage of transfer is toxicologically 
significant and if repeated exposure leads to retention of particles within such 
organs/ systems resulting in a build up of dose.  
4.3.135 Due to the sensitivity of the system, the transfer of nanoparticles to the reproductive 
system, in particular the foetus should be considered a very high short term priority.  
4.3.136 Another interesting attribute which requires further investigation is which physico-
chemical parameters influence particle transfer rates and retention? In the study by 
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Semmler-Behnke et al (2008) they demonstrated the importance of particle surface 
charge in particle transaction by demonstrating an increase in translocation to 8% 
of the instilled dose into the lungs.  
4.3.137 In order to address the issue of nanoparticle toxicokinetics, there is the need to 
develop improved methods to detect particles so as to establish the likelihood and 
rate of particle transfer across a barrier and tissue accumulation. In particular 
improvements both in the sensitivity of test methods as well as ways in which to 
detect particles is needed especially for those which do not lend themselves to easy 
identification via detection of metal ions, radiolabels etc. Also as outlined in the 
RIVM nanosilver case study (Pronk et al. 2009), there are also issues with 
identifying if the detected substance is in particulate form, ionic form or both.  
4.3.138 Cardiovascular toxicity  
4.3.139 In terms of toxicological information, RIVM (2009) proposes the following base set 
information requirements for nanomaterials: toxicokinetic testing; repeated dose 
toxicity testing for the inhalation route (or other routes, depending on the anticipated 
exposure routes), preferably with inclusion of additional parameters to the standard 
repeated dose toxicity study, such as cardiovascular and/or inflammatory 
parameters. 
4.3.140 One endpoint specifically identified as an additional endpoint, albeit subordinate to 
the repeat dose toxicity Information Requirement, is cardiovascular toxicity.  
4.3.141 An overview of the rationale for acknowledging this endpoint in updated guidance is 
provided. 
4.3.142 Within the repeated dose toxicity information requirement (R.7.5) there are 
guidance and requirements for different levels of histopathology and haematological 
analysis with differing exposure periods. However, only analysis of the gross 
pathology of the heart is performed and specifically addresses the cardiovascular 
system, As such it would not detect such cardiovascular disease as atherosclerosis, 
indeed atherogenic effects are not demonstrated in standard laboratory strain 
rodents and are usually only shown in transgenic apolopoprotein E knockout mice 
which, in relation to the presence of atherosclerotic plaques more accurately reflect 
the normal human condition. Within appendix (1) to R.7.5 there is some information 
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as to the testing strategy for specific system/ organ toxicity. However this does not 
specifically specify the cardiovascular system as a target. Instead the guidance 
states “Specific investigation (or further investigation) of any organ/system toxicity 
(e.g. immune, endocrine or nervous system) may sometimes be necessary and 
should be addressed on a case- by-case basis.”  
4.3.143 However there exists robust information to suggest that the cardiovascular system 
is a particular target of concern for (nano)particles. Indeed much of this evidence 
stems from robust epidemiological studies and other experimental studies, 
highlighting the link between air pollution (e.g. PM10, PM2.5 ) and adverse 
cardiovascular effects. Among the various components of air pollution, particulate 
matter (PM) has been reported as the main driver of harmful effects on health. 
Increases in the air concentration of particles with an aerodynamic diameter of less 
than 10 μm (PM10) are clearly related to more adverse cardiovascular effects (Mills 
et al. 2009). Notably, epidemiological studies reported the relationship between 
increased mortality from cardiac disease and particulate pollution, even at a very 
low mass concentration (Pope et al. 1992, Schwartz 1994). Inhalation studies have 
demonstrated that nanoparticles are inhaled and retained in the lungs (Ferin et al. 
1992). This led to the development of the “ultrafine hypothesis” which highlighted 
the role of nanoparticles in the health effects of air pollution.  
4.3.144 The hypotheses relating to cardiovascular effects of PM in general, and thought to 
be particularly relevant to nanoparticles, have been summarised by Donaldson et 
al. (2005) and are shown in the following: 
4.3.145 1) Particle-induced lung inflammation affects the endothelium, thrombotic 
potential, fibrinolytic balance and atheromatous plaque activity in ways that 
favour plaque rupture and thrombosis;  
4.3.146 2) Particles enter the interstitium and/or cause inflammation which affects the 
autonomic nerve endings that regulate the heart rhythm leading to 
dysrhythmia;  
4.3.147 3) Particles translocate to the blood and have direct effects on the endothelium, 
plaques and thrombogenic mechanism.  
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4.3.148 Thus it is suggested that (nano)particles may generate cardiovascular effects either 
via systemic release of non-particle mediators generated as a result of 
(nano)particle exposure, interaction with the autonomic nervous system, or with 
direct interaction with components of the cardiovascular system itself due to particle 
transfer in the blood stream.   
4.3.149 In various models nanoparticles are shown to be highly potent in these three areas 
of effect i.e. certain nanoparticles can be very potent at causing inflammation, some 
interstitialise readily and also it has been demonstrated that some can gain access 
to the blood (although in small amounts but the level of translocation required to 
cause an effect has not been established). For these reasons combustion derived 
nanoparticles, the principal nanoparticle in ambient air, are implicated in the 
cardiovascular effects of PM in these studies. 
4.3.150 Whilst further epidemiological studies are required in order to validate this theory, 
there is an increasing weight of evidence to support this hypothesis but research is 
required to ascertain if nanoparticles are indeed to the crucial driver behind PM 
cardiovascular effects. It has been demonstrated in humans that a good correlation 
exists between an increase in PM2.5 and increased cardiovascular mortality and 
morbidity (Miller et al. 2007). Indeed, it has also been suggested that particle 
number is a better metric to correlate with the risk of heart attack (Seaton et al. 
2010). Moreover, numerous studies are strengthening this proposal by studying the 
potential mechanisms by which nanoparticles could affect the cardiovascular 
system.  
4.3.151 Applying such a theory of cardiovascular toxicity to nanomaterials, in vivo studies 
have suggested that exposure to CNT could be associated with vascular damage & 
pro-thrombic responses (Radomski et al. 2005). Wang et al, (2007) identified 
markers of cardiac damage following oral administration of TiO2 nanoparticles. 
4.3.152  A number of in vitro investigations have also suggested that nanoparticles have the 
propensity to stimulate cardiovascular disease. For example, Randomski et al. 
(2005) showed the CNT were capable of promoting platelet aggregation in vitro, 
and Helfenstein et al. (2008) demonstrated that SWCNT and TiO2 were capable of 
promoting an inflammatory response in cardiac cells. Metal oxides have also been 
shown to detrimentally affect endothelial function, negatively impact on 
cardiomyocyte function (Courtois et al, 2008), disturb normal cardiac 
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electrophysiology, enhance, and promote an inflammatory response in blood 
vessels (Oesterling et al, 2008).  
4.3.153 In animal models such as apolopoprotein E knockout mice, it was suggested that 
the ultrafine component of PM2.5 had more pro-atherogenic effects than its fine 
component compared to control, promoting plaque growth and destabilization 
(Araujo JA et al. 2008). Disruption of atherosclerotic plaque leads to thrombus 
formation (atherothrombosis) and the risk of acute ischaemic events such 
myocardial infarction. Atherothrombosis is the main cause of cardiovascular death. 
It has been suggested that nanomaterials could have pro-thrombotic properties via 
various mechanisms such as increased expression of tissue factor and 
accumulation of fibrin and platelets on the endothelium creating a pro-thrombotic 
environment. Moreover, it has been suggested that exposure to PM could alter the 
vasomotor proprieties of the vascular system (for review see Mills et al. 2009).  
4.3.154 Thus, to ascertain whether the cardiovascular system may be a specific target for 
toxicity further R&D is required. As outlined above, several studies have been 
conducted as to the cardiovascular effects of nanoparticles administered by indirect 
routes (e.g. via inhalatory or oral routes) but a large number of studies are 
conducted using direct intravenous routes of exposure. Such a route of exposure is 
of little value in the REACH regulatory context for risk assessment. However it may 
offer some mechanistic information as to the effect of blood borne nanoparticles, 
although the dose of particles in the blood arising from IV injection compared to the 
one via translocation is likely to be several orders of magnitude higher.  
4.3.155 Due to the prominent link between particle exposure in the form of air pollution 
(particularly from combustion generated nanoparticles) and adverse cardiovascular 
effects, it seems pertinent to ascertain if nanoparticles can cause or exacerbate 
cardiovascular effects. Further research into establishing and understanding the 
contribution that particle exposure has to cardiovascular disease, including if such 
effects are threshold or non threshold in nature, is seen as a priority which should 
be addressed within the short/ medium term.  In addition, consideration to the 
driving metric should be made so that test and exposure data can be expressed in 
the most appropriate and useful way.  In order to protect human health, appropriate 
test methods that are sufficiently sensitive and predictive need to be established 
and developed within a frame that ensures that they are standardised and 
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internationally recognised. Whilst tests systems are in development for research 
purposes and mechanistic evaluation, these are not yet suitable for regulation. The 
development of suitable regulatory test methods could be judged as a medium term 
priority.   
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4.3.156 ECOTOXICOLOGICAL ENDPOINTS & TESTING 
4.3.157 The importance of sample preparation and characterisation in conducting 
ecotoxicological tests and the potential impact this may have on the reliability of test 
data is universally acknowledged within the project consortium. In doing so, we have 
proposed amendments to the guidance document at the relevant junctures directing 
registrants to the relevant section on sample preparation for consideration of a 
range of issues such as dispersibility/ solubility, aggregation/agglomeration state, 
characterisation of actual test concentration during exposure etc. The impact of such 
issues is considered further more generally followed by more specific issues. It 
should be noted that whilst the consortium does agree that a consideration must be 
made of the issues surrounding sample preparation and measurement, there is not 
consensus on the effect this may have on the suitability of the tests list 
subsequently.     
4.3.158 GENERAL CONSIDERATIONS  
4.3.159 Aquatic testing 
4.3.160 Water solubility is an essential parameter in ecotoxicological testing and data 
should be available prior to any aquatic effects testing. Failure to do so could result 
in testing above the solubility limit leading to misinterpretation of the results. Poorly 
soluble substances are defined by OECD (2000) as substances with a limit of 
solubility <100 mg/L although technical problems are more likely to occur at 
<1mg/L. Based on the summary of difficult substance testing issues provided in the 
guidance (i.e. Table 7.8-3) the following issues are relevant in regard to 
nanomaterials and need to be explored further:  
1. Even if nanomaterials are put into suspension, it may be difficult to 
maintain and verify concentrations due to problems in developing an 
analytical method – such methods should be developed and be put in place 
to allow analysis;  
2. Many nanomaterials are likely to be lost from the water column and hence 
results expressed in terms of nominal concentration might exceed the true 
concentration of the substance in the test medium – a better understanding 
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of nanomaterials aggregation/agglomeration, dispersibility and 
sedimentation is needed and methods to verify this need to be developed;  
3. Many nanomaterials have low water-solubility and physical effects (e.g. 
entrapment) may occur if the test concentration is significantly above water 
solubility which again influences the ecotoxicity of the nanomaterials tested 
– a better understanding of the mechanisms behind entrapment and 
physical effect is needed as well as methods to verify such effects need to 
be developed; and  
4. Nanomaterials can be highly hydrophobic and insufficient test duration 
might lead to non-steady state conditions, and effectiveness of aquatic 
tests needs to be explored further and validated. 
4.3.161 These issues are important and should be addressed within ecotoxicology studies 
by verifying exposure concentration over time which may require the further 
development and implementation of methods and analysis to allow.  
4.3.162 Soil testing  
4.3.163 In regard to soil ecotoxicity studies there is a fundamental need for an analytical 
method capable of verifying the actual exposure concentration in the soil and over 
time. There is also a need to develop an analytical method to verify nanomaterial 
concentrations, aggregations/agglomeration behaviour and stability of 
nanomaterials in soil. The applicability of soil tests for nanomaterials needs to be 
explored further and validated.  
4.3.164 ENDPOINT SPECIFIC R&D PRIORITIES 
4.3.165 In relation to the general issues above, the view of part of the project consortium 
was that further R&D should be conducted in relation to the following tests to 
validate them for nanomaterials. Furthermore, it was also concluded that there is a 
need for the development of an analytical methods to verify nanomaterial 
concentrations, aggregations/agglomeration behaviour and stability of 
nanomaterials in a range of environments including aquatic and soils.  
4.3.166 R.7.8.4.1 Data on aquatic pelagic toxicity  
 Growth inhibition study aquatic plants (algae preferred)  
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 Short-term toxicity testing on invertebrates (preferred species Daphnia)  
 Long-term toxicity testing on invertebrates (preferred species Daphnia), 
(unless already provided as part of Annex VII requirements)  
 Short-term toxicity testing on fish 
 Long-term toxicity testing on fish, (unless already provided as part of 
Annex VIII requirements)  
 Fish early-life stage (FELS) toxicity test 
 Fish short-term toxicity test on embryo and sac-fry stages 
 Fish, juvenile growth test 
 
4.3.167 R.7.8.9.1 Laboratory data on toxicity to sediment organisms  
 Long-term toxicity to sediment organisms  
4.3.168 R.7.8.15 Information requirements for toxicity to STP microorganisms  
 Activated sludge respiration inhibition testing  
4.3.169 R.7.9.2.1 Annex VII (Registration tonnage >1 t/y -<10 t/y)  
 Ready biodegradability  
4.3.170 R.9.2.2 Annex VIII (Registration tonnage ≥ 10 t/y)  
 Hydrolysis as a function of pH  
4.3.171 R.7.10.3.1 Laboratory data on aquatic bioaccumulation 
 Bioaccumulation in aquatic species, preferably fish  
4.3.172 It should be noted that OECD 305 is currently under revision in order to include 
dietary route of exposure and hence it might be worthwhile to consider the dietary 
exposure route against water exposure. 
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4.3.173 R.7.10.16.1 Laboratory data on avian toxicity 
 Long-term or reproductive toxicity to birds 
4.3.174 R.7.11.3.1 Laboratory data  
 Effects on soil micro-organisms  
 Soil short-term toxicity to invertebrates  
 Long-term toxicity testing on soil invertebrates, unless already provided as 
part of Annex IX requirements  
 Short-term toxicity to plants  
 Long-term toxicity testing on plants, unless already provided as part of 
Annex IX requirements  
4.3.175 This however is not universally acknowledged within the consortium as the request 
for updates of existing OECD testing guidance is not completely inline with the 
preliminary conclusion by OECD WPMN. Their conclusions state that many of the 
OECD testing guidance in their current wording is applicable with the reinforced 
statement that attention needs to be given to measuring, dosing, delivery and 
tracking of the substance in the testing system.   
4.3.176 The importance of issues surrounding sample preparation, characterisation and 
dosimetry are agreed upon within the consortium. In line with the conclusions of 
OECD WPMN (ENV/JM/MONO(2009)21, it is recognised that there is a need for a 
guidance document(s) for sample preparation and dosimetry which the OECD 
WPMN feel should be independent from the existing OECD guidance documents 
perhaps rather than update each guidance document separately.  
4.3.177 Additional Relevant Specific Intrinsic Properties 
4.3.178 There exists debate within the project consortium as to the usability and applicability 
of a range of potential additional endpoints and biological markers of toxicity 
identified within the RNC/RIP-oN2/B2/2/FINAL (paragraphs 5.4.1 to 5.4.7) and 
RNC/RIP-oN2/B3/2/FINAL (paragraphs 4.3.7 to 4.3.13) reports. These additional 
endpoints/ markers areas follows:  
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4.3.179 R.7.8.4.1 Data on aquatic pelagic toxicity  
 Fish ventilation rate 
 Fish gill pathologies 
 Fish Mucus secretion 
 Fish brain pathology 
 Animal behaviour 
 Oxidative stress fish (CAT, SOD, GPX, GST)  
 *Daphnia heart rate 
 *Daphnia hopping frequency 
 *Number of cycles per minute of daphnia in appendage movement  
 *Trojan horse effect of nanomaterials 
4.3.180 In support of these proposed endpoints it was noted in the review of the literature 
that a number of new significant effects for nanomaterials have been observed in 
e.g. fish (see Smith et al. (2007) and Federici et al. (2007) reviewed in RNC/RIP-
ON2/B3/2/FINAL section 4.3.7-4.3.13 and Stone 2009). On the basis of these 
findings, candidate endpoints considered include ventilation rate, gill pathologies, 
mucus secretion, brain and gill Zn and Cu, Na+K+-ATPase activity, behavioural 
changes, and changes in the brain.  These may provide additional information 
requirements not currently in Technical Guidance Documents and aid the 
assessment of a nanomaterial’s ecotoxicity. Although standardised guidance 
documents are not available from the OECD or other international standardisation 
bodies, methods for establishing these endpoints have been available in the 
literature for some time (see Smith et al. 2007, Bouskill et al. 2006).   
4.3.181 A large number of studies on C60, TiO2, ZnO, and CdSe quantum dots in 
crustaceans and fish have reported observing increased and/or decreased activities 
of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD), 
glutathione peroxidase (GPX), and glutathione-S-transferase (GST) (Oberdörster 
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2004, Zhu et al. 2008, Wang et al. 2008, Klaper et al. 2009, Wong et al. 2010), 
which are associated with the defence system to oxidative stress (Klaper et al. 2009, 
Kim et al. 2010).  Collectively, this suggests that the use of such biochemical 
biomarkers for oxidative stress may provide useful data for predicting the ecotoxicity 
of nanomaterials, although generic applicability across all species has yet to be 
established. Although standardised guidance documents are not available from the 
OECD or other international standardisation bodies, methods for establishing these 
endpoints have again been available in the literature for some time.    
4.3.182 In relation to the ‘Trojan horse effect’ of nanomaterials, there are indications that 
nanomaterials increase both the toxicity and the bioaccumulation potential of known 
environmental pollutants in comparison with "bulk" materials and with suspected 
important differences between nano and non-nano and with insufficient evidence 
basis for guidance to be provided (RNC/RIP-ON2/B3/2/FINAL (paras 4.3.51 to 
4.3.57, 4.3.96 to 4.3.98). Reported effects as well as the development of test 
methods need to be explored further and validated as a mid-term priority. 
Development of an analytical method to verify nanomaterial concentrations, 
aggregations/agglomeration behaviour and stability of nanomaterials in water is 
furthermore needed as well as exploration of the feasibility of using this endpoint in 
regulatory guidance.  
4.3.183 The opposing position regarding the use of these endpoints/ biomarkers is based 
within the conclusions of the RNC/RIP-ON2/B1/2/FINAL report (para 6.42) which 
concluded that it is currently premature due to significant lack of scientific 
justification for the relevance of these endpoints, to include them in a regulatory 
context. Therefore, further research is needed to develop reliable methods and 
understanding of these endpoints but not only for nanomaterials but also for 
substances in general. It is also important to remember that according to the current 
assessment of the adverse effects on the environment. Individuals are not studied 
but populations. Some of these endpoints impose a paradigm shift in this respect 
which demand a significant increase in knowledge before such can be included in 
guidance for industry in how to fulfil legal obligations. However, the relevance of 
these parameters for regulatory purposes is questionable nor should it be raised as 
a nano-specific issue. This is an animal test for research purposes and is 
inconsequential for regulatory purposes. 
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4.3.184 Despite the opposing opinions in relation to these identified new endpoints and 
biomarkers, it is noted by the project consortium as a whole that whilst there is 
evidence of the use of these endpoints within the literature, before definitive 
conclusions can be proposed, further R&D is required. Specifically the applicability 
of these endpoints for nanomaterials needs to be explored further and validated as 
well as exploration of the feasibility of using this endpoint in regulatory guidance. In 
addition, further R&D is required for the development of international standards that 
could support regulatory guidance and in addition there is a need to develop 
analytical methods to verify nanomaterial concentrations, 
aggregations/agglomeration behaviour and stability of nanomaterials in water.   
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